2023 Annual Report and 2024 Proxy Statement
2023 Annual Report and 2024 Proxy Statement
2023 Annual Report and 2024 Proxy Statement
4
CEO Letter
Our Culture
Disruption is a battleground. It changes business models. It reshapes value propositions. It renames winners and
losers. It’s exciting for the underserved who have a chance to gain from new constructs. And it’s terrifying for
the incumbents who are likely to lose power and value. Understanding these emotional dynamics – and how to
manage through them – is an important part of our journey.
Lumen is playing to win. We are building leadership at every level of this company. We are building a
courageous culture that supports our operating principles of team, trust, and transparency. We are building
deeper relationships inside Lumen and across our industry ecosystem. That’s why we are training our people to
have tough conversations, to build emotional resilience, and to navigate the emotional complexities of our
business transformation.
We are seeing a return on our skills building investment with greater employee engagement, lower attrition,
and a fundamental positive shift in how we work. Additionally, we have been recognized eight times in the past
few months with various industry culture awards.
Finally, a significant part of our culture is focused on giving back to the communities we serve. I’m particularly
passionate about leveraging Lumen’s most valuable asset – our fiber network – to ensure that every person in
the United States has access to broadband. With telehealth and a rapidly digitizing education system,
broadband is quickly becoming critical infrastructure. Lumen is committed to building public-private
partnerships to ensure we do our part to ensure digital inclusion for all.
Closing
Overall, we made significant and meaningful progress in 2023, and while we have more work ahead,
I’m confident in our ability to deliver the results you expect and deserve.
As we move forward in 2024, we are optimistic about our future. We have a clear and compelling strategy, a
strong and focused execution plan, and a talented and engaged team. We are well positioned to capitalize on
the massive opportunities emerging in the digital economy, and to create long-term value for our customers
and shareholders.
On behalf of the Board of Directors and the Lumen management team, I want to thank you for your continued
support and confidence in Lumen Technologies. This was a pivotal year for our company, and we appreciate
your trust as we continue to transform Lumen and unleash the world’s digital potential.
Sincerely,
Kate Johnson
02 Governance ITEM 6 76
Advisory Vote on Executive
ITEM 1 19 Compensation – “Say-On-Pay”
Election of Directors
Compensation Discussion & Analysis 77
Board of Directors and Governance 20
Skills and Relevance to Lumen’s Strategy 20 SECTION ONE 78
Refreshment 21 Executive Summary
Recent Board Changes 21 Executive Summary 78
6
Table of Contents
Items of Business
ITEM 1 ITEM 2 ITEM 3
Elect the 11 Director nominees named Ratify the appointment of KPMG LLP Approve our 2024 Equity
in this proxy statement as our independent auditor for 2024 Incentive Plan
Vote FOR See page 19 Vote FOR See page 49 Vote FOR See page 53
Vote FOR
Vote FOR See page 62 See page 65 Vote FOR See page 76
A, B, and C
Transact other business that may properly come before the annual meeting
Proxy Voting
Shareholders are invited to attend the live virtual meeting. Even if you expect to attend, we urge you to vote in advance using
any of the following methods:
Your vote is important to us. We urge your participation.
8
About Lumen
Who We Are
We are a facilities-based technology and communications company that provides a broad array of
integrated products and services to our domestic and global business customers and our domestic mass
markets customers. We operate one of the world’s most interconnected networks. Our platform
empowers our customers to swiftly adjust digital programs to meet immediate demands, create
efficiencies, accelerate market access and reduce costs - allowing customers to rapidly evolve their IT
programs to address dynamic changes.
$1.8 170,000
billion EMEA Business On-Net buildings
Divestiture
(1)
All amounts are revenue.
See Appendix A for definitions of terms used above, a reconciliation of our non-GAAP metrics used above to
GAAP measures, and a description of our special items. For more complete information on Lumen and our
recent performance, see the remainder of this proxy statement, including Appendix B.
Our Value:
Our networking, edge cloud, collaboration and security solutions and managed services are designed to
elevate enterprise business performance and deliver the most user-friendly, intuitive and productive
technology environments.
Proactively invest in the Optimize sales and channel Digitize the customer, employee,
customer experience and productivity to perform at or and partner experience to drive
leverage key partnerships to above market growth rates, better connection across the
help customers modernize and simplify and automate Lumen’s business and cloudify the
migrate from legacy services to internal systems to drive network securely, seamlessly,
next-gen solutions. efficiency and a better customer and faster
and employee experience
10
About Lumen
ESG Highlights
We believe our strong Our platform and
corporate governance solutions are a gateway
principles and our to exploring
culture of teamwork, technological potential,
trust, and transparency enabling our customers
allow us to build trust
Building strong Unlocking to achieve amazing
and protect the governance sustainability things, and inspiring
interests of our and through and enabling others
company and to join our
our stakeholders.
transparency innovation sustainability journey.
SUSTAINABILITY HIGHLIGHTS
Commitment to ESG Double Materiality Award Highlights
Pay Equity Assessment
• U.S. News: 2024 Best Telecomms Companies to
Partnered with Syndio, Evaluated ESG impacts Work For
a workforce equity and opportunities. Top • Disability IN: 100 Disability Equality Index Best
analytics platform, to priorities included: (1) Places to Work For Disability Inclusion 2023
advance our pay equity Cybersecurity and data
goals and deepen our privacy, (2) Ethical • Newsweek: America’s Most Responsible
understanding of equity conduct (including tax), Companies 2024
issues in our workplace. and (3) Network • Human Rights Campaign Foundation Corporate
resilience and reliability. Equality Index 2023: perfect score of 100 for the
fifth year in a row
• FlexJobs: Top 100 companies to Watch for
Remote Jobs
• RippleMatch: 2024 Campus Forward Award Winner
12
About Lumen
Human Capital
Lumen’s ability to fulfill our purpose is dependent on the quality and capabilities of our people. Lumen’s highly
competitive business requires attracting, developing and retaining a motivated team that is inspired by
leadership, engaged in meaningful work, driven by growth opportunities and thriving in a culture that embraces
inclusion, diversity, equity, allyship and social impact (IDEAS).
• World-class talent acquisition programs:
– Recognized as one of the best places to work, see “Awards Highlights” on the prior page
– Flexible work schedules
– University Relations and recruiting programs
• Broad-based development for all of our employees:
– Wide variety of skills-building programs tailored to our workforce, including: M365 Copilot and trustworthy
AI training for our professional employees, cutting-edge Wi-Fi certification training for our technicians,
360-degree immersive experience and upskill training for our sales and customer experience employees
– Suite of leadership development courses
– Tuition reimbursement
– Tailored mentoring programs
• Commitment to our communities:
– Through our annual Campaign to Fight Hunger to support hunger relief efforts around the globe, employee
donations and a corporate match enabled us to provide over 472,599 meals for those in need in 2022.
– Our Employee Relief Fund, established in 2022, is able to provide immediate assistance to employees
following casualty events such as natural disasters or house fires.
– In support of STEM Education, Lumen partnered with organizations such as Pathways in Technology Early
College High School (P-TECH) to provide an innovative education opportunity to first-generation college-
seekers, English language learners, women and low-income students.
– By encouraging volunteerism year-round, and matching volunteer rewards from the Lumen Clarke M.
Williams Foundation, we donated to more than 3,800 nonprofits in our communities in 2023.
• Committed to IDEAS: Inclusion, Diversity, Equity, Allyship and Social Impact:
– Through our nine employee resource groups we provide support through career development, connection,
and a sense of belonging, empowering our employees to bring their whole selves to work every day.
– Sharpened our focus on pay equity through our strategic partnership with Syndio, a workforce analytics
platform, to advance our pay equity goals.
– Launched Allyship at work training for employees in the upper management of our Company.
• Committed to fostering a culture built on Teamwork, Trust, Transparency, Clarity, Customer Obsession,
Courage, Growth Mindset and Allyship:
– Shaping our culture by offering Brené Brown’s “Dare to Lead” training to all of our employees.
– Revamped our strategy and goal setting process across the Company with greater rigor, alignment
and transparency.
• Progressive employee benefits:
– Our benefits and enhancements recognize the diverse needs of our employees and their families and
include a comprehensive suite of offerings: core medical, prescription drug, dental, and vision benefits,
extended maternity and paternity leave, fertility benefits, gender-affirming and same sex/domestic partner
healthcare benefits, adoption benefits, survivor benefits, financial wellness, mental wellness, and
disability accommodations.
For additional information regarding our management of human capital, please see “Compensation Discussion &
Analysis – Section Five – HRCC Engagement and Compensation Governance”, and our Annual Report on Form
10-K for the year ended December 31, 2023.
Our Board collectively possesses a wide array of skills, experiences and perspectives that we believe strengthen
its ability to fulfill its oversight roles in creating and maintaining long-term sustainable shareholder value.
Each year, the Board reviews the skills necessary to effectively discharge its oversight responsibilities. We strive
to maintain a well-rounded and diverse Board. Below please find information about our nominees.
14
Proxy Voting Roadmap
Board Demographics
Diversity Age Tenure
Board Skills
Skills
Digital
Transformation 7/11 Finance 7/11 HR Leadership 4/11
ITEM 2
KPMG is an independent firm that provides us with significant industry and financial reporting expertise
at reasonable fees. The audit committee annually evaluates KPMG and determined that its retention
continues to be in the best interests of Lumen and its shareholders.
ITEM 3
Key terms of the 2024 Equity Incentive Plan (the “Plan”) are aligned with shareholder interests. Lumen
cannot make equity awards to employees beyond the remaining allotment under the previously
approved Second Amended and Restated 2018 Equity Incentive Plan, which we do not believe will be
sufficient for future grants. Approval of our 2024 Equity Incentive Plan is primarily designed to authorize
43 million shares for equity grants.
ITEM 4
Our Board is inviting shareholders to ratify our recently amended and restated NOL rights plan,
principally to extend the term of such plan from December 1, 2023 to December 1, 2026. Our NOL rights
plan, which we first adopted in 2019, is designed to safeguard our ability to use our NOLs to reduce
anticipated future tax liabilities. Previously at each of our 2019 and 2021 annual meetings of
shareholders, our shareholders ratified our NOL rights plan by approximately 90% of the votes cast.
16
Proxy Voting Roadmap
ITEM 5A
The Board is recommending that our shareholders grant the Board discretionary authority to amend our
Articles of Incorporation to effect a reverse stock split on the terms and conditions described herein (a
“Reverse Stock Split”). We are proposing that the Board have the discretion to select the Reverse Stock
Split ratio (the “Reverse Split Ratio”) from within a range between and including one-for-fifteen (1:15)
shares and one-for-twenty-five (1:25) shares, rather than proposing a specific fixed ratio at this time.
ITEM 5B
The Board is recommending that our shareholders approve an amendment to our Articles of
Incorporation to reduce the number of authorized shares of our common stock from 2,200,000,000 to
200,000,000, which would be effectuated if and only if Item 5A is both approved and implemented. We
have designed this Share Reduction Proposal so that we do not have what some shareholders might
view as an unreasonably large number of authorized Common Shares that are unissued or unreserved
for issuance following any Reverse Stock Split.
ITEM 5C
The Board is recommending that the shareholders approve an amendment to our Articles of
Incorporation to eliminate the $1.00 per share par value of our common stock so that each of our
Common Shares have no par value. The elimination of the par value of our common stock is intended to
bring the Company in line with the practice of other public companies with respect to par value.
ITEM 6
n Base Salary
As with most companies, base salary is annual fixed cash
compensation that provides competitively set and stable
income to our executives.
18
ITEM 1
Election of Directors
Lumen’s mission is to ignite business growth by connecting people, data, and applications - quickly,
securely, and effortlessly. We believe that strong corporate governance is key to achieving our mission.
Following the NCG Committee’s recommendation, the Board of Directors has nominated each of the
11 nominees below for a one-year term expiring at our 2025 annual meeting of shareholders, or until his
or her successor is duly elected and qualified. All of the nominees with the exception of James Fowler
and Diankha Linear were elected to the Board at the 2023 annual meeting.
To be elected, each of the 11 nominees must receive an affirmative vote of a majority of the votes cast in
the director’s election. Any director failing to receive a majority of votes cast must promptly tender his
or her resignation, which will be addressed by us in the manner described in our Bylaws.
Director Nominees
Quincy L. Allen Kevin P. Chilton T. Michael Glenn Diankha Linear
Martha Helena Bejar Steven T. “Terry” Clontz Kate Johnson Laurie Siegel
Peter C. Brown James Fowler Hal Stanley Jones
The Board unanimously recommends a vote FOR each of the above named nominees
for director.
20
Board of Directors and Governance
Refreshment
Board and committee refreshment are regularly reviewed by our NCG Committee. Our Board periodically
receives recommendations from the NCG Committee about possible changes designed to staff the Board and its
committees with individuals who have the skills, experiences and perspectives necessary to make meaningful
contributions to shaping and implementing Lumen’s business strategies. Given the significant change the
Company is undergoing, the NCG Committee has adopted an evergreen approach to board refreshment. As
such, the ongoing search for candidates whose skills are aligned to the evolving strategic direction of the
Company could result in the addition of new board members or the resignation of current board members prior
to next year’s annual meeting.
In 2023 and for our 2024 slate of nominees, the NCG Committee and Board considered a wide range of factors
in assessing the composition of the Board, including:
• shareholder input on important elements of Board composition;
• skill sets necessary to oversee the successful development and implementation of our business strategies,
including our continued evolution to a digital technology company offering a simpler and improved
customer experience;
• balancing fresh, diverse perspectives with institutional and industry knowledge;
• current and long-term needs of the Board; and
At the 2024 annual meeting, Michael Roberts, will retire from the Board. Mr. Roberts has served as a director
since 2011. Effective February 21, 2024, we added Diankha Linear to the Board following a vigorous
national search.
At the 2023 annual meeting, W. Bruce Hanks retired from the Board. Mr. Hanks had served as a director since
1992. Effective August 7, 2023, we added James Fowler to the Board following a robust national search.
In November 2022, Jeffrey K. Storey retired from the Board, and our new President and CEO Kate Johnson
joined the Board.
At the 2021 annual meeting, Virginia Boulet retired from the Board, capping 26 years of service as a director.
Effective February 25, 2021, we added Quincy L. Allen to the Board following an extensive national search.
We remain actively focused on taking additional steps designed to ensure that our Board continues to be
staffed with a collection of individuals meeting our objectives.
Quincy L. Allen
Experience
Quincy L. Allen has over 35 years of leadership experience in the technology
services industry.
IBM Corporation
• Go-To-Market Leader of Cognitive Process Services and Chief Marketing Officer for
Director since: IBM Cloud (2015 to 2018)
2021 Unisys Corporation, a global information technology company
• Chief Marketing and Strategy Officer (2012 to 2015)
Independent
Vertis Communications, a direct marketing and advertising company
64 years old
• Chief Executive Officer (2009 to 2010)
Committees: Xerox Corporation (1982-2009)
• Audit Committee • President of the Global Services and Strategic Marketing Group
• Human • President of Production Systems Group
Resources and Other Public Company Directorships
Compensation • Office Depot
Committee(1) • ABM Industries, Inc.
Skills:
(1)
Service on this committee to commence May 2024; previously served on the Risk and Security Committee from May 2023 through the
effective date of the change.
22
Board of Directors and Governance
Skills:
Peter C. Brown
Experience
Peter C. Brown is a business leader with significant, finance, strategy, corporate
development, and management experience.
Grassmere Partners, LLC, a private investment firm
• Chairman (2009-present)
Director since: AMC Entertainment Inc.
2009
• Chairman and Chief Executive Officer (1999 to 2009)
Independent • Chief Financial Officer (1991 to 1999)
65 years old EPR Properties, a NYSE-listed real estate investment trust
• Founder and Chairman of the Board (1997-2000)
Committees: • Member of the Audit Committee and Chairman of the Finance Committee (2010
• Audit Committee to present)
• Risk and Security Other Public Company Directorships
Committee
Cineverse Corporation (Chairman of the Audit Committee, and serves on the
Compensation and Nominating Committees)
Skills:
Kevin P. Chilton
Experience
Kevin P. Chilton is retired from the U.S. Air Force as a four-star general and
contributes considerable cybersecurity, risk management and scientific leadership
experience to our Board.
Skills:
24
Board of Directors and Governance
Skills:
James Fowler
Experience
James Fowler has more than 25 years of leadership experience driving leading digital
technology innovation at two Fortune 100 companies.
Nationwide Mutual Insurance Company
• Chief Technology Officer (2018 to present)
Director since: General Electric
2023 • Group Chief Information Officer (2015 to 2018)
• Business Unit Chief Information Officer (2003 to 2015)
Independent
• Business Unit Six Sigma Blackbelt and Infrastructure Architect (2000 to 2003)
52 years old
Accenture
Committees: • Technology Manager (1996 to 2000)
• Audit Committee AT&T
• Risk and Security • Systems Analyst (1993 to 1996)
Committee
Other Public Company Directorships
• None
Skills:
T. Michael Glenn
Experience
T. Michael Glenn’s executive leadership roles bring significant market development,
customer, communications, strategic development and operational experience to
our Board.
FedEx Corp. (1981 to 2016)
Director since: • President and Chief Executive Officer of FedEx Corporate Services and a member
2017 of its five-person Executive Committee responsible for developing and
implementing strategic business activities
Independent • Executive Vice President of Market Development and Corporate Communications
68 years old • Senior Vice President, Worldwide Marketing, Customer Service and Corporate
Chairman of the Communications for FedEx Express
Board Oak Hill Capital Partners, a private equity firm (2017 to 2020)
• Senior Advisor
Committees:
Other Public Company Directorships
• Human
Resources and • Pentair PLC
Compensation
Committee
Skills:
26
Board of Directors and Governance
Kate Johnson
Experience
Kate Johnson is a seasoned technology innovator with a proven track record of
driving business transformation success at several of the world’s top Fortune 100
technology companies.
Lumen
Director since: • President and Chief Executive Officer (November 2022 to present)
2022 Microsoft Corporation
• President of Microsoft U.S., a division of Microsoft Corporation (2017 to 2021)
56 years old
GE Digital
Committees: • Executive Vice President of GE Digital and Corporate Vice President (2013 to 2017)
• None Oracle
• Senior Vice President for North America Technology and Government Consulting
(2007 to 2013)
Red Hat, a provider of enterprise open source software products
• Vice President of Global Services and Strategic Accounts (2004 to 2007)
Other Public Company Directorships
• United Parcel Service
Skills:
Skills:
Diankha Linear
Experience
Diankha Linear is a senior executive and proven operator with more than 20 years of
experience leading across highly regulated technology, logistics, and retail industries.
Community, Inc., one of the world’s most trusted customer engagement and
communications channels
Director since: • President & Chief Executive Officer (2021 to present)
2024 Convoy, Inc., an American technology and logistics company
Skills:
28
Board of Directors and Governance
Laurie Siegel
Experience
Laurie Siegel is a business advisor with extensive expertise in human capital and
executive compensation.
Tyco International
• Senior Vice President of Human Resources and Internal Communication (2003
Director since: to 2012)
2009 Honeywell International, Inc.
• Held various senior level positions (1994 to 2002)
Independent
68 years old LAS Advisory Services, a business and human resources consultancy
• Founder and Principal since 2012
Committees: G100
• Human Resources • Chairman (Talent Consortium) (2013 to 2023)
and • Senior Advisor
Compensation
Committee (Chair) Other Public Company Directorships
• Nominating and • CECO Environmental Corp.
Corporate • FactSet Research Systems, Inc.
Governance
Previous Public Company Directorships
Committee
• California Resources Corporation
• Volt Information Sciences, Inc.
Skills:
2 Action Items Over the past several years, this evaluation process has consistently
found that the Board and committees are operating effectively, while
These evaluations have also enabling us to continually refine the way the Board and Board
consistently enabled committees operate, including:
us to refine our
governance practices. • Adjusting the size and composition of the Board to address the
evolving strategic priorities of the Company
• Rotating committee chairs and memberships to ensure fresh
perspectives and leadership
• Ensuring committee chairs have ample time to review agendas and
committee members have sufficient time to review materials in
advance of meetings
Nomination
In considering director nominees, the NCG Committee reviews candidates suggested by our directors, executive
officers or shareholders who comply with our Bylaws. A shareholder or group of up to 10 shareholders owning
3% or more of Lumen’s outstanding common stock continuously for at least three years can nominate director
candidates constituting up to 20% of the Board and include these nominations in our annual meeting proxy
materials. From time to time, the NCG Committee engages a third-party search firm to assist in identifying and
evaluating qualified candidates.
The NCG Committee assesses each director candidate based on his or her skills, judgment, character,
independence, diversity, and experience in the context of the needs of the Board. Potential conflicts and
overboarding are also evaluated. When evaluating candidates for nomination as new directors, the NCG
Committee considers (and asks any search firm that it engages to provide) a pool of candidates that includes
women and individuals from diverse backgrounds, in accordance with the “Rooney Rule” the Board adopted
in 2019.
30
Board of Directors and Governance
Our Corporate Governance Guidelines also establish a target average director tenure of no more than ten years,
set a goal of all Board members (except our CEO) being independent and express the Board’s general sense
that no director should be age 75 or older prior to the next annual shareholders meeting. No director may serve
on more than three other unaffiliated public company boards, unless this prohibition is waived by the Board.
The ͏NCG Committee may, but has not formally chosen to, establish additional qualifications. The NCG
Committee and the Board also evaluate on a periodic basis the effectiveness of its nominating processes
and procedures.
1 Succession Planning
The NCG Committee meets with the CEO to discuss the Company’s long-term strategy and what
skills (if any) are missing from the Board to best complement that strategy.
2 Identification of Candidates
In the event of an open seat or skill gap, the NCG Committee engages in a search process,
which typically includes the use of an independent search firm. The NCG Committee, the Chairman
of the Board, the CEO, and search firm will put together a candidate profile to identify candidates’
skills, experience, and background that best align with the Company’s strategy.
3 Interviewing Candidates
The NCG Committee forms a search committee that is comprised of the Chairman of the Board,
the HRCC and NCG Committee chairs, and the CEO who will request to interview with a diverse
slate of candidates that best fit the profile. The candidates are initially interviewed remotely by
the search committee members and if selected to advance, with the NCG Committee
members in-person.
After the NCG Committee determines that the director candidates are the best fit for the
Company and its shareholders, the NCG Committee will recommend them to the Board for
approval. Following Board approval, the director candidates are appointed to the Board,
will complete an onboarding process, and will stand for election by shareholders at the next
annual meeting.
5 Election
The shareholders consider the nominees and elect directors by majority vote to serve
one-year terms.
6 Ongoing Assessment
The NCG Committee continuously assesses the composition of the Board to maintain alignment
with the Company’s evolving corporate strategy. This includes a periodic review of the
contributions by each director; the skills, experiences and diversity represented on the Board;
the benefits of Board refreshment; and the results of previous shareholder votes.
Over the course of 2023, our Board collectively attended a combination of over 34 continuing education
webinars and seminars covering an extensive list of topics ranging from board committee effectiveness,
cybersecurity, and ESG, to human capital management and SOX controls.
Independence
All directors other than our CEO are independent and the Board regularly meets in executive sessions with only
the independent directors. Each year and prior to nominating a new director, the Board evaluates and
affirmatively determines each director nominee’s independence using standards required by the SEC, NYSE and
our Corporate Governance Guidelines. Annually, each director nominee completes a detailed questionnaire that
solicits information about relationships that could have an impact on independence. Our management delivers
reports on those relationships to the NCG and Audit Committees. Both the NCG and Audit Committees evaluate
the reports from management and consider any other factors which could influence a nominee’s independence.
During their reviews, the NCG and Audit Committees consider transactions and relationships between the
Company, its subsidiaries or affiliates and any directors, executive officers, their immediate family members or
an entity in which any of them have a significant interest. Both the NCG and Audit Committee chairs make
reports on these independence evaluations to the Board. In early 2024, the Board reviewed all relationships
between the Company and each director and affirmatively determined that all of our director nominees are
independent other than Ms. Johnson, our CEO.
The Board also weighed the potential impact of tenure on the independence of our longest-serving director
nominees, Mr. Brown and Ms. Siegel. The Board noted that these directors possess significant experience
serving at Lumen under different operating environments, management teams and financial market cycles,
and have served on the Board under three consecutive CEOs. The Board further concluded that each of
these directors (i) are effective directors who fulfill their responsibilities with integrity and independence
of thought, (ii) appropriately challenge management and the status quo, and (iii) are reasoned, balanced,
and thoughtful in Board deliberations and in communications with management. The Board ultimately
determined that neither of these long-tenured directors’ independence from management has been
diminished by their years of service.
32
Board of Directors and Governance
Glenn • In consultation with the CEO, establishes the agendas for Board meetings
• Provides direction to the CEO on the quality, quantity and timeliness of the flow of
Chairman
information from management that is necessary for the independent directors to
of the Board
perform their duties effectively and responsibly
• Can call special meetings and preside over shareholder meetings
• Performs any additional duties the Board may identify
The NCG Committee periodically reviews the Board’s leadership structure and, when appropriate, recommends
changes, taking into consideration the needs of the Board and the Company at the time. Since 2009, we have
elected a non-executive chairman.
Mr. Glenn has served as Lumen’s independent, non-executive Chairman since May 2020. Mr. Glenn’s extensive
experience developing and implementing strategic business activities makes him uniquely qualified to lead
the Board as Lumen executes its strategic plan for growth.
We believe that separation of the Chairman and CEO positions has functioned effectively over the past several
years. Separating these positions has allowed our CEO to have primary responsibility for the operational
leadership and strategic direction of our business, while allowing our Chairman to lead the Board in its
fundamental role of providing guidance to and separate oversight of management.
As noted in our Corporate Governance Guidelines, it is the sense of the Board that the Chairman of the
Board and the chairs of our committees should rotate approximately every five years.
From 2004 through our 2023 annual meeting, the Board had also elected a non-executive Vice Chairman each
year. The Board currently has no plans to select a successor Vice Chairman following the retirement in 2023 of
our former Vice Chairman, W. Bruce Hanks.
Board Committees
Each of our four standing Board committees supports the full Board with various risk management, governance
and strategic responsibilities.
Audit Committee*
Meetings in 2023: 9
Key Responsibilities
• Oversees the Company’s system of • Assists the Board in fulfilling its oversight
financial reporting responsibilities relating to the adequacy and
• Reviews and discusses our major financial risks, effectiveness of
including matters potentially impacting financial – our internal controls over financial reporting,
reporting, with management, our internal – our internal controls regarding information
auditors and our independent auditors technology security and
• Monitors the qualifications, independence and – our disclosure controls and procedures
performance of Lumen’s independent auditors
34
Board of Directors and Governance
Key Responsibilities
• Establishes executive compensation strategy • Oversees, in consultation with management, our
compliance with regulations governing executive
• Oversees design and administration of equity
and director compensation
incentive plans
• Monitors compensation, labor relations, and
• Approves compensation of senior officers
workforce risk
• Oversees human capital strategy, including
diversity and inclusion culture and talent
recruiting, development and retention
• Final Review and Approval of 2022 STI • Discussion of Performance Assessments for
Q1 • Discussion of Performance for our Senior Officers
Outstanding LTI Programs • Approval of 2023 Compensation of
• Approval of 2023 Incentive Design Plan Senior Officers
Key Responsibilities
• Recommends to the Board nominees to serve as • Annually leads Board and Committee evaluations
directors and officers • Evaluates Board composition, skills and
• Oversees CEO’s annual performance evaluation director independence
36
Board of Directors and Governance
Key Responsibilities
• Assists the Board in fulfilling its oversight • Oversees our corporate ethics and compliance and
responsibilities with respect to, among others: enterprise risk management (“ERM”) programs
and activities
– risks posed by cyberattacks or other
casualty events • Receives periodic reports on various risk
exposures. These include quarterly reports on
– risks related to network reliability, privacy
cybersecurity, which typically include reports on
and regulations
recent cyber intrusions, mitigation steps taken in
– other key enterprise or operational risks as response to those intrusions and ongoing
jointly determined by the Committee cybersecurity initiatives and periodic reports from
and management outside consultants regarding cyber security
– insurance program reviews • Coordinates risk oversight functions of other
• Oversees our classified activities and facilities Board committees
through a subcommittee
Additional information about the responsibilities of our committees is available in the committees’ respective
charters, which can be obtained on our website: https://www.lumen.com/en-us/about/governance/
board-committees.html.
Audit
7
37
Total Board and
Committee Meetings in
Nominating and Corporate Governance 4
2023
Risk and Security 4
Executive Sessions of Independent Directors As needed
without Management throughout the year
Our Board and its committees collectively oversee our business and management’s development and
implementation of our strategies through regular meetings and communications with Lumen’s executive team.
We believe our governance policies and practices provide a transparent framework for effective governance
and compliance with SEC and NYSE requirements. The Board continually reviews our governance practices for
alignment with best practices and stakeholder interests and acts to enhance our ability to oversee the execution
of strategies that drive value for Lumen, our customers, employees and shareholders. Our Corporate
Governance Guidelines, along with other governance documents, including our Code of Conduct, Bylaws and
other governance policies are available on our website: lumen.com/en-us/about/governance/
documentation.html
38
Board of Directors and Governance
• Members of • Our Board regularly • The Board • The Board, • The Board and
management engages in active oversees along with its the NCG
and the Board discussions with succession committees, Committee, in
engage on a year- management to planning for reviews and conjunction with
round basis with formulate and members of our oversees Lumen’s designated
holders of our implement senior leadership risk management management teams
equity and debt appropriate team, including the processes. periodically evaluate
securities, as well strategies for the CEO, and monitors • The Board also our ESG programs
as proxy advisory Company and each of the performance of works with and seek to identify
firms and ESG its business each member of management to meaningful
rating firms, segments. such team. assess our key opportunities
among others. • In addition to regular short- and long- to enhance
Board and committee term risks and our programs.
meetings, the Board mitigation efforts. • The Board strives to
participates in an set an appropriate
annual in-depth “tone at the top”
dedicated review of stressing a positive
the Company’s overall corporate culture.
strategy with our
management team.
Shareholder Engagement
The Board believes that input from shareholders is a critical component in our efforts to continually enhance our
governance practices and maximize long-term shareholder value. As illustrated below, members of management
and the Board engage on a year-round basis with holders of our equity and debt securities, as well as proxy
advisory firms and ESG rating firms, among others.
These efforts complement management’s outreach through participation by our CEO, CFO and other senior
leaders in investor conferences in the U.S. and abroad, and through regular investor dialogue conducted by our
Investor Relations department.
In 2023, our Investor Relations department led meetings with over 250 equity investors and over 350 debt
investors. We believe these Investor Relations-led engagements help build strong relationships and
goodwill with the analyst and investor community. Some of our investor presentations are made available in
the Investor Events section of Lumen’s corporate website at ir.lumen.com.
Board Responsiveness
Our Board is committed to constructive engagement and dialogue with our investors. We regularly evaluate and
respond to the views expressed by our equity and debt holders. This dialogue has led to enhancements in our
corporate governance, sustainability, and executive compensation activities that the Board believes are in the
best interests of Lumen and our shareholders.
Our 2023 Investor • Board Chairman • Senior Vice President, Investor Relations
Engagement Team • Chair, HRCC Committee • Chief Diversity and Inclusion Officer
• Chair, NCG Committee • Senior Vice President, Treasurer
• Executive Vice President, • Vice President, Deputy General Counsel,
Human Resources Corporate Governance & Transactions
What We Learned • Investors were interested in learning • Investors expressed a desire to see
more about Lumen’s growth strategy, distinct metrics for STI and LTI
long-term strategic plan, capital • Investors asked about Board discussions
allocation, and governance around ethnic/gender diversity and
• Investors were interested in learning several indicated they like to see at least
more about Lumen’s climate action plan 30% gender diversity on the Board.
and the impact our 2022 and 2023
divestitures will have on our plan to set
new science based targets
• Investors wanted to learn more about
succession planning and what went into
the search and selection of Mr. Fowler
to our Board in August 2023
40
Board of Directors and Governance
The chart below summarizes engagement topics discussed and governance actions taken over the past couple
years in response to specific shareholder feedback or voting guidelines published by our shareholders or
proxy advisors.
• Commitment to ongoing publication of EEO-1 Data • All non-CEO directors independent since 2020
on Sustainability webpage beginning in April 2022 annual meeting
9
segments. The Board and management routinely discuss key initiatives, potentially
transformative technologies, innovation, culture and corporate governance opportunities
focused on driving long-term value. During 2023, this collaboration targeted
(1) developing new revenue streams; (2) enhancing and scaling capabilities to establish
market leadership; (3) managing costs primarily through digitalizing and automating our special meetings
operations; (4) maximizing cash and encouraging customer migrations to our growth in 2023 to discuss
products; and (5) increasing margins through select price increases. In addition to regular strategic topics
Board and committee meetings, which include presentations and discussions of strategic
and tactical initiatives, the Board participates in an annual in-depth dedicated review of
the Company’s overall strategy with our management team. The Board and our
management team discuss the industry and competitive landscapes, short and long-term
plans, capital allocation strategies and other mission-critical topics.
• Identified and
reviewed
potential external
CEO candidates
42
Board of Directors and Governance
Risk Oversight
BOARD OF DIRECTORS
MANAGEMENT
• Under our ERM program, management develops a response plan for prioritized risks, including our cyber incident
response playbook. Management also develops plans for monitoring and mitigating identified key risks.
• Management provides regular reports on our key risks and risk mitigation strategies to the Risk and Security
Committee, and assists other Committees in monitoring the risks for which they are responsible.
• Committees report each quarter on risk issues to the full Board.
Assess
• The ERM process involves an annual enterprise risks assessment based around 40 key financial, compliance,
operational and strategic risks facing the company. This assessment process is facilitated by Internal Audit in
collaboration with the Ethics & Compliance team within the legal department and involves interviews with executives
across business functions, and consideration of other factors such as the external environmental and the history of
previous issues which could indicate a relatively higher or lower risk in a particular area.
• The results of the assessment are presented by Internal Audit to the senior leaders, the Audit Committee and the Risk
and Security Committee in order to define the most critical risks (typically six to eight) which the Board and
management believe warrant more detailed and frequent monitoring throughout the year.
• Internal Audit also uses the results of this Enterprise Risk Assessment to determine key focus areas within the Internal
Audit plan for the upcoming year and performs a quarterly update to the risk assessment to identify any changes
potentially requiring a Board or Internal Audit response.
Monitor
• For each of the six to eight critical ERM risks we identify executive risk owners who are responsible for defining key
risk indicators, metrics and targets to indicate how effectively the respective risk is being managed.
• On an annual basis each risk owner presents a deep-dive assessment to the Risk & Security Committee explaining their
quantitative measures, goals and plans for the upcoming year.
• On a quarterly basis Internal Audit works with each executive risk owner to update these indicators, identify any
divergence from goals and note actions taken and planned. The risk owners assign specific performance scores to
indicate their overall assessment of their management of that risk. The resulting dashboard and detail for these ERM
risks is presented to the Risk & Security Committee at each quarterly meeting.
• Each Committee regularly reports to the full Board regarding its risk oversight functions.
Align
• The results of the Annual Enterprise Risk Assessment are compared to both the Risk Factors disclosed in the
company’s annual report (10-K) and against the charters and agendas for the Board Committees to ensure alignment
between the Company’s assessment, external disclosures and coverage by the Board of the respective key risks. We
believe this combination of annual and quarterly review by the Board Committees, along with the ability of the Board
to call upon risk owners at any time as required, allows the Board to effectively exercise its oversight function over key
risks to Lumen.
Oversight of As a technology and communications company that transmits large amounts of information
Cybersecurity Risks over our global networks, maintaining the security and integrity of information and systems
under our control is a priority among our operational risk management efforts. We view
cybersecurity risk as an enterprise-wide risk, subject to control and monitoring at various
levels of management throughout the Company. The Risk and Security Committee and its
Chair review Cybersecurity and Data Privacy quarterly and such topics of review include:
• risk assessments from information security, privacy and internal audit management teams
with respect to cybersecurity, including the adequacy and effectiveness of the Company’s
internal controls regarding cybersecurity,
• emerging cybersecurity developments and threats and
• the Company’s strategy to mitigate cybersecurity risks, such as our contingency plans in
the event of security breaches or other system disruptions and cyber insurance coverage.
To assess and mitigate cybersecurity risk, we have implemented a global information security
management program that includes administrative, technical and physical safeguards and we
periodically engage both internal and external auditors and consultants to assess and enhance
our program, all of which is subject to oversight by and reporting to the Risk and Security
Committee. We engage independent external auditors and consultants who are fully
accredited under various information security standards, including those administered by the
International Organization for Standardization and the PCI Security Council. Since 2021,
Lumen has maintained a Technology Security and Privacy Council that meets on a bi-monthly
basis. The meetings are led by Lumen’s Chief Privacy Officer, Chief Security Officer and Chief
Information Officer, who provide organization level updates and also invite other presenters to
provide updates on emerging threats and other topical issues. For additional information,
see our most recent annual report on Form 10-K filed with the SEC.
Oversight of Data In addition to securing our network, we also take steps to protect the content of information
Privacy Risks Lumen collects, stores, uses and shares. Employee and customer information is encrypted,
consistent with industry standards or legal requirements, both at rest and in transmission. We
have adopted a data minimization policy designed to comply with and detect breaches of
applicable laws and provide appropriate protections when sharing information with third
parties, including vendors. We maintain other plans or programs to manage our data privacy
risks, including a privacy policy and a cyber incident response plan. As part of the ERM
process, the Risk and Security Committee receives reports on data privacy protection efforts
and controls across the enterprise.
Oversight of Political Our Board and NCG Committee oversee our political initiatives and annually review Lumen’s
Contributions Risks political and lobbying activities and related budgets. We strive to advocate public policy
solutions that best serve our stakeholders. Our semi-annual Political Contributions Reports
provide transparency in this process, demonstrating ethical corporate governance and
promoting confidence in the democratic process. Specifically, our Reports disclose our
corporate political contributions and those of our political action committees in accordance
with applicable federal and state campaign finance laws and contributions to trade
associations and 501(c) (4) organizations. Although not part of this proxy statement, our most
recent Political Contributions Reports can be located on our website at lumen.com.
Oversight of Our highly competitive business requires skilled and motivated employees and leaders with
Human Capital the necessary expertise to execute our innovation, efficiency and transformation strategies.
Developing and retaining top talent is a priority. The Board regularly discusses with
Management Risks management Lumen’s continuous efforts to attract and retain the caliber of employee with
the type of knowledge and skills necessary to realize our goals. Both our directors and
management set a “tone at the top” through:
• regularly meeting with our most senior human resources executive to discuss culture, talent
strategy and leadership development and staying ahead of market trends by identifying
early the skills needed for our future;
• developing compensation programs that incentivize employees to pursue goals that align
with our strategies and operational imperatives;
• designing strategies to attract a diverse range of skills and perspectives; and
• designing strategies to bridge any gaps in our succession plans by cultivating our in-house
talent or engaging third parties.
Oversight of Our Audit Committee is primarily responsible for assisting the Board in its oversight of
Finance Risks financial risks. In performing this function, the Audit Committee monitors our capital needs
and financing plans and oversees our strategy for managing interest rate and currency risk.
The Audit Committee monitors compliance with debt covenants in our financial instruments,
including those that require us or our subsidiaries to comply with certain maximum levels of
leverage and minimum levels of interest coverage. The Audit Committee also periodically
reviews our pension and other postretirement benefit obligations.
Oversight of Our Board committees oversee certain other risks specified in the preceding section “— Board
Other Risks Committees,” and our Board and committees further oversee the ESG program and other risks
discussed under the heading “ESG Sustainability Leadership” below.
and Information
44
Board of Directors and Governance
Director Compensation
Overview
The Board believes that each of our non-employee directors (whom we also refer to as outside directors or
non-management directors) should be compensated through a mix of cash and equity-based compensation.
Our HRCC, consisting entirely of independent directors, has primary responsibility for periodically reviewing and
considering any revisions to director compensation.
The table and the discussion below summarize how we compensated our outside directors in 2023. This table
does not include compensation paid to our current President and CEO Kate Johnson, who does not receive any
additional compensation for her service as a director. Please see the “Summary Compensation Table” below for
details regarding all compensation paid by us to Ms. Johnson during 2023.
Annual Outside Director Compensation Additional Annual Cash Compensation Supplemental Board Fee
• Non-Executive Chairman of the Board - $200,000
• Non-Executive Vice Chairman of the Board - $100,000(1)
(1)
Paid through May 2023, when our Vice Chairman retired and was not replaced.
CASH FEES – We pay each outside director an annual cash retainer of $100,000 (“Annual Board Retainer”) and
annual fees to the chairs and members of each of the committees as set forth in the table above.
We currently pay annual supplemental Board fees to our non-executive Chairman of the Board, Mr. Glenn of
$200,000. The Chairman’s duties are set forth principally in our Corporate Governance Guidelines; see “How
Our Board is Organized—Board Leadership Structure.”
In addition to the above described annual cash fees, if outside directors are requested to perform supplemental
responsibilities, the additional time and effort may be eligible for a discretionary, supplemental cash or
equity compensation.
EQUITY GRANT – During 2023, the HRCC awarded an annual equity grant valued at $200,000 to each outside
director, with the number of shares determined by dividing this target value by the volume-weighted average
closing price of our Common Shares over a 15-day trading period ending prior to the grant date.
On May 17, 2023, following the election of our directors at our 2023 Annual Shareholders Meeting, each outside
director was granted time-vested shares of restricted stock unless the director made an election to defer all or a
portion of the award under our Non-Employee Directors Deferred Compensation Plan (discussed below). For
those directors who elected to defer any portion of the grant, the portion deferred was issued to the director as
time-vested restricted stock units. These awards are scheduled to vest on May 17, 2024 (one year after their
grant), subject to the director’s continued service through that date, with vesting accelerated in certain
circumstances as described in the director’s award agreement.
On August 7, 2023, following his appointment, Mr. Fowler was granted a prorated award of time-vested shares
of restricted stock which will vest on August 7, 2024 (one year after the grant), subject to his continued service
through that date, with vesting accelerated in certain circumstances as described in his award agreement.
Dividends (or, for restricted stock units, dividend equivalents) on these awards are not paid currently but rather
accrue from the grant date through the date of vesting (for restricted stock) or the date of issuance of the
underlying shares (for restricted stock units) and are subject to the same vesting terms as the related award.
As described in further detail in “Compensation Discussion & Analysis—Section Five—HRCC Engagement and
Corporate Governance—Stock Ownership Guidelines” each outside director is expected to beneficially own
Lumen stock equal in market value to five times the annual cash retainer payable to outside directors.
46
Board of Directors and Governance
(1)
For fiscal 2023, the HRCC granted an award of restricted shares or restricted stock units (i) on May 17, 2023 to each outside director, except
Mr. Hanks and Mr. Fowler, valued at $200,000 and (ii) a prorated award of restricted shares on August 7, 2023 to Mr. Fowler, based upon
the volume-weighted average closing price of our Common Shares over a 15-day trading period ending prior to the respective grant date.
However, as required by SEC rules, the dollar value reported in this column reflects the grant date fair value of that award based upon the
closing stock price of our Common Shares on the grant date in accordance with FASB ASC Topic 718. These awards vest on the one-year
anniversary of grant date of May 17, 2024 and August 7, 2024, respectively, subject to the director’s continued service through that date
(with vesting accelerated in certain limited circumstances). See “—Cash and Stock Payments.”
(2)
As of December 31, 2023, outside directors held the following unvested equity-based awards: (i) Ms. Siegel and Messrs. Brown, Clontz, Jones
and Roberts each held, 85,605 shares of restricted stock; (ii) Ms. Bejar and Messrs. Allen, Chilton and Glenn each held 85,605 RSUs; and (iii)
Mr. Fowler held 83,038 shares of restricted stock.
(3)
As of December 31, 2023, the following outside directors held the following vested RSUs deferred under the Non-Employee Director
Deferred Compensation Plan: Mr. Allen – 33,050; Ms. Bejar – 44,122; Mr. Chilton – 28,378; Mr. Glenn – 64,195; Mr. Roberts – 14,706. For further
information on our directors’ stock ownership, see “Ownership of Our Securities—Executive Officers and Directors,” and for information on
certain deferred equity and cash fee arrangements, see “—Non-Qualified Deferred Compensation.”
(4)
Includes (i) reimbursements for the cost of annual physical examinations and related travel of $5,652 for Mr. Hanks, (ii) the payments related
to the attendance of the NACD Conference of $2,000 for Mr. Allen. Except as otherwise noted in the prior sentence, the table above does
not reflect reimbursements for travel expenses.
(5)
Does not include Diankha Linear, who was appointed to the Board in February 2024.
(6)
James Fowler was appointed to the Board in August 2023.
(7)
Mr. Roberts’ term will end immediately following the 2024 annual shareholders meeting.
(8)
Mr. Hanks’ term ended immediately following the 2023 annual shareholders meeting.
If a non-employee director elects to defer all or a portion of the director’s annual equity award under this plan,
as noted above, the portion of the award subject to the deferral election will be issued as restricted stock units
instead of shares of restricted stock.
Five of our current directors, Ms. Bejar and Messrs. Allen, Chilton, Glenn and Roberts, participate in this plan.
LEGACY QWEST DEFERRED COMPENSATION PLAN – CLOSED TO NEW PARTICIPANTS
AND CONTRIBUTIONS – In connection with our 2011 merger with Qwest, we assumed the Qwest Deferred
Compensation Plan for Non-Employee Directors. Under this plan, Qwest outside directors could elect to defer all
or a portion of their cash directors’ fees, which were then converted to a number of “phantom units” based on
the value of a share of Qwest stock, with credit for dividends paid to shareholders “reinvested” in additional
phantom units. Plan balances attributable to amounts deferred on or after January 1, 2005, by Qwest directors
who joined our Board following the merger were converted, based on the merger exchange ratio, to phantom
units based on the value of one of our Common Shares. Other than the crediting and “reinvestment”
of dividends for outstanding phantom units, the Company does not make any contributions to and no additional
elective deferrals are permitted under this plan. As of December 31, 2023, Michael J. Roberts was the only
remaining participant in this plan, with a balance of 9,569 phantom units with an aggregate value of
approximately $17,511. Subject to the terms of the plan, Mr. Roberts’ account will be distributed as a lump sum in
cash as soon as practicable following the end of his service as a director at the 2024 annual
shareholders meeting.
Other Benefits
Each outside director is entitled to be reimbursed: (i) for expenses incurred in attending Board and committee
meetings, (ii) for expenses incurred in attending director education programs and (iii) up to $5,000 per year for
the cost of an annual physical examination, plus related travel expenses. We supply company-owned tablets to
certain of our outside directors for use in reviewing materials posted to a dedicated portal that permits
management to communicate with the Board.
Directors may use our aircraft in connection with company-related business. However, we generally do not
permit either our directors or their family members to use our aircraft for personal trips.
Our Bylaws require us to indemnify our directors and officers so that they will be free from undue concern about
personal liability in connection with their service to the Company. We have signed agreements with each of
those individuals contractually obligating us to provide these indemnification rights. We also provide our
directors with customary directors and officers liability insurance.
48
ITEM 2
Ratify KPMG as Our 2024
Independent Auditor
The Audit Committee of the Board has appointed KPMG LLP as our independent auditor for the fiscal
year ending December 31, 2024 and we are submitting that appointment to our shareholders for
ratification on an advisory basis at the meeting. Although shareholder ratification of KPMG’s
appointment is not legally required, we are submitting this matter to the shareholders, as in the past,
as a matter of good corporate practice.
If the shareholders fail to vote on an advisory basis in favor of the appointment, the Audit Committee will
reconsider whether to retain KPMG and may appoint that firm or another without re-submitting the matter to
the shareholders. Even if the shareholders ratify the appointment, the Audit Committee may, in its discretion,
select a different independent auditor at any time during the year if it determines that such a change would be
in the Company’s best interests.
In connection with the audit of the 2023 financial statements, we entered into an engagement letter with KPMG
which sets forth the terms by which KPMG provided audit services to us. Any future disputes between KPMG
and us under that letter will be subject to certain specified alternative dispute resolution procedures, none of
which are intended to restrict the remedies that our shareholders might independently pursue against KPMG.
KPMG has advised us that one or more of its partners plan to participate in the meeting. We understand that
these representatives will be available to respond to appropriate questions and will have an opportunity to make
a statement if they desire to do so.
For a discussion of factors the Audit Committee considered in connection with re-appointing KPMG for
the 2024 audit, see “-Annual Evaluation and Selection of Independent Auditors.”
Ratification of KPMG’s appointment as our independent auditor for 2024 will require the affirmative vote of a
majority of the votes cast on the proposal at the meeting.
• External data on audit quality and performance, including recent PCAOB reports on KPMG and its peer
firms; and
• The appropriateness of KPMG’s fees, KPMG’s tenure as independent auditors (including the advantages and
disadvantages of a longer tenure) and the controls and processes in place that help ensure KPMG’s
continued independence.
Over the last several years, the Audit Committee has attempted to strike an appropriate balance between
auditor rotation and retention. Over the past few years, KPMG’s engagement partner for our audit has been
rotated more frequently than required. In addition, since our 2017 combination with Level 3, not only has the
engagement partner been rotated multiple times but the KPMG office charged with the audit has alternated
between Shreveport, Louisiana and Denver, Colorado. The factors that the Audit Committee considered that
favored the retention of KPMG as the Company’s independent auditors included:
• Enhanced audit quality – KPMG’s significant institutional knowledge and deep expertise of the Company’s
global business, accounting policies and practices, recent divestiture transactions and internal control over
financial reporting enhance audit quality.
• Competitive fees – Because of KPMG’s familiarity with the Company and the communications industry, audit
and other fees are competitive with peer companies.
• Avoid costs associated with a new auditor – Bringing on new independent auditors would be costly and
require a significant time commitment, which could lead to management distractions.
(1)
Includes the cost of services rendered in connection with (i) auditing our annual consolidated financial statements, (ii) auditing our internal
control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, (iii) reviewing our quarterly financial
statements, (iv) auditing the financial statements of several of our subsidiaries, (v) statutory audits for certain of our foreign subsidiaries and
(vi) consultations regarding accounting standards.
(2)
Includes (i) the cost of preparing agreed upon procedures reports and providing general accounting consulting services, for both years, and
(ii) 2022 audit-related fees from the divestitures of the Latin American business and incumbent local exchange business, and the 2023
divestiture of the EMEA business.
(3)
Reflects costs associated with general tax planning, consultation and compliance.
(4)
Reflects costs associated to assess program and project activities related to system implementation.
The Audit Committee maintains written procedures that require it to annually review and pre-approve the scope
of all services to be performed by our independent auditor. This review includes an evaluation of whether the
provision of non-audit services by our independent auditor is compatible with maintaining the auditor’s
independence in providing audit and audit-related services. The Committee’s procedures prohibit the
independent auditor from providing any non-audit services unless the service is permitted under applicable law
and is pre-approved by the Audit Committee or its Chairman. The Chairman is authorized to pre-approve
projects if the total anticipated cost of all projects pre-approved by him during any fiscal quarter does not
exceed $250,000. The Audit Committee has pre-approved the Company’s independent auditor to provide up
to $75,000 per quarter of miscellaneous permitted tax services that do not constitute discrete and separate
projects. The Chairman and the Chief Financial Officer are required periodically to advise the full Committee of
the scope and cost of services not pre-approved by the full Committee. Although applicable regulations permit
us to waive these pre-approval requirements in certain limited circumstances, the Audit Committee did not use
these waiver provisions in either 2022 or 2023.
50
ITEM 2 Ratify KPMG as Our 2024 Independent Auditor
Among other matters, over the course of the past year, the Committee also:
• reviewed the scope of and overall plans and • discussed Company capital allocation, investment,
progress for the annual audit and the internal audit and tax planning strategies;
program, including a review of critical accounting • reviewed the performance of KPMG and KPMG’s
estimates and significant unusual transactions; lead engagement partner and planned for the
• reviewed and discussed each quarterly and annual future rotation of the lead engagement partner
financial statements and related earnings press should KPMG be retained as the
releases before issuance, including reviewing the Company’s auditor;
Company’s issuance of guidance and use of non- • reviewed and discussed the effectiveness of our
GAAP financial information, the adequacy of disclosure controls and procedures;
disclosures and management’s ICFR report and
discussion and analysis; • received quarterly reports from the Director of
Internal Audit, including the Company’s work
• discussed our 2023 critical accounting policies regarding ICFR and met with other members of
with KPMG; the Internal Audit staff;
• discussed SEC regulatory changes; • received and discussed reports each quarter on
• reviewed the Company’s debt compliance process, the Company’s significant litigation issues;
including primary debt covenants, debt agreement • received and evaluated a report concerning the
restrictions, maintenance covenant calculations Company’s major financial risks along with the
and liquidity implications; Company’s mitigating actions;
• received reports on the Company’s goodwill • reviewed the Company’s accounting for
impairment testing; income taxes;
• received periodic reports pursuant to our policy • reviewed the Company’s accounting for pension
for the submission of confidential communications assets and liabilities; and
from employees and others about accounting,
internal controls and auditing matters and • received an annual report with regard to any hiring
conducted certain follow-up inquiries of former employees of KPMG.
as necessary;
Taking all of these reviews and discussions into account and subject to the limitations on the role and
responsibilities of the Committee referred to in its charter, the undersigned Committee members recommended
that the Board include the Company’s audited consolidated financial statements in our Annual Report on Form
10-K for the year ended December 31, 2023.
In addition to the Company’s corporate compliance program and integrity line, the Audit Committee has
established procedures for the receipt and evaluation, on a confidential basis, of any complaints or concerns
regarding our accounting, auditing, financial reporting or related matters. To report such matters, please send
written correspondence to Audit Committee Chair, c/o Post Office Box 4364, Monroe, Louisiana 71211.
Submitted by the Audit Committee of the Board of Directors.
Hal Stanley Jones Quincy L. Allen Peter C. Brown Kevin P. Chilton James Fowler
(CHAIR)
52
ITEM 3
Approval of Our 2024 Equity
Incentive Plan
Our future success depends upon the efforts of our officers, directors, employees, consultants, and advisors. We
believe that our current equity compensation plan, the 2018 Equity Incentive Plan, as amended and restated
(the “2018 Plan”), provides an effective means of attracting, retaining, and motivating qualified key personnel
while encouraging long-term focus on maximizing shareholder value. As noted in the chart on page 61, we had
5,974,868 Common Shares available for grant under the 2018 Plan as of March 21, 2024, which we do not believe
will be sufficient for future grants.
At the meeting, we are asking shareholders to approve our 2024 Equity Incentive Plan (the “Plan”), which
authorizes the issuance of up to 43,000,000 Common Shares, subject to adjustment, plus any Common Shares
subject to incentives previously granted under the 2018 Plan that are subsequently cancelled, forfeited or expire
prior to exercise or realization. If the Plan is approved by our shareholders, no new awards will be made under
the 2018 Plan following March 21, 2024, the record date.
The number of shares of Common Stock authorized under the Plan, and the other share-based disclosures
including in this proposal, do not reflect the implementation of the proposed reverse stock split of our Common
Shares. If the shareholders approve Item 5A at the meeting, then the number of shares of Common Stock
authorized for issuance and other share-based limitations in the Plan will be adjusted accordingly.
We have carefully reviewed the provisions of the Plan in its entirety, and we feel that the plan reflects good
equity compensation practices and is in line with shareholder interests. Our Board, on the recommendation of its
Human Resources and Compensation Committee, has unanimously approved the Plan, subject to approval by
our shareholders at the meeting.
The principal features of the Plan are summarized below. However, this summary is qualified in its entirety by
reference to the full text of the Plan, as attached to this proxy statement as Appendix C. Because this is a
summary, it may not contain all the information that you may consider to be important. Therefore, we
recommend that you read Appendix C carefully before you decide how to vote on this proposal.
Given the limited number of Common Shares remaining available for issuance as of December 31, 2023, for our
annual LTI award in March 2024, we shifted the 60% performance-based portion from equity to cash for our
executives and awarded LTI below executive level in cash for the second year in a row. If shareholders do not
approve the Plan at the annual meeting, we will continue to use our 2018 Plan but, given the limited number of
Common Shares remaining available for issuance as of March 21, 2024, we will be required to re-evaluate our
compensation structure to ensure that it remains competitive. Specifically, if the Plan is not approved, we will
likely increase our use of cash-based employee compensation, which could reduce the alignment of employee
and shareholder interests.
54
ITEM 3 Approval of Our 2024 Equity Incentive Plan
We measure dilution as (a) the total number of shares issuable under our unvested and outstanding equity
based awards (with PBRS reflected at the maximum performance level) at the end of the fiscal year, divided by
(b) the total shares of common stock outstanding at the end of the fiscal year. Our average dilution over the last
three fiscal years is approximately 4.67%.
3-Year
(Share Amounts in Thousands) 2023 2022 2021 Average
For the years ending December 31
TBRS and PBRS Granted 14,787 18,788 13,908
Gross Burn Rate 1.50% 1.86% 1.31% 1.56%
TBRS and PBRS Cancelled/Forfeited 6,844 4,524 1,828
Net Burn Rate 0.81% 1.42% 1.14% 1.12%
Unvested TBRS and PBRS 28,052 27,279 22,427
As of December 31
Total shares available for grant 10,909 18,549 35,706
Dilution 3.96% 4.55% 5.49% 4.67%
Weighted-average common stock outstanding 983,081 1,007,517 1,059,541
Common stock outstanding 1,008,486 1,001,688 1,023,512
We also monitor “overhang” to measure the cumulative impact of our equity compensation plans. We measure
overhang as (a) the number of full-value shares subject to equity awards outstanding (with PBRS reflected at
the maximum performance level) plus the number of shares available for grant, divided by (b) the total shares of
common stock outstanding. As of March 21, 2024, our overhang was approximately 3.76%. However, assuming
the Plan had been approved as of March 21, 2024, our overhang would have been approximately 7.41% as of
such date.
(1)
No Incentives will be granted under the 2018 Plan after March 21, 2024, unless the Plan is not approved by our shareholders. Upon approval
of the Plan by our shareholders, the shares remaining available for grant under the 2018 Plan will be cancelled and we will cease using the
2018 Plan for new Incentive awards.
Shares Issuable under the Plan. If the Plan is approved by the shareholders at the meeting, a total of
43,000,000 of our Common Shares are authorized for issuance under the Plan, plus any Common Shares
subject to Incentives previously granted under the 2018 Plan that are subsequently cancelled, forfeited or expire
prior to exercise or realization. The closing price of a Common Share on the record date, as quoted on the
NYSE, was $1.71.
Limitations on Shares Issuable under the Plan. Under the Plan, all of the Common Shares available under the
Plan may be issued upon exercise of options intended to qualify as incentive stock options under the Code. A
limit of $1 million per calendar year applies to the sum of all cash and Incentives and other compensation
granted to non-employee directors, although the maximum value of Incentives that may be granted under the
Plan to each non-employee director of Lumen during a single calendar year is $500,000.
Share Counting. For purposes of determining the maximum number of Common Shares available for delivery
under the Plan, shares that are not delivered because an Incentive is forfeited, canceled, or expired will return to
the Plan and be available for reissuance. However, Common Shares subject to an Incentive will not be recycled if
(a) they are tendered in payment of exercise or base price of a stock option or stock-settled SAR; (b) they were
covered by, but not issued upon settlement of, stock-settled SARs; or (c) they were delivered or withheld by the
Company to satisfy any tax withholding obligation related to stock options or stock-settled SARs. If an
Incentive, by its terms, may only be settled in cash, it will not impact the number of Common Shares available
for issuance under the Plan.
Adjustments to Shares Issuable under the Plan. Proportionate adjustments will be made to all of the share
limitations provided in the Plan, including shares subject to outstanding Incentives, in the event of any
recapitalization, reclassification, stock dividend, stock split, combination of shares, or other comparable change
in our Common Shares, and the terms of any Incentive will be adjusted to the extent appropriate to provide
participants with the same relative rights before and after the occurrence of any such event.
Minimum Vesting Periods. Except for any Incentives that are issued in payment of cash amounts earned under
our short-term incentive program, all Incentives must be granted with a minimum vesting period of at least one
year without providing for incremental vesting during that first year, except that Incentives covering up to 5% of
the Common Shares reserved for issuance under the Plan may be granted without compliance with this
minimum vesting requirement.
Dividends and Dividend Equivalents. The Plan provides that the Committee may grant dividends or dividend
equivalent rights on certain types of awards (restricted stock, RSUs, and Other Stock-Based Awards). If the
Committee elects to grant such rights, any such rights must vest and pay out or be forfeited in tandem with
underlying Incentives rather than during the vesting period.
Amendments to the Plan. Our Board may amend or discontinue the Plan at any time. However, our shareholders
must approve any amendment to the Plan that would:
• materially increase the number of Common Shares that may be issued through the Plan;
• materially increase the benefits accruing to participants;
• materially expand the classes of persons eligible to participate;
• expand the types of awards available for grant;
• materially extend the term of the Plan;
• materially reduce the price at which Common Shares may be offered through the Plan; or
• permit the repricing of an option or stock appreciation right.
Duration of the Plan. No Incentives may be granted under the Plan after May 15, 2034 (the tenth anniversary of
the date on which the Plan was initially approved by our shareholders).
Clawback. All Incentives granted under the Plan will be subject to such deductions, clawback, recoupment or
recovery as may be required to be made (x) pursuant to any applicable policy adopted by the Company which
provides for such deduction, clawback, recoupment or recovery, as currently effective or subsequently
amended, or (y) to the extent required pursuant to any currently effective or subsequently adopted law,
government regulation or stock exchange listing requirement.
56
ITEM 3 Approval of Our 2024 Equity Incentive Plan
Types of Incentives. Each type of Incentive that may be granted under the Plan is described below.
Stock Options. A stock option is a right to purchase Common Shares from Lumen. The Committee will determine
the number and exercise price of the options, and the time or times that the options become exercisable,
provided that the option exercise price may not be less than the fair market value of a Common Share on the
date of grant, except for an option granted in substitution of an outstanding award in an acquisition. The term of
an option will also be determined by the Committee, but may not exceed ten years. The Committee may
accelerate the exercisability of any stock option at any time. As noted above, the Committee may not, without
the prior approval of our shareholders, decrease the exercise price for any outstanding option after the date of
grant. In addition, an outstanding option may not, as of any date that the option has a per share exercise price
that is greater than the then-current fair market value of a Common Share, be surrendered to us as
consideration for the grant of a new option with a lower exercise price, another Incentive, a cash payment,
or Common Shares, unless approved by our shareholders. Incentive stock options will be subject to certain
additional requirements necessary in order to qualify as incentive stock options under Section 422 of the Code.
The option exercise price may be paid:
• in cash or by check;
• in Common Shares;
• through a “cashless” exercise arrangement with a broker approved by Lumen;
• through a net exercise procedure if approved by the Committee; or
• in any other manner authorized by the Committee.
Stock Appreciation Rights. A stock appreciation right, or SAR, is a right to receive, without payment to Lumen,
a number of Common Shares determined by dividing the product of the number of shares as to which the stock
appreciation right is exercised and the amount of the appreciation in each share by the fair market value of a
share on the date of exercise of the right. The Committee will determine the base price used to measure share
appreciation (which may not be less than the fair market value of a Common Share on the date of grant),
whether the right may be paid in cash, and the number and term of stock appreciation rights, provided that the
term of a SAR may not exceed ten years. The Committee may accelerate the exercisability of any SAR at any
time. The Plan restricts decreases in the base price and certain exchanges of SARs on terms similar to the
restrictions described above for options.
Restricted Stock. The Committee may grant Common Shares subject to restrictions on sale, pledge, or other
transfer by the recipient for a certain restricted period. All shares of restricted stock will be subject to such
restrictions as the Committee may provide in an agreement with the participant, including provisions that may
obligate the participant to forfeit the shares to us in the event of termination of employment or if specified
performance goals or targets are not met. Subject to restrictions provided in the participant’s incentive
agreement and the Plan, a participant receiving restricted stock shall have all of the rights of a shareholder as to
such shares, including the right to receive dividends although, as noted above, any such dividends would not be
paid currently but would vest or be forfeited in tandem with the related shares of restricted stock.
Restricted Stock Units. A restricted stock unit, or RSU, represents the right to receive from Lumen one Common
Share on a specific future vesting or payment date. All RSUs will be subject to such restrictions as the
Committee may provide in an agreement with the participant, including provisions that may obligate the
participant to forfeit the RSUs in the event of termination of employment or if specified performance goals or
targets are not met. Subject to the restrictions provided in the incentive agreement and the Plan, a participant
receiving RSUs has no rights of a shareholder until Common Shares are issued to him or her. RSUs may be
granted with dividend equivalent rights. Any such dividend equivalent rights would not be paid currently but
would vest or be forfeited in tandem with the related RSUs.
Other Stock-Based Awards. The Plan also permits the Committee to grant to participants awards of Common
Shares and other awards that are denominated in, payable in, valued in whole or in part by reference to, or are
otherwise based on the value of, or the appreciation in value of, Common Shares (other stock-based awards).
The Committee has discretion to determine the times at which such awards are to be made, the size of such
awards, the form of payment, and all other conditions of such awards, including any restrictions, deferral
periods, or performance requirements.
Termination of Employment. In the event that a participant ceases to be an employee of Lumen or its
subsidiaries or to provide services to us for any reason, including death, disability, early retirement, or normal
retirement, any Incentives may be exercised, shall vest, or shall expire at such times as provided in the
applicable incentive agreement or as may be otherwise determined by the Committee.
Change of Control. Upon a change of control of Lumen, as defined in the Plan, the vesting of time-based
Incentives will only occur if an employee participant has a contemporaneous or subsequent involuntary
termination of employment as provided in the applicable agreement. In addition, the payout of any
performance-based Incentives upon a change of control may not exceed the greater of a pro-rata payout based
on target performance or payout of the Incentive based on actual performance. However, within certain time
periods and under certain conditions, the Committee may:
• require that all outstanding Incentives be exercised by a certain date;
• require the surrender to Lumen of some or all outstanding Incentives in exchange for a stock or cash payment
for each Incentive equal in value to the per share change of control value, calculated as described in the Plan,
over the exercise or base price, if any;
• make any equitable adjustment to outstanding Incentives as the Committee deems necessary to reflect our
corporate changes; or
• provide that an Incentive shall become an Incentive relating to the number and class of shares of stock or
other securities or property (including cash) to which the participant would have been entitled in connection
with the change of control transaction if the participant had been a shareholder.
Transferability of Incentives. No Incentives granted under the Plan may be transferred, pledged, assigned, or
otherwise encumbered by a participant except: (a) by will; (b) by the laws of descent and distribution;
(c) if permitted by the Committee and so provided in the applicable incentive agreement, pursuant to a
domestic relations order, as defined in the Code; or (d) as to options only, if permitted by the Committee and
so provided in the applicable incentive agreement, to immediate family members or to a partnership,
limited liability company or trust for which the sole owners, members or beneficiaries are the participant or
immediate family members.
Tax Withholding. We may withhold from any payments or share issuances under the Plan, or collect as a
condition of payment, any taxes required by law to be withheld. The participant may, but is not required to,
satisfy his or her withholding tax obligation by electing to deliver currently-owned Common Shares, or to have
us withhold shares from the shares the participant would otherwise receive, in either case having a value equal
to the maximum amount required to be withheld. This election must be made prior to the date on which the
amount of tax to be withheld is determined. The Committee has the right to disapprove of any such election,
except for participants who are subject to Section 16 of the Exchange Act.
Purchase of Incentives. The Committee may approve the repurchase by Lumen of an unexercised or unvested
Incentive from the holder by mutual agreement, so long as the repurchase would not constitute the repricing of
an option or SAR.
58
ITEM 3 Approval of Our 2024 Equity Incentive Plan
Incentive stock options may only be granted to employees. An employee generally will not recognize any
income upon the exercise of any incentive stock option, but the excess of the fair market value of the shares at
the time of exercise over the option price will be an item of tax preference, which may, depending on particular
factors relating to the employee, subject the employee to the alternative minimum tax imposed by Section 55 of
the Code. The alternative minimum tax is imposed in addition to the federal individual income tax, and it is
intended to ensure that individual taxpayers do not completely avoid federal income tax by using preference
items. An employee will recognize capital gain or loss in the amount of the difference between the exercise
price and the sale price on the sale or exchange of shares acquired pursuant to the exercise of an incentive
stock option, provided the employee does not dispose of such shares within two years from the date of grant
and one year from the date of exercise of the incentive stock option (the holding periods). An employee
disposing of such shares before the expiration of the holding periods will recognize ordinary income generally
equal to the difference between the option price and the fair market value of the shares on the date of exercise.
The remaining gain, if any, will be capital gain. We will not be entitled to a federal income tax deduction in
connection with the exercise of an incentive stock option, except where the employee disposes of the shares
received upon exercise before the expiration of the holding periods.
If the exercise price of a non-qualified option is paid by the surrender of previously-owned shares, the basis and
the holding period of the previously-owned shares carry over to the same number of shares received in
exchange for the previously-owned shares. The compensation income recognized on exercise of these options is
added to the basis of the shares received. If the exercised option is an incentive stock option and the shares
surrendered were acquired through the exercise of an incentive stock option and have not been held for the
holding periods, the optionee will recognize income on such exchange, and the basis of the shares received will
be equal to the fair market value of the shares surrendered. If the applicable holding period has been met on the
date of exercise, there will be no income recognition and the basis and the holding period of the previously
owned shares will carry over to the same number of shares received in exchange, and the remaining shares will
begin a new holding period and have a zero basis.
Stock Appreciation Rights. Generally, a participant who is granted a SAR under the Plan will not recognize any
taxable income at the time of the grant. The participant will recognize ordinary income upon exercise equal to
the amount of cash or the fair market value of the shares received on the day they are received.
In general, there are no federal income tax deductions allowed to Lumen upon the grant of SAR. Upon the
exercise of the SAR, however, we will be entitled to a deduction equal to the amount of ordinary income that
the participant is required to recognize as a result of the exercise, provided that the deduction is not otherwise
disallowed under Section 162(m).
Restricted Stock. Unless the participant makes an election to accelerate recognition of the income to the date
of grant under Section 83(b) of the Code (as described below), the participant will not recognize income,
and we will not be allowed a tax deduction, at the time the restricted stock award is granted. When the
restrictions lapse, the participant will recognize ordinary income equal to the fair market value of the shares as
of that date, and we will be allowed a corresponding federal income tax deduction at that time, subject to any
applicable limitations under Section 162(m). If the participant files an election under Section 83(b) of the Code
within 30 days of the date of grant of restricted stock, the participant will recognize ordinary income as of the
date of the grant equal to the fair market value of the shares as of that date, and we will be allowed a
corresponding federal income tax deduction at that time, subject to any applicable limitations under Section
162(m). Any future appreciation in the shares will be taxable to the participant at capital gains rates. If the shares
are later forfeited, however, the participant will not be able to recover the tax previously paid pursuant to a
Section 83(b) election.
Restricted Stock Units. A participant will not be deemed to have received taxable income upon the grant of
RSUs. The participant will be deemed to have received taxable ordinary income at such time as shares are
distributed with respect to the RSUs in an amount equal to the fair market value of the shares distributed to the
participant. Upon the distribution of shares to a participant with respect to RSUs, we will ordinarily be entitled to
a deduction for federal income tax purposes in an amount equal to the taxable ordinary income of the
participant, subject to any applicable limitations under Section 162(m). The basis of the shares received will
equal the amount of taxable ordinary income recognized by the participant upon receipt of such shares.
Other Stock-Based Awards. Generally, a participant who is granted an Other Stock-Based Award under the Plan
will recognize ordinary income at the time the cash or Common Shares associated with the award are received.
If shares are received, the ordinary income will be equal to the excess of the fair market value of the shares
received over any amount paid by the participant in exchange for the shares.
In the year that the participant recognizes ordinary taxable income in respect of such Incentive, we will be
entitled to a deduction for federal income tax purposes equal to the amount of ordinary income that the
participant is required to recognize, provided that the deduction is not otherwise disallowed
under Section162(m).
Section 162(m). Section 162(m) of the Code limits the amount of compensation paid to certain covered
employees that we may deduct for federal income tax purposes to $1 million per employee per year. Under
Section 162(m), “covered employees” consist of any individual who served as our CEO or CFO at any time
during the taxable year plus the three other most highly-compensated officers (other than the CEO and CFO)
for the taxable year. Once an individual becomes a covered employee for any taxable year beginning after
December 31, 2016, that individual will remain a covered employee for all future years, including after
termination of employment or even death. As a result, compensation payable to a covered employee under the
Plan that might otherwise be deductible may not be deductible if all compensation paid to the employee for the
taxable year exceeds $1 million.
Section 409A of the Code. If any Incentive constitutes non-qualified deferred compensation under Section
409A, it will be necessary that the Incentive be structured to comply with Section 409A to avoid the imposition
of additional tax, penalties, and interest on the participant.
Tax Consequences of a Change of Control. If, upon a change of control of Lumen, the exercisability, vesting,
or payout of an Incentive is accelerated, any excess on the date of the change of control of the fair market value
of the shares or cash issued under accelerated Incentives over the purchase price of such shares, if any, may be
characterized as “parachute payments” (within the meaning of Section 280G of the Code) if the sum of such
amounts and any other such contingent payments received by the employee exceeds an amount equal to three
times the “base amount” for such employee. The base amount generally is the average of the annual
compensation of the employee for the five years preceding such change in ownership or control. An “excess
parachute payment,” with respect to any employee, is the excess of the parachute payments to such person,
in the aggregate, over and above such person’s base amount. If the amounts received by an employee upon a
change of control are characterized as parachute payments, the employee will be subject to a 20% excise tax on
the excess parachute payment and we will be denied any deduction with respect to such excess
parachute payment.
The foregoing discussion summarizes the federal income tax consequences of Incentives that may be granted
under the Plan based on current provisions of the Code, which are subject to change. This summary does not
cover any foreign, state, or local tax consequences.
Plan Benefits. Awards under the Plan are subject to the discretion of the Committee and, except as noted
below, no determinations have been made by the Committee as to any awards that may be granted in the future
pursuant to the Plan. Therefore, it is not possible to determine the benefits that will be received in the future by
participants in the Plan.
Certain tables below, under “Compensation—Compensation Tables,” including the Summary Compensation
Table, Grants of Plan-Based Awards table, Outstanding Equity Awards table, and Stock Vesting Table, set forth
information with respect to prior awards granted to our NEOs under our stock incentive plans.
In early 2024, the Committee approved the following awards under the 2018 Plan to the individuals and groups
noted below:
Number of
Name and Position/Group TBRSs(1)
Kate Johnson, President and CEO 3,609,194
Chris Stansbury, EVP and CFO 1,393,022
Stacey W. Goff, EVP, General Counsel and Secretary —
Ashley Haynes-Gaspar, EVP and Chief Revenue Officer 595,200
Scott A. Trezise, Former EVP, Human Resources —
Executive Officer Group (4 persons) 5,597,416
Non-Employee Director Group 34,317
Non-Executive Officer Employee Group 5,597,037
(1)
The Committee also approved separate performance-based long-term cash incentive awards for our senior officers in lieu of the
equity-͏based performance awards granted in prior years, given the limited number of shares available under the 2018 Plan.
60
ITEM 3 Approval of Our 2024 Equity Incentive Plan
Vote Required
Approval of the Plan requires the affirmative vote of the holders of a majority of the votes cast on the proposal
at the meeting by holders of our Voting Shares.
Number of securities
Number of securities remaining available for
to be issued upon Weighted-average future issuance under
exercise of exercise price of plans (excluding
outstanding options outstanding options securities reflected in
Plan Category and rights (a)(1) and rights (b)(2) column (a)) (c)
Equity Compensation Plans approved 16,535,500 $— 10,909,097
by shareholders
Equity Compensation Plans not approved — $— —
by shareholders
(3) (4)
Totals 16,535,500 $— 10,909,097
(1)
These amounts include restricted stock units, some of which represent the difference between the number of shares of restricted stock
subject to market conditions granted at target and the maximum possible payout for these awards. Depending on performance, the actual
share payout of these awards may range between 0 and 200% of target.
(2)
The amounts in column (a) include restricted stock units, which do not have an exercise price.
(3)
This figure consists of 3,298,908 Common Shares subject to restricted stock units (RSUs). In addition, as of December 31, 2023, we had
24,753,874 unvested shares of restricted stock outstanding (which, when combined with the Common Shares subject to RSUs in the prior
sentence, yields a total of 28,052,782 full-value awards outstanding). These were the only types of equity awards outstanding as of
December 31, 2023.
(4)
Represents the number of shares remaining available for issuance as new awards under our 2018 Plan as of December 31, 2023.
Number of securities
Number of securities remaining available for
to be issued upon Weighted-average future issuance under
exercise of exercise price of plans (excluding
outstanding options outstanding options securities reflected in
Plan Category and rights (a)(1) and rights (b)(2) column (a)) (c)
Equity Compensation Plans approved 12,532,528 $— 5,974,868
by shareholders
Equity Compensation Plans not approved — $— —
by shareholders
(3) (4)
Totals 12,532,528 $— 5,974,868
(1)
These amounts include restricted stock units, some of which represent the difference between the number of shares of restricted stock
subject to market conditions granted at target and the maximum possible payout for these awards. Depending on performance, the actual
share payout of these awards may range between 0 and 200% of target.
(2)
The amounts in column (a) include restricted stock units, which do not have an exercise price.
(3)
This figure consists of 2,412,990 Common Shares subject to restricted stock units (RSUs). In addition, as of March 21, 2024, we had
29,833,854 unvested shares of restricted stock outstanding (which, when combined with the Common Shares subject to RSUs in the prior
sentence, yields a total of 32,246,844 full-value awards outstanding). These were the only types of equity awards outstanding as of March
21, 2024.
(4)
Represents the number of shares remaining available for issuance as new awards under our 2018 Plan as of March 21, 2024. If the Plan is
approved by our shareholders, these shares will be cancelled.
62
ITEM 4 Ratify the Amendment and Restatement of Our NOL Rights Plan
The Rights. Beginning on February 25, 2019 and ending on the Distribution Date or earlier expiration of the
Rights, the Rights have traded with and will continue to trade with, and have been inseparable from and will
continue to be inseparable from, our Common Shares outstanding during this period, including Common Shares
issued hereafter.
Exercise Price. Each Right allows its holder to purchase from the Company one ten-thousandth of a share of
Series CC Junior Participating Preferred Stock (“NOL Preferred Share”) for $9, subject to adjustment (the
“Exercise Price”), once the Rights become exercisable. This fraction of a NOL Preferred Share is intended to
provide the shareholder approximately the same dividend, voting and liquidation rights as would one share of
common stock. Prior to exercise, each Right does not give its holder any dividend, voting, or liquidation rights.
We refer to the date when the Rights become exercisable as the “Distribution Date.” Until that date or earlier
expiration of the Rights, each Common Share (whether certificated or book-entry) also evidences the Rights,
and any transfer of our Common Shares also constitutes a transfer of Rights. After the Distribution Date,
the Rights will separate from our Common Shares and be evidenced by book-entry credits or by Rights
certificates that we will mail or furnish to all eligible holders of our Common Shares. Any Rights held by an
Acquiring Person, or any Affiliates or Associates thereof, will be void and will not be exercisable.
Consequences of a Person or Group Becoming an Acquiring Person. If a person or group becomes an
Acquiring Person, all holders of Rights except the Acquiring Person, or any Affiliates or Associates of the
Acquiring Person, may, upon payment of the Exercise Price and subject to the terms and conditions of the
Restated Plan, purchase our Common Shares with an aggregate market value of twice the Exercise Price,
based on the “current per share market price” of our Common Shares (as defined in the Restated Plan) on the
date of the acquisition that resulted in such person or group becoming an Acquiring Person.
Exchange. After a person or group becomes an Acquiring Person, our Board in its sole discretion may extinguish
the Rights by exchanging one Common Share or an equivalent security for each Right, other than Rights held by
the Acquiring Person or any Affiliates or Associates of the Acquiring Person.
Preferred Share Provisions. Subject to adjustment in certain instances, each one ten-thousandth of a NOL
Preferred Share, if issued:
• would not be redeemable;
• would entitle holders to dividends equal to the dividends, if any, paid on one Common Share;
• would entitle holders upon liquidation either to receive $1.00 or an amount equal to the payment made on
one Common Share, whichever is greater;
• would vote together with the Common Shares as one class on all matters submitted to a vote of our
shareholders and would have the same voting power as one Common Share, except as otherwise provided by
law; and
• would entitle holders to a per share payment equal to the payment made on one Common Share, if our
Common Shares are exchanged via merger, consolidation, or a similar transaction.
Exercisability. The Rights will not be exercisable until 10 business days (as may be extended in the sole
discretion of the Board) after the public announcement that a person or group has become an Acquiring Person
unless the Restated Plan is theretofore terminated or the Rights are theretofore redeemed (as described below).
Redemption. Our Board may redeem the Rights for $0.0001 per Right at any time before the Distribution Date.
If our Board redeems any Rights, it must redeem all of the Rights. Once the Rights are redeemed, the only right
of the holders of Rights will be to receive the redemption price of $0.0001 per Right (the “Redemption Price”),
subject to adjustment as noted below.
Expiration. The Rights will expire on the earliest of (i) December 1, 2026, (ii) the time at which the Rights are
redeemed, (iii) the time at which the Rights are exchanged, (iv) the time at which the Board determines that the
Company’s NOLs are utilized in all material respects or that an ownership change under Section 382 of the Code
would not adversely impact in any material respect the time period in which the Company could use the NOLs,
or materially impair the amount of the NOLs that could be used by the Company in any particular time period,
for applicable tax purposes, (v) December 1, 2024 if approval of the Restated Plan by the affirmative vote of a
majority of the votes cast at a duly called shareholders meeting has not been obtained prior to such date, or (vi)
a determination by the Board, prior to the Distribution Date, that the Restated Plan and the Rights are no longer
in the best interests of the Company and its shareholders.
Adjustment Provisions. Upon the terms and conditions specified in the Restated Plan, one or more of the
Exercise Price, the number of NOL Preferred Shares issuable per Right, the number of outstanding Rights and
the Redemption Price are subject to adjustment in connection with a stock dividend, a subdivision,
a combination or consolidation of our Common Shares or NOL Preferred Shares (by reclassification or
otherwise) or any similar transaction in order to preserve equivalent rights of the holders of Rights. Pursuant to
Item 5A of this proxy statement, the Board is soliciting approval at the annual meeting] of a proposal that would
grant the Board discretionary authority to amend our articles of incorporation to effect a reverse stock split. If
such proposal is approved and implemented, (i) each Right would entitle its holder to purchase a larger number
of one-ten-thousandths of a NOL Preferred Share in exchange for the Exercise Price and (ii) the Redemption
Price would be increased, in each case in accordance with the adjustment provisions in the Restated Plan.
Amendments. The terms of the Restated Plan may be amended without the consent of the holders of the
Rights, including to effect additional extensions of the expiration date of the Rights in the future. After any
Distribution Date, the Restated Plan may not be amended in a way that adversely affects holders of the Rights
(other than an Acquiring Person, or an Affiliate or Associate thereof).
Vote Required
Approval of this proposal will require the affirmative vote of the holders of a majority of the votes cast on the
proposal at the meeting by holders of our Voting Shares.
64
ITEMS 5A, 5B, and 5C
Amendments to Articles to Authorize a
Reverse Stock Split, Reduce our
Authorized Common Shares, and
Eliminate the Par Value of our
Common Shares
Under Item 5A (the “Reverse Split Proposal”), the Board is recommending that our shareholders grant the Board
discretionary authority to amend our Articles of Incorporation to effect a reverse stock split on the terms and
conditions described herein (a “Reverse Stock Split”). Under closely-related Items 5B and 5C, the Board is also
recommending to amend our Articles of Incorporation to reduce the number of our authorized Common Shares
and to eliminate the par value of our Common Shares, respectively, on the terms and conditions specified below.
Attached hereto as Appendix E is the text of the proposed form of Articles of Amendment to our Articles of
Incorporation (the “Articles of Amendment”), which reflects all of the amendments proposed pursuant to Items
5A, 5B and 5C
ITEM 5A
Approval of a Reverse Stock Split
We are proposing that the Board have the discretion to select the Reverse Stock Split ratio (the “Reverse Split
Ratio”) from within a range between and including one-for-fifteen (1:15) shares and one-for-twenty-five (1:25)
shares, rather than proposing a specific fixed ratio at this time. We believe that enabling the Board to set the
Reverse Split Ratio within this stated range will provide the Board with the flexibility to implement a Reverse
Stock Split at a ratio reflecting the Board’s then-current assessment of the factors described below under the
heading “—Criteria to be Used for Determining Whether to Implement a Reverse Stock Split” and thereby
enhance our ability to implement a Reverse Stock Split that maximizes the anticipated benefits for our
shareholders. If the Board decides to implement a Reverse Stock Split, we would file the Articles of Amendment
with the Secretary of State of the State of Louisiana (the “Louisiana Secretary of State”), reflecting the Reverse
Split Ratio selected by the Board. The Reverse Stock Split would be effective (the “Effective Date”) when the
Articles of Amendment are filed with the Louisiana Secretary of State, or such later date and time as is chosen
by the Board and set forth in the Articles of Amendment. Except for adjustments that may result from the
treatment of fractional share interests as described below, each of our shareholders will hold the same
percentage of our outstanding Common Shares immediately following the Reverse Stock Split as such
shareholder holds immediately prior to the Reverse Stock Split.
At any time prior to filing Articles of Amendment implementing a Reverse Stock Split, the Board reserves the
right to forego implementing any Reverse Stock Split approved at the meeting if it determines, in its sole
discretion, that effectuating a Reverse Stock Split is no longer in the best interests of the Company and its
shareholders. If the Board does not implement a Reverse Stock Split prior to the one-year anniversary of the
date on which this Reverse Split Proposal is approved by the shareholders at the meeting (the “Approval
Anniversary Date”), the authority granted in this proposal to implement a Reverse Stock Split will terminate.
Although this Reverse Split Proposal affords the Board sole discretion regarding whether and when to
implement a Reverse Stock Split, the Board currently plans to effect a Reverse Stock Split promptly after receipt
of shareholder approval of this proposal.
66
ITEM 5A Approval of Reverse Stock Split
Certain Risks and Potential Disadvantages Associated with a Reverse Stock Split
We cannot assure you that a Reverse Stock Split would increase our stock price. We expect that a Reverse
Stock Split would increase the per share market price of our common stock to a level that could attract more
investors. However, the effect of a Reverse Stock Split on the per share market price of our common stock
cannot be predicted with any certainty, and the history of reverse stock splits for other companies is varied,
particularly since some investors may view a reverse stock split negatively. It is possible that the per share
market price of our common stock after a Reverse Stock Split would not increase in the same proportion as the
reduction in the number of our outstanding Common Shares following the Reverse Stock Split, which would
cause a reduction in the value of the Company as measured by our market capitalization. In addition, it is also
possible that a Reverse Stock Split may not result in a per share market price that would attract increased
investor interest in our stock. Although we believe a Reverse Stock Split may enhance the desirability of our
Common Shares to certain potential investors, we cannot provide you with any assurances to this effect. Even if
we successfully implement a Reverse Stock Split, the market price of our common stock may thereafter
decrease due to factors unrelated to the Reverse Stock Split, including our results of operations or financial
position. If a Reverse Stock Split is consummated and the per share market price of the common stock declines,
the percentage decline as a percentage of our overall market capitalization may be greater than would occur in
the absence of a Reverse Stock Split.
A Reverse Stock Split may decrease the liquidity of our common stock and result in higher transaction costs
for “odd lot” positions of less than 100 shares. The liquidity of our common stock may be negatively impacted
by a Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse
Stock Split, particularly if the stock price does not increase as a result of the Reverse Stock Split. In addition, if a
Reverse Stock Split is implemented, it would likely increase the number of our shareholders who own “odd lots”
of fewer than 100 Common Shares. Brokerage commission and other costs of transactions in odd lots are
generally higher than the costs of transactions of 100 or more Common Shares. Accordingly, a Reverse Stock
Split may not achieve the desired results of increasing marketability and lowering trading costs of our Common
Shares described above.
The effective increase in the authorized number of shares of our common stock available for issuance as a
result of the Reverse Stock Split could have anti-takeover or other negative implications. Regardless of
whether Item 5B is approved by our shareholders, the implementation of a Reverse Stock Split would, as
described in greater detail below, effectively result in an increase in the proportionate number of our authorized
Common Shares available for issuance in relation to our outstanding Common Shares. See “Item 5B – Approval
of a Reduction of Our Authorized Shares—Reasons for the Share Reduction Proposal; Certain Risks.”
The additional Common Shares that would become available for issuance could be used by us in a manner
objectionable to shareholders, including to authorize dilutive transactions, to oppose a hostile takeover attempt
or to delay or prevent changes in control of the Company or our management. For example, to defend against
offers determined to be inadequate, the Board could authorize the issuance of additional Common Shares so as
to dilute the stock ownership or voting power of persons seeking to obtain control of the Company, even if the
persons seeking to obtain control of the Company offered an above-market premium that is favored by a
majority of shareholders. Any such issuance of Common Shares, or proposal to issue Common Shares,
could cause the potential acquiror to terminate its takeover attempt or make it more difficult for the potential
acquiror to successfully complete its proposed takeover. Although we are not proposing Items 5A and 5B to
deter any takeover attempt, shareholders should be aware that our implementation of a Reverse Stock Split on
the terms proposed by us hereunder could facilitate future efforts by us to deter or prevent takeover proposals
that our Board determines do not adequately value the Company, including transactions in which the
shareholders might otherwise receive a premium for their shares over then-current market prices.
68
ITEM 5A Approval of Reverse Stock Split
The following table contains illustrative information, based on share data as of March 21, 2024, intended to show
the impacts of implementing a Reverse Stock Split based on certain potential Reverse Split Ratios (without
giving effect to the treatment of fractional share interests), assuming that the 2024 Equity Incentive Plan
Proposal and Share Reduction Proposal are both approved:
Number of Number of Common
Number of Common Shares Number of Common Shares Authorized but
Common Shares Issued and Shares Reserved for Unissued and
Potential Scenarios Authorized Outstanding Future Issuance Unreserved
Pre-Reverse Stock Split 2,200,000,000 1,016,005,958 43,000,000 1,140,994,042
Post-Reverse Stock Split 1:15 200,000,000 67,733,731 2,866,667 129,399,602
Post-Reverse Stock Split 1:20 200,000,000 50,800,298 2,150,000 147,049,702
Post-Reverse Stock Split 1:25 200,000,000 40,640,238 1,720,000 157,639,762
The following table contains illustrative information, based on share data as of March 21, 2024, intended to show
the impacts of implementing a Reverse Stock Split based on certain potential Reverse Split Ratios (without
giving effect to the treatment of fractional share interests) assuming that the 2024 Equity Incentive Plan
Proposal is approved and the Share Reduction Proposal is not approved:
After the Effective Date of any Reverse Stock Split that the Board elects to implement, our common stock
would have a new CUSIP number, which is a number used to identify our Common Shares.
Our common stock is currently registered under Section 12(b) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and we are subject to the periodic reporting and other requirements of the
Exchange Act. The implementation of any proposed Reverse Stock Split would not affect the registration of our
common stock under the Exchange Act. We anticipate that our Common Shares would continue to be listed on
the NYSE under the symbol “LUMN” immediately following any Reverse Stock Split.
As of March 21, 2024, there were 77,671 shareholders of record of our Common Shares (which excludes
beneficial owners of our Common Shares). If the shareholders approve this Reverse Split Proposal and the
Board elects to implement it, shareholders owning, prior to the Reverse Stock Split, less than the number of
whole shares of common stock that will be combined into one share of common stock in the Reverse Stock Split
would no longer be shareholders. For example, if a shareholder held 10 Common Shares immediately prior to the
Reverse Stock Split and the Reverse Split Ratio selected by the Board was 1:15, such shareholder would cease to
be a shareholder of the Company following the Reverse Stock Split and would not have any voting, dividend or
other rights, except the right to receive the cash payment described above. Based on our shareholders of record
as of March 21, 2024, and based upon our Reverse Split Ratio range of 1:15 to 1:25, we expect that cashing out
fractional shareholders would reduce the number of shareholders of record to a range of 34,670 to 44,737
holders, respectively.
This reduction in the number of our record shareholders would be incidental to implementing a Reverse Stock
Split. We have not proposed this Reverse Split Proposal for this purpose, and we do not intend for this
transaction to be the first step in a series of plans or proposals of a “going private transaction” within the
meaning of Rule 13e-3 of the Exchange Act.
No Appraisal Rights
Under the LBCA, shareholders will not be entitled to appraisal rights with respect to this Reverse Split Proposal.
70
ITEM 5A Approval of Reverse Stock Split
Certain U.S. Federal Income Tax Considerations Related to a Reverse Stock Split
The discussion below is only a summary of certain U.S. federal income tax considerations generally applicable to
beneficial holders of Common Shares if we implement a Reverse Stock Split and does not purport to be a
complete discussion of all possible tax considerations or consequences. This summary addresses only those
shareholders who hold their pre-Reverse Stock Split shares as “capital assets” as defined in the Internal Revenue
Code of 1986, as amended (the “Code”), and will hold their post-Reverse Stock Split shares as capital assets.
This discussion does not address all U.S. federal income tax considerations or consequences that could be
relevant to particular shareholders in light of their individual circumstances or to shareholders that are subject to
special rules, such as financial institutions, tax-exempt organizations, insurance companies, securities dealers,
and foreign shareholders. The following summary is based upon the provisions of the Code, applicable Treasury
Regulations thereunder, judicial decisions and current administrative rulings, as of the date hereof, all of which
are subject to change, possibly on a retroactive basis. Tax considerations and consequences under state, local,
foreign, and other laws are not addressed herein. Each shareholder should consult his, her or its own tax advisor
as to the particular facts and circumstances that could be unique to such shareholder and also as to any estate,
gift, state, local or foreign tax considerations arising out of any Reverse Stock Split.
Any Reverse Stock Split implemented by us will qualify as a recapitalization for U.S. federal income tax
purposes. As a result:
• shareholders should not recognize any gain or loss as a result of the Reverse Stock Split, except as described
below with respect to cash received in lieu of fractional share interests;
• the aggregate basis of a shareholder’s pre-Reverse Stock Split Common Shares will become the aggregate
basis of the Common Shares held by such shareholder immediately after the Reverse Stock Split (excluding
any portion of such basis that is allocated to a fractional interest in a Common Share); and
• the holding period of the shares owned immediately after the Reverse Stock Split will include the
shareholder’s holding period of the pre-Reverse Stock Split Common Shares.
A shareholder who receives cash in lieu of a fractional interest in a Common Share should be treated as first
receiving such fractional share interest and then receiving cash in redemption of such fractional share
interest. A shareholder who receives cash in lieu of a fractional share interest should recognize capital gain or
loss equal to the difference between the amount of the cash received in lieu of the fractional share interest
and the portion of the shareholder’s adjusted tax basis allocable to the fractional share interest. Such gain or
loss generally will be long-term capital gain or loss if the shareholder’s holding period in its pre-Reverse
Stock Split Common Shares is more than one year as of the Effective Date. The deductibility of net capital
losses by individuals and corporations is subject to limitations. Shareholders should consult their tax advisors
regarding the tax effects to them of receiving cash in lieu of a fractional share interest based on their
particular circumstances.
A shareholder may be subject to information reporting with respect to any cash received in exchange for a
fractional share interest. Shareholders who are subject to information reporting and who do not provide a
correct taxpayer identification number and other required information (such as by submitting a properly
completed Internal Revenue Service Form W-9) may also be subject to backup withholding at the applicable
rate. Any amount withheld under such rules is not an additional tax and may be refunded or credited against
the shareholder’s U.S. federal income tax liability, provided that the required information is properly
furnished in a timely manner to the Internal Revenue Service. THE ABOVE DISCUSSION IS NOT INTENDED TO
BE USED BY ANY PERSON, FOR THE PURPOSE OF AVOIDING U.S. FEDERAL TAX PENALTIES. IT HAS BEEN
PROVIDED SOLELY IN CONNECTION WITH PROVIDING INFORMATION IN CONNECTION WITH SOLICITING
VOTES IN FAVOR OF THIS REVERSE SPLIT PROPOSAL.
Required Vote
Approval of this Reverse Split Proposal requires the affirmative vote of at least a majority of the votes entitled
to be cast on this proposal by holders of our Voting Shares. You may vote “FOR,” “AGAINST,” or “ABSTAIN” on
this Reverse Split Proposal. Abstentions and uninstructed shares will have the same effect as a vote against
this proposal.
The Board recommends that you vote FOR approval of the Reverse Split Proposal.
The Board is recommending that our shareholders approve an amendment to our Articles of Incorporation to
reduce the number of authorized shares of our common stock from 2,200,000,000 to 200,000,000 (the “Share
Reduction Proposal”), which would be effectuated if and only if Item 5A is both approved and implemented.
The text of the proposed Articles of Amendment is attached as Appendix E, which reflects all of the
amendments proposed pursuant to Items 5A, 5B and 5C.
The implementation of this Share Reduction Proposal is expressly conditioned upon the approval by the
shareholders of the Reverse Split Proposal and implementation of a Reverse Stock Split at the discretion of the
Board, as described in Item 5A above. Accordingly, if we do not receive the required shareholder approval for
the Reverse Split Proposal, or if no Reverse Stock Split is implemented on or prior to the Approval Anniversary
Date, we will not implement this Share Reduction Proposal. On the other hand, the Board’s authorization to
implement a Reverse Stock Split is not conditioned in any way upon the approval by the shareholders of this
Share Reduction Proposal. If the shareholders approve the Reverse Split Proposal but do not approve this Share
Reduction Proposal, the Board will nonetheless retain the ability to implement a Reverse Stock Split and, if so
effected, the total number of our authorized Common Shares would remain unchanged.
72
ITEM 5B Approval of Reduction of Our Authorized Common Shares
No Appraisal Rights
Pursuant to the LBCA, shareholders will not be entitled to appraisal rights with respect to this Share
Reduction Proposal.
Required Vote
Approval of this Share Reduction Proposal requires the affirmative vote of at least a majority of the votes
entitled to be cast on this proposal by holders of our Voting Shares. You may vote “FOR,” “AGAINST,”
or “ABSTAIN” on this Shares Reduction Proposal. Abstentions and uninstructed shares have the same effect as
a vote against this proposal.
The Board recommends that you vote FOR approval of the Share Reduction Proposal.
ITEM 5C
Approval of Elimination of the Par
Value of Our Common Shares
The Board is recommending that the shareholders approve an amendment to our Articles of Incorporation to
eliminate the $1.00 per share par value of our common stock so that each of our Common Shares have no par
value (the “Par Value Elimination Proposal”). If the shareholders approve this Par Value Elimination Proposal,
then our Articles of Incorporation would be amended to eliminate the par value of our common stock and all of
our authorized as well as issued and outstanding Common Shares would be designated as having no par value.
The text of the proposed Articles of Amendment is attached as Appendix E, which reflects all of the
amendments proposed pursuant to Items 5A, 5B and 5C.
The par value of our common stock currently is reflected in its financial statements by an amount equal to the
number of Common Shares issued and outstanding, multiplied by the par value of $1.00. Upon the approval of
this Par Value Elimination Proposal, for accounting purposes we plan to revise our balance sheet presentation to
combine all accounts reflected as “Common Stock” or “Additional paid-in capital” into a single line item called
“Common Stock.” There will be no other effect on our financial statements.
For the foregoing reasons, and since the Board believes that par value is unrelated to the intrinsic or market
value of our Common Shares, the Board recommends eliminating the par value of our common stock,
as permitted under the LBCA.
No Appraisal Rights
Pursuant to the LBCA, shareholders will not be entitled to appraisal rights with respect to this Par Value
Elimination Proposal.
Required Vote
Approval of this Par Value Elimination Proposal requires the affirmative vote of at least a majority of the votes
entitled to be cast on this proposal by holders of our Voting Shares. You may vote “FOR,” “AGAINST,” or
“ABSTAIN” on this Par Value Elimination Proposal. Abstentions and uninstructed shares have the same effect as
a vote against this proposal.
The Board recommends that you vote FOR approval of the Par Value Elimination Proposal.
74
Our Executive Officers
We currently have four executive officers. Biographical information for each of them (other than Ms. Johnson,
who also serves as a director and whose biography may be found under “Board of Directors and Governance –
Our Director Nominees”) is found below:
• Ashley Haynes-Gaspar joined Lumen in January 2023 and served as Lumen’s Executive
Vice President, Chief Experience Officer from January to December 2023 and was
appointed Executive Vice President, Chief Revenue Officer in January 2024.
• With nearly 25 years of marketing, sales and operations experience, Ms. Haynes-
Gaspar is responsible for Lumen’s global sales and customer success.
Ashley Haynes- • Ms. Haynes-Gaspar previously served as the Chief Operating Officer for the U.S.
Gaspar Industry and Business Applications division at Microsoft Corporation from 2017
46 years old through December 2022. Prior to that, Ms. Haynes-Gaspar held various marketing and
Executive Vice general manager positions at General Electric Company.
President, Chief
Revenue Officer
• Stacey W. Goff is Executive Vice President, General Counsel and Secretary for Lumen.
• Mr. Goff is responsible for Lumen’s legal function, as well as community relations and
public policy functions.
• Mr. Goff joined Lumen in 1998 and has served as General Counsel since 2009.
Stacey W. Goff
58 years old
Executive Vice
President,
General Counsel
and Secretary
• Christopher Stansbury has served as Lumen’s Executive Vice President, Chief Financial
Officer since April 2022.
• Mr. Stansbury has global responsibility for financial planning, accounting, tax, treasury,
investor relations, procurement and supply chain management and the global real
estate portfolio.
• Mr. Stansbury previously served as the Senior Vice President and Chief Financial
Christopher Officer of Arrow Electronics, Inc. from May 2016 through March 2022. Prior to that,
Stansbury
Mr. Stansbury served as Vice President, Finance, and Chief Accounting Officer of
58 years old Arrow Electronics, Inc. beginning in August 2014.
Executive Vice • Prior to joining Arrow Electronics, Inc., Mr. Stansbury held finance positions at Hewlett-
President, Chief Packard, Inc. and PepsiCo, Inc.
Financial Officer
Each year, we provide our shareholders the opportunity to vote on a non-binding, advisory resolution to
approve the compensation of our named executive officers (NEOs) as disclosed in our annual proxy statements
in accordance with SEC rules.
Under our executive compensation programs, our NEOs are rewarded for achieving specific annual and
long-͏term goals, as well as increased shareholder value. We believe this structure aligns executive pay with our
financial performance and the creation of sustainable shareholder value. The Human Resources and
Compensation Committee of our Board (HRCC) continually reviews our executive compensation programs to
ensure they achieve the goals of aligning our compensation with both current market practices and your
interests as shareholders.
As discussed in greater detail elsewhere in this proxy statement, the HRCC spends considerable time and effort
to ensure that not only do we have the right leadership in place, but also that our executive compensation
programs continue to appropriately incentivize and reward each key member of the team in a manner that
aligns with shareholder interests. In recent years, the HRCC has also placed a significant emphasis on
shareholder outreach and taking action in response to the input we received from shareholders. For additional
information on our executive compensation programs generally and our recent compensation actions
specifically, we urge you to read the “Compensation Discussion & Analysis” and “Compensation Tables” sections
of this proxy statement.
At the meeting, we will ask you to vote, in an advisory manner, to approve the overall compensation of our
NEOs, as described in this proxy statement, including the Compensation Discussion & Analysis, the Summary
Compensation Table and the other related tables and disclosures. This proposal, commonly known as a
“say-on-pay” proposal, gives you the opportunity to express your views. This advisory vote is not intended to
address any specific element of compensation, but rather relates to the overall compensation of our NEOs and
our executive compensation policies and practices as described in this proxy statement. Accordingly, your vote
will not directly affect or otherwise limit any existing compensation or award arrangement of any of our NEOs.
While this “say-on-pay” vote is advisory and will not be binding on our Company or the Board, it will provide
valuable information for future use by our HRCC regarding shareholder sentiment about our executive
compensation. We understand that executive compensation is an important matter for our shareholders.
Accordingly, we invite shareholders who wish to communicate with our Board on executive compensation
or any other matters to contact us as provided under “Board of Directors and
Governance–Shareholder Engagement.”
Approval of this proposal will require the affirmative vote of the holders of a majority of the votes cast on the
proposal at the meeting.
76
Compensation Discussion
& Analysis
The Compensation Discussion & Analysis (CD&A) is divided into five sections: (1) Executive Summary; (2)
Compensation Philosophy and Oversight; (3) Pay and Performance Alignment; (4) Compensation Design,
Awards and Payouts for 2023; and (5) HRCC Engagement and Compensation Governance. Please refer to the
roadmap below in order to navigate this portion of the proxy statement.
Roadmap
Compensation Discussion & Analysis 77
Section One - Executive Summary 78
Executive Summary 78
2023 Executive Compensation Aligned with Business Performance 80
Continued Leadership Transition 81
Our Compensation Best Practices 83
2023 Shareholder Engagement Highlights 84
Section Two - Compensation Philosophy and Oversight 85
Compensation Objectives and Design 85
Our Pay Elements 89
Section Three - Pay and Performance Alignment 90
Pay Mix 90
Realized and Realizable Pay for Our NEOs 91
Section Four - Compensation Design, Awards and Payouts for 2023 92
Target Compensation 92
Base Salary 93
2023 Short-Term Incentive Program 93
2023 Long-Term Incentive Compensation 98
LTI Linkage to Performance - No Payouts Under 2021 PBRS Awards 102
LTI Governance and Oversight 103
Compensation Arrangements Related to Leadership Transition 105
Other Benefits 107
Section Five - HRCC Engagement and Compensation Governance 109
Role of Human Resources and Compensation Committee 109
Year-round Engagement Informs Compensation Design and Awards 110
HRCC Executive Compensation Review Process 111
Role of CEO and Management 111
Role of Compensation Consultants 112
Role of Peer Companies 112
Stock Ownership Guidelines 116
Human Resources and Compensation Committee Report 117
President & Chief Executive Vice President, Executive Vice President, Executive Vice President,
Executive Officer Chief Financial Officer Chief Revenue Officer General Counsel
& Secretary
As previously disclosed and described elsewhere herein, Mr. Trezise ceased serving as EVP, Human Resources
with Lumen effective April 24, 2023, and was involuntarily terminated on April 5, 2024.
Executive Summary
As described in greater detail throughout this proxy statement, for the last few years our performance has fallen
short of our desired financial results and stock performance. In response to our performance, our Board, CEO,
Senior Leadership Team and HRCC have spent considerable time and effort developing a multi-year
transformation strategy that we believe will reposition us for stabilization and growth. The primary objectives of
this transformation strategy can be summarized as follows:
• Business Transformation: Streamline our business by monetizing non-core assets and deploy our capital to
invest for growth and strengthen our balance sheet.
• Operational Transformation: Execute on our three-pronged strategy to secure the base by creating more
durable revenue streams, drive commercial excellence through sales and other go-to-market enhancements,
and innovate for growth (described in greater detail in the “About Lumen” section of this proxy statement).
• Leadership Transformation: Ensure that we have a leadership team in place who know how to deliver high-
impact results and who can guide us on a path to growth (described in greater detail in “Continued
Leadership Transition” later in this CD&A).
• Incentive Programs Aligned with our Strategy and Performance: Ensure our compensation programs support
our efforts to incentivize and retain this new leadership team, which is essential to our ability to execute on
our transformation strategy (described in greater detail throughout this CD&A).
Our transformation began in earnest with the hiring of a new CEO and CFO and completion of two divestitures
in 2022. During 2023, we completed our third major divestiture, hired four new leaders and revised our
short-term incentive program in light of our changing business strategy. The HRCC restructured our 2024
long-term incentive program to conserve shares by shifting from 60% performance-based equity to 60%
performance-based cash awards and proposed creating a 43 million share equity pool under a new 2024 Equity
Incentive Plan, subject to shareholder approval at the meeting.
78
Compensation Discussion & Analysis
The following table summarizes our timeline and achievements under our transformation strategy objectives
during 2022, 2023 and early 2024:
(1)
For more complete information on Lumen, our business transformation and our recent performance, see the remainder of this proxy
statement, including “About Lumen” and Appendix B.
(2)
See “Continued Leadership Transition” for more information on on-boarding compensation and severance packages for departing NEOs.
(3)
See “Item 3 - Approval of Our 2024 Equity Incentive Plan” for more information.
Revenue: Improving the revenue trajectory of our business is critical to achieving our strategy.
In 2023, we achieved $14,526 million of Revenue, which was below our target.
Customer experience: During 2023, we achieved slight gains for most of our Customer
Experience categories and outperformed the average for our industry.
The chart below shows our overall level of achievement and company performance funding for the financial and
qualitative metrics in our 2023 STI plan:
Dollars in Millions
Customer Met
100.0% 15.0%
Experience Expectations
80
Compensation Discussion & Analysis
(1)
For more information on our Adjusted EBITDA and Revenue targets see “Section Two - Compensation Philosophy and Oversight — Rigorous
Design and Target Goal Setting Process” and “Section Four - Compensation Design, Awards and Payouts for 2023 — 2023 Short-Term
Incentive Program.”
Relative TSR Modifier: Our stock performance for three-year period ending December 31, 2023
was -81.18%, which was the 0th percentile relative to our peers.
Dollars in Millions
Cumulative
Adjusted 91.8% 0.0% 0.0%
EBITDA
(1)
For more information on our Cumulative Adjusted EBITDA target see “Section Two - Compensation Philosophy and Oversight — Rigorous
Design and Target Goal Setting Process.”
(2)
If Lumen’s TSR is negative over the three-year period, the payout cannot exceed target regardless of our TSR performance relative to
our peers.
What’s New
“In our journey to become a growing, customer-obsessed business, we will continue to hire leaders who
know how to deliver high-impact results,” said Kate Johnson, President and CEO of Lumen.
During 2023, we brought in four new members of our senior leadership team, one of whom (Ms. Haynes-Gaspar)
is an NEO whose compensation is described further below and elsewhere in this proxy statement. In early 2024,
we hired three additional members of our senior leadership team and announced the termination of Mr. Trezise,
one of the longer-standing NEOs.
Our new senior leadership team brings deep and diverse experiences to Lumen and are energized to drive the
transformation described above. As is often seen in such periods of leadership team transformations, there were
on-boarding payments associated with new hire packages (the majority of which were awarded in the form of
equity and aligns their interests with our shareholders by providing immediate equity stake in the Company),
transition awards to key executives and severance payments to departing executives. While we are committed
to limiting the use of these payments and adhering to best practices when doing so, our Board determined they
were essential to pursuing our long-term strategy to transform our Company and build the leadership team
required for the challenges and opportunities ahead. For more information, see “Section Four — Compensation
Related to Leadership Transition.”
82
Compensation Discussion & Analysis
Spring Engagement: Following the filing of our 2023 proxy 2023 Say-on-Pay Vote
statement, we engaged our top 30 shareholders, representing Results: At our 2023 annual
approximately 60% of shares outstanding, to hear their feedback on meeting, we received support
executive compensation actions during 2022 and considerations from the holders of 87% of
going forward. the shares voted on our
say-on-pay proposal.
What We Heard: The shareholders we met with provided positive
feedback on the compensation packages for our CEO and CFO
during 2022. Specifically, these shareholders indicated that our
compensation programs were aligned with our business strategy
and our STI and LTI payouts (for performance periods ending
December 31, 2022) were appropriately linked with performance.
Fall Engagement: Given our stock performance and limited equity Response to Shareholder
pool available for future grants, we undertook a significant effort to Feedback: The HRCC reviewed
seek input from shareholders as the HRCC considered changes to shareholder feedback and
our 2024 compensation programs and a new equity plan proposal. approved the following
changes to our 2024 LTI
We also met with one of the major proxy advisors in December
awards: shift the 60%
2023. This meeting was attended by our Chairman of the Board
performance-based portion
(who is also a member of the HRCC), Chair of HRCC and Chair of
from equity to cash, which we
NCG Committee in addition to members of management.
intend to be temporary, and
What We Heard: The shareholders and proxy advisor we held add a +/-20% revenue kicker
meetings with provided feedback on metrics for our incentive to the cumulative adjusted
compensation programs, our upcoming proposal to replenish our EBITDA metric.
equity pool and changes for our 2024 LTI awards given our recent
These are discussed in greater
stock performance. In addition to these discussions we also met
detail at "Changes to 2024
with shareholders who were focused on our culture and
LTI Design.”
ESG strategies.
(1)
For more information, see “Shareholder Engagement - By the Numbers: Shareholder Engagement in 2023”
We look forward to continuing to engage in productive dialogue with our stakeholders on all governance and
stewardship matters, including compensation.
84
Compensation Discussion & Analysis
Challenging Goals Setting short-and long-term targets at challenging See “Section Four -
but reasonably achievable levels that reflect Compensation Design,
priorities and drive progress toward our Awards and Payouts
long-term vision for 2023”
Formulaic Maintaining STI and LTI programs with formulaic See “Section Four -
payouts that are determined based on actual Compensation Design,
performance against challenging financial and Awards and Payouts for
operational goals; with limited adjustments, positive 2023” and “Incentive
or negative, as permitted and outlined in our Program Guidelines” in
Incentive Program Guidelines described herein. this section
Pay and Performance Assessing effectiveness of prior year(s) incentive See “Section Three - Pay
Alignment designs and targets on a quarterly basis and Performance
Alignment - Realized and
Realizable Pay for
Our NEOs”
Peer Benchmarked Utilizing an objective set of criteria to determine See “Section Five - HRCC
companies for our compensation benchmarking peer Engagement and
group and TSR peer group Compensation
Governance - Role of
Peer Companies”
Pay Mix Allocating a significant portion of our NEOs target See “Section Three - Pay
compensation to performance-based; components, and Performance
with a balance between cash and equity and Alignment - Pay Mix”
short- and long-term incentives
Monitor Equity Usage Monitoring share expense, burn rate and dilution See “Section Four -
against peer benchmarks Compensation Design,
Awards and Payouts for
2023 - 2023 Long-Term
Incentive Compensation”
Shareholder Feedback Incorporating shareholder views, including results of See “Section One -
our annual say-on-pay vote and our shareholder Executive Summary -
engagement initiatives 2023 Shareholder
Engagement Highlights”
For additional information on Lumen and our recent performance, see Item 7. Management’s Discussion and
Analysis of the Financial Condition and Results of Operations included in Appendix B.
86
Compensation Discussion & Analysis
Discretionary Adjustments. The second type of For our 2023 STI Plan and 2021 LTI Awards:
adjustment provides the HRCC with
• We adjusted the performance results to
discretionary authority to adjust STI and LTI
performance results based on any other eliminate the effect of foreign currency
“extraordinary, unusual, or non-recurring fluctuations and true-up of bonus accruals
transactions or items” to prevent award for revenue and adjusted EBITDA in our 2023
payouts from being unfairly impacted by such STI Plan and three-year cumulative adjusted
items. The adjustments may be positive or EBITDA in our 2021 LTI Awards.
negative and will only be made if the events
• We adjusted the performance results to
were not known on the date the performance
eliminate the CAF II and RDOF revenue that
goals were established or were not reflected in
the forward-looking financial information used was not included in original targets for the
to set such goals. three-year cumulative adjusted EBITDA in
our 2021 LTI Awards.
Traditionally the HRCC has used this
discretionary authority infrequently and
principally to adjust for foreign currency
fluctuations necessary to measure our
performance results in the same manner the
targets were set.
88
Compensation Discussion & Analysis
CEO Element and Description(1) 2023 Performance Objectives Aligned with Strategy
Base Salary Base Salary
As with most companies, base salary is annual
fixed cash compensation that provides
competitively set and stable income to
our executives.
(1)
For more information, see “Section Four — Compensation Design, Awards and Payouts for 2023.”
For a discussion of how the HRCC allocates compensation among these three key components, see “Section
Three — Pay and Performance Alignment.”
Pay Mix
The following chart illustrates the approximate allocation of the total direct compensation (at target), as of
December 31, 2023, for our CEO and named executive officers (NEOs), respectively, between elements that are
fixed, variable, performance-based and “at risk.” As a result, the actual (or take home) pay that our executives
realize in a given year may be more or less than their total target compensation for that year, as illustrated in the
“Pay Versus Performance” below.
A fixed annual salary (base salary) represents 7% of our CEO’s total target compensation and 15% of our current
NEOs’ average target total compensation.
Variable pay, consisting of an STI bonus opportunity and LTI awards, represents 93% of our CEO’s total target
compensation and 85% of our other NEOs’ average target total compensation. This portion of pay is considered
at-risk since the receipt or value of the award is subject to the attainment of certain performance goals, vesting
requirements and overall stock performance. LTI performance-based compensation is the largest component,
representing 48% of our CEO’s and 40% of our other NEOs target total compensation, and provides the greatest
alignment between our NEO compensation and the interests of our shareholders.
(1)
NEOs at December 31, 2023 excludes Mr. Trezise who ceased serving as an executive officer of Lumen effective April 24, 2023.
90
Compensation Discussion & Analysis
(1)
Realized Pay measures the actual pay realized by adding together (i) actual salary paid during the year, (ii) STI bonus that was ultimately
paid for that year and (iii) the value of time- and performance-based LTI awards that vested (based on the closing stock price on each
vesting date and achieved payout levels for PBRS).
(2)
Realizable Pay measures the actual pay realizable for a given year by adding together the (i) realized pay, as describe in note (1) and (ii) the
value of unvested time- and performance-based LTI, at “target” levels, based on our stock price as of March 1, 2024.
(3)
For further information on our 2019, 2020, 2021 and 2022 STI performance and 2021 PBRS awards, see our 2020, 2021, 2022 and 2023 proxy
statements. For further discussion on our 2023 STI payout, see “Section Four - 2023 Short-Term Incentive Program.”
(4)
For further discussion on our 2019, 2020 and 2021 PBRS performance, see our 2021 and 2022 proxy statements. For further discussion on
our 2021 PBRS performance, see “Section Four - LTI Linkage to Performance - No Payouts Under 2021 PBRS Awards.” “TBD” means to be
determined upon completion of the performance periods ending on December 31, 2024 and 2025 and are assumed at target for
this calculation.
(5)
Longer-Tenured NEOs is comprised of Mr. Goff and Mr. Trezise.
Target Compensation
As noted previously, the three key elements of our executive compensation program are base salary, STI bonus
opportunity and LTI awards (60% of which are PBRS). The HRCC establishes target compensation levels for
each of our senior officers on each of these three elements, reviewing the pay mix and pay levels at least
annually. As of December 31, 2023, the total target compensation opportunities for our NEOs as of such date
were as follows:
(1)
For more complete information presented in accordance with the SEC’s rules, see the Summary Compensation Table below.
(2)
The LTI target in this table represents the target levels of equity awards as of December 31, 2023, except Mr. Stansbury’s LTI target does not
include a one-time increase of $2.5 million for his 2023 equity grant. As discussed further below, these amounts differ materially from the
amounts reported in “Compensation Tables—Summary Compensation Table”, which are calculated in accordance with FASB ASC Topic 718
and reflect significantly lower grant date values ($0.92-$2.39) as compared to the stock price used to calculate the number of time-based
and performance-based equity awards granted ($3.90), which was based on a 15-day volume-weighted average closing price.
(3)
Based on our compensation benchmarking data, the Total Target Compensation for Messrs. Goff and Stansbury and Ms. Haynes-Gaspar was
near the 50th percentile of compensation paid to comparable executives, and near the 25th percentile for Ms. Johnson.
On an annual basis, we review the competitive market analyses of the total direct compensation for our NEOs
and senior officers. We target the median of our compensation peer group, while taking into consideration all
relevant factors, including (i) the need to attract and retain employees with essential expertise and skill, (ii)
internal equity for employees who make similar contributions and have comparable skill sets and expertise and
(iii) individual performance. For more information on how we determined specific pay levels in 2023, see further
discussion in “Section Four - Compensation Design, Awards and Payouts for 2023” and under the heading
“—Compensation Benchmarking Peer Group.”
Each of these elements is discussed in greater detail below. For more information on how we determined
specific pay levels in 2023, see further discussion under the heading “—Compensation Benchmarking
Peer Group.”
92
Compensation Discussion & Analysis
Base Salary
Early each year, the HRCC takes a number of steps in connection with setting annual base salaries, including the
review of (i) compensation tally sheets and benchmarking data, (ii) each senior officer’s pay and performance
relative to other senior officers, (iii) the scope and complexity of the officer’s role, (iv) the officer’s experience
and proficiency and the criticality of the skill set needed to execute the officer’s role and (v) when the officer
last received a pay increase.
Annual Review Process (February 2023). During its annual review of executive compensation in February 2023,
the HRCC reviewed the compensation benchmarking data for each senior officer, comparing the officer’s pay to
our peer group. Following this review and discussion, the HRCC increased Ms. Haynes-Gaspar’s annual base
salary to $575,000 and left unchanged the base salaries for our other NEOs employed at the time. The base
salary for Ms. Johnson remained unchanged and the amount reported in the Summary Compensation Table
reflects a full year of employment during 2023; whereas, the amount reported for 2022 was pro-rated based on
55 days of employment (from hire date of November 7, 2022).
Mid-Year Actions. As described elsewhere herein, in April 2023, Mr. Trezise ceased serving as EVP,
Human Resources and the HRCC decreased his salary from $575,000 to $535,000 commensurate with the
reduction of his responsibilities.
The table below reconciles our actual adjusted 2022 results to our actual adjusted 2023 results.
(1)
As used in our STI plan, adjusted earnings before interest, taxes, depreciation, amortization and stock-based compensation expense
(“Adjusted EBITDA”) is a non-GAAP metric that excludes certain one time or non-recurring charges or credits and eliminates the effects of
certain unanticipated, extraordinary, unusual, or non-recurring transactions or items. See Appendix A for more information.
(2)
As explained in greater detail in our 2023 Proxy Statement, these 2022 results have been adjusted to reflect the net effect of certain charges
or credits to eliminate the impact of certain unanticipated, extraordinary, unusual, or non-recurring transactions or items not reflected in
Appendix A. See “Section Two - Incentive Program Guidelines” for more information.
(3)
Represents the net financial impacts related to (i) the Latin American business divested on August 1, 2022 and the 20-state ILEC business
divested on October 3, 2022, and the EMEA business divested on November 1, 2023 (the "divestitures”), which will not recur in periods
following the completion of these divestitures, (ii) actual amounts received or paid by the Company under its post-closing agreements with
the purchasers of the divested businesses and (iii) the Federal Communications Commission's Connect America Fund ("CAF") Phase II
program, which lapsed on December 31, 2021.
(4)
As explained in greater detail below, these 2023 results have been adjusted to reflect the net effect of certain charges or credits to eliminate
the impact of certain unanticipated, extraordinary, unusual, or non-recurring transactions or items not reflected in Appendix A. See “Section
Two - Incentive Program Guidelines” and for more information.
In February 2024, the HRCC approved the calculated Company performance funding of 83.2% (as confirmed by
our Internal Auditors) for our 2023 STI program and based on the financial and qualitative metrics detailed
below. The HRCC reviewed audited results of the Company’s performance as compared to the financial and
operational targets established in February 2023 and, as described in greater detail in this section, determined
and approved certain adjustments for our financial metrics in accordance with our Guidelines.
For additional information on Lumen and our recent performance, see Item 7. Management’s Discussion and
Analysis of the Financial Condition and Results of Operations included in Appendix B.
Alignment to Strategy
Adjusted EBITDA remained our most heavily-weighted STI financial performance objective at 50% for 2023.
We believe this metric is aligned with our shareholders’ best interests and our corporate strategy of pursuing
profitable growth. As described elsewhere herein, in light of the systemic revenue decline for our higher-margin
legacy services, we continuously need to adjust our cost structure - requiring a disciplined focus on Adjusted
EBITDA and margins. The metric of Adjusted EBITDA is designed to incentivize and reward our senior officers to
focus on both cost savings and profitable revenue growth.
(1)
In February 2023, we projected earning Adjusted EBITDA of $4.6 to $4.8 billion for 2023, which assumed the sale of our EMEA business
after 2023 and did not contemplate the sale of our CDN business.
(2)
As mandated under our Guidelines, the HRCC decreased our Adjusted EBITDA target by $34 million to reflect the net impact of (i) the
EMEA divestiture closing approximately two months earlier than originally projected in our 2023 budget and (ii) the sale of our CDN
business which was not contemplated in our budget. See “Section Two - Incentive Program Guidelines” for more information.
(3)
As permitted under our Guidelines, the HRCC increased our actual Adjusted EBITDA by $3 million to reflect the net effect of certain charges
or credits to eliminate the impact of certain unanticipated, extraordinary, unusual, or non-recurring transactions or items not reflected in our
2023 budget. These net charges and credits include the elimination of the effect of foreign currency fluctuations and true-up of bonus
accruals for 2023. See “Section Two - Incentive Program Guidelines” for more information.
(4)
The achieved payout percentage is calculated for each financial performance objective based on a corresponding payout scale approved by
the HRCC. If the threshold performance level with respect to any particular financial performance objective under our STI program is not
attained, the bonus payable to the participating officer with respect to that portion of his or her targeted bonus opportunity will be
calculated as zero. If threshold performance is met on any particular metric, each participating officer will earn a reduced portion of his or
her target bonus amount for that portion of the award. If the maximum performance level with respect to any particular metric is met or
exceeded, each participating officer will earn a maximum of 200% of his or her target bonus amount for that portion of the award.
Measurement of the attainment of any particular metric is interpolated if actual performance is between (i) the “threshold” and the “target”
performance levels or (ii) the “target” and the “maximum” performance levels.
94
Compensation Discussion & Analysis
Alignment to Strategy
The generation of revenue is critical to our goal of increasing revenue from our growth products in amounts
sufficient to offset our continuing and systemic legacy revenue losses. Thus, we continued to include revenue as
a metric and, for the second year in a row, increased its weighting by 10%, from 25% to 35% for our 2023
STI plan.
The HRCC believes our senior officers are appropriately incentivized to achieve our 2023 revenue targets with a
balanced approach, since the majority of our 2023 STI is based on Adjusted EBITDA, which rewards our senior
officers for achieving profitable revenue growth.
(1)
As mandated under our Guidelines, the HRCC decreased our revenue target by $129 million to reflect the net impact of (i) the EMEA
divestiture closing approximately two months earlier than originally projected in our 2023 budget and (ii) the sale of our CDN business
which was not contemplated in our budget. See “Section Two - Incentive Program Guidelines” for more information.
(2)
As permitted under our Guidelines, the HRCC increased our actual revenues to include $31 million to reflect the net effect of certain charges
or credits to eliminate the impact of certain unanticipated, extraordinary, unusual, or non-recurring transactions or items not reflected in
Appendix A. See “Section Two - Incentive Program Guidelines” for more information.
Alignment to Strategy
One of our five core priorities is to develop customer obsession. In January 2023, we hired Ms. Haynes-Gaspar
to lead our Customer Experience organization, bringing an increased level of energy and focus to this
critical area.
“We help guide the company toward our North Star by listening and learning from our customers, then
acting on their needs. That way, we surprise and delight them while accomplishing our mission of digitally
connecting people, data and apps — quickly, securely and effortlessly.” Ms. Haynes-Gaspar
We believe that improving customer satisfaction and service scores, increasing investment in priority areas and
reducing complexity, customer inconveniences and repair times will drive gains in customer satisfaction,
correlating to higher revenue for the Company. Thus, we continued to include customer experience as a metric
and increased its weighting from 10% to 15% for our 2023 STI plan.
We believe the ease of doing business with the Company is a top driver of customer loyalty. Net Promoter
Score (NPS) is a lagging indicator of our performance. Customer experience research suggests increased
promoter scores will generate increased customer spending within 24 months. Customer Ease Score (CES) is a
leading indicator with direct correlation to NPS. As such, the primary measures for Customer Experience
performance are NPS and CES, which together provide a good combination of leading indicators and outcomes.
2023 Goals
Although there are quantitative metrics that we use to measure our Customer Experience, the overall metric is
qualitative in nature. Each business unit is charged with improving relationships with our customers and is part
of the annual planning process. Our customer experience goals and transformation programs are informed and
prioritized using customer data trends and insights. Using regression analysis, we can model which programs
drive the greatest improvements for the greatest number of customers. For goal setting, we consider historical
Lumen performance trends and industry benchmarks to ensure that we are setting appropriate performance
targets by segment.
Targets
In February 2023, in connection with our initiative to improve customer experience, the HRCC approved the
following aspirational goals and objectives for our 2023 STI plan:
• Execute on Company-wide transformative programs that truly improve the way we operate in order to
achieve meaningful improvement in customer experience
• Improve rNPS and CES for our Enterprise business and improve transactional NPS (tNPS) for our Mass
Markets business
Performance Highlights
During 2023, we achieved year over year improvement with gains in our Enterprise rNPS (as adjusted for
revenue) and tNPS for Mass Markets.
As a result of these factors, the HRCC approved 100% funding for our 2023 customer experience goal.
• Relationship NPS (revenue weighted) increased • Transactional NPS increased 3 points vs. prior
17 points vs. prior year year, which was 1 point above target
• Relationship CES held flat vs. prior year, which
was 2 points below target
96
Compensation Discussion & Analysis
Individual
Performance
NEO Individual Performance Scorecard Modifier
Current NEOs
Ms. Johnson • Created a new, compelling north star, strategy and culture transformation with 100%
internal and external validation
• Exceptional connection and impact with employees, customers, investors and
the Board
• Executed on leadership transition strategy by hiring an experienced and
energized senior leadership team
• Oversaw the completion of the divestiture of our EMEA business and
restructuring of our debt
Mr. Stansbury • Exceptional leadership on our debt restructuring which moved approximately 110%
$10 billion of near-term debt maturities to 2029 and beyond and provided us
with ample runway to execute a turnaround
• Substantially improved our standing with investors and customers in clarifying
our financial position and outlining a path towards improved performance
• Is a champion of our culture and truly lives and leads with clarity and
transparency. He has built trusting relationships with key stakeholders and
customers.
Mr. Goff • Exceptional leadership on our debt restructuring 100%
3) Bonus Amounts
The HRCC approved each NEO’s STI bonus as summarized in the table below.
Company Individual
STI Target Bonus Performance Performance Calculated STI
NEO Opportunity(1) Funding(2) Modifier(3) Bonus Amount
Current NEOs
Ms. Johnson $ 2,400,000 X 83.2% X 100% = $1,996,800
Mr. Stansbury 1,000,000 X 83.2% X 110% = 915,200
Mr. Goff 840,000 X 83.2% X 100% = 698,880
Ms. Haynes-Gaspar 553,972 X 83.2% X 105% = 483,950
Former NEO
Mr. Trezise $ 548,041 X 83.2% X 90% = $ 410,372
(1)
Determined based on earned salary and applicable STI target bonus percentage during 2023. The amount for Ms. Haynes-Gaspar reflects a
pro–rated amount based on 357 days of employment during 2023 (from hire date of January 9, 2023) and also an increase in salary (from
$500,000 to $575,000), effective as of February 19, 2023 and an STI target bonus percentage of 100%. The amount for Mr. Trezise reflects a
pro-rated amount based on decrease in salary (from $575,000 to $535,000), effective as of April 30, 2023 and an STI target bonus
percentage of 100%. For more information on amounts for Ms. Johnson and Messrs. Stansbury and Goff, see “Section Four — Target
Compensation” above.
(2)
Calculated and adjusted as discussed in “Company Performance Funding” above.
(3)
See “Individual Performance Modifier” above.
Annual Review Process (February 2023). During its annual review of executive compensation in February 2023,
the HRCC reviewed the compensation benchmarking data for each senior officer, comparing the officer’s pay to
our peer group. Following this review and discussion, the HRCC increased the annual LTI target opportunity for
Mr. Stansbury to $5,000,000, Ms. Haynes-Gaspar to $2,000,000 and Mr. Trezise to $2,000,000 and left
unchanged the LTI target opportunities for Ms. Johnson and Mr. Goff. See further discussion under the heading
“Role of Peer Companies” below.
Time-Vested
Restricted Shares Performance-Based
or RSUs Restricted Shares or RSUs
No. of Target Grant No. of Target Grant Total Target
Named Officer Shares(1)(3) Value(4) Shares(2)(3) Value(4) Grant Value(4)
Current NEOs
Ms. Johnson(5) 1,459,854 $ 5,700,000 2,189,781 $ 8,550,000 $ 14,250,000
Mr. Stansbury(5)(6) 768,344 3,000,000 1,152,517 4,500,000 7,500,000
Mr. Goff 230,503 900,000 345,755 1,350,000 2,250,000
(7)
Ms. Haynes-Gaspar 204,891 800,000 307,338 1,200,000 2,000,000
Former NEO
Mr. Trezise(8) 307,337 1,200,000 461,007 1,800,000 3,000,000
(1)
Represents the number of restricted shares granted on March 1, 2023 with graded-vesting on March 1, 2024, 2025 and 2026.
(2)
Represents the target number of performance-based restricted shares granted on March 1, 2023 for Ms. Haynes-Gaspar and Messrs. Goff and
Trezise and granted on May 18, 2023 for Ms. Johnson and Mr. Stansbury, all with three-year cliff vesting on March 1, 2026. As discussed
under “2023 LTI Performance Metrics” below, the actual number of shares that vest in the future may be lower or higher (between 0-200%),
depending on the level of performance achieved.
(3)
Any dividends on the shares of restricted stock would not be paid on unvested awards but would accrue and be paid or be forfeited in
tandem with the vesting of the related shares or RSUs.
(4)
For purposes of these grants, we determined both the number of time-vested and target performance-based restricted shares granted by
dividing the total grant value approved for the executive by $3.90, which was the volume-weighted average closing price of a share of our
common stock over the 15-trading-day period ending one trading day prior to the grant date (March 1, 2023). However, as noted previously,
98
Compensation Discussion & Analysis
for purposes of reporting these awards in the Summary Compensation Table, our shares of time-vested restricted stock are valued based on
the closing price of our common stock on the date of grant and our shares of performance-based restricted stock are valued as of the grant
date based on probable outcomes, as required by applicable accounting and SEC disclosure rules. For 2023, this resulted in the values
reported in the Summary Compensation Table being materially lower than those show above for most of our NEOs. See footnote 2 to the
Summary Compensation Table for more information.
(5)
Ms. Johnson and Mr. Stansbury’s 2023 annual LTI awards were approved by the HRCC on February 24, 2023 with a mix of 40% TBRS and
60% PBRS shares determined as described in Footnote 4 above. However, the PBRS awards were subject to shareholder approval of our
Amended and Restated 2018 Equity Plan at the 2023 Annual Shareholders’ Meeting in May 2023.
(6)
In recognition of his performance demonstrated in 2022 and to incentivize Mr. Stansbury’s retention during our Company’s transformation
and execution against our long-term strategy, the HRCC approved a one-time increase to his 2023 equity grant value of $2.5 million, which
is included in the table above.
(7)
Excludes the on-boarding equity grant awarded to Ms. Haynes-Gaspar in early January 2023, as described under “2023 On-Boarding
Equity Grant.”
(8)
On March 1, 2023, the HRCC approved a one-time increase to the 2023 equity grant value of $1.0 million (included in the table above) for
Mr. Trezise in recognition for the trusted advice he provided to the HRCC and our CEO and in connection with building a new senior
leadership team over the preceding year and early 2023. As discussed elsewhere herein, Mr. Trezise’s employment was involuntarily
terminated on April 5, 2024 and the outstanding TBRS and PBRS related to this one-time increase were forfeited. See discussion under
“Severance Compensation to Be Paid to Scott Trezise, our former EVP, Human Resources” below for how his termination impacted
these awards.
(1)
Cumulative Adjusted EBITDA is the sum of our Adjusted EBITDA excluding special items (except with adjustments to reflect a 100% bonus
accrual for each year) for 2023, 2024 and 2025. See Appendix A for more information.
(2)
Payouts interpolated between defined performance levels.
(3)
Our Cumulative Adjusted EBITDA target is the sum of forward-looking guidance communicated in June 2023 for 2023 including EMEA,
2024 and 2025.
(4)
We do not feel it is appropriate to disclose our Cumulative Adjusted EBITDA maximum and threshold goals as it would constitute
competitively sensitive forward-looking guidance.
Payout as a % of this
Target Component of Target Award(1)
Maximum ≥ 75th Percentile 200%
Target 50th Percentile 100%
Threshold 25th Percentile 50%
Below Threshold < 25th Percentile 0%
(1)
Payouts interpolated between defined performance levels.
100
Compensation Discussion & Analysis
Time-Vested
Restricted Shares
No. of Grant
Named Officer Shares(1)(2) Value(3)
Ms. Haynes-Gaspar 224,022 $ 1,200,000
(1)
Represents the number of time-based restricted shares granted to Ms. Haynes-Gaspar on January 9, 2023 which have graded-vesting on
January 9, 2024, 2025 and 2026.
(2)
Any dividends on the shares of restricted stock would not be paid on unvested awards but would accrue and be paid or be forfeited in
tandem with the vesting or forfeiture of the related shares.
(3)
For purposes of this grant, we determined the number of time-vested restricted shares by dividing the total grant value granted to
Ms. Haynes-Gaspar by the volume-weighted average closing price of a share of our common stock over the 15-trading-day period ending
one trading day prior to the grant date, rounding to the nearest whole share. However, as noted previously, for purposes of reporting these
awards in the Summary Compensation Table, our shares of time-vested restricted stock are valued based on the closing price of our
common stock on the date of grant. See footnote 1 to the Summary Compensation Table for more information.
Performance Metric
Grant Year Period Weighting 2021 2022(1) 2023(2) 2024 2025
(6)
2021 2021-2023 50% 3-YR Cumulative Adjusted EBITDA(3)
(1)
The sale our Latin American and 20-state ILEC business, which were completed in August 2022 and October 2022, respectively, occurred
during the second and first year of each three-year performance period for our outstanding 2021 and 2022 LTI awards, respectively.
(2)
The sale our CDN and EMEA business, which was completed in October and November 2023, respectively occurred during the third, second
and first year of each three-year performance period for our outstanding 2021, 2022 and 2023 LTI awards, respectively.
(3)
For 2021 PBRS, when the three-year Cumulative Adjusted EBITDA target was set in the first quarter of 2021, we had not yet entered into
definitive agreements for these divestitures. As such, the targets assumed our continued operations of those businesses throughout the full
three-year performance period. As discussed in further detail below (under the heading “LTI Linkage to Performance”), in February 2023
and February 2024, the HRCC approved adjustments to measure our performance results to prevent holders of PBRS Awards from being
penalized by the impact of these transactions.
(4)
For 2022 PBRS, when the three-year Cumulative Adjusted EBITDA target was set in the first quarter of 2022, the Company expected its
pending divestitures of both its Latin American and 20-state ILEC business to close in 2022, but did not know the actual closing date. For
purposes of setting this target, the HRCC assumed both divestitures would close on July 1, 2022. The sale our Latin American and 20-state
ILEC business were actually completed in August 2022 and October 2022, respectively. The Company had not yet entered into definitive
agreement for the EMEA divestiture; as such, the targets assumed continued operations of that business throughout the full three-year
performance period. The HRCC approved adjustments to targets to prevent holders of PBRS from receiving an unintended benefit from the
delayed closing of its Latin American and 20-state ILEC business or an unintended penalty from the accelerated sale of our EMEA business.
(5)
For 2023 PBRS, when the three-year Cumulative Adjusted EBITDA target was set in the first quarter of 2023, the Company expected its
pending divestitures of its EMEA business to close in 2023, but did not know the actual closing date. For purposes of setting this target, the
HRCC assumed the divestiture would close on January 1, 2024. The sale our EMEA business was actually completed in November 2023. The
HRCC approved adjustments to targets to prevent holders of PBRS from receiving an unintended penalty from the accelerated closing.
(6)
For more information on below threshold 0% payout for our 2021 PBRS, see “LTI Linkage to Performance” below.
(1)
As used in our 2021 LTI plan, adjusted earnings before interest, taxes, depreciation, amortization and stock-based compensation expense
(“Adjusted EBITDA”) is a non-GAAP metric that excludes certain one time or non-recurring charges or credits and eliminates the effects of
certain unanticipated, extraordinary, unusual, or non-recurring transactions or items. See Appendix A for more information.
(2)
As permitted under our Guidelines, we adjusted our actual results to reflect a net increase of $1.886 million in Adjusted EBITDA (not
reflected in Appendix A), comprised of (i) an increase of $2,446 million to reflect the sale our Latin American, 20-state ILEC, EMEA and CDN
businesses, which were completed in August 2022, October 2022 and November 2023, respectively. (ii) a decrease of $543 million to
eliminate the CAF II and RDOF revenue that was not included in original targets and (iii) a decrease of $17 million of other adjustments to
measure our performance in the same manner the targets were set. The targets for our 2021 Cumulative Adjusted EBITDA were set before
we entered into these definitive agreements and thus the targets assumed our continued operations of those businesses during the entire
three-year performance period. These adjustments were necessary to measure our performance results in the same manner the targets were
set in the first quarter of 2021. See “Section Two - Incentive Program Guidelines - Mandatory Adjustments.”
102
Compensation Discussion & Analysis
Performance-Based
Restricted Shares or RSUs
No. of Grant
Named Officer Shares(1)(2) Value
Current and Former NEOs
Mr. Goff 100,728 $ 1,200,000
Mr. Trezise 60,437 $ 720,000
All other executive officers and employees as a group (1,005 persons)(3) 2,910,535 $34,674,084
Overall Total 3,071,700 $ 36,594,084
(1)
Represents the target number of performance-based restricted shares granted on February 24, 2021
(2)
Dividends on the shares of restricted stock were not be paid on unvested awards; the related accrued dividends were forfeited in tandem
with the forfeiture of the related performance-based restricted shares or RSUs.
(3)
Includes any former executive or senior officers and employees who retained any 2021 PBRS, subject to performance criteria, as part of their
severance or retirement packages.
In early 2024, based on the extensive analysis performed in the second half of 2023, the HRCC further modified
our grant practices for 2024:
• Senior Leadership Team: the HRCC recalibrated our 2024 LTI program and modified the structure of the
awards to our senior leadership team as follows:
– Maintained 40% time-based restricted stock
– Shifted the 60% performance-based portion from equity to cash
– Maintained our two equally-weighted metrics of Relative TSR and Cumulative Adjusted EBITDA
– Added a +/-20% revenue modifier to the cumulative adjusted EBITDA metric
• Employees below the executive level: we granted annual LTI awards to approximately 1,200 employees below
the executive level, and for the second consecutive year, their 2024 LTI awards were granted in the form of
time-based cash (which, subject to continued employment, will vest over three years) instead of a mix of
time- and performance-based equity.
104
Compensation Discussion & Analysis
We intend our use of cash-settled LTI awards (granted to our senior leadership team in 2024 and employees
below the executive level in 2023 and 2024) to be a temporary measure, which we hope to discontinue or
reduce when circumstances warrant. Adoption of our new 2024 Equity Incentive Plan at the annual meeting
would significantly enhance our ability to reinstate equity-based awards for all award recipients.(1)
(1)
See “Item 3 - Approval of Our 2024 Equity Incentive Plan” for more information.
In addition, to partially offset amounts that Ms. Haynes-Gaspar forfeited upon her departure from her prior
employer, the HRCC approved certain on-boarding payments described below. Based on information provided
by its compensation consultant, the HRCC determined that these awards are customary for executive
on-boarding pay packages and, in this case, were necessary to induce Ms. Haynes-Gaspar to join the Company.
• Cash award of $500,000 to offset a portion of equity and annual bonus that Ms. Haynes-Gaspar forfeited
upon termination from her prior employer. This cash award was paid in two installments:
– The first installment of $250,000 was paid upon her joining the Company, subject to a “clawback” if
Ms. Haynes-Gaspar resigns or is terminated by the Company for cause before the 2-year anniversary of her
start date.
– The second installment of $250,000 was paid to her in early 2024 on the first anniversary of her start date,
subject to “clawback” if Ms. Haynes-Gaspar resigns or is terminated by the Company for cause before the
2-year anniversary of her start date.
• Equity award valued at $1,200,000 consisting of time-based restricted stock, which will vest in one-third
annual installments, subject to continued service and other customary terms(1). This equity award offsets
equity that Ms. Haynes-Gaspar forfeited upon termination from her prior employer and aligned her interests
with shareholders by providing immediate equity stake in the Company.
(1)
For more information see “Section Four - 2023 Long-Term Incentive Compensation” above.
106
Compensation Discussion & Analysis
Other Benefits
As a final component of executive compensation, we provide certain benefits designed to be competitive, in the
aggregate, with similar benefits provided by our peers. We summarize these additional benefits below.
Retirement Plans
We maintain traditional broad-based qualified defined benefit and defined contribution retirement plans for our
employees who meet certain eligibility requirements. In addition to these qualified plans, we maintain
nonqualified supplemental plans that permit our officers to receive or defer amounts in excess of contribution
caps under the Code that limit the amount of benefits highly compensated employees are entitled to receive or
contribute under qualified plans. Additional information regarding our retirement plans is provided in the tables
and accompanying discussion included below under the heading “Compensation Tables.”
Multiple of Years of
Annual Cash Welfare
Protected Period Compensation Benefits
CEO 2 years 2.5 times 2.5 years
Other Executives 1.5 years 2 times 2 years
Other Officers 1 year 1 time 1 year
For more information on change of control arrangements applicable to our executives, including our rationale
for providing these benefits, see “Compensation Tables — Potential Termination Payments — Payments Made
Upon a Change of Control.” For information on change of control severance benefits payable to our junior
officers and managers, see “— Severance Benefits” in the next subsection below.
Severance Benefits
Our executive severance plan provides cash severance payments equal to two years of total targeted cash
compensation (defined as salary plus the targeted amount of annual incentive bonus) for our CEO or one year
of total targeted cash compensation for any other senior officer in the event that the senior officer is
involuntarily terminated by us without cause in the absence of a change of control.
The table below shows (i) the multiple of salary and bonus payment and (ii) years of welfare benefits to which
officers will be entitled if a senior officer is involuntarily terminated by us without cause in the absence of a
change of control:
Multiple of Years of
Annual Cash Welfare
Compensation Benefits
CEO 2 times 2 years
Other Executives and Senior Officers 1 time 1 year
Under our executive severance plan, subject to certain conditions and exclusions, more junior officers or
managers receive certain specified cash payments and other benefits if they are either (i) involuntarily
terminated without cause in the absence of a change of control or (ii) involuntarily terminated without cause or
resign with good reason in connection with a change of control. Our full-time non-represented employees not
covered by our executive severance plan may, subject to certain conditions, be entitled to certain specified cash
severance payments in connection with certain qualifying terminations.
Under a policy that we adopted in 2012, we have committed to seek shareholder approval of any future senior
executive severance agreements providing for cash payments, perquisites and accelerated health or welfare
benefits with a value greater than 2.99 times the sum of the executive’s base salary plus target bonus.
Perquisites
Officers are entitled to be reimbursed for the cost of an annual physical examination, plus related
travel expenses.
For several years and during the majority of 2023, the Company operated a fleet of company-owned aircraft for
use by our CEO and executives for business and personal travel. During this period, use of company-owned
aircraft by our executives was governed by an aircraft usage policy approved by the HRCC.
During 2023, our aircraft usage policy permitted the CEO to use our aircraft for personal travel up to $200,000
per year without reimbursing us and permitted each other executive officer to use our aircraft for personal
travel only if he or she paid for the cost of a flight in accordance with the terms of an Aircraft Timesharing
Agreement. In all such cases, personal travel was permitted only if aircraft was available and not needed for
superseding business purposes.
In late 2023, the Company sold its entire fleet of aircraft and entered into a time-share agreement with NetJets
to provide business and personal travel for our CEO and executives. In light of the change to NetJets, in early
2024, the HRCC reviewed the anticipated cost associated with the personal use of aircraft for our CEO and
executives and revised our aircraft usage policy to change the annual usage limit for our CEO from $200,000 to
50 flight hours.
For purposes of valuing and reporting the use of our aircraft, we determine the incremental cost of aircraft
usage on an hourly basis, calculated in accordance with applicable guidelines of the SEC. The incremental cost
of this usage, which may be substantially different than the cost as determined under alternative calculation
methodologies, is reported in the Summary Compensation Table appearing below.
108
Compensation Discussion & Analysis
For more information on the items under this heading, see the Summary Compensation Table appearing below.
110
Compensation Discussion & Analysis
Rigorous design and target setting process Performance results and calculated payouts
The HRCC establishes rigorous threshold, target and Upon completion of each fiscal year, after our actual
maximum performance levels for the selected financial performance results are determined,
objectives that are rooted in our annual budget, including any adjustments or discretion applied under
public guidance and long-range strategic plan. The our Guidelines, the incentive payouts are calculated
HRCC takes into consideration various factors and reviewed by Lumen’s Internal Audit. Then,
influencing our business, including but not limited to, individual bonus and equity payouts are determined
the decline in our legacy wireline revenues, the pace for our officers based on our LTI and STI programs
at which revenues are growing for digital services and the related performance and relevant individual
and new products, and the continuous need to adjust performance considerations.
our cost structure.
112
Compensation Discussion & Analysis
In the first step, we have used the framework below to capture companies that are comparable in size, have
similar business strategies and financial models, recognizing that there are very few, if any direct peers. The
following attributes were reviewed and screened in order of importance:
Primary Screen • There are a limited number 2023 Compensation Benchmarking Peer Group
• Revenues (target of potential peer companies In August 2022, as a result of the screening process and
between one-half and with comparable revenues, based on input from HRCC’s independent consultant, the
two times our so the annual revenue for HRCC reviewed the 2022 Compensation Benchmarking
revenue); some of our peers are more Peer Group of 18 companies and approved the following
• Market capitalization or less than our targeted changes and approval of the 14 peer companies in our
(target between multiple. Our revenue is well 2023 Compensation Benchmarking Peer Group
one-third and three listed below.
positioned at the 47th
times our market cap); percentile compared to the • Remove 4 companies:
Secondary Screen peer company revenue. – Verizon Communications Inc. is a direct competitor
Additionally, each company in the cloud solutions business, but the other
• Assets (target between
one-third and three in our Compensation aspects of their business deviate from our business.
times our assets); and Benchmarking Peer Group is Verizon Communications Inc. is considerably larger
engaged in a line of business than us for all four financial screens.
• Enterprise value
(target between conducted by us, and are – Comcast Corporation is a direct competitor in
one-third and three included in the peer of peers broadband business, but the other aspects of their
times our and proxy advisor peer business deviate from our business. Comcast
enterprise value). screens, which further Corporation lists us as one of their peers, but is
considerably larger than us for all four
supports their inclusion in
Qualitative Screen financial screens.
such group.
• Focus on companies – BCE Inc. is a direct competitor in the traditional
with a growth strategy • There are very few peers fiber and telecommunications business in Canada,
similar to Lumen as it with market capitalization but the other aspects of their business deviate from
transitions away from similar to ours. The HRCC, in our business. BCE Inc. meets our revenue, assets
its traditional telecom agreement from its and enterprise value screens, but fails to meet our
business to independent consultant, market cap screen.
its enterprise believe revenue is a more – TELUS Corporation is a direct competitor in the
technology business.
appropriate, stable and traditional fiber and telecommunications business
• Disclosed peer common metric for sizing in Canada, but the other aspects their business
of peers; and selecting peer groups deviate from our business. TELUS Corporation
meets all four financial screens.
• Reverse peers; and and is a better measure for
• Peer group disclosed assessing organizational 2024 Compensation Benchmarking Peer Group
by proxy advisors. complexity. In August 2023, as a result of the screening process and
• The HRCC believes the use based on input from HRCC’s independent consultant, the
of the median and not the HRCC reviewed the 2023 Compensation Benchmarking
Peer Group of 14 companies and approved no changes
average, for competitive
to our 2024 Compensation Benchmarking Peer Group.
market data mitigates the
inclusion of both larger and
smaller peer companies.
Compared to the 2023 Compensation Benchmarking Peer Group, Lumen’s 2024 Compensation Benchmarking
Peer Group is positioned at the 47th percentile in terms of revenue and the 2nd percentile in terms of market
capitalization. These statistics represent a slight downwards shift compared to last year’s analysis, where Lumen
was positioned at the 54th and 16th percentiles, respectively.
In the second step, the HRCC’s compensation consultant calculates median salaries for our senior officer
positions using compensation data publicly disclosed by members of the Compensation Benchmarking Peer
Group and, for executive positions with no publicly disclosed compensation data, the HRCC reviews
compensation survey data for companies in the telecommunications industry and general industry that are
generally similar to us in size. Then, the HRCC compares the compensation of each of our senior officers to the
median compensation of comparable officers derived from such market analysis to determine if our senior
officers are being paid below, at or above “market” rates.
The HRCC used median compensation data derived from its analysis of pay by members of our 2023
Compensation Benchmarking Peer Group to inform its compensation decisions and offer packages for our
senior officers throughout 2023. For more information see “Section One - Executive Summary - Continued
Leadership Transition” and “Section Four - Compensation, Design, Awards and Payouts for 2023” above.
Once established, we believe that a well-selected peer group for compensation benchmarking should remain
fairly stable for several years to help inform reliable and consistent market positioning, longer-term pay trends
and market practices. Our Compensation Benchmarking Peer Group is summarized in the table following
discussion of our TSR Peer Group below.
114
Compensation Discussion & Analysis
During the second half of 2022 and early 2023, in preparation for the 2023 LTI grant, the HRCC’s independent
consultant collaborated with management as part of an evaluation process to identify and screen relevant public
companies to determine our TSR Peer Group, with the desired result of at least 15 to 20 peer companies,
as follows:
Primary Screen • The analysis of our 2023 TSR 2023 TSR Peer Group
• The primary consideration Peer Group started with a In January 2023, as a result of the screening
when selecting our TSR Peer review of our 2022 TSR Peer process and based on input from HRCC’s
Group for 2023 was the need Group, which was independent consultant, the HRCC reviewed
to have peers with similar comprised of: and approved the following changes:
industry, business and risk
– 12 TSR peers from U.S. • Remove 1 US and 4 non-US companies:
profiles as ours.
technology and telecom
• Start with a universe of – BT Group, plc
industry; and
potential similar industry peers – Orange S.A.
with technology, – 3 large international
telecommunications, cable and integrated telco – Telefonica S.A.
satellite services and various companies based outside – TELUS Corporation
technology industries within the U.S. (BT Group plc,
our GICS industry and – United States Cellular Corporation
Orange S.A. and
sub-industry; • Add 5 companies in the Communications
Telefonica S.A.).
Secondary Screen Services sector:
• The three non-U.S. companies
• Conduct a historical stock price were recommended for – 4 of the 5 were highly correlated for
correlation between Lumen and removal due to the recently historical stock price and Beta screens
a potential peer universe based completed divestitures of our ◦ Cable One, Inc.
on the industry sectors Latin American and EMEA
identified; and ◦ Charter Communications, Inc.
business that make their
• Perform back-testing on inclusion less relevant ◦ Cogent Communications Holding, Inc.
historical stock performance going forward. ◦ Consolidated Communications
(including TSR and Beta and
• In the next step, management Holding, Inc.
impacts of macroeconomic
factors that would impact all and the HRCC’s independent – Frontier Communications Parent, Inc.,
companies similarly). consultant reviewed which recently emerged from bankruptcy
Qualitative Screen companies in the S&P 1500 • Therefore, the HRCC approved the 15 peer
Communications Services companies in our 2023 TSR Peer Group
• Focus on companies with a sector and selected five listed below.
growth strategy similar to
additional companies to 2024 TSR Peer Group
Lumen as it transitions away
maintain a robust sample of
from its traditional Telecom
peers (of at least 15 to 20 In August 2023, as a result of the screening
business to Enterprise
process and based on input from HRCC’s
Technology. peer companies) and because
independent consultant, the HRCC reviewed
they are large, complex and
• Disclosed peer of peers; the 2023 TSR Peer Group of 15 companies and
provide services similar approved no changes to our 2024 TSR
• Reverse peers; and
to ours. Peer Group.
• Disclosed compensation peer
group by proxy advisors. In December 2023, DISH Network Corp was
acquired by EchoStar Corporation and will be
excluded from our 2024 TSR peer group and
2024 annual LTI awards.
Compared to the 2023 TSR Peer Groups, Lumen’s 2024 TSR Peer Group is positioned at the 5th percentile
in terms of three-year TSR and the 23rd percentile in terms of market cap. These statistics represent a
downwards shift compared to last year’s analysis, where Lumen was positioned at the 31st and 46th
percentiles, respectively.
The 2023 Compensation Benchmarking and TSR Peer Groups are summarized in the table below.
(1)
Value for CEO of $7.2M is based on Ms. Johnson’s annual salary as of December 31, 2023.
(2)
Value for our other Current NEOs is based on the average annual salary for such officers as of December 31, 2023.
Each executive officer and outside director has three and five years, respectively, to attain these targets. For any
year during which an executive or outside director does not meet his or her ownership target, the executive or
director is required to hold 65% of the Lumen stock that he or she acquires through our equity compensation
programs, excluding shares sold to pay related taxes.
Before the recent decline in the trading price of the Common Shares, all of our executive officers and all of our
outside directors were in compliance with our stock ownership guidelines, or otherwise within their three and
five year compliance window.
In November 2023, Ms. Johnson and Mr. Stansbury acquired 1,000,000 and 500,000 shares, respectively, on the
open market.
116
Compensation Discussion & Analysis
As of March 21, 2024, out of our 15 executive officers and outside directors, five(1) were in compliance, six(2) were
out of compliance and four(3) were within were within their respective three and five year compliance windows,
against their respective stock ownership guidelines.
In accordance with the guidelines, each executive officer and outside director not in compliance with the
guidelines will be required to hold 65% of the Common Shares that he or she acquires through Lumen’s equity
compensation programs, excluding shares sold to pay related taxes, until they are once again in compliance.
(1)
Messrs. Clontz, Glenn and Stansbury and Messes. Johnson and Haynes-Gaspar were in compliance.
(2)
Messrs. Chilton, Brown, Goff and Roberts and Messes. Bejar and Siegel were out of compliance.
(3)
Mr. Allen, who joined our Board on February 25, 2021, has until February 25, 2026 to comply with these guidelines. Mr. Fowler, who
joined our Board on August 7, 2023, has until August 7, 2028 to comply with these guidelines. Mr. Jones, who joined our Board on January 1,
2020, has until January 1, 2025 to comply with these guidelines. Ms. Linear, who joined our Board on February 22, 2024, has until February
22, 2029 to comply with these guidelines.
(1)
Represents on-boarding bonuses paid following start date and subject to 2-year clawback if the NEO resigns or is terminated for Cause
before the 2-year anniversary of their start date.
(2)
For 2023, the amounts shown in this column reflect the fair value of annual grants of restricted stock or restricted stock unit awards made to
our named executives under our LTI program. For additional information about these equity grants, see the section entitled, “Long-Term
Incentive Compensation” in our CD&A. The fair value of the time-vested and performance-based awards presented in the table above has
been determined in accordance with FASB ASC Topic 718, based on the closing trading price of our Common Shares on the day of grant, as
well as certain adjustments and assumptions set forth in Note 12 titled “Stock-based Compensation” of the notes to our audited financial
statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. The aggregate value of the LTI awards
granted to each named executive in 2023, assuming maximum payout of his or her performance-based award, would be as follows:
Ms. Johnson, $6,927,009, Mr. Stansbury, $4,706,110, Ms. Haynes-Gaspar, $2,630,902, Mr. Goff, $1,608,913 and Mr. Trezise, $2,145,217. As
noted in the Compensation Discussion and Analysis, the grant date values of the equity awards reflect significantly lower grant date values
($0.92-$2.39) as compared to the stock price used to calculate the number of time-based and performance-based equity awards granted
($3.90), which was based on a 15-day volume-weighted average closing price. As a result, the values reported in this column are significantly
below the NEOs’ LTI target grant values for 2023.
(3)
The amounts shown in this column reflect cash payments made under our short-term incentive program for actual performance in the
respective years. For additional information, see the section entitled, “2023 STI Program” in our CD&A.
(4)
Reflects the net change during each of the years reflected in the present value of Mr. Goff’s accumulated benefits under the defined benefit
plan discussed below under the heading “— Pension Benefits.”
(5)
For fiscal 2023, the amounts shown in this column are comprised of (i) personal use of our aircraft; (ii) Company contributions or other
allocations to our defined contribution plans; (iii) payments of life insurance premiums under a legacy reimbursement plan; and (iv) personal
identity theft protection service, in each case for and on behalf of the named executives as follows:
118
Compensation Tables
For additional information regarding perquisites, see “Compensation Discussion & Analysis.”
(6)
Ms. Johnson’s employment with us began on November 7, 2022.
(7)
Mr. Stansbury’s employment with us began on April 4, 2022.
(8)
Ms. Haynes-Gaspar’s employment with us began on January 9, 2023.
(9)
Mr. Trezise’s’ employment with Lumen will end on April 5, 2024.
All other
Estimated Future Share Payouts Stock
Range of Payouts Under Non-Equity Under Equity Incentive Awards:
Type of Incentive Plan Awards(1) Plan Awards (2)
Unvested Grant Date
Award and Threshold Target Maximum Threshold Target Maximum Shares(4) Fair Value
NEO Grant Date(3) ($) ($) ($) (#) (#) (#) (#) Awards(5)
Current NEOs
Ms. Johnson Bonus $1,200,000 $2,400,000 $4,800,000 — — — — —
TBRS - Annual — — — — — — 1,459,854 $3,489,051
PBRS - EBITDA — — — 547,446 1,094,891 2,189,782 — 1,718,979
PBRS - Relative — — — 547,445 1,094,890 2,189,780 — 1,007,299
TSR
Mr. Stansbury Bonus $ 500,000 $1,000,000 $2,000,000 — — — — —
TBRS - Annual — — — — — — 768,344 $1,836,342
PBRS - EBITDA — — — 288,130 576,259 1,152,518 — 904,727
PBRS - Relative — — — 288,129 576,258 1,152,516 — 530,157
TSR
Ms. Haynes- Bonus $ 276,986 $ 553,972 $ 1,107,944 — — — — —
Gasper TBRS - Initial — — — — — — 224,022 $1,200,758
TBRS - Annual — — — — — — 204,891 489,689
PBRS - EBITDA — — — 76,835 153,669 307,338 — 241,260
PBRS - Relative — — — 76,835 153,669 307,338 228,967
TSR
Mr. Goff Bonus $ 420,000 $ 840,000 $ 1,680,000 — — — — —
TBRS - Annual — — — — — — 230,503 $ 550,902
PBRS - EBITDA — — — 86,439 172,878 345,756 — 271,418
PBRS - Relative — — — 86,439 172,877 345,754 — 257,587
TSR
All other
Estimated Future Share Payouts Stock
Range of Payouts Under Non-Equity Under Equity Incentive Awards:
Type of Incentive Plan Awards(1) Plan Awards(2) Unvested Grant Date
Award and Threshold Target Maximum Threshold Target Maximum Shares(4) Fair Value
NEO Grant Date(3) ($) ($) ($) (#) (#) (#) (#) Awards(5)
Former NEO
Mr. Trezise(6) Bonus $ 274,021 $ 548,041 $ 1,096,082 — — — — —
TBRS - Annual — — — — — — 307,337 $ 734,535
PBRS - EBITDA — — — 115,252 230,504 461,008 — 361,891
PBRS - Relative — — — 115,252 230,503 461,006 — 343,449
TSR
(1)
Represents potential payouts under the annual STI bonus program for 2023 for our named executives. The actual amounts paid for 2023
performance are reported in the “Non-Equity Incentive Plan Compensation” column of the Summary Compensation Table. Failure to meet
the “threshold” level of performance would result in no payout to the executive.
(2)
Represents the performance-based portion of our annual LTI grants, which were issued on May 18, 2023 to Ms. Johnson and Mr. Stansbury,
and on March 1, 2023 to all other NEOs. Payout under these awards (restricted stock or RSUs) may range between zero to 200%. For
information regarding the performance metrics on which vesting is contingent, please see note 6 to the “Outstanding Equity Awards” table.
(3)
Definitions of these terms and information on the grant dates appear elsewhere in these footnotes.
(4)
Represents the time-based portion of our annual LTI awards granted to our NEOs on March 1, 2023 (restricted stock or RSUs). One-third of
these annual LTI grants vested on March 1, 2024 and the remainder will vest on March 1 of 2025 and 2026. For Ms. Haynes-Gaspar, also
includes an initial on-boarding award granted on January 9, 2023, one-third of which vested on January 9, 2024 and the remainder of which
will vest in two equal installments on January 9 of 2025 and 2026, as described in more detail under “Compensation Discussion & Analysis —
Part Four — Compensation Arrangements Related to Leadership Transition — Compensation for Ashley Haynes-Gaspar, our new EVP,
Customer Experience Officer.” Vesting of all of the aforementioned time-based restricted stock or RSUs is subject to the executive’s
continued employment through the vesting date or as otherwise provided in the executive’s award agreement.
(5)
Calculated in accordance with FASB ASC Topic 718 in the manner described in Note 1 to the Summary Compensation Table above.
(6)
Mr. Trezise’s employment was involuntarily terminated on April 5, 2024, and in exchange for delivering of a release of claims, the HRCC
accelerated vesting of a pro-rated portion of his outstanding time-based restricted stock awards and permitted him to retain a portion of his
outstanding performance-based restricted stock awards, subject to their original performance conditions and vesting dates, with the
remainder of his equity grants forfeited, all as described in more detail under “Compensation Discussion & Analysis — Part Four —
Compensation Arrangements Related to Leadership Transition — Severance Compensation to be Paid to Scott Trezise, our former EVP,
Human Resources.”
For more information, see Compensation Discussion & Analysis—Section Four—Compensation Design, Awards
and Payouts for 2023” and “—Potential Termination Payments.”
120
Compensation Tables
(1)
Represents performance-based equity awards, payouts of which may range between zero to 200%. The table above assumes that, as of
December 31, 2023, we would perform at “target” levels for our annual 2021, 2022 and 2023 awards, such that all performance-based shares
granted to each named executive would vest at 100%. With respect to our 2021 performance-based equity awards, our actual performance
was "below threshold" and no shares vested (see note 6 below).
(2)
Except as otherwise provided in notes 3, 4 or 5 below, represents an annual grant of time-vested restricted stock that will vest in three equal
installments on March 1 of each of the first three years following the grant date, subject to the executive’s continued employment through
the applicable vesting date.
Vesting Dates
(3)
Represents the unvested portion of a pro-rated annual grant of time-vested restricted stock for Ms. Johnson that was granted upon her start
and will vest in two equal installments on November 7 of 2024 and 2025, subject to her continued employment through the applicable
vesting date. If Ms. Johnson is terminated without Cause or she resigns with Good Reason before the third anniversary of her start date
(November 7, 2022), a prorated number of outstanding awards (based on number of days from grant date to separation date) will
accelerate (time-based) or remain outstanding subject to original terms (performance-based); any remaining outstanding shares will
be forfeited.
(4)
Mr. Stansbury was awarded two grants of time-vested restricted stock upon his start, consisting of an (1) annual grant and (2) initial grant,
subject to his continued employment through the applicable vesting dates. Of the 105,082 shares of his unvested restricted stock granted in
connection with his annual award, half vested on April 4, 2024 and the other half is scheduled to vest on April 4 2025, subject to his
continued employment through such date. Of the 317,058 shares of his unvested restricted stock granted in connection with his initial grant,
22,647 vested on April 4, 2024, 22,647 are scheduled to vest on April 4, 2025, and two installments of 135,882 each are scheduled to vest on
April 4, 2027 and April 4, 2029, subject to his continued employment through such vesting dates.
(5)
One-third of Ms. Haynes-Gaspar’s time-vested restricted stock granted upon her start vested on January 9, 2024, with the remainder
scheduled to vest in two equal installments on January 9, 2025 and January 9, 2026, subject to her continued employment through such
vesting dates.
(6)
Represents the performance-based portion of our 2023 annual restricted stock or restricted stock unit awards. The number of shares earned
will range between 0 to 200% of the number granted, with the number earned determined depending on the Company’s achievement of the
following two separate performance targets for the three-year period from 2023 to 2025: (1) 50% of the total target shares granted will be
earned depending on the Company’s cumulative Adjusted EBITDA results and (2) 50% of the total target shares granted will be based on
the Company’s relative total shareholder return against the performance of a peer group of companies in the communications industry,
subject to certain limits if our TSR is negative. These awards will vest on March 1, 2026, subject to meeting such targets and the executive’s
continued employment through the vesting date.
(7)
Represents the performance-based portion of our 2022 annual restricted stock or restricted stock unit awards. The number of shares earned
will range between 0 to 200% of the number granted, with the number earned determined depending on the Company’s achievement of the
following two separate performance targets for the three-year period from 2022 to 2024: (1) 50% of the total target shares granted will be
earned depending on the Company’s cumulative Adjusted EBITDA results and (2) 50% of the total target shares granted will be based on
the Company’s relative total shareholder return against the performance of a peer group of companies in the communications industry,
subject to certain limits if our TSR is negative. These awards will vest as follows, subject to meeting such targets and the executive’s
continued employment through the vesting date.
Vesting Dates
(8)
Represents the performance-based portion of our 2021 annual restricted stock or restricted stock unit awards. The number of shares earned
could range between 0 to 200% of the number granted, with the number earned determined depending on the Company’s achievement of
the following two separate performance targets for the three-year period from 2021 to 2023: (1) 50% of the total target shares granted will
be earned depending on the Company’s cumulative Adjusted EBITDA results and (2) 50% of the total target shares granted will be based on
the Company’s relative total shareholder return against the performance of a peer group of companies in the communications industry,
subject to certain limits if our TSR is negative. On March 1, 2024, Messrs. Goff and Trezise forfeited 100% of these shares due to our failure to
attain threshold levels with respect to both our Cumulative Adjusted EBITDA and TSR over the three-year performance period.
(1)
Represents time-vested equity awards that vested during 2023.
(2)
Based on the closing trading price of the Common Shares on the applicable vesting date.
Pension Benefits
The following table and discussion summarize pension benefits payable to one of our named executives under
(i) the Lumen Combined Pension Plan, a qualified retirement plan under Code Section 401(a), which permits
eligible participants (including officers) who have completed at least five years of service to receive a pension
benefit upon attaining early or normal retirement age and (ii) our non-qualified supplemental defined benefit
plan, which is designed to pay supplemental retirement benefits to certain officers in amounts equal to the
benefits such officers would otherwise forego due to Code limitations on compensation and benefits under
qualified plans. We refer to these particular defined benefit plans below as our “Qualified Plan” and our
“Supplemental Plan,” respectively and as our “Pension Plans,” collectively.
122
Compensation Tables
Pension Benefits
Present Value of
Number of Years of Accumulated Benefit Payments During
Participating NEO(1) Plan Name Credited Service as of 12/31/23(2) Last Fiscal Year
Mr. Goff Qualified Plan 25 $ 861,841 $—
Supplemental Plan 25 506,506 —
(1)
None of Messes. Johnson or Haynes-Gaspar or Messrs. Stansbury or Trezise are eligible to participate in these plans since they joined the
company after both of our Pension Plans were closed to new participants.
(2)
These figures represent accumulated benefits as of December 31, 2023 based on several assumptions, including the assumption that the
executive remains employed by us and begins receiving retirement benefits at the normal retirement age of 65, with such accumulated
benefits being discounted from the normal retirement age to December 31, 2023 using discount rates ranging between 5.20% and 5.21%. See
Note 11 titled “Employee Benefits” of the notes to our audited financial statements included in Appendix B for additional information.
PENSION PLANS. With limited exceptions specified in the Pension Plans, we “froze” our Qualified Plan and
Supplemental Plan as of December 31, 2010, which means that no additional monthly pension benefits have
accrued under such plans since that date (although service after that date continues to count towards vesting
and benefit eligibility and a limited transitional benefit for eligible participants continued to accrue
through 2015).
Prior to this freezing of benefit accruals, the aggregate amount of each senior officer’s total monthly pension
benefit under the Qualified Plan and Supplemental Plan was equal to his or her years of service since 1999 (up
to a maximum of 30 years) multiplied by the sum of (i) 0.5% of his or her final average pay plus (ii) 0.5% of his
or her final average pay in excess of his or her Social Security covered compensation, where “final average pay”
was defined as his or her average monthly compensation during the 60 consecutive month period within his
or her last ten years of employment in which he received his or her highest compensation. Effective
December ͏31, 2010, the Pension Plans were amended to cease all future benefit accruals under the above
formula (except where a collective bargaining agreement provides otherwise). In lieu of additional accruals
under the above-described formula, each affected participant’s accrued benefit as of December 31, 2010 were
increased 4% per year, compounded annually through the earlier of December 31, 2015 or the termination of the
participant’s employment.
Under both Pension Plans, “average monthly compensation” is determined based on the participant’s salary plus
annual cash incentive bonus. Although the retirement benefits described above are provided through separate
plans, we have in the past transferred benefits from the Supplemental Plan to the Qualified Plan and reserve the
right to make further similar transfers to the extent allowed under applicable law. The value of benefits
transferred to the Qualified Plan, which directly offset the value of benefits in the Supplemental Plan, will be
payable to the recipients in the form of enhanced annuities or supplemental benefits and are reflected in the
table above under the “Present Value of Accumulated Benefits as of 12/31/23” column.
The normal form of benefit payment under both of our Pension Plans is (i) in the case of unmarried participants,
a monthly annuity payable for the life of the participant and (ii) in the case of married participants, an actuarially
equivalent monthly annuity payable for the lifetime of the participant and a survivor annuity payable for the
lifetime of the spouse upon the participant’s death. Participants may elect optional forms of annuity benefits
under each Pension Plan and, in the case of the Qualified Plan, an annuity that guarantees ten years of benefits,
all of which are actuarially equivalent in value to the normal form of benefit. The enhanced annuities described in
the prior paragraph may be paid in the form of a lump sum, at the participant’s election.
The normal retirement age is 65 under both of the Pension Plans. Participants may receive benefits under both
of these plans upon “early retirement,” which is defined as attaining age 55 with five years of service. Under
both of these plans, the benefit payable upon early termination is calculated under formulas that pay between
60% to 100% of the base plan benefit and 48% to 92% of the excess plan benefit, in each case with the lowest
percentage applying to early retirement at age 55 and proportionately higher percentages applying to early
retirement after age 55. For additional information on early retirement benefits, please see the applicable early
retirement provisions of the Qualified Plan, a copy of which we have filed with the SEC.
Deferred Compensation
The following table and discussion provide information on our (i) Supplemental Savings Plan, under which
certain named officers may elect to defer a portion of their salary in excess of the amounts that may be deferred
under our qualified 401(k) plans, and (ii) the deferred compensation arrangements we have with Mr. Goff,
which is described in more detail in the text following the table below. Only Mr. Goff has elected to participate in
the Supplemental Savings Plan and made contributions to the plan during 2023.
Deferred Compensation
Aggregate Aggregate
Balance at Executive Company Aggregate Aggregate Balance at
December 31, Contributions Contributions Earnings in Withdrawals/ December 31,
Participating NEO 2022(1) in 2023(2) in 2023(3) 2023(4) Distributions 2023(1)
Mr. Goff $ 2,869,692 $ 71,503 $40,842 $ 606,126 $— $ 3,588,163
(1)
This figure represents the aggregate balance of Mr. Goff’s Supplemental Savings Plan account.
(2)
The amount in this column reflects Mr. Goff’s contributions under the Supplemental Savings Plan of salary paid in 2023 and reported as 2023
salary compensation in the Summary Compensation Table.
(3)
This column includes our partial match of Mr. Goff’s contribution under the terms of the Supplemental Savings Plan, all of which was
included as 2023 compensation in the column of the Summary Compensation Table labeled “All Other Compensation.”
(4)
This column represents aggregate earnings in 2023 including interest, dividends and distributions earned with respect to deferred
compensation invested by Mr. Goff in the manner described in the text below.
124
Compensation Tables
126
Compensation Tables
Under the terms of our equity incentive plans, incentives granted under those plans will not vest, accelerate,
become exercisable or be deemed fully paid unless otherwise provided in a separate agreement, plan or
instrument. None of our equity award agreements provide for any such accelerated recognition of benefits
solely upon a change of control. Instead, our award agreements provide that any holder of incentives who is
terminated by us or our successor without cause or resigns with good reason following a change of control will
be entitled to receive full vesting of his or her time-vested restricted shares and continued rights under his or
her performance-based restricted shares (on the same terms as if he or she had not been terminated).
We believe the above-described change of control benefits enhance shareholder value because:
• prior to a takeover, these protections help us to recruit and retain talented officers and to help maintain the
productivity of our workforce by alleviating concerns over economic security and
• during or after a takeover, these protections (i) help our personnel, when evaluating a possible business
combination, to focus on the best interests of Lumen and its shareholders and (ii) reduce the risk that
personnel will accept job offers from competitors after the commencement of takeover discussions.
(1)
All data in the table reflects our estimates of the value of payments and benefits assuming the named officer was terminated on
December ͏31, 2023. The closing price of the Common Shares on such date was $1.83. The table reflects only estimates of amounts earned or
payable through or at such date based on various assumptions. Actual amounts can be determined only at the time of termination. If a
named officer voluntarily resigns or is terminated with cause, he or she will not be entitled to any special or accelerated benefits but will be
entitled to receive various payments or benefits that vested before the termination date. The table reflects potential payments based upon a
physical disability; additional benefits may be payable in the event of a mental disability.
(2)
As further described above, upon termination of employment, the named officers may become entitled to receive certain special,
accelerated or enhanced benefits, including, subject to certain exceptions, the right to receive payment of their annual cash incentive bonus,
an acceleration under certain circumstances of the vesting of their outstanding equity awards, current or enhanced pension and welfare
benefits, or cash severance payments. The table excludes (i) payments or benefits made under broad-based plans or arrangements
generally available to all salaried full-time employees and (ii) benefits, awards or amounts that the officer was entitled to receive prior to
termination of employment.
(3)
The amounts listed in this column reflect payments to which the named officer would be entitled to under our executive severance plan if
involuntarily terminated by us without cause prior to a change of control. The amounts listed in this column would not be payable if the
officer voluntarily resigns or is terminated for cause.
(4)
The amounts listed in this column reflect payments to which Mr. Goff and Mr. Trezise would be entitled to under the provisions our STI plan.
Mr. Goff is eligible to retire early under Lumen’s defined benefit pension plans described above under the heading “Executive
Compensation —Pension Benefits.” The amounts reflected in this column do not reflect the amount of lifetime annuity payments payable
upon early retirement, upon which Mr. Goff would have been entitled at December 31, 2023 to monthly annuity payments of approximately
$8,734 over his lifetime.
(5)
The information in this column assumes each named officer became entitled on December 31, 2023 to the benefits under Lumen’s
agreements in existence on such date described above under “—Payments Made Upon a Change of Control” upon an involuntary
termination without cause or resignation with good reason. All amounts are based on several assumptions.
(6)
The information in this row reflects the benefit to the named officer arising out of the accelerated vesting of some or all of his or her
restricted stock or RSUs triggered by the termination of employment. The information in this row also assumes that the HRCC would not
approve the named officer receiving accelerated vesting of any portion of his or her unvested time-based equity awards or being permitted
to retain any portion of his or her unvested performance-based equity awards, notwithstanding that in the past the HRCC has generally
approved both with respect to equity awards granted at least one year prior to the termination date.
(7)
The information in this row reflects only the incremental benefits that accrue upon an event of termination and excludes benefits that were
vested on December 31, 2023. For information on the present value of the named officers’ accumulated benefits under our defined benefit
pension plans, see “—Pension Benefits,” and for information on the aggregate balances of Mr. Goff’s non-qualified deferred compensation,
see “—Deferred Compensation.” As indicated above, the named officer would also be entitled to receive a distribution of his or her 401(k)
benefits and various other broad-based benefits.
(8)
The information in this row excludes, in the case of disability or death, payments made by insurance companies.
(9)
For actual amounts to be paid to Mr. Trezise in connection with his involuntary termination of employment on April 5, 2024, see “– Amounts
Paid to Former Executive” immediately below.
128
Compensation Tables
Value of
Initial Fixed
$100
Average Investment
Summary Average based on:(4)
Summary Summary Compensation Compensation
Compensation Compensation Compensation Compensation Table Total Actually Paid Peer
Table Total for Table Total for Actually Paid to Actually Paid to for Non-PEO to Non-PEO Group Net Adjusted
PEO 1(1) PEO 2(1) PEO 1(1),(2),(3) PEO 2(1),(2),(3) NEOs(1) NEOs(1),(2),(3) TSR TSR Income EBITDA(5)
Year ($) ($) ($) ($) ($) ($) ($) ($) ($ Millions) ($ Millions)
(1)
Jeffery K. Storey was our PEO from May 24, 2018 to November 7, 2022 (“PEO 1”). Kathleen Johnson has been our PEO since November 7,
2022 (“PEO 2”). The individuals comprising the Non-PEO NEOs for each year presented are listed below.
(2)
The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not
reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation
Table Total with certain adjustments as described in footnote 3 below.
(3)
For 2023, compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEOs and the Non-PEO NEOs as set
forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards column are the
totals from the Stock Awards column set forth in the Summary Compensation Table. Amounts in the Exclusion of Change in Pension Value
column reflect the amounts, if any, attributable to the Change in Pension Value reported in the Summary Compensation Table. There are no
amounts reported in the Inclusion of Pension Service Cost because with limited exceptions specified in the Pension Plans, we “froze” our
defined benefit pension plans as of December 31, 2010, as described under the heading “ – Pension Benefits”.
Average Average
Summary Exclusion of Average Average Inclusion Average Inclusion Average
Compensation Change in Exclusion of of Pension of Equity Values Compensation
Table Total for Pension Value for Stock Awards for Service Cost for for Non-PEO Actually Paid to
Non-PEO NEOs Non-PEO NEOs Non-PEO NEOs Non-PEO NEOs NEOs Non-PEO NEOs
Year ($) ($) ($) ($) ($) ($)
2023 $3,396,054 $ (44,141) $(1,987,921) $— $ 482,695 $ 1,846,687
The amounts in the “Inclusion of Equity Values” columns in the tables above are derived from adding or
deducting the amounts set forth in the following tables:
Change in Fair
Year-End Fair Value from Last
Value of Equity Change in Fair Day of Prior Year
Awards Granted Value from Last Vesting-Date Fair to Vesting Date
During Year That Day of Prior Year Value of Equity of Unvested Fair Value at Last
Remained to Last Day of Awards Granted Equity Awards Day of Prior Year
Unvested as of Year of Unvested During Year that that Vested of Equity Awards Total - Inclusion
Last Day of Year Equity Awards for Vested During During Year for Forfeited During of Equity Values
for PEO 2 PEO 2 Year for PEO 2 PEO 2 Year for PEO 2 for PEO 2
Year ($) ($) ($) ($) ($) ($)
2023 $5,712,642 $(793,527) $— $ (1,038,322) $— $ 3,880,793
Average Year-
End Fair Value of Average Change
Equity Awards Average Change in Fair Value from
Granted During in Fair Value from Average Vesting- Last Day of Prior Average Fair
Year That Last Day of Prior Date Fair Value of Year to Vesting Value at Last Day
Remained Year to Last Day Equity Awards Date of Unvested of Prior Year of
Unvested as of of Year of Granted During Equity Awards Equity Awards Total - Average
Last Day of Year Unvested Equity Year that Vested that Vested Forfeited During Inclusion of
for Non-PEO Awards for Non- During Year for During Year for Year for Non-PEO Equity Values for
NEOs PEO NEOs Non-PEO NEOs Non-PEO NEOs NEOs Non-PEO NEOs
Year ($) ($) ($) ($) ($) ($)
2023 $ 1,580,761 $ (990,288) $— $(107,778) $— $482,695
(4)
The Peer Group TSR set forth in this table utilizes the S&P 500 Communication Services Sector Index, which we also utilize in the stock
performance graph appearing herein under the heading “Other Items-Lumen Performance History”. The comparison assumes $100 was
invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the S&P 500 Communication
Services Sector Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
(5)
We determined Adjusted EBITDA to be the most important financial performance measure used to link Company performance to
Compensation Actually Paid to our PEO 2 and Non-PEO NEOs in 2023. Adjusted EBITDA measures the operational performance and
profitability of our businesses, and we use this measure in our compensation programs to incentivize and reward our senior officers to focus
on the combination of cost savings and profitable revenue growth. Adjusted EBITDA, which is described in further detail in Appendix A –
Non-GAAP Reconciliations, is a non-GAAP metric. This performance measure may not have been the most important financial performance
measure for prior years and we may determine a different financial performance measure to be the most important financial performance
measure in future years.
130
Compensation Tables
PEO and Average Non-PEO NEO Compensation Actually Paid Versus TSR
PEO and Average Non-PEO NEO Compensation Actually Paid Versus Net Income
PEO and Average Non-PEO NEO Compensation Actually Paid Versus Adjusted EBITDA
Adjusted EBITDA
Free Cash Flow
Revenue
132
Other Matters
Stock Ownership
The following table sets forth information regarding ownership of our Common Shares by the persons known to
us to have beneficially owned more than 5% of the outstanding Common Shares on December 31, 2023 (the
“investors”), unless otherwise noted.
Stock Ownership
Amount and
Nature of
Beneficial Percent of
Ownership of Outstanding
Name and Address Common Shares(1) Common Shares(1)
(2)
Blackrock, Inc. 152,311,260 15.1%
50 Hudson Yards
New York, NY 10001
(3)
The Vanguard Group 118,327,820 11.7%
100 Vanguard Blvd.
Malvern, PA 19355
(4)
State Street Corporation 53,171,627 5.3%
State Street Financial Center
One Lincoln Street
Boston, MA 02111
(1)
The figures and percentages in the table above have been determined in accordance with Rule 13d-3 of the SEC based upon information
furnished by the investors, except that we have calculated the percentages in the table based on the actual number of Common Shares
outstanding as of the record date, as opposed to the estimated percentages set forth in the reports of such investors referred to below in
such notes. In addition to Common Shares, we have outstanding Preferred Shares that vote together with the Common Shares as a single
class on all matters. One or more persons beneficially own more than 5% of the Preferred Shares; however, the percentage of total voting
power held by such persons is immaterial. For additional information regarding the Preferred Shares, see “Frequently Asked Questions —
How many votes may I cast?”
(2)
Based on information contained in a Schedule 13G/A Report dated as of January 22, 2024, that this investor filed with the SEC. In this report,
the investor indicated that, as of December 31, 2023, it (i) shared voting power with respect to none of these shares, (ii) held sole voting
power with respect to 148,604,763 of these shares and (iii) held sole dispositive power with respect to all of the above-listed shares.
(3)
Based on information contained in a Schedule 13G/A Report dated as of February 13, 2024, that this investor filed with the SEC. In this
report, the investor indicated that, as of December 31, 2023, it (i) held sole voting power with respect to none of these shares, (ii) shared
voting power with respect to 657,954 of these shares, (iii) held sole dispositive power with respect to 116,595,555 of these shares and
(iv) shared dispositive power with respect to 1.732,265 of these shares.
(4)
Based on information contained in a Schedule 13G/A Report dated as of January 24, 2024, that this investor filed with the SEC. In this
report, the investor indicated that, as of December 31, 2023, it (i) held sole voting power with respect to none of these shares, (ii) shared
voting power with respect to 41,648,190 of these shares, (iii) held sole dispositive power with respect to none of these shares and (iv)
shared dispositive power with respect to 53,171,627 of these shares.
134
Other Matters
December 31,
2018 2019 2020 2021 2022 2023
Lumen $ 100.00 $ 95.65 $ 84.28 $ 101.85 $ 71.43 $ 55.76
S&P 500 Index $ 100.00 $129.44 $ 151.43 $ 191.71 $159.39 $ 197.06
S&P 500 Communication Service Sector Index(1) $ 100.00 $ 128.71 $155.67 $ 186.03 $ 118.47 $ 174.77
(1)
As of December 31, 2023, the S&P 500 Communications Service Sector Index consisted of Omnicom Group, Inc., Verizon Communications,
Inc., The Walt Disney Company, Alphabet Inc., AT&T Inc., Charter Communications Inc., Match Group Inc., Netflix Inc., Warner Bros Discovery
Inc., Comcast Corp., Paramount Global, Electronic Arts Inc., Meta Platforms Inc., Take-Two Interactive Software Inc., Interpublic Group,
T-͏Mobile US, Inc., Fox Corp., News Corp, and Live Nation Entertainment Inc.
136
Frequently Asked Questions
About Voting and the
Annual Meeting
Q Why am I receiving these proxy materials?
A Our Board of Directors is soliciting your proxy to vote at our 2024 annual meeting of shareholders because
you owned shares of our stock at the close of business on March 21, 2024, the record date for the meeting
and are entitled to vote those shares at the annual meeting. This proxy statement and our annual report were
first made available to shareholders on or about April 5, 2024. This proxy statement is furnished in
connection with the solicitation of proxies by our Board to be voted during the annual meeting for the
purposes set forth in the accompanying Notice of 2024 Annual Shareholders Meeting.
Q When and how will the meeting be held?
A Date: May 15, 2024
Time: 12:00 noon Central Time
Virtual Meeting Location: virtualshareholdermeeting.com/LUMN2024
Q How may I access these materials?
A We are furnishing proxy materials to our shareholders primarily via the Internet instead of mailing printed
copies of those materials to each shareholder. By doing so, we save costs and reduce the environmental
impact of our annual meeting. On or about April 5, 2024, we commenced mailing a Notice of Internet
Availability of Proxy Materials to most of our shareholders. The Notice contains instructions about how to
access our proxy materials online and submit your proxy online or by telephone. If you previously chose to
receive our proxy materials electronically, you will continue to receive access to these materials via email
unless you elect otherwise. If you would like to receive a paper copy of our proxy materials, please follow the
instructions included in the Notice of Internet Availability of Proxy Materials.
Q What matters will be considered at the meeting and what vote will be required?
A The following table summarizes the proposals being considered at the meeting, the votes required for
passage of each proposal and the effect of abstentions and uninstructed shares held by brokers.
Effect of
Board Voting Vote Required Effect of Uninstructed Page
Item Recommendation for Approval Abstentions Shares(1) Reference
(1)
“Uninstructed Shares” refers to shares as to which a broker or custodian receives no voting instructions from the shares’ beneficial owner
and which, other than as noted below for Items 2, 5A and 5B, cannot be voted under applicable NYSE standards. Because brokers will have
discretionary authority to vote with respect to Items 2, 5A and 5B, there should be no uninstructed shares for those items.
138
Frequently Asked Questions About Voting and the Annual Meeting
For Items 5A, 5B and 5C, approval requires the affirmative vote of at least a majority of the votes entitled to
be cast on the proposal. For each of these matters, abstentions and uninstructed shares will have the same
impact as a vote against the proposal.
Q How many votes may I cast?
A You may cast one vote for every share of our Common Stock or Series L Preferred Stock that you owned on
the record date, which vote together as a single class on all matters. In this proxy statement, we refer to
these shares as our “Common Shares” and “Preferred Shares,” respectively and as our “Voting Shares,”
collectively. As of the Record Date, we had 1,016,005,958 Common Shares and 7,018 Preferred Shares issued
and outstanding.
Q What is the difference between holding shares as a shareholder of record and as a beneficial owner?
A If shares are registered in your name with our transfer agent, Computershare Investor Services L.L.C., you are
the “shareholder of record” of those shares and you may directly vote these shares, together with any shares
credited to your account if you are a participant in our automatic dividend reinvestment and stock
purchase service.
If your shares are held on your behalf in a stock brokerage account or by a bank or other nominee, you are
the “beneficial owner” of shares held in “street name.” We have requested that our proxy materials be made
available to you by your broker, bank or nominee, who is considered the shareholder of record of
those shares.
Q If I am a shareholder of record, how do I vote?
A Regardless of whether you plan to join the annual meeting, please promptly submit your proxy and voting
instructions via the Internet, or by phone or mail as described herein. Shareholders are encouraged to submit
proxies and voting instructions in advance of the meeting as early as possible to avoid any possible delays. If
you are a shareholder of record, you may vote yourself or by proxy in any of the following four ways:
• By Internet: visit proxyvote.com and follow the instructions at that site
• By phone: call 1-800-690-6903 and follow the instructions provided;
• By mail: if you have received printed proxy materials, mark, sign and date your proxy or voting instructions
card and return it to Broadridge Financial Solutions Inc.; if you have not received printed proxy materials
but would like to, you can request a paper copy of our proxy materials and, following receipt thereof,
mark, sign and date your proxy or voting instructions card and return it to Broadridge Financial
Solutions, Inc.
• By Live virtual meeting: vote electronically at the virtual annual meeting –
virtualshareholdersmeeting.com/LUMN2024
Prior to the live meeting, if you need additional help with voting, please call proxy support at 866-232-3037
(Toll-free) or 720- 358-3640 (International Toll). If you encounter any difficulties accessing the virtual
meeting webcast, please call the technical support number that will be posted on the annual meeting website
log-in page.
Unless otherwise noted below, you may vote by telephone or the Internet up until 11:59 p.m. Eastern Time on
May 14, 2024, but not thereafter.
Q If I am a beneficial owner of shares held in street name, how do I vote?
A As the beneficial owner, you have the right to instruct your broker, bank or nominee how to vote your shares
by using any voting instruction card supplied by them or by following their instructions for voting by
telephone, the Internet, or live during the virtual meeting.
Q If I am a benefit plan participant, how do I vote?
A If you beneficially own any of our Common Shares by virtue of participating in our retirement plan, then you
will receive separate voting instructions that will enable you to direct the voting of these shares. You are
entitled, on a confidential basis, to instruct the trustees how to vote the shares allocated to your plan
account. The plan requires you to act as a “named fiduciary,” which requires you to exercise your voting
rights prudently and in the interests of all plan participants. Plan participants who wish to vote should
instruct the trustees how to vote the shares allocated to their plan accounts in accordance with the voting
instructions. If you elect not to vote the shares allocated to your accounts, your shares will be voted in the
same proportion as voted shares regarding each of the items submitted to a vote at the meeting. Plan
participants that wish to revoke their voting instructions must contact the trustee and follow its procedures.
To be counted, your voting instructions for shares held in our retirement plan must be received by 11:59 p.m.
Eastern Time on May 12, 2024, but not thereafter.
Q How do I participate in the annual meeting?
A This year’s annual meeting will be held in a virtual format through a live webcast.
You are entitled to participate in the annual meeting if you were a record shareholder as of the close of
business on March 21, 2024, the record date, or hold a valid proxy for the meeting. To be admitted to the
annual meeting at proxyvote.com, you must enter the 16-digit control number found next to the label
“Control Number” on your Notice of Internet Availability, proxy card, or voting instruction form, or in
the email sending you the proxy statement. If you are a beneficial shareholder, you may contact the broker,
bank or other institution with whom you hold your account if you have questions about obtaining your
Control Number.
The question and answer session of the meeting will include questions submitted in advance of and
questions submitted live during the annual meeting. You may submit a question in advance of the meeting at
proxyvote.com after logging in with your Control Number. Questions may be submitted during the live
virtual annual meeting by following the instructions on your log-in screen.
We encourage you to access the annual meeting before it begins. Online check-in will start approximately
15 minutes before the meeting on May 15, 2024.
Q What can I do if I need technical assistance during the annual meeting?
A The virtual meeting platform is fully supported across browsers (Internet Explorer, Firefox, Chrome and
Safari) and devices (desktops, laptops, tablets and cell phones) running the most updated version of
applicable software and plugins. If you encounter any difficulties accessing the virtual Meeting webcast,
please call the technical support number that will be posted on the annual meeting website log-in page.
Q Who sets the rules regarding conduct at the meeting?
A Under our Bylaws, the Chairman has broad responsibility and legal authority to conduct the meeting in an
orderly and timely manner. This authority includes establishing rules for shareholders who wish to address
the meeting. Copies of these rules will be available prior to the meeting in the “Events & Presentations”
section of our website ir.lumen.com and during the meeting. The Chairman may also exercise broad
discretion regarding (i) recognizing shareholders who wish to speak, (ii) determining the extent of discussion
on each item of business and (iii) consolidating the Company’s response to similar questions. In light of the
need to conduct all necessary business and to conclude the meeting within a reasonable period of time, we
cannot assure you that each question submitted will be addressed.
Q What is the quorum requirement for the meeting?
A Our Bylaws provide that the presence at the meeting, including by proxy, of a majority of the outstanding
Voting Shares constitutes a quorum to organize the meeting. For these purposes, abstentions and
uninstructed shares are counted as being present.
Q Can I revoke or change my voting instructions after I deliver them?
A Shareholders of record may revoke their proxy or change their votes at any time before their proxy is voted
at the meeting by timely giving a written revocation notice to our secretary before the virtual meeting,
by timely delivering a proxy bearing a later date or by voting during the virtual meeting. Joining the virtual
meeting will not be enough to revoke your proxy. Beneficial shareholders may revoke or change their voting
instructions by contacting the broker, bank or nominee that holds their shares.
Q Who pays the cost of soliciting proxies?
A The Board, on behalf of the Company, is soliciting the proxy accompanying this proxy statement. Proxies
may be solicited by Lumen officers, directors and employees, none of whom will receive any additional
compensation for their services. Alliance Advisors, LLC may solicit proxies at a cost we anticipate will not
exceed $40,000. These solicitations may be made personally or by mail, telephone, messenger, email, or
other electronic transmission. Lumen will pay persons holding shares of common stock in their names or in
the names of nominees, but not owning such shares beneficially, such as brokerages, banks and other
fiduciaries, for the expense of forwarding solicitation materials to their principals. Lumen will pay all proxy
solicitation costs.
140
Frequently Asked Questions About Voting and the Annual Meeting
Proxy Materials
As described further above, shareholders will receive only a written notice of how to access our proxy materials
and will not receive printed copies of the proxy materials unless requested. If you would like to receive a paper
copy of our proxy materials, you should follow the instructions for requesting the materials in the notice.
The full set of our materials include:
• the notice and proxy statement for the meeting,
• a proxy or voting instruction card, and
• our 2023 annual report furnished in the following two parts: (1) our 2023 Annual Financial Report, which
constitutes Appendix B to this proxy statement and (2) our CEO’s letter appearing at the beginning of
this document.
April 5, 2024
142
Appendix A
Non-GAAP Reconciliations
Description of Non-GAAP Metrics
Pursuant to Regulation G, the company is hereby providing (i) definitions of non-GAAP financial metrics that are
used in the sections of the proxy statement under the headings “About Lumen,” “Compensation Discussion &
Analysis — Section One — Executive Summary” and “Compensation Discussion & Analysis — Section Four —
Compensation Design, Awards and Payouts for 2023” and (ii) reconciliations of these metrics to the most
directly comparable GAAP measures.
The following describes and reconciles those financial measures as reported under accounting principles
generally accepted in the United States (GAAP) with those financial measures as adjusted by the items detailed
below. These calculations are not prepared in accordance with GAAP and should not be viewed as alternatives
to GAAP.
We use the term Special Items as a non-GAAP measure to describe items that impacted a period’s statement of
operations for which investors may want to give special consideration due to their magnitude, nature or both.
We do not call these items non-recurring because, while some are infrequent, others may recur in future periods.
In connection with setting performance targets for purposes of executive compensation, the company from
time to time uses modified versions of the non-GAAP metrics referred to below. For further information of such
modifications, see “Compensation Discussion & Analysis — Section Two — Compensation Philosophy and
Oversight — Incentive Program Guidelines.”
Adjusted EBITDA ($) is defined as net income (loss) from the Statements of Operations before income tax
(expense) benefit, total other income (expense), depreciation and amortization, stock-based compensation
expense and impairments.
Adjusted EBITDA Margin (%) is defined as Adjusted EBITDA divided by total revenue.
Management believes that Adjusted EBITDA and Adjusted EBITDA Margin are relevant and useful metrics to
provide to investors, as they are an important part of our internal reporting and are key measures used by
management to evaluate profitability and operating performance of Lumen and to make resource allocation
decisions. Management believes such measures are especially important in a capital-intensive industry such as
telecommunications. Management also uses Adjusted EBITDA and Adjusted EBITDA Margin (and similarly uses
these terms excluding Special Items) to compare our performance to that of our competitors and to eliminate
certain non-cash and non-operating items in order to consistently measure from period to period our ability to
fund capital expenditures, fund growth, service debt and determine bonuses. Adjusted EBITDA excludes non-
cash stock compensation expense and impairments because of the non-cash nature of these items. Adjusted
EBITDA also excludes interest income, interest expense and income taxes, and in our view constitutes an
accrual-based measure that has the effect of excluding period-to-period changes in working capital and shows
profitability without regard to the effects of capital or tax structure. Adjusted EBITDA also excludes
depreciation and amortization expense because these non-cash expenses primarily reflect the impact of
historical capital investments, as opposed to the cash impacts of capital expenditures made in recent periods,
which may be evaluated through cash flow measures. Adjusted EBITDA further excludes the gain (or loss) on
extinguishment and modification of debt and other income (expense), net, because these items are not related
to the primary business operations of Lumen.
There are material limitations to using Adjusted EBITDA as a financial measure, including the difficulty
associated with comparing companies that use similar performance measures whose calculations may differ
from our calculations. Additionally, by excluding the above-listed items, Adjusted EBITDA may exclude items
that investors believe are important components of our performance. Adjusted EBITDA and Adjusted EBITDA
Margin (either with or without Special Items) should not be considered a substitute for other measures of
financial performance reported in accordance with GAAP.
Free Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures as
disclosed in the Statements of Cash Flows. Management believes that Free Cash Flow is a relevant metric to
provide to investors, as it is an indicator of our ability to generate cash to service our debt. Free Cash Flow
excludes cash used for acquisitions, principal repayments and the impact of exchange rate changes on cash and
cash equivalents balances.
There are material limitations to using Free Cash Flow to measure our performance as it excludes certain
material items that investors may believe are important components of our cash flows. Comparisons of our Free
Cash Flow to that of some of our competitors may be of limited usefulness since until recently we did not pay a
significant amount of income taxes due to net operating loss carryforwards, and therefore, generated higher
cash flow than a comparable business that does pay income taxes. Additionally, this financial measure is subject
to variability quarter over quarter as a result of the timing of payments related to interest expense, accounts
receivable, accounts payable, payroll and capital expenditures. Free Cash Flow (either with or without Special
Items) should not be used as a substitute for net change in cash, cash equivalents and restricted cash on the
Consolidated Statements of Cash Flows.
Net Debt is defined as total long-term debt, excluding unamortized discounts, premiums, net and unamortized
debt issuance costs, minus cash and cash equivalents.
Net Debt-to-Adjusted EBITDA Ratio is defined as Net Debt, divided by Adjusted EBITDA.
(1)
Transaction and separation costs associated with (i) the sale of our Latin American business on August 1, 2022, (ii) the sale of our 20-state
ILEC business on October 3, 2022, (iii) the sale of our EMEA business on November 1, 2023 and (iv) our evaluation of other
potential transactions.
(2)
Real estate transactions include the Q2 2023 and Q4 2023 loss on donation of real estate and Q3 2021 (gain) on sale of real estate, net of
impairment charges or acceleration of costs associated with our real estate rationalization program.
(3)
Reflects primarily (i) the pre-tax gain of $597 million recorded in operating income as a result of our Latin American business divestiture
completed August 1, 2022, (ii) the pre-tax gain of $176 million recorded in operating income as a result of our 20-state ILEC business
divestiture completed October 3, 2022 and (iii) the net loss of $102 million recorded for the year ended 2023 operating income and $660
million recorded for the year ended 2022 operating income as a result of our EMEA business divestiture completed November 1, 2023.
(4)
Reflects a gain as a result of (i) $19 million of debt exchanges in Q2 2023, (ii) $1.5 billion of debt exchanges in Q1 2023, (iii) $4.4 billion in
early debt retirement in Q4 2022 and (iv) $2.3 billion in early debt retirement in Q3 2022
(5)
Income from transition and separation services includes charges we billed for transition services and IT professional services provided to the
purchasers in connection with our 2022 and 2023 divestitures.
(6)
Tax effect calculated using the annualized statutory tax rate, excluding any non-recurring discrete items.
A-2
Appendix A
2023 2022
Net loss $(10,298) (1,548)
Income tax expense 61 557
Total other expense, net 653 1,086
Depreciation and amortization expense 2,985 3,239
Stock-based compensation expense 52 98
Goodwill impairment 10,693 3,271
Adjusted EBITDA $ 4,146 6,703
(1)
Add back: Severance $ 74 12
Add back: Consumer and other litigation(1) (3) (3)
Add back: Transaction and separation costs(1) 108 219
Add back: Real estate transactions(1) 109 —
Add back: Net loss on sale of select CDN contracts(1) 73 —
(1)
Add back: Net loss (gain) on sale of businesses 121 (113)
Add back: Loss on disposal group held for sale(1) — 40
Adjusted EBITDA excluding Special Items $ 4,628 6,858
Net income excluding Special Items(1) $ 193 1,564
Total revenue $ 14,557 17,478
Net loss margin (70.7)% (8.9)%
Net income margin, excluding Special Items 1.3% 8.9%
Adjusted EBITDA margin 28.5% 38.4%
Adjusted EBITDA margin excluding Special Items 31.8% 39.2%
(1)
Refer to Non-GAAP Special Items table for details of the Special Items included above.
(1)
Refer to Non-GAAP Special Items table for details of the Special Items impacting cash flow included above.
(2)
Reflects cash pension contribution following a revaluation of the pension obligation and pension assets for the Lumen Pension Plan, in
connection with the closing of the sale of the 20-state ILEC business on October 3, 2022.
(3)
Reflects income from transition and separation services including charges we billed for transition services and IT professional services
provided to the purchasers in connection with our 2022 and 2023 divestitures.
A-4
Appendix B
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of B-2
Equity Securities
Management’s Discussion and Analysis of Financial Condition and Results of Operations B-2
Quantitative and Qualitative Disclosures about Market Risk xx
Consolidated Financial Statements and Supplementary Data B-22
Report of Independent Registered Public Accounting Firm B-22
Report of Independent Registered Public Accounting Firm B-24
Consolidated Statements of Operations B-25
Consolidated Statements of Comprehensive (Loss) Income B-26
Consolidated Balance Sheets B-27
Consolidated Statements of Cash Flows B-28
Consolidated Statements of Stockholders’ Equity B-29
Notes to Consolidated Financial Statements* B-29
Overview
We are a facilities-based technology and communications company that provides a broad array of integrated
products and services to our domestic and global business customers and our domestic mass markets
customers. We operate one of the world's most interconnected networks. Our platform empowers our
customers to swiftly adjust digital programs to meet immediate demands, create efficiencies, accelerate market
access and reduce costs, which allows our customers to rapidly evolve their IT programs to address dynamic
changes. With approximately 170,000 on-net buildings and 350,000 route miles of fiber optic cable globally,
we are among the largest providers of communications services to domestic and global enterprise customers.
Our long-haul network throughout North America and Asia Pacific connects to metropolitan fiber networks that
we operate.
B-2
Appendix B
Reporting Segments
Our reporting segments are currently organized as follows, by customer focus:
• Business Segment: Under our Business segment, we provide our products and services under four
sales channels:
– Large Enterprise: Under our large enterprise sales channel, we provide our products and services to large
enterprises, including multinational and global enterprise customers and carriers.
– Mid-Market Enterprise: Under our mid-market enterprise sales channel, we provide our products and
services to medium-sized enterprises directly and through our indirect channel partners.
– Public Sector: Under our public sector sales channel, we provide our products and services to the public
sector, including the U.S. Federal government, state and local governments and research and
education institutions.
– Wholesale: Under our wholesale sales channel, we provide our products and services to a wide range of
other communication companies providing wireline, wireless, cable, voice and data center services.
• Mass Markets Segment. Under our Mass Markets segment, we provide products and services to residential and
small business customers. At December 31, 2023, we served 2.8 million broadband subscribers under our Mass
Markets segment.
See Note 17—Segment Information to our consolidated financial statements in Item 8 of Part II of our Annual
Report on Form 10-K for the year ended December 31, 2023 for additional information.
We categorize our Business segment revenue among the following products and services categories:
• Grow, which includes products and services that we anticipate will grow, including our dark fiber, Edge Cloud
services, IP, managed security, software-defined wide area networks ("SD WAN"), secure access service edge
("SASE"), Unified Communications and Collaboration ("UC&C") and wavelengths services;
• Nurture, which includes our more mature offerings, including ethernet and VPN data networks services;
• Harvest, which includes our legacy services managed for cash flow, including Time Division Multiplexing
("TDM") voice, private line and other legacy services; and
• Other, which includes equipment sales, IT solutions and other services.
We categorize our Mass Markets products and services revenue among the following categories:
• Fiber Broadband, under which we provide high speed broadband services to residential and small business
customers utilizing our fiber-based network infrastructure;
• Other Broadband, under which we provide primarily lower speed broadband services to residential and small
business customers utilizing our copper-based network infrastructure; and
• Voice and Other, under which we derive revenues from (i) providing local and long-distance voice services,
professional services, and other ancillary services, and (ii) federal broadband and state support programs.
B-4
Appendix B
• The operating margins of several of our newer, more technologically advanced services, some of which may
connect to customers through other carriers, are lower than the operating margins on our traditional, on-net
wireline services.
• Uncertainties regarding our financial performance, leverage and debt covenant compliance have caused, and
may continue to cause, certain of our customers and other third parties to reduce or cease transacting
business with us.
• Our expenses will be impacted by higher vendor costs, reduced economies of scale and other dis-synergies
due to our completed 2022 and 2023 divestitures and any future divestitures.
• Declines in our traditional wireline services and other more mature offerings have necessitated right-sizing
our cost structures to remain competitive.
Inflation has placed downward pressure on our margins and macroeconomic uncertainties have likely
contributed to delayed decision-making by certain of our customers, which are trends that will likely continue to
impact us as long as inflation rates remain elevated. These and other developments and trends impacting our
operations are discussed elsewhere in this Item 7.
Results of Operations
In this section, we discuss our overall results of operations and highlight special items that are not included in
our segment results. In "Segment Results" we review the performance of our two reporting segments in more
detail. Results in this section include the results of our Latin American, ILEC and EMEA businesses prior to their
sale on August 1, 2022, October 3, 2022 and November 1, 2023 respectively.
Revenue
The following table summarizes our consolidated operating revenue recorded under each of our two segments
and in our four revenue sales channels within the Business segment described above:
2023 vs 2022 vs
Years Ended December 31, 2022 % 2021 %
2023 2022 2021 Change Change
(Dollars in millions)
Business Segment:
Large Enterprise $ 4,616 5,377 5,918 (14)% (9)%
Mid-Market Enterprise 2,011 2,212 2,398 (9)% (8)%
Public Sector 1,783 1,861 2,111 (4)% (12)%
Wholesale 3,125 3,591 3,692 (13)% (3)%
Business Segment Revenue 11,535 13,041 14,119 (12)% (8)%
Mass Markets Segment Revenue 3,022 4,437 5,568 (32)% (20)%
Total operating revenue $ 14,557 17,478 19,687 (17)% (11)%
Our consolidated operating revenue decreased by $2.9 billion for the year ended December 31, 2023 as
compared to the year ended December 31, 2022, $2.1 billion of which is attributable to the sale of our Latin
American and ILEC businesses in the second half of 2022, and the sale of our EMEA business on
November 1, 2023. Our consolidated revenue decreased by $2.2 billion for the year ended December 31, 2022
compared to the year ended December 31, 2021 due to revenue declines in all of our revenue categories listed
above, in addition to an approximately $1.0 billion decrease attributable to the sale of our Latin American and
ILEC businesses in the second half of 2022. See our segment results below for additional information.
Operating Expenses
The following table summarizes our operating expenses for the years ended December 31, 2023 and 2022. For
information regarding expenses for the year ended December 31, 2021, see "Management's Discussion and
Analysis of Financial Condition and Results of Operations" in Item 7 of Part II of our Annual Report Form 10-K for
the year ended December 31, 2022.
nm Percentages greater than 200% and comparisons between positive and negative values or to/from zero values are considered
not meaningful.
Depreciation expense decreased by $201 million for the year ended December 31, 2023 as compared to the year
ended December 31, 2022 primarily due to the discontinuation during the fourth quarter of 2022 of the
depreciation of the tangible EMEA assets we divested, resulting in a decrease of $152 million of depreciation
expense during the year ended December 31, 2023 compared to the year ended December 31, 2022. In addition,
for the year ended December 31, 2023 as compared to the year ended December 31, 2022, depreciation expense
decreased $137 million due to the impact of annual rate depreciable life changes, The decreases were partially
offset by higher depreciation expense of $92 million associated with net growth in depreciable assets.
B-6
Appendix B
Amortization expense decreased by $53 million for the year ended December 31, 2023 as compared to the year
ended December 31, 2022. The decrease was primarily due to the discontinuation during the fourth quarter of
2022 of the amortization of the intangible EMEA assets we divested, resulting in a decrease of $30 million of
amortization expense during the year ended December 31, 2023 compared to the year ended
December 31, 2022. In addition, for the year ended December 31, 2023, as compared to the year ended
December 31, 2022, amortization expense decreased $18 million resulting from certain customer relationship
intangible assets becoming fully amortized in the second quarter of 2023.
Further analysis of our segment operating expenses by segment is provided below in "Segment Results."
Goodwill Impairments
We are required to perform impairment tests related to our goodwill annually, which we perform as of
October 31, or sooner if an indicator of impairment occurs. We considered the sustained decline in our share
price during the second quarter of 2023 an event or change in circumstance requiring evaluation of
goodwill impairment.
We report under two segments: Business and Mass Markets. As of December 31, 2023, we had three reporting
units for goodwill impairment testing, which are (i) Mass Markets, (ii) North America Business ("NA Business")
and (iii) Asia Pacific ("APAC") region. Prior to the divestiture of the EMEA business, the EMEA region was also
a reporting unit and was tested for impairment in the pre-classification test as of October 31, 2022 discussed
elsewhere herein. Prior to its August 1, 2022 divestiture, the Latin American ("LATAM") region was also a
reporting unit.
During the second and fourth quarters of 2023, we determined circumstances existed indicating it was more
likely than not that the carrying value of one or more of our reporting units exceeded its fair value. When we
performed an impairment test, we concluded that the estimated fair value of certain of our reporting units was
less than their carrying value of equity as of our testing date. As a result, we recorded non-cash,
non-tax-deductible goodwill impairment charges aggregating to $10.7 billion for the year ended
December 31, 2023. When we performed our impairment tests during the fourth quarter of 2022, we concluded
that the estimated fair value of certain of our reporting units was less than our carrying value of equity as of our
testing date. As a result, we recorded non-cash, non-tax-deductible goodwill impairment charges aggregating
to $3.3 billion in the fourth quarter of 2022. When we performed our annual impairment test in the fourth
quarter of 2021, we concluded it was more likely than not that the fair value of each of our reporting units
exceeded the carrying value of equity of our reporting units. Therefore, we concluded no impairment existed as
of our annual assessment date in the fourth quarter of 2021.
We are currently experiencing competitive, macroeconomic and financial pressures, including dis-synergies
resulting from our 2022 and 2023 divestitures and concerns about our ability to refinance debt in the future.
In 2023, we also experienced a sustained decline in our share price. These and other factors contributed to us
recognizing the above-described goodwill impairments. If these pressures continue, we may experience
additional deterioration in our projected cash flows or market capitalization, or make significant changes to our
assumptions of discount rates and market multiples. Any of these could result in additional goodwill
impairments in future quarters.
See Note 3—Goodwill, Customer Relationships and Other Intangible Assets to our consolidated financial
statements in Item 8 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2023 for
further details on these tests and impairment charges.
nm Percentages greater than 200% and comparisons between positive and negative values or to/from zero values are considered
not meaningful.
Interest Expense
Interest expense decreased by $174 million for the year ended December 31, 2023 as compared to the year
ended December 31, 2022. The decline was primarily due to a $4.5 billion decrease in average outstanding
long-term debt (inclusive of debt classified as held for sale), which was partially offset by an increase in the
average interest rate from 5.14% to 5.9%.
See Note 14—Fair Value of Financial Instruments for more information regarding the losses recognized on our
investments in equity securities and a limited partnership.
B-8
Appendix B
Segment Results
General
Reconciliation of segment revenue to total operating revenue is below. The results presented in this section
include results of our Latin American, ILEC and EMEA businesses prior to their sale on August 1, 2022,
October 3, 2022 and November 1, 2023 respectively:
For additional information on our reportable segments and product and services categories,
see Note 4—Revenue Recognition and Note 17—Segment Information to our consolidated financial statements
in Item 8 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2023.
Business Segment
Year ended December 31, 2023 compared to the years ended December 31, 2022 and December 31, 2021
Business segment revenue decreased $1.5 billion for the year ended December 31, 2023 compared to
December 31, 2022 and decreased $1.1 billion for the year ended December 31, 2022 compared to
December 31, 2021. Approximately $1.0 billion of the decrease for the year ended December 31, 2023 compared
to December 31, 2022 was due to the sale of the Latin American, ILEC and EMEA businesses in late 2022 and
2023. For the year ended December 31, 2022 compared to December 31, 2021, the sale of the Latin American
and ILEC businesses in the second half of 2022 caused a decrease of $511 million. More specifically, within each
product category for the year ended December 31, 2023 compared to December 31, 2022 and for the year
ended December 31, 2022 compared to December 31, 2021:
• Grow decreased $126 million and $92 million, reflecting decreases of approximately $370 million and
$176 million associated with the sale of the divested businesses. This was offset by increases of approximately
$244 million primarily in our IP, wavelengths, dark fiber, enterprise broadband and colocation products for the
year ended December 31, 2023 compared to December 31, 2022 and approximately $84 million primarily in
our IP, enterprise broadband, and wavelengths products for the year ended December 31, 2022 compared to
December 31, 2021;
• Nurture decreased $629 million and $446 million, approximately $262 million and $119 million of which was
attributable to the sale of the divested businesses. The remainder of these declines are principally attributable
to declines in traditional VPN networks services of $261 million and $245 million and declines in Ethernet
services of $112 million and $87 million;
• Harvest decreased by $772 million and $512 million, approximately $370 million and $209 million of which
was attributable to the sale of the divested businesses. The remainder of the decline is principally attributable
to a $265 million and $211 million decline in legacy voice services;
• Other increased by $21 million for the year ended December 31, 2023 compared to December 31, 2022 and
decreased $28 million for the year ended December 31, 2022 compared to December 31, 2021. Equipment
revenue drove both the increase for the year ended December 31, 2023 and the decrease for the year ended
December 31, 2022 with an increase of $35 million and a decrease of $20 million, respectively.
The decrease in Business segment revenue for the year ended December 31, 2023 was also driven by $31 million
of unfavorable foreign currency adjustments as compared to December 31, 2022. The decrease in Business
segment revenue for the year ended December 31, 2022 was also driven by $54 million of unfavorable foreign
currency adjustments for the year ended December 31, 2022 as compared to December 31, 2021.
Business segment expense decreased by $102 million for the year ended December 31, 2023 compared to
December 31, 2022 primarily due to the sale of the divested businesses of $230 million. This decrease was
partially offset by an increase of $80 million in cost of sales and $48 million in selling, general and administrative
expenses, primarily $31 million of increased professional fees and $17 million of increased employee-related
costs. A portion of these and other expense increases were driven by our ongoing growth and optimization
initiatives. Business segment expenses decreased by $289 million for the year ended December 31, 2022
compared to December 31, 2021, primarily due to a $138 million decrease in expenses from the divested
businesses, as well as decreases in cost of sales of $105 million and $46 million in selling, general and
administrative expenses, primarily in reduced employee-related costs of $38 million.
Business segment adjusted EBITDA as a percentage of revenue was 62%, 66% and 66% for the years ended
December 31, 2023, 2022 and 2021.
B-10
Appendix B
Year ended December 31, 2023 compared to the years ended December 31, 2022 and December 31, 2021
Mass Markets segment revenue decreased by $1.4 billion for the year ended December 31, 2023 compared to
December 31, 2022 and decreased $1.1 billion for the year ended December 31, 2022 compared to
December 31, 2021. Approximately $1.1 billion and $448 million of these decreases are due to the sale of our ILEC
business in the fourth quarter of 2022. More specifically, within each product category for the year ended
December 31, 2023 compared to December 31, 2022 and for the year ended December 31, 2022 compared to
December 31, 2021:
• Fiber Broadband revenue increased $32 million and $80 million, primarily driven by $73 million and $83
million of increases driven by growth in the number of fiber customers associated with our continued increase
in enabled locations from our Quantum Fiber buildout, which was partially offset by respective decreases of
$41 million and $3 million due to the sale of the ILEC business relating to such periods;
• Other Broadband revenue decreased $770 million and $343 million. Approximately $563 million and $230
million of this decrease was due to the ILEC divestiture and $207 million and $113 million was due to fewer
customers for our lower speed copper-based broadband services;
• Voice and Other decreased $677 million and $868 million. These declines were principally due to (i) a $472
million and $215 million decrease due to the sale of the ILEC business, (ii) a $146 million and $222 million
decrease due to the continued loss of copper-based voice customers and (iii) for the year ended December
31, 2023 compared to December 31, 2022, the recognition in the first quarter of 2022 of $59 million of
previously deferred revenue related to the CAF II program, which lapsed on December 31, 2021. The decrease
for the year ended December 31, 2022 compared to December 31, 2021 was additionally driven by the net
reduction in CAF II revenue of $431 million.
Mass Markets segment expense decreased by $314 million for the year ended December 31, 2023 compared to
December 31, 2022 primarily due to a $295 million decrease due to the ILEC divestiture and a $37 million
decrease in professional fees, partially offset by an increase of $42 million in employee-related costs and $27
million in marketing and advertising costs. Mass Markets segment expense decreased $91 million for the year
ended December 31, 2022 compared to December 31, 2021 primarily due to a $176 million decrease due to the
divestiture of the ILEC business, partially offset by $107 million of increased bad debt expense, network expense
and professional fees.
Mass Markets segment adjusted EBITDA as a percentage of revenue was 53%, 61% and 67% for the years ended
December 31, 2023, 2022 and 2021, respectively.
Intangible assets arising from business combinations, such as goodwill, customer relationships, capitalized
software, trademarks and tradenames, are initially recorded at estimated fair value. We amortize customer
relationships primarily over an estimated life of 7 to 14 years, using the straight-line method, depending on the
customer. Certain customer relationship intangible assets became fully amortized at the end of the first quarter
2021 using the sum-of-years-digits method, which we no longer use for any of our remaining intangible assets.
We amortize capitalized software using the straight-line method primarily over estimated lives ranging up to 7
years. We amortize our other intangible assets using the straight-line method over an estimated life of 9 to 20
years. Other intangible assets not arising from business combinations are initially recorded at cost. Where there
are no legal, regulatory, contractual or other factors that would reasonably limit the useful life of an intangible
asset, we classify them as indefinite-lived intangible assets and such intangible assets are not amortized.
We assess our long-lived intangible assets, other than goodwill, with indefinite lives for impairment annually, or,
under certain circumstances, more frequently, such as when events or changes in circumstances indicate there
may be an impairment. These assets are carried at the estimated fair value at the time of acquisition and assets
not acquired in acquisitions are recorded at historical cost. However, if their estimated fair value is less than their
carrying amount, we recognize an impairment charge for the amount by which the carrying amount of these
assets exceeds their estimated fair value. For the year ended December 31, 2023 and 2022, we concluded it was
more likely than not that our indefinite-lived intangible assets were not impaired; thus we recorded no
impairment charge for these assets.
We are required to assess our goodwill for impairment annually, or more frequently if an event occurs or
circumstances change that indicates it is more likely than not the fair values of any of our reporting units were
less than their carrying values. In assessing goodwill for impairment, we may first assess qualitative factors to
determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.
Our annual impairment assessment date for goodwill is October 31, at which date we assess our reporting units.
We report two segments: Business and Mass Markets. At October 31, 2023, we had three reporting units for
goodwill impairment testing, which are (i) Mass Markets (ii) North America Business ("NA Business") and (iii)
Asia Pacific ("APAC") region. Prior to their divestitures in 2023 and 2022, the EMEA and Latin American
("LATAM") regions were also each considered their own reporting unit.
B-12
Appendix B
Our reporting units are not discrete legal entities with discrete full financial statements. Our assets and liabilities
are employed in and relate to the operations of multiple reporting units and are allocated to individual reporting
units based on their relative revenue or earnings before interest, taxes depreciation and amortization
("EBITDA"). For each reporting unit, we compare its estimated fair value of equity to its carrying value of equity
that we assign to the reporting unit. If the estimated fair value of the reporting unit is greater than its carrying
value, we conclude that no impairment exists. If the estimated fair value of the reporting unit is less than the
carrying value, we record a non-cash impairment charge equal to the excess amount. Depending on the facts
and circumstances, we typically estimate the fair value of our reporting units by considering either or both of (i)
a discounted cash flow method, which is based on the present value of projected cash flows over a discrete
projection period and a terminal value, which is based on the expected normalized cash flows of the reporting
units following the discrete projection period, and (ii) a market approach, which includes the use of multiples of
publicly-traded companies whose services are comparable to ours. With respect to our analysis using the
discounted cash flow method, the timing and amount of projected cash flows under these forecasts require
estimates developed from our long-range plan, which is informed by wireline industry trends, the competitive
landscape, product lifecycles, operational initiatives, capital allocation plans and other company-specific and
external factors that influence our business. These projected cash flows consider recent historical results and are
consistent with our short-term financial forecasts and long-term business strategies. The development of these
projected cash flows, and the discount rate applied to such cash flows, is subject to inherent uncertainties, and
actual results could vary significantly from such estimates. Our determination of the discount rate is based on a
weighted average cost of capital approach, which uses a market participant’s cost of equity and after-tax cost
of debt and reflects certain risks inherent in the projected cash flows. With respect to our analysis using the
market approach, we estimate the fair value of a reporting unit based upon a market multiple applied to the
reporting unit’s revenue and EBITDA, adjusted for an appropriate control premium based on recent market
transactions. We weigh these revenue and EBITDA market multiples depending on the characteristics of the
individual reporting unit. We also reconcile the estimated fair values of the reporting units to our market
capitalization to conclude whether the indicated control premium is reasonable in comparison to recent
transactions in the marketplace.
Declines in our stock price have in the past caused an impairment of our goodwill, and future declines in our
stock price could potentially cause additional impairments of our goodwill. Changes in the underlying
assumptions that we use in allocating the assets and liabilities to reporting units under either the discounted
cash flow or market approach method can result in materially different determinations of fair value. We perform
sensitivity analyses that consider a range of discount rates and a range of EBITDA market multiples and we
believe the estimates, judgments, assumptions and allocation methods used by us are reasonable. Nonetheless,
changes in any of them can significantly affect whether we must incur impairment charges, as well as the size of
such charges.
For additional information on our goodwill balances by segment and results of our impairment analyses,
see Note 3—Goodwill, Customer Relationships and Other Intangible Assets to our consolidated financial
statements in Item 8 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2023.
In 2023, approximately 62% of the Combined Pension Plan's January 1, 2023 net actuarial loss balance of $1.4
billion was subject to amortization as a component of net periodic expense over the average remaining service
period of 14 years for participating employees expected to receive benefits under the plan. We treated the other
38% of the Combined Pension Plan's beginning net actuarial loss balance as indefinitely deferred during 2023. In
2023, approximately 56% of the beginning net actuarial gain of $371 million at January 1, 2023 for the
post-retirement benefit plans was subject to amortization as a component of net periodic expense, with the
other 44% of the beginning net actuarial gain balance for the post-retirement benefit plans treated as
indefinitely deferred.
In 2022, approximately 62% of the Combined Pension Plan's January 1, 2022 net actuarial loss balance of $2.2
billion was subject to amortization as a component of net periodic expense over the average remaining service
period of 14 years for participating employees expected to receive benefits under the plan. We treated the other
38% of the Combined Pension Plan's beginning net actuarial loss balance as indefinitely deferred during 2022.
Additionally, upon the sale of the ILEC business on October 3, 2022, we recognized $564 million of net actuarial
loss, pre-tax, related to the Lumen Pension Plan, which partially offset our gain on the sale of the business. We
treated the entire beginning net actuarial loss of $217 million at January 1, 2022 for the post-retirement benefit
plans as indefinitely deferred during 2022.
As of January 1, 2021, our qualified pension plan had a net actuarial loss balance of approximately $3.0 billion. A
portion of this balance was subject to amortization as a component of net periodic expense over the average
remaining service period for participating employees expected to receive benefits under the plan. During 2021,
our lump sum pension settlement payments exceeded the settlement threshold and as a result we recognized a
non-cash settlement charge of $383 million, accelerating previously unrecognized actuarial losses from our net
actuarial loss balance. For our post-retirement benefit plans, the majority of the beginning net actuarial loss
balance of $346 million at January 1, 2021 continued to be deferred during 2021.
In computing our pension and post-retirement health care and life insurance benefit obligations, our most
significant assumptions are the discount rate and mortality rates. In computing our periodic pension expense,
our most significant assumptions are the discount rate and the expected rate of return on plan assets. In
computing our post-retirement benefit expense, our most significant assumption is the discount rate.
The discount rate for each plan is the rate at which we believe we could effectively settle the plan's benefit
obligations as of the end of the year. We selected each plan's discount rate based on a cash flow matching
analysis using hypothetical yield curves from high-quality U.S. corporate bonds and projections of the future
benefit payments that constitute the projected benefit obligation for the plans. This process establishes the
uniform discount rate that produces the same present value of the estimated future benefit payments as is
generated by discounting each year's benefit payments by a spot rate applicable to that year. The spot rates
used in this process were derived from a yield curve created from yields on the 60th to 90th percentile of U.S.
high quality bonds.
The table below illustrates hypothetical changes in our benefit obligation for the qualified pension plan and the
post-retirement benefit plans obligation if we had selected a higher or lower discount rate.
Percentage Increase/(decrease) at
point change December 31, 2023
(Dollars in millions)
Combined Pension Plan discount rate 1% $ (451)
(1)% 373
Post-retirement benefit plans discount rate 1% (158)
(1)% 158
Published mortality rates help predict the expected life of plan participants and are based on historical
demographic studies by the Society of Actuaries ("SOA"). The SOA publishes new mortality tables and
projection scales on a regular basis which reflect updates to projected life expectancies in North America.
Historically, we have adopted the new projection tables immediately after publication. The SOA did not release
any revised mortality tables or projection scales in 2022 or 2023.
The expected rate of return on plan assets is the long-term rate of return we expect to earn on the plans' assets
in the future, net of administrative expenses paid from plan assets. The rate of return is determined by the
strategic allocation of plan assets and the long-term risk and return forecast for each asset class. The forecasts
for each asset class are generated primarily from an analysis of the long-term expectations of various
third-party investment management organizations, to which we then add a factor of 50 basis points to reflect
the benefit we expect to result from our active management of the assets. The expected rate of return on plan
assets is reviewed annually by management and our Board of Directors and is revised, as necessary, to reflect
changes in the financial markets and our investment strategy.
B-14
Appendix B
Changes in any of the above factors could significantly impact operating expenses in our consolidated
statements of operations and other comprehensive loss in our consolidated statements of comprehensive
income (loss), as well as the amount of the liability and accumulated other comprehensive loss of stockholders'
equity on our consolidated balance sheets.
Income Taxes
Our provision for income taxes includes amounts for tax consequences deferred to future periods. We record
deferred income tax assets and liabilities reflecting future tax consequences attributable to (i) tax credit
carryforwards, (ii) differences between the financial statement carrying value of assets and liabilities and the tax
basis of those assets and liabilities and (iii) tax NOLs. Deferred taxes are computed using enacted tax rates
expected to apply in the year in which the differences are expected to affect taxable income. The effect of a
change in tax rate on deferred income tax assets and liabilities is recognized in earnings in the period that
includes the enactment date.
The measurement of deferred taxes often involves the exercise of considerable judgment related to the
realization of tax basis. Our deferred tax assets and liabilities reflect our assessment that tax positions taken in
filed tax returns and the resulting tax basis are more likely than not to be sustained if they are audited by taxing
authorities. Assessing tax rates that we expect to apply and determining the years when the temporary
differences are expected to affect taxable income requires judgment about the future apportionment of our
income among the states in which we operate. Any changes in our practices or judgments involved in the
measurement of deferred tax assets and liabilities could materially impact our financial condition or results
of operations.
In connection with recording deferred income tax assets and liabilities, we establish valuation allowances when
necessary to reduce deferred income tax assets to amounts that we believe are more likely than not to be
realized. We evaluate our deferred tax assets quarterly to determine whether adjustments to our valuation
allowances are appropriate in light of changes in facts or circumstances, such as changes in tax law, interactions
with taxing authorities and developments in case law. In making this evaluation, we rely on our recent history of
pre-tax earnings. We also rely on our forecasts of future earnings and the nature and timing of future deductions
and benefits represented by the deferred tax assets, all of which involve the exercise of significant judgment. At
December 31, 2023, we established a valuation allowance of $399 million primarily related to state NOLs, based
on our determination that it was more likely than not that this amount of these NOLs would expire unused. If
forecasts of future earnings and the nature and estimated timing of future deductions and benefits change in
the future, we may determine that existing valuation allowances must be revised or eliminated or new valuation
allowances created, any of which could materially impact our financial condition or results of operations. See
Note 16—Income Taxes to our consolidated financial statements in Item 8 of Part II of our Annual Report on
Form 10-K for the year ended December 31, 2023.
Market Risk
As of December 31, 2023, we were exposed to market risk from changes in interest rates on our variable rate
long-term debt obligations and fluctuations in certain foreign currencies.
Management periodically reviews our exposure to interest rate fluctuations and periodically implements
strategies to manage the exposure. From time to time, we have used derivative instruments to swap our
exposure to variable interest rates for fixed interest rates. We have established policies and procedures for risk
assessment and the approval, reporting and monitoring of derivative instrument activities. As of
December 31, 2023, we did not hold or issue derivative financial instruments for trading or speculative purposes.
As of December 31, 2023, we had approximately $7.9 billion of unhedged floating rate debt based on the
secured overnight financing rate ("SOFR"). A hypothetical increase of 100 basis points in SOFR relating to our
$7.9 billion of unhedged floating rate debt would, among other things, decrease our annual pre-tax earnings by
approximately $79 million.
We conduct a portion of our business in currencies other than the U.S. dollar, the currency in which our
consolidated financial statements are reported. Prior to the November 1, 2023 divestiture of our EMEA business,
certain of our former European subsidiaries used the local currency as their functional currency, as the majority
of their sales and purchases were transacted in their local currencies. Although we continue to evaluate
strategies to mitigate risks related to the effect of fluctuations in currency exchange rates, we will likely
recognize gains or losses from international transactions. Accordingly, changes in foreign currency rates relative
to the U.S. dollar could positively or negatively impact our operating results.
Certain shortcomings are inherent in the method of analysis presented in the computation of exposures to
market risks. Actual values may differ materially from those disclosed by us from time to time if market
conditions vary from the assumptions used in the analyses performed. These analyses only incorporate the risk
exposures that existed at December 31, 2023.
B-16
Appendix B
In January 2024, we received a cash federal income tax refund of $729 million, including interest. For additional
information, see Note 24—Subsequent Events, to our consolidated financial statements included under Item 8 of
Part II of this annual report.
As discussed elsewhere herein, we recorded an aggregate of $14.0 billion of non-cash, non tax-deductible
goodwill impairment charges in 2023 and 2022, which has substantially reduced our total stockholders’ equity.
See "Results of Operations—Goodwill Impairments" discussing the potential for additional goodwill impairments
in future quarters.
We will continue to monitor our future sources and uses of cash, and anticipate that we will make adjustments
to our capital allocation strategies when, as and if determined by our Board of Directors. We may also draw on
our revolving credit facility as a source of liquidity for operating activities and to give us additional flexibility to
finance our capital investments, repayments of debt, pension contributions and other cash requirements.
For additional information, see "Risk Factors—Financial Risks" in Item 1A of Part I of our Annual Report on Form
10-K for the year ended December 31, 2023.
Impact of the Divestitures of the Latin American, ILEC and EMEA Businesses
As discussed in Note 2—Divestitures of the Latin American, ILEC and EMEA Businesses to our consolidated
financial statements in Item 8 of Part II of our Annual Report on Form 10-K for the year ended
December 31, 2023, we sold our Latin American, ILEC and EMEA businesses on August 1, 2022, October 3, 2022
and November 1, 2023, respectively. As further described elsewhere herein, these transactions have provided us
with a substantial amount of cash proceeds but have also reduced our base of income-generating assets that
generate our recurring cash from operating activities. For a discussion of the impact of our divestitures upon our
federal income taxes, see "Liquidity and Capital Resources–Federal Income Tax Obligations.”
Capital Expenditures
We incur capital expenditures on an ongoing basis to expand and improve our service offerings, enhance and
modernize our networks and compete effectively in our markets. We evaluate capital expenditure projects
based on a variety of factors, including expected strategic impacts (such as forecasted impact on revenue
growth, productivity, expenses, service levels and customer retention) and our expected return on investment.
The amount of capital investment is influenced by, among other things, current and projected demand for our
services and products, our network requirements, cash flow generated by operating activities, cash required for
debt services and other purposes, regulatory considerations (such as governmentally-mandated infrastructure
buildout requirements) and the availability of requisite supplies, labor and permits.
Our capital expenditures continue to be focused on enhancing network operating efficiencies, supporting new
service developments, and expanding our fiber network, including our Quantum Fiber buildout plan. A portion
of our 2023 capital expenditures will also be focused on restoring network assets destroyed or damaged by
Hurricane Ian in Florida during 2022 or replacing aged network assets. For more information on our capital
spending, see (i) "—Overview of Sources and Uses of Cash" above, (ii) "Cash Flow Activities—Investing
Activities" below and (iii) Item 1 of Part 1 of our Annual Report on Form 10-K for the year ended
December 31, 2023.
Debt Instruments
On January 22, 2024, Lumen entered into an amended and restated transaction support agreement with a
group of creditors representing over $12.5 billion of the outstanding indebtedness of the Company and its
subsidiaries to, among other things, extend maturities of the debt instruments of the Company and Level 3
Financing, Inc. and provide access to a new revolving credit facility in an amount expected to be approximately
$1.0 billion. In addition, the creditors have committed to provide $1.325 billion of financing to the Company
through new long-term debt. The consummation of the transactions contemplated by the amended and
restated transaction support agreement is subject to the satisfaction of various closing conditions. For more
information, see Note 24—Subsequent Events, to our consolidated financial statements included under Item 8
of Part II of this annual report.
Pursuant to exchange offers commenced on March 16, 2023 (the "Exchange Offers"), (i) on March 31, 2023,
Level 3 Financing, Inc. issued $915 million of its 10.500% Senior Secured Notes due 2030 in exchange for
$1.535 billion of Lumen’s outstanding senior unsecured notes and (ii) on April 17, 2023, Level 3 Financing, Inc.
issued an additional $9 million of its 10.500% Notes in exchange for $19 million of Lumen's outstanding senior
unsecured notes. All exchanged notes were concurrently cancelled. These transactions resulted in a net
reduction in the aggregate principal amount of Lumen’s consolidated indebtedness of approximately
$630 million and, along with a repurchase of notes in the first quarter of 2023, a gain of $618 million during the
year ended December 31, 2023.
At December 31, 2023, we had $11.4 billion of outstanding consolidated secured indebtedness, $8.5 billion of
outstanding consolidated unsecured indebtedness (excluding (i) finance lease obligations, (ii) unamortized
premiums, net and (iii) unamortized debt issuance costs) and approximately $1.8 billion of unused borrowing
capacity under our revolving credit facility, as discussed further below.
Under our amended and restated credit agreement dated as of January 31, 2020 (the “Amended Credit
Agreement”), we maintained at December 31, 2023 (i) a $2.2 billion senior secured revolving credit facility,
under which we owed $200 million and had $218 million of letters of credit issued and undrawn as of such date,
and (ii) $5.1 billion of senior secured term loan facilities. For additional information, see (i) "—Overview of
Sources and Uses of Cash," and (ii) Note 7—Long-Term Debt and Credit Facilities to our consolidated financial
statements in Item 8 of Part II of our Annual Report on Form 10-K for the year ended December 31, 2023.
At December 31, 2023, we had $260 million undrawn letters of credit outstanding, $218 million of which were
issued under our revolving line of credit, $40 million of letters of credit outstanding under our $225 million
uncommitted letter of credit facility and $2 million of which were issued under a separate facility maintained by
one of our subsidiaries (the full amount of which is collateralized by cash that is reflected on our consolidated
balance sheets as restricted cash within other assets).
In addition to its indebtedness under our Amended Credit Agreement, Lumen Technologies is indebted under
its outstanding senior notes, and several of its subsidiaries are indebted under separate credit facilities or
senior notes.
For additional information on the terms and conditions of other debt instruments of ours and our subsidiaries,
including financial and operating covenants, see (i) Note 7—Long-Term Debt and Credit Facilities to our
consolidated financial statements in Item 8 of Part II of our Annual Report on Form 10-K for the year ended
December 31, 2023 and (ii) "—Other Matters" below.
Our credit ratings are reviewed and adjusted from time to time by the rating agencies. Any future changes in the
senior unsecured or secured debt ratings of us or our subsidiaries could impact our access to capital or
borrowing costs. We cannot provide any assurances that we will be able to borrow additional funds on
favorable terms, or at all. See "Risk Factors—Financial Risks" in Item 1A of Part I of our Annual Report on Form
10-K for the year ended December 31, 2023.
From time to time over the past couple of years, we have engaged in various refinancings, redemptions, tender
offers, open market purchases and other transactions designed to reduce our consolidated indebtedness,
improve our financial flexibility or otherwise enhance our debt profile. Subject to market conditions, restrictions
under our debt covenants, and other limitations, we may pursue similar transactions in the future to the extent
feasible. See Note 7—Long-Term Debt and Credit Facilities to our consolidated financial statements in Item 8 of
Part II of our Annual Report on Form 10-K for the year ended December 31, 2023 for additional information.
B-18
Appendix B
Stock Repurchases
Effective November 2, 2022, our Board of Directors authorized a new two-year program to repurchase up to an
aggregate of $1.5 billion of our outstanding common stock (the "November 2022 stock repurchase program").
During the year ended December 31, 2023, we did not repurchase any shares of our outstanding common stock
under this program. As of December 31, 2023, we were authorized to purchase up to an aggregate of $1.3 billion
of our outstanding common stock under this program. We currently do not plan to purchase any shares of our
outstanding common stock under this program in the near term.
Substantially all of our post-retirement health care and life insurance benefits plans are unfunded and are paid
by us with available cash. As described further in Note 11—Employee Benefits, aggregate benefits paid by us
under these plans (net of participant contributions and direct subsidy receipts) were $194 million, $210 million
and $203 million for the years ended December 31, 2023, 2022 and 2021, respectively. For additional information
on our expected future benefits payments for our post-retirement benefit plans, see Note 11—Employee Benefits
to our consolidated financial statements in Item 8 of Part II of our Annual Report on Form 10-K for the year
ended December 31, 2023.
For 2023, our expected annual long-term rate of return on the pension plan assets, net of administrative
expenses, was 6.5%. For 2024, our expected annual long-term rate of return on these assets is 6.5%. However,
actual returns could be substantially different.
Our pension plan contains provisions that allow us, from time to time, to offer lump sum payment options to
certain former employees in settlement of their future retirement benefits. We record an accounting settlement
charge, consisting of the recognition of certain deferred costs of the pension plan, associated with these lump
sum payments only if, in the aggregate, they exceed the sum of the annual service and interest costs for the
plan’s net periodic pension benefit cost, which represents the settlement accounting threshold. As of December
31, 2021, lump sum pension settlement payments exceeded the settlement threshold. As a result, for the year
ended December 31, 2021 we recognized a non-cash settlement charge of $383 million to accelerate the
recognition of a portion of the previously unrecognized actuarial losses in the qualified pension plan, which was
allocated and reflected in other (expense) income, net in our consolidated statement of operations for the year
ended December 31, 2021. The settlement threshold was not exceeded for the years ended December 31, 2023
or December 31, 2022. The amount of any future non-cash settlement charges will be dependent on several
factors, including the total amount of our future lump sum benefit payments.
B-20
Appendix B
Operating Activities
Net cash provided by operating activities decreased by $2.6 billion for the year ended December 31, 2023 as
compared to the year ended December 31, 2022 primarily due to lower net income adjusted for non-cash
expenses and gains, largely due to the impacts of the 2022 and 2023 divestitures discussed elsewhere herein.
Cash provided by operating activities is subject to variability period over period as a result of timing differences,
including with respect to the collection of receivables and payments of interest expense, accounts payable,
income taxes and bonuses.
For additional information about our operating results, see "Results of Operations" above.
Investing Activities
Net cash (used in) provided by investing activities changed by $6.7 billion for the year ended
December 31, 2023 as compared to the year ended December 31, 2022 primarily due to substantial pre-tax cash
proceeds from the sales of our Latin American and ILEC businesses in 2022, partially offset by pre-tax cash
proceeds from the sale of the EMEA business in 2023.
Financing Activities
Net cash used in financing activities decreased by $9.3 billion for the year ended December 31, 2023 as
compared to the year ended December 31, 2022 primarily due to substantially higher debt repayments and
dividends paid in 2022.
See Note 7—Long-Term Debt and Credit Facilities to our consolidated financial statements in Item 8 of Part II of
our Annual Report on Form 10-K for the year ended December 31, 2023 for additional information on our
outstanding debt securities.
Other Matters
We have cash management and loan arrangements with a majority of our income-generating subsidiaries, in
which a substantial portion of the aggregate cash of those subsidiaries' is periodically advanced or loaned to us
or our service company affiliate. Although we periodically repay these advances to fund the subsidiaries' cash
requirements throughout the year, at any given point in time we may owe a substantial sum to our subsidiaries
under these arrangements. In accordance with generally accepted accounting principles, these arrangements
are reflected in the balance sheets of our subsidiaries, but are eliminated in consolidation and therefore not
recognized on our consolidated balance sheets.
Our network includes some residual lead-sheathed copper cables installed years ago. These lead-sheathed
cables constitute a small portion of our network. Due to recent media coverage of potential health and
environmental risks associated with these cables, we anticipate incurring certain investigative costs. We also
may incur other costs from related proceedings, including litigation, regulatory initiatives, and remediation. As of
December 31, 2023, we had not accrued for any such potential costs and will only accrue when such costs are
probable and reasonably estimable. For additional information about related litigation and potential risks, see
Note 18—Commitments, Contingencies and Other Items to our consolidated financial statements in Item 1 of Part
I of our Annual Report on Form 10-K for the year ended December 31, 2023, and the risk factor disclosures
incorporated by reference herein under “Risk Factors” in Item 1A of Part II of our Annual Report on Form 10-K
for the year ended December 31, 2023.
We are also involved in various legal proceedings that could substantially impact our financial position. See Note
18—Commitments, Contingencies and Other Items to our consolidated financial statements in Item 8 of Part II of
our Annual Report on Form 10-K for the year ended December 31, 2023 for additional information.
B-22
Appendix B
We identified the evaluation of the sufficiency of audit evidence over revenue as a critical audit matter. Complex
auditor judgment was required in evaluating the sufficiency of audit evidence over revenue due to the large
volume of data and the number and complexity of the revenue accounting systems. Specialized skills and
knowledge were needed to test the IT systems used for the processing and recording of revenue.
The following are the primary procedures we performed to address this critical audit matter. We applied auditor
judgment to determine the nature and extent of procedures to be performed over the processing and recording
of revenue, including the IT systems tested. We evaluated the design and tested the operating effectiveness of
certain internal controls related to the processing and recording of revenue. This included manual and
automated controls over the IT systems used for the processing and recording of revenue. For a selection of
transactions, we compared the amount of revenue recorded to a combination of Company internal data,
executed contracts, and other relevant third-party data. In addition, we involved IT professionals with
specialized skills and knowledge who assisted in the design and performance of audit procedures related to
certain IT systems used by the Company for the processing and recording of revenue. We evaluated the
sufficiency of audit evidence obtained by assessing the results of procedures performed, including the relevance
and reliability of evidence obtained.
Goodwill impairments for the North America Business and Mass Markets reporting units
As discussed in Note 3 to the consolidated financial statements, the goodwill balance at December 31, 2023 was
$2.0 billion. The Company assesses goodwill for impairment at least annually, or more frequently, if events or
circumstances indicate the carrying value of a reporting unit likely exceeds its fair value. During the second
quarter of 2023, the Company determined circumstances related to the sustained decline in the Company's
share price indicated it was more likely than not that the carrying value of their reporting units exceeded their
fair value. Also, as of October 31, 2023, the Company performed their annual goodwill impairment test. For both
the second quarter and annual impairment tests, the Company estimated the fair value of its reporting units
using a market approach. The second quarter and annual impairment tests each determined the carrying value
of the North America Business and Mass Markets reporting units exceeded their estimated fair value. As a result,
the Company recorded non-cash impairment charges of $7.9 billion and $2.8 billion, respectively, reducing the
carrying value of goodwill for the North America Business and Mass Markets reporting units.
We identified the assessment of the Company’s impairment testing of the goodwill of the North America
Business and Mass Markets reporting units as a critical audit matter. Subjective auditor judgment was required in
evaluating the earnings before interest, taxes, depreciation, and amortization (“EBITDA”) market multiple
assumptions used to estimate the fair value of the reporting units. The evaluation of these assumptions was
challenging as differences in judgment used to determine these assumptions could have had a significant effect
on each reporting unit’s estimated fair value. Specialized skills and knowledge were required in the assessment
of the EBITDA market multiple assumptions.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the
design and tested the operating effectiveness of certain internal controls related to the goodwill impairment
tests. This included controls related to the Company’s determination of the EBITDA market multiple
assumptions. We involved valuation professionals with specialized skills and knowledge, who assisted in
evaluating the EBITDA market multiple assumptions by:
• comparing to EBITDA market multiple ranges developed using publicly available market data for
comparable entities
• performing sensitivity analyses that considered a range of EBITDA market multiples.
/s/ KPMG LLP
We have served as the Company’s auditor since 1977.
Denver, Colorado
February 22, 2024
B-24
Appendix B
B-26
Appendix B
B-28
Appendix B
General
We are a facilities-based technology and communications company that provides a broad array of integrated
products and services to our domestic and global business customers and our domestic mass markets
customers. We operate one of the world’s most interconnected networks. Our platform empowers our
customers to swiftly adjust digital programs to meet immediate demands, create efficiencies, accelerate market
access and reduce costs, which allows our customers to rapidly evolve their IT programs to address dynamic
changes. Our specific products and services are detailed in Note 4—Revenue Recognition.
Basis of Presentation
The accompanying consolidated financial statements include our accounts and the accounts of our subsidiaries
in which we have a controlling interest. Intercompany amounts and transactions with our consolidated
subsidiaries have been eliminated.
To simplify the overall presentation of our consolidated financial statements, we report immaterial amounts
attributable to noncontrolling interests in certain of our subsidiaries as follows: (i) income attributable to
noncontrolling interests in other (expense) income, net, (ii) equity attributable to noncontrolling interests in
additional paid-in capital and (iii) cash flows attributable to noncontrolling interests in other, net
financing activities.
We reclassified certain prior period amounts to conform to the current period presentation, including the
recategorization of our Business revenue by product category and sales channel in our segment reporting for
2022 and 2021. See Note 17—Segment Information for additional information. These changes had no impact on
total operating revenue, total operating expenses or net (loss) income for any period.
Operating Expenses
Our current definitions of operating expenses are as follows:
• Cost of services and products (exclusive of depreciation and amortization) are expenses incurred in providing
products and services to our customers. These expenses include: employee-related expenses directly
attributable to operating and maintaining our network (such as salaries, wages, benefits and professional
fees); facilities expenses (which include third-party telecommunications expenses we incur for using other
carriers' networks to provide services to our customers); rents and utilities expenses; equipment sales
expenses (such as data integration and modem expenses); and other expenses directly related to our
operations; and
• Selling, general and administrative expenses are corporate overhead and other operating expenses. These
expenses include: employee-related expenses (such as salaries, wages, internal commissions, benefits and
professional fees) directly attributable to selling products or services and employee-related expenses for
administrative functions; marketing and advertising; property and other operating taxes and fees; external
commissions; litigation expenses associated with general matters; bad debt expense; and other selling,
general and administrative expenses.
These expense classifications may not be comparable to those of other companies.
Summary of Significant Accounting Policies
Use of Estimates
Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting
principles. These accounting principles require us to make certain estimates, judgments and assumptions. We
believe that the estimates, judgments and assumptions we make when accounting for specific items and matters
are reasonable, based on information available at the time they are made. These estimates, judgments and
assumptions can materially affect the reported amounts of assets, liabilities and components of stockholders'
equity as of the dates of the consolidated balance sheets, as well as the reported amounts of revenue, expenses
and components of cash flows during the periods presented in our other consolidated financial statements. We
also make estimates in our assessments of potential losses in relation to threatened or pending tax and legal
matters. See Note 16—Income Taxes and Note 18—Commitments, Contingencies and Other Items for
additional information.
For matters not related to income taxes, if a loss is considered probable and the amount can be reasonably
estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the
estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated
loss if recovery is also deemed probable.
For matters related to income taxes, if we determine the impact of an uncertain tax position is more likely than
not to be sustained upon audit by the relevant taxing authority, then we recognize a benefit for the largest
amount that is more likely than not to be sustained. We do not recognize any portion of an uncertain tax
position if the position has less than a 50% likelihood of being sustained. We recognize interest on the amount
of unrecognized benefit from uncertain tax positions.
For all of these and other matters, actual results could differ materially from our estimates.
Assets Held for Sale
We classify assets and related liabilities as held for sale when: (i) management has committed to a plan to sell
the assets, (ii) the net assets are available for immediate sale, (iii) there is an active program to locate a buyer
and (iv) the sale and transfer of the net assets is probable within one year. Assets and liabilities held for sale
are presented separately on our consolidated balance sheets with a valuation allowance, if necessary, to
recognize the net carrying amount at the lower of cost or fair value, less costs to sell. Depreciation of
property, plant and equipment and amortization of finite-lived intangible assets and right-of-use assets are not
recorded while these assets are classified as held for sale. For each period that assets are classified as being
held for sale, they are tested for recoverability. Unless otherwise specified, the amounts and information
presented in the notes do not include assets and liabilities that were classified as held for sale as of December
31, 2023 and December 31, 2022. See Note 2—Divestitures of the Latin American, ILEC and EMEA Businesses for
additional information.
B-30
Appendix B
Revenue Recognition
We earn most of our consolidated revenue from contracts with customers, primarily through the provision of
communications and other services. Revenue from contracts with customers is accounted for under Accounting
Standards Codification ("ASC") 606. We also earn revenue from leasing arrangements (primarily fiber capacity
and colocation agreements) and governmental subsidy payments, which are not accounted for under ASC 606.
Revenue is recognized when control of the promised goods or services is transferred to our customers, in an
amount that reflects the consideration we expect to be entitled to receive in exchange for those goods or
services. Revenue is recognized based on the following five-step model:
• Identification of the contract with a customer;
• Identification of the performance obligations in the contract;
• Determination of the transaction price;
• Allocation of the transaction price to the performance obligations in the contract; and
• Recognition of revenue when, or as, we satisfy a performance obligation.
We provide an array of communications services to business and residential customers, including local voice,
VPN, Ethernet, data, broadband, private line (including special access), network access, transport, voice,
information technology, video and other ancillary services. We provide these services to a wide range of
businesses, including global, enterprise, wholesale, government, and small and medium business customers.
Certain contracts also include the sale of equipment, which is not significant to our business.
We recognize revenue for services when we provide the applicable service or when control of a product is
transferred. Recognition of certain payments received in advance of services being provided is deferred. These
advance payments may include certain activation and certain installation charges. If the activation and
installation charges are not separate performance obligations, we recognize them as revenue over the actual or
expected contract term using historical experience, which typically ranges from one to five years depending on
the service. In most cases, termination fees or other fees on existing contracts that are negotiated in conjunction
with new contracts are deferred and recognized over the new contract term.
For access services, we generally bill fixed monthly charges one month in advance to customers and recognize
revenue as service is provided over the contract term in alignment with the customer's receipt of service. For
usage and other ancillary services, we generally bill in arrears and recognize revenue as usage or delivery
occurs. In most cases, the amount invoiced for our service offerings constitutes the price that would be billed on
a standalone basis.
In certain cases, customers may be permitted to modify their contracts. We evaluate the change in scope or
price to identify whether the modification should be treated as a separate contract, as a termination of the
existing contract and creation of a new contract, or as a change to the existing contract.
Customer contracts are evaluated to determine whether the performance obligations are separable. If the
performance obligations are deemed separable and separate earnings processes exist, the total transaction
price that we expect to receive with the customer is allocated to each performance obligation based on its
relative standalone selling price. The revenue associated with each performance obligation is then recognized
as earned.
We periodically sell transmission capacity on our network. These transactions are generally structured as
indefeasible rights of use, commonly referred to as IRUs, which are the exclusive right to use a specified amount
of capacity or fiber for a specified term, typically 20 years. In most cases, we account for the cash consideration
received on transfers of transmission capacity as ASC 606 revenue which is adjusted for the time value of
money and is recognized ratably over the term of the agreement. Cash consideration received on transfers of
dark fiber is accounted for as non-ASC 606 lease revenue, which we also recognize ratably over the term of the
agreement. We do not recognize revenue on any contemporaneous exchanges of our transmission capacity
assets for other non-owned transmission capacity assets.
In connection with offering products and services provided to the end user by third-party vendors, we review
the relationship between us, the vendor and the end user to assess whether revenue should be reported on a
gross or net basis. In assessing whether revenue should be reported on a gross or net basis, we consider
whether we act as a principal in the transaction and control the goods and services used to fulfill the
performance obligations associated with the transaction.
We have service level commitments pursuant to contracts with certain of our customers. To the extent that we
determine that such service levels were not achieved or may not have been achieved, we estimate the amount
of credits to be issued and record a corresponding reduction to revenue in the period that the service level
commitment was not met or may not be met.
Customer payments are made based on billing schedules included in our customer contracts, which is typically
on a monthly basis.
We defer (or capitalize) incremental contract acquisition and fulfillment costs and recognize (or amortize) such
costs over the average contract life. Our deferred contract costs for our customers have average amortization
periods of approximately 36 months for mass markets customers and 33 months for business customers. These
deferred costs are periodically monitored to reflect any significant change in assumptions.
See Note 4—Revenue Recognition for additional information.
Advertising Costs
Costs related to advertising are expensed as incurred and recorded as selling, general and administrative
expenses in our consolidated statements of operations. Our advertising expense was $87 million, $62 million and
$56 million for the years ended December 31, 2023, 2022 and 2021, respectively.
Legal Costs
In the normal course of our business, we incur costs to hire and retain external legal counsel to advise us on
finance, regulatory, litigation and other matters. Subject to certain exceptions, we expense these costs as the
related services are received.
Income Taxes
We file a consolidated federal income tax return with our eligible subsidiaries. The provision for income taxes
reflects taxes currently payable, tax consequences deferred to future periods and adjustments to our liabilities
for uncertain tax positions. We record deferred income tax assets and liabilities reflecting future tax
consequences attributable to tax NOLs, tax credit carryforwards and differences between the financial
statement carrying value of assets and liabilities and the tax basis of those assets and liabilities. Deferred taxes
are computed using enacted tax rates expected to apply in the year in which the differences are expected to
affect taxable income. The effect on deferred income tax assets and liabilities of a change in tax rate is
recognized in earnings in the period that includes the enactment date.
We establish valuation allowances when necessary to reduce deferred income tax assets to the amounts that we
believe are more likely than not to be recovered. Each quarter we evaluate the need to retain or adjust each
valuation allowance on our deferred tax assets. See Note 16—Income Taxes for additional information.
B-32
Appendix B
Restricted Cash
Restricted cash consists primarily of cash and investments that collateralize our outstanding letters of credit and
certain performance and operating obligations. Restricted cash and securities are recorded as current or
non-current assets in the consolidated balance sheets depending on the duration of the restriction and the
purpose for which the restriction exists. Restricted securities are stated at cost which approximated their fair
value as of December 31, 2023 and 2022.
We review long-lived tangible assets for impairment whenever facts and circumstances indicate that the
carrying amounts of the assets may not be recoverable. For assessment purposes, long-lived assets are grouped
with other assets and liabilities at the lowest identifiable level for which we generate cash flows independently
of other groups of assets and liabilities, absent a material change in operations. An impairment loss is
recognized only if the carrying amount of the asset group is not recoverable and exceeds its estimated fair
value. Recoverability of the asset group to be held and used is assessed by comparing the carrying amount of
the asset group to the estimated undiscounted future net cash flows expected to be generated by the asset
group. If the asset group's carrying value is not recoverable, we recognize an impairment charge for the amount
by which the carrying amount of the asset group exceeds its estimated fair value.
B-34
Appendix B
Foreign Currency
Local currencies of our foreign subsidiaries are the functional currencies for financial reporting purposes except
for certain foreign subsidiaries, primarily in Latin America prior to the August 1, 2022 sale of our Latin American
business. For operations outside the United States that have functional currencies other than the U.S. dollar,
assets and liabilities are translated to U.S. dollars at period-end exchange rates, and revenue, expenses and cash
flows are translated using average monthly exchange rates. Prior to the November 1, 2023 sale of our EMEA
business and the August 1, 2022 sale of our Latin American business, a significant portion of our non-United
States subsidiaries used the British pound, the Euro, or the Brazilian Real, as their functional currency, each of
which experienced significant fluctuations against the U.S. dollar during the years ended December 31, 2023,
2022 and 2021. We recognize foreign currency translation gains and losses as a component of accumulated
other comprehensive loss in stockholders' equity in our consolidated balance sheet and in our consolidated
statements of comprehensive (loss) income in accordance with accounting guidance for foreign currency
translation. Prior to the announcement of our divestitures as discussed in Note 2—Divestitures of the Latin
American, ILEC and EMEA Businesses, we considered the majority of our investments in our foreign subsidiaries
to be long-term in nature. Our foreign currency transaction gains (losses), including where transactions with our
non-United States subsidiaries are not considered to be long-term in nature, are included within other (expense)
income, net on our consolidated statements of operations.
Common Stock
As of December 31, 2023, we had 11 million shares authorized for future issuance under our equity
incentive plans.
Preferred Stock
Holders of outstanding Lumen Technologies preferred stock are entitled to receive cumulative dividends,
receive preferential distributions equal to $25 per share plus unpaid dividends upon Lumen's liquidation and
vote as a single class with the holders of common stock.
Dividends
The declaration and payment of dividends is at the discretion of our Board of Directors. On November 2, 2022,
we announced that our Board had terminated our quarterly cash dividend program.
Credit Losses
On January 1, 2023, we adopted ASU 2022-02, “Financial Instruments-Credit Losses (Topic 326): Troubled Debt
Restructurings (“TDR”) and Vintage Disclosures” (“ASU 2022-02”). The ASU eliminates the TDR recognition and
measurement guidance, enhances existing disclosure requirements and introduces new requirements related to
certain modifications of receivables made to borrowers experiencing financial difficulty. The adoption of ASU
2022-02 did not have a material impact to our consolidated financial statements.
Government Assistance
On January 1, 2022, we adopted ASU 2021-10 "Government Assistance (Topic 832): Disclosures by Business
Entities about Government Assistance” (“ASU 2021-10”) ASU 2021-10. This ASU requires business entities to
disclose information about certain types of government assistance they receive. Please refer to
Note 4—Revenue Recognition for more information.
Leases
On January 1, 2022, we adopted ASU 2021-05, “Leases (Topic 842): Lessors—Certain Leases with Variable Lease
Payments” (“ASU 2021-05”). This ASU (i) amends the lease classification requirements for lessors to align them
with practice under ASC Topic 840, (ii) provides criteria for lessors to classify and account for a lease with
variable lease payments that do not depend on a reference index or a rate as an operating lease; and (iii)
provides guidance with respect to net investments by lessors under operating leases and other related topics.
The adoption of ASU 2021-05 did not have a material impact to our consolidated financial statements.
Debt
On January 1, 2021, we adopted ASU 2020-09, "Debt (Topic 470) Amendments to SEC Paragraphs Pursuant to
SEC Release No. 33-10762" ("ASU 2020-09"). This ASU amends and supersedes various SEC guidance to reflect
SEC Release No. 33-10762, which includes amendments to the financial disclosure requirements applicable to
registered debt offerings that include credit enhancements, such as subsidiary guarantees. The adoption of ASU
2020-09 did not have a material impact to our consolidated financial statements.
B-36
Appendix B
Investments
On January 1, 2021, we adopted ASU 2020-01, "Investments - Equity Securities (Topic 321), Investments - Equity
Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) - Clarifying the Interactions
between Topic 321, Topic 323, and Topic 815)" ("ASU 2020-01"). This ASU, among other things, clarifies that a
company should consider observable transactions that require a company to either apply or discontinue the
equity method of accounting under Topic 323, Investments - Equity Method and Joint Ventures, for the
purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or
upon discontinuing the equity method. As of December 31, 2023, we determined there was no application or
discontinuation of the equity method during the reporting periods covered in our Annual Report on Form 10-K
for the year ended December 31, 2023. The adoption of ASU 2020-01 did not have an impact to our
consolidated financial statements.
Income Taxes
On January 1, 2021, we adopted ASU 2019-12, "Simplifying the Accounting for Income Taxes (Topic 740)" ("ASU
2019-12"). This ASU removes certain exceptions for investments, intra-period allocations and interim
calculations, and adds guidance to reduce complexity in accounting for income taxes. The adoption of ASU
2019-12 did not have a material impact to our consolidated financial statements.
In August 2023, the FASB issued ASU 2023-04, “Liabilities (Topic 405): Amendments to SEC Paragraphs
Pursuant to SEC Staff Accounting Bulletin No. 121” (“ASU 2023-04”). This ASU amends and adds various SEC
paragraphs to the FASB Codification to reflect guidance regarding the accounting for obligations to
safeguard crypto assets an entity holds for platform users. This ASU does not provide any new guidance.
ASU 2023-04 became effective for us once the addition to the FASB Codification was made available. As of
December 31, 2023, we do not expect ASU 2023-04 will have any impact to our consolidated
financial statements.
In July 2023, the FASB issued ASU 2023-03, “Presentation of Financial Statements (Topic 205), Income
Statement—Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480),
Equity (Topic 505), and Compensation—Stock Compensation (Topic 718): Amendments to SEC Paragraphs
Pursuant to SEC Staff Accounting Bulletin No. 120, SEC Staff Announcement at the March 24, 2022 EITF
Meeting, and Staff Accounting Bulletin Topic 6.B, Accounting Series Release 280—General Revision of
Regulation S-X: Income or Loss Applicable to Common Stock” (“ASU 2023-03”). This ASU amends or
supersedes various SEC paragraphs within the applicable codification to conform to past SEC staff
announcements. This ASU does not provide any new guidance. ASU 2023-03 became effective for us once the
addition to the FASB Codification was made available. As of December 31, 2023, we do not expect ASU 2023-03
will have any impact to our consolidated financial statements.
In March 2023, the FASB issued ASU 2023-02, “Investments-Equity Method and Joint Ventures (Topic 323):
Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method” (“ASU
2023-02”). These amendments allow reporting entities to elect to account for qualifying tax equity investments
using the proportional amortization method, regardless of the program giving rise to the related income tax
credits. ASU 2023-02 will become effective for us in the first quarter of fiscal 2024 and early adoption is
permitted. As of December 31, 2023, we do not expect ASU 2023-02 will have any impact to our consolidated
financial statements.
In March 2023, the FASB issued ASU 2023-01, “Leases (Topic 842): Common Control Arrangements” (“ASU
2023-01”). These amendments require all entities to amortize leasehold improvements associated with common
control leases over the useful life to the common control group. ASU 2023-01 will become effective for us in the
first quarter of fiscal 2024 and early adoption is permitted. As of December 31, 2023, we do not expect ASU
2023-01 will have any impact to our consolidated financial statements.
In December 2022, the Financial Accounting Standards Board (“FASB”) issued ASU 2022-06, “Reference Rate
Reform (Topic 848) – Deferral of the Sunset Date of Topic 848" ("ASU 2022-06"). These amendments extend
the period of time preparers can utilize the reference rate reform relief guidance in Topic 848, which defers the
sunset date from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to
apply the relief in Topic 848. ASU 2022-06 is effective upon issuance. Based on our review of our key material
contracts through December 31, 2023, ASU 2022-06 does not have a material impact to our consolidated
financial statements.
In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement (Topic 820): Fair Value Measurement
of Equity Securities Subject to Contractual Sale Restrictions” (“ASU 2022-03”). These amendments clarify that
a contractual restriction on the sales of an investment in an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring its fair value. ASU 2022-03
will become effective for us in the first quarter of fiscal 2024 and early adoption is permitted. As of
December 31, 2023, we do not expect ASU 2022-03 will have any impact to our consolidated
financial statements.
In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848): Scope" ("ASU 2021-01"),
which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and
hedge accounting apply to derivatives that are affected by the discounting transition. ASU 2021-01 also amends
the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification
and to tailor the existing guidance to derivative instruments affected by the discounting transition. These
amendments may be applied prospectively to contract modifications made and hedging relationships entered
into or evaluated on or before December 31, 2022. ASU 2021-01 provides optional expedients for a limited time
to ease the potential burden in accounting for reference rate reform. Based on our review of our key material
contracts through December 31, 2023, ASU 2021-01 will not have a material impact to our consolidated
financial statements.
B-38
Appendix B
ILEC Business
On October 3, 2022, we and certain of our affiliates sold the portion of our incumbent local exchange ("ILEC")
business primarily conducted within 20 Midwestern and Southeastern states to affiliates of funds advised by
Apollo Global Management, Inc. In exchange, we received $7.5 billion of consideration, which was reduced by
approximately $0.4 billion of closing adjustments and partially paid through purchaser's assumption of
approximately $1.5 billion of our long-term consolidated indebtedness, resulting in pre-tax cash proceeds of
approximately $5.6 billion.
For the year ended December 31, 2022, we recorded a $176 million net pre-tax gain on disposal associated with
the sale of our ILEC business. This gain is reflected as operating income within the consolidated statements
of operations.
In connection with the sale, we entered into a transition services agreement under which we provide the
purchaser various support services. In addition, Lumen and the purchaser entered into commercial agreements
whereby they provide each other various network and other commercial services. Under these agreements, we
committed to ordering services of approximately $373 million from the purchaser over a period of three years
and the purchaser has committed to ordering services of approximately $67 million from us over a period of
three years. We indemnified the purchaser for certain matters for which, at the time of closing, future cash
payments by Lumen were expected. Lumen had estimated the fair value of these indemnifications to be
$89 million, which was included in other current liabilities in our consolidated balance sheet as of
December 31, 2022 and increased our income tax expense accordingly as of December 31, 2022. As of the first
quarter of 2023, the full $89 million payments had been made.
The ILEC business was included in our continuing operations and classified as assets and liabilities held for sale
on our consolidated balance sheets through the closing of the transaction on October 3, 2022. As a result of
closing the transaction, we derecognized net assets of $4.8 billion, primarily made up of (i) property, plant and
equipment, net of accumulated depreciation, of $3.6 billion, (ii) goodwill of $2.6 billion and (iii) long-term debt,
net of discounts, of $1.4 billion. In addition, we reclassified $403 million of net actuarial loss and prior service
credit related to the Lumen Pension Plan, net of tax, conveyed to the purchaser to partially offset the gain on
the sale of our ILEC business.
EMEA Business
On November 1, 2023, affiliates of Level 3 Parent, LLC, sold Lumen's operations in Europe, the Middle East and
Africa (the "EMEA business") to Colt Technology Services Group Limited, a portfolio company of Fidelity
Investments, for pre-tax cash proceeds of $1.7 billion after certain closing adjustments and transaction costs.
This consideration is further subject to other post-closing adjustments and indemnities set forth in the purchase
agreement, as amended and supplemented to date. In connection with the sale, we entered into a transition
services agreement under which we provide the purchaser various support services. In addition, Lumen and the
purchaser entered into commercial agreements whereby they provide each other various network and other
commercial services.
The classification of the EMEA business as held for sale was considered an event or change in circumstance
which requires an assessment of the goodwill of the disposal group for impairment each reporting period until
disposal. We performed a pre-classification and post-classification goodwill impairment test of the disposal
group as described further in Note 3—Goodwill, Customer Relationships and Other Intangible Assets. As a result
of our impairment tests, we determined the EMEA business disposal group was impaired, resulting in a
non-cash, non-tax-deductible goodwill impairment charge of $43 million in the fourth quarter of 2022. We
evaluated the recoverability of the carrying value of the assets and liabilities held for sale relative to the agreed
upon sales price, adjusted for costs to sell, and recorded an estimated loss on disposal of $660 million during
the year ended December 31, 2022 in the consolidated statement of operations and a valuation allowance
included in assets held for sale on the consolidated balance sheet as of December 31, 2022. For the year ended
December 31, 2023, we recorded a $102 million net loss on disposal associated with the sale of our EMEA
business. This loss is reflected as operating expense within the consolidated statements of operations.
The EMEA business was included in our continuing operations and classified as assets and liabilities held for sale
on our consolidated balance sheets through the closing of the transaction on November 1, 2023. As a result of
closing the transaction, we derecognized net assets of $2.1 billion, primarily made up of (i) property, plant and
equipment, net of accumulated depreciation, of $2.0 billion and (ii) customer relationships and other intangible
assets, net of accumulated amortization of $107 million. In addition, we reclassified $382 million of realized loss
on foreign currency translation, net of tax, with an offset to the valuation allowance and loss on sale of the
EMEA business.
Other Information
We do not believe these divestiture transactions represented a strategic shift for Lumen. Therefore, the divested
businesses discussed above did not meet the criteria to be classified as discontinued operations. As a result, we
continued to report our operating results for the Latin American, ILEC and EMEA businesses in our consolidated
operating results through their respective disposal dates of August 1, 2022, October 3, 2022, and
November 1, 2023, respectively.
As of December 31,
2023 2022(1)
(Dollars in millions)
Goodwill(2) $ 1,964 12,657
Indefinite-lived intangible assets $ 9 9
Other intangible assets subject to amortization:
Customer relationships(3), less accumulated amortization of $4,248 and $3,606 3,811 4,574
Capitalized software, less accumulated amortization of $4,045(4) and $3,895 1,564 1,482
Trade names, patents and other, less accumulated amortization of $72(4) and $188 86 101
Total other intangible assets, net $ 5,470 6,166
(1)
These values exclude assets classified as held for sale.
(2)
We recorded cumulative non-cash, non-tax-deductible goodwill impairment charges of $10.7 billion during the year ended
December 31, 2023.
(3)
For the year ended December 31, 2023, customer relationships decreased $121 million in conjunction with the sale of select CDN customer
contracts in the fourth quarter of 2023 that resulted in a net loss of $73 million included in selling, general and administrative expenses in
our consolidated statements of operations.
(4)
Certain capitalized software with a gross carrying value of $183 million and trade names with a gross carrying value of $130 million became
fully amortized during 2022 and were retired during the first quarter of 2023.
B-40
Appendix B
As of December 31, 2023, the gross carrying amount of goodwill, customer relationships, indefinite-lived and
other intangible assets was $15.8 billion.
Our goodwill was derived from numerous acquisitions where the purchase price exceeded the fair value of the
net assets acquired.
We are required to assess our goodwill and other indefinite-lived intangible assets for impairment annually, or,
under certain circumstances, more frequently, such as when events or changes in circumstances indicate there
may be impairment. Our annual impairment assessment date for indefinite-lived intangible assets other than
goodwill is December 31. We completed our qualitative assessment of our indefinite-lived intangible assets other
than goodwill as of December 31, 2023, 2022 and 2021 and concluded it is more likely than not that our
indefinite-lived intangible assets are not impaired; thus, no impairment charge for these assets was recorded in
2023, 2022 or 2021. We are required to write down the value of goodwill only when our assessment determines
the carrying value of equity of any of our reporting units exceeds its fair value. Our annual impairment
assessment date for goodwill is October 31, at which date we assess our reporting units.
We report our results within two segments: Business and Mass Markets. See Note 17—Segment Information for
more information on these segments and the underlying sales channels. As of December 31, 2023, we had three
reporting units for goodwill impairment testing, which are (i) Mass Markets, (ii) North America Business ("NA
Business") and (iii) Asia Pacific ("APAC") region. Prior to the divestiture of the EMEA business, the EMEA region
was also a reporting unit and was tested for impairment in the pre-classification test as of October 31, 2022
discussed below. Prior to its August 1, 2022 divestiture, the Latin American ("LATAM") region was also a
reporting unit.
Our reporting units are not discrete legal entities with discrete full financial statements. Our assets and liabilities
are employed in and relate to the operations of multiple reporting units. For each reporting unit, we compare its
estimated fair value of equity to its carrying value of equity that we assign to it. If the estimated fair value of the
reporting unit is greater than the carrying value, we conclude that no impairment exists. If the estimated fair
value of the reporting unit is less than its carrying value, we record a non-cash impairment charge equal to the
excess amount. Depending on the facts and circumstances, we typically estimate the fair value of our reporting
units by considering either or both of (i) a discounted cash flow method, which is based on the present value of
projected cash flows over a discrete projection period and a terminal value, which is based on the expected
normalized cash flows of the reporting units following the discrete projection period, and (ii) a market approach,
which includes the use of market multiples of publicly-traded companies whose services and markets are
comparable to ours.
The market approach that we used in the quarter ended June 30, 2023 and October 31, 2023 tests incorporated
estimates and assumptions related to the forecasted results for the remainder of the year, including revenues,
expenses, and the achievement of certain strategic initiatives. In developing the market multiples applicable to
each reporting unit, we considered observed trends of our industry participants. Our assessment included many
factors that required significant judgment. Alternative interpretations of these factors could have resulted in
different conclusions regarding the size of our impairments.
Our classification of the EMEA Business as being held for sale as described in Note 2—Divestitures of the Latin
American, ILEC and EMEA Businesses was considered an event or change in circumstance which required an
assessment of our goodwill for impairment as of October 31, 2022. We performed a pre-announcement goodwill
impairment test described above to determine whether there was an impairment prior to the classification of
these assets as held for sale and to determine the November 2, 2022, fair values to be utilized for goodwill
allocation regarding the disposal group to be classified as assets held for sale. We also performed a
post-announcement goodwill impairment test using our estimated post-divestiture cash flows and carrying
value of equity to evaluate whether the fair value of our NA Business, Mass Markets and APAC reporting units
that will remain following the divestiture exceeds the carrying value of the equity of such reporting units after
classification of assets held for sale. We concluded no impairment existed regarding our post-divestiture
reporting units.
Separate from the annual, pre-announcement and post-announcement goodwill assessments discussed above,
we performed an assessment of our EMEA business disposal group for impairment using the purchase price
compared to the carrying value of the EMEA business net assets. As a result, the EMEA business disposal group
was impaired, resulting in a non-cash, non-tax-deductible goodwill impairment charge of $43 million. See Note
2—Divestitures of the Latin American, ILEC and EMEA Businesses for additional information regarding the
purchase price, carrying value, and impairment for goodwill of the EMEA business. See the goodwill rollforward
by segment table below for the impairment charges by segment.
B-42
Appendix B
(1)
Goodwill at December 31, 2023, December 31, 2022 and December 31, 2021 is net of accumulated impairment losses of $21.7 billion, $11.0
billion and $7.7 billion, respectively.
We estimate that total amortization expense for finite-lived intangible assets for the years ending
December 31, 2024 through 2028 will be as provided in the table below.
(Dollars in millions)
2024 $ 922
2025 847
2026 803
2027 722
2028 657
B-44
Appendix B
B-46
Appendix B
(1)
Includes regulatory revenue and lease revenue not within the scope of ASC 606.
(1)
Reflects gross customer receivables of $1.3 billion and $1.5 billion, net of allowance for credit losses of $60 million and $73 million, at
December 31, 2023 and December 31, 2022, respectively. At December 31, 2022 amounts exclude customer receivables, net, classified as
held for sale of $76 million, related to the EMEA business which was sold November 1, 2023.
(2)
At December 31, 2022 these amounts exclude contract assets classified as held for sale of $16 million, related to the EMEA business which
was sold November 1, 2023.
(3)
At December 31, 2022 these amounts exclude contract liabilities classified as held for sale of $59 million, related to the EMEA business which
was sold November 1, 2023.
Contract liabilities are consideration we have received from our customers or billed in advance of providing
goods or services promised in the future. We defer recognizing this consideration as revenue until we have
satisfied the related performance obligation to the customer. Contract liabilities include recurring services billed
one month in advance and installation and maintenance charges that are deferred and recognized over the
actual or expected contract term, which typically ranges from 1 to 5 years depending on the service. Contract
liabilities are included within deferred revenue in our consolidated balance sheets. During the years ended
December 31, 2023 and December 31, 2022, we recognized $434 million and $539 million, respectively, of
revenue that was included in contract liabilities of $715 million and $841 million as of January 1, 2023 and 2022,
respectively, including contract liabilities that were classified as held for sale.
Performance Obligations
As of December 31, 2023, we expect to recognize approximately $6.8 billion of revenue in the future related to
performance obligations associated with existing customer contracts that are partially or wholly unsatisfied. As
of December 31, 2023, the transaction price related to unsatisfied performance obligation that are expected to
be recognized in 2024, 2025 and thereafter was $2.8 billion, $1.7 billion and $2.3 billion, respectively.
These amounts exclude (i) the value of unsatisfied performance obligations for contracts for which we
recognize revenue at the amount to which we have the right to invoice for services performed (for example,
uncommitted usage or non-recurring charges associated with professional or technical services to be
completed) and (ii) contracts that are classified as leasing arrangements or government assistance that are not
subject to ASC 606.
Contract Costs
The following tables provide changes in our contract acquisition costs and fulfillment costs:
B-48
Appendix B
(1)
Represents changes in amounts classified as held for sale related to the divestitures of our Latin American and ILEC businesses on August 1,
2022 and October 3, 2022, respectively, as well as changes of $6 million acquisition costs and no fulfillment costs classified as held for sale
as of December 31, 2022 related to the divestiture of the EMEA business, held for sale as of December 31, 2022 and completed November 1,
2023. See Note 2—Divestitures of the Latin American, ILEC and EMEA Businesses.
Acquisition costs include commission fees paid to employees as a result of obtaining contracts. Fulfillment costs
include third party and internal costs associated with the provision, installation and activation of services to
customers, including labor and materials consumed for these activities.
We amortize deferred acquisition and fulfillment costs based on the transfer of services on a straight-line basis
over the average contract life of approximately 36 months for mass markets customers and 33 months for
business customers. We include amortized fulfillment costs in cost of services and products and amortized
acquisition costs are included in selling, general and administrative expenses in our consolidated statements of
operations. We include the amount of these deferred costs that are anticipated to be amortized in the next 12
months in other current assets on our consolidated balance sheets. We include the amount of deferred costs
expected to be amortized beyond the next twelve months in other non-current assets on our consolidated
balance sheets. We assess deferred acquisition and fulfillment costs for impairment on a quarterly basis.
Governmental Funding
Lumen participates in various U.S. federal and state programs under which government support payments are
received to offset costs associated with providing services in targeted locations such as unserved or
underserved high-cost or rural areas, or for certain types of customers, including non-profit organizations,
educational institutions and local governmental bodies. In certain instances, support payments are conditioned
on specified infrastructure buildouts by milestone deadlines or provision of services at specified locations and
speed requirements. Commitments may be made annually, on a multi-year basis ranging from one to ten years
or be on-going subject to periodic change or termination. Consistent with customary practice and as referenced
in ASC 832 Government Assistance, Lumen applies a grant model of accounting by which it accounts for these
transactions as non-ASC 606 revenue over the periods in which the costs for which the funding is intended to
compensate are incurred. This non-ASC 606 revenue is included in operating revenue in our consolidated
statements of operations. Corresponding receivables are recorded when services have been provided to the
customers and costs incurred, but the cash has not been received. These amounts are included in our accounts
receivable, less allowance in our consolidated balance sheets. Certain programs are subject to audits of
compliance with program commitments and, subject to the outcomes of those assessments, Lumen may be
required to reimburse the government entity for cash previously received, or, in some cases, pay a penalty.
Lumen evaluates each program and establishes a liability under the principles of ASC 450 if it is probable
support payments will be recaptured or a penalty will be imposed.
For the years ended December 31, 2023 and 2022, Lumen recorded non-customer revenue of $85 million and
$190 million, respectively, under government assistance programs, of which 17% and 31%, respectively, was
associated with state universal service fund support programs.
Between 2015 and 2021, we received approximately $500 million annually through the Federal Communications
Commission (the "FCC")'s Connect America Fund II ("CAF II"), a federal multi-year recurring subsidy program
for more extensive broadband deployment in price-cap ILEC territories. For this program, which ended on
December 31, 2021, we were required to meet certain specified infrastructure buildout requirements in 33 states
by the end of 2021, which required substantial capital expenditures. In the first quarter of 2022, we recognized
$59 million of previously deferred revenue related to the conclusion of the CAF II program based upon our final
buildout and filing submissions. The government has the right to audit our compliance with the CAF II program
and the ultimate outcome of any remaining examinations is unknown, but could result in a liability to us in
excess of our reserve accruals established for these matters.
In early 2020, the FCC created the Rural Digital Opportunity Fund (the “RDOF”) program, a federal support
program designed to fund broadband deployment in rural America. For the first phase of this program, RDOF
Phase I, the FCC ultimately awarded $6.4 billion support payments to be paid in equal monthly installments over
10 years. We were awarded RDOF funding in several of the states in which we operate and began receiving
monthly support payments during the second quarter of 2022. We received approximately $17 million in annual
RDOF Phase I support payments for the years ended December 31, 2023 and 2022 and expect to receive this
same amount each year thereafter during the program period.
Lumen participates in multiple state sponsored programs for broadband deployment in unserved and
underserved areas for which the states have state universal service funds sourced from fees levied on
telecommunications providers and passed on to consumers. During the years ending December 31, 2023 and
2022, Lumen participated in these types of programs primarily in the states of Nebraska, North Carolina, New
Mexico, Minnesota, Virginia and Wisconsin.
(5) Leases
We primarily lease to or from third parties various office facilities, colocation facilities, equipment and
transmission capacity. Leases with an initial term of 12 months or less are not recorded on our consolidated
balance sheets; we recognize lease expense for these leases on a straight-line basis over the lease term.
We determine if an arrangement is a lease at inception and whether that lease meets the classification criteria of
a finance or operating lease. Lease-related assets, or right-of-use assets, are recognized at the lease
commencement date at amounts equal to the respective lease liabilities. Lease-related liabilities are recognized
at the present value of the remaining contractual fixed lease payments, discounted using our incremental
borrowing rates. As part of the present value calculation for the lease liabilities, we use an incremental
borrowing rate as the rates implicit in the leases are not readily determinable. The incremental borrowing rates
used for lease accounting are based on our unsecured rates, adjusted to approximate the rates at which we
could borrow on a collateralized basis over a term similar to the recognized lease term. We apply the
incremental borrowing rates to lease components using a portfolio approach based upon the length of the lease
term and the reporting entity in which the lease resides. Operating lease expense is recognized on a straight-line
basis over the lease term, while variable lease payments are expensed as incurred. Operating lease assets are
included in other, net under goodwill and other assets on our consolidated balance sheets. Noncurrent operating
lease liabilities are included in other under deferred credits and other liabilities on our consolidated
balance sheets.
Some of our lease arrangements contain lease components, non-lease components (including common-area
maintenance costs) and executory costs (including real estate taxes and insurance costs). We generally account
for each component separately based on the estimated standalone price of each component. For colocation
leases, we account for the lease and non-lease components as a single lease component.
Many of our lease agreements contain renewal options; however, we do not recognize right-of-use assets or
lease liabilities for renewal periods unless we determine that we are reasonably certain of renewing the lease.
Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold
improvements are limited by the expected lease term, unless there is a transfer of title or purchase option
reasonably certain to be exercised. Our lease agreements do not generally contain any material residual value
guarantees or material restrictive covenants.
Lease expense consisted of the following:
B-50
Appendix B
We primarily lease from third parties various equipment, office facilities, retail outlets, switching facilities and
other network sites or components. These leases, with few exceptions, provide for renewal options and rent
escalations that are either fixed or based on the consumer price index. Any rent abatements, along with rent
escalations, are included in the computation of rent expense calculated on a straight-line basis over the lease
term. The lease term for most leases includes the initial non-cancelable term plus any term under renewal
options that we believe are reasonably assured.
Beginning in the second half of 2020 and continuing into 2023, we rationalized our lease footprint and ceased
using 42 underutilized leased property locations. We determined that we no longer needed the leased space
and, due to the limited remaining term on the contracts, concluded that we had neither the intent nor ability to
sublease the properties. For the years ended December 31, 2023 and 2021, we incurred accelerated lease costs
of approximately $8 million and $35 million, respectively. We did not incur material accelerated lease costs
during 2022. Additionally, during the second quarter of 2023, we also donated our Monroe, Louisiana campus
and leased back a portion thereof. This donation resulted in a $101 million loss recognized for the year ended
December 31, 2023. In conjunction with our plans to continue to reduce costs, we expect to continue our real
estate rationalization efforts and expect to incur additional accelerated real estate costs in future periods.
For the years ended December 31, 2023, 2022 and 2021, our gross rental expense, including the accelerated
lease costs discussed above, was $503 million, $503 million and $588 million, respectively. We also received
sublease rental income of $25 million for each of the years ended December 31, 2023, 2022 and 2021.
Supplemental consolidated balance sheet information and other information related to leases is included below:
As of December 31,
Leases (Dollars in millions) Classification on the Balance Sheet 2023 2022
Assets
Operating lease assets Other, net $ 1,230 1,340
Finance lease assets Property, plant and equipment, net of 260 317
accumulated depreciation
Total leased assets $ 1,490 1,657
Liabilities
Current
Operating Current operating lease liabilities $ 268 344
Finance Current maturities of long-term debt 16 16
Noncurrent
Operating Other 1,040 1,088
Finance Long-term debt 215 234
Total lease liabilities $ 1,539 1,682
Weighted-average remaining lease term (years)
Operating leases 8.2 7.7
Finance leases 11.3 12.0
Weighted-average discount rate
Operating leases 7.59% 5.98%
Finance leases 4.98% 4.96%
At December 31, 2022, we classified certain operating and finance lease assets and liabilities related to the
EMEA business, which was sold as of November 1, 2023, as held for sale and discontinued recording
amortization on the related right-of-use assets upon this classification. These operating and finance lease assets
and liabilities held for sale are not reflected in the above or throughout the disclosures within this note. See
Note 2—Divestitures of the Latin American, ILEC and EMEA Businesses for more information.
Supplemental consolidated cash flow statement information related to leases is included below:
As of December 31, 2023, we had no material operating or finance leases that had not yet commenced.
B-52
Appendix B
forecast period. We measure our forecast period based on the average days to collect payment on billed
accounts receivable. To determine our current allowance for credit losses, we combine the historical and
expected credit loss rates and apply them to our period end accounts receivable.
If there is an unexpected deterioration of a customer's financial condition or an unexpected change in economic
conditions, including macroeconomic events, we assess the need to adjust the allowance for credit losses. Any
such resulting adjustments would affect earnings in the period that adjustments are made.
The assessment of the correlation between historical observed default rates, current conditions and forecasted
economic conditions requires judgment. Alternative interpretations of these factors could have resulted in
different conclusions regarding our allowance for credit losses. The amount of credit loss is sensitive to changes
in circumstances and forecasted economic conditions. Our historical credit loss experience, current conditions
and forecast of economic conditions may also not be representative of the customers' actual default experience
in the future, and we may use methodologies that differ from those used by other companies.
The following table presents the activity of our allowance for credit losses by accounts receivable portfolio for
the years ended December 31, 2023 and December 31, 2022:
Mass
Business Markets Total
(Dollars in millions)
Beginning balance at January 1, 2021 $ 109 82 191
Provision for expected losses 50 55 105
Write-offs charged against the allowance (76) (101) (177)
Recoveries collected 13 6 19
Classified as assets held for sale(1) (8) (16) (24)
Balance at December 31, 2021 $ 88 26 114
Provision for expected losses 25 108 133
Write-offs charged against the allowance (61) (114) (175)
Recoveries collected 10 6 16
Change in allowance in assets held for sale(2) (5) 2 (3)
Balance at December 31, 2022 $ 57 28 85
Provision for expected losses 35 65 100
Write-offs charged against the allowance (62) (65) (127)
Recoveries collected 6 3 9
Balance at December 31, 2023 $ 36 31 67
(1)
Represents the amounts classified as held for sale related to the divestitures of our Latin American and ILEC businesses on August 1, 2022
and October 3, 2022, respectively. See Note 2—Divestitures of the Latin American and ILEC Businesses and Planned Divestiture of the
EMEA Business.
(2)
Represents changes in amounts classified as held for sale related to the divestitures of our Latin American and ILEC businesses on August 1,
2022 and October 3, 2022, respectively, and the inclusion of a $5 million allowance for credit losses classified as held for sale as of
December 31, 2022 related to the divestiture of the EMEA business. See Note 2—Divestitures of the Latin American, ILEC and
EMEA Businesses.
As of December 31,
Interest Rates(1) Maturities(1) 2023 2022
(Dollars in millions)
Senior Secured Debt: (2)
Lumen Technologies, Inc.
Revolving Credit Facility(3) SOFR + 2.00% 2025 $ 200 —
Term Loan A(4) SOFR + 2.00% 2025 933 991
Term Loan A-1(4) SOFR + 2.00% 2025 266 283
Term Loan B(5) SOFR + 2.25% 2027 3,891 3,941
Senior notes 4.000% 2027 1,250 1,250
Subsidiaries:
Level 3 Financing, Inc.
Tranche B 2027 Term Loan(6) SOFR + 1.75% 2027 2,411 2,411
Senior notes 3.400% - 10.500% 2027 - 2030 2,425 1,500
Senior Notes and Other Debt:
Lumen Technologies, Inc.
Senior notes 4.500% - 7.650% 2025 - 2042 2,143 3,722
Subsidiaries:
Level 3 Financing, Inc.
Senior notes 3.625% - 4.625% 2027 - 2029 3,940 3,940
Qwest Corporation
Senior notes 6.500% - 7.750% 2025 - 2057 1,986 1,986
Term loan(7) SOFR + 2.50% 2027 215 215
Qwest Capital Funding, Inc.
Senior notes 6.875% - 7.750% 2028 - 2031 192 192
(8)
Finance lease and other obligations Various Various 285 317
Unamortized discounts, net (4) (7)
Unamortized debt issuance costs (145) (169)
Total long-term debt 19,988 20,572
Less current maturities (157) (154)
Long-term debt, excluding current maturities $ 19,831 20,418
(1)
As of December 31, 2023.
(2)
See the remainder of this Note for a description of certain parent or subsidiary guarantees and liens securing this debt.
(3)
Revolving Credit Facility had an interest rate of 7.464% as of December 31, 2023.
(4)
Term Loans A and A-1 had interest rates of 7.470% and 6.384% as of December 31, 2023 and December 31, 2022, respectively.
(5)
Term Loan B had interest rates of 7.720% and 6.634% as of December 31, 2023 and December 31, 2022, respectively.
(6)
The Level 3 Tranche B 2027 Term Loan had interest rates of 7.220% and 6.134% as of December 31, 2023 and December 31,
2022, respectively.
(7)
The Qwest Corporation Term Loan had interest rates of 7.970% and 6.640% as of December 31, 2023 and December 31, 2022, respectively.
(8)
December 31, 2022 excludes finance lease obligations of our EMEA business that were classified as held for sale as of December 31, 2022
and sold on November 1, 2023. See Note 2—Divestitures of the Latin American, ILEC and EMEA Businesses.
B-54
Appendix B
(Dollars in millions)
2024 $ 157
2025 1,864
2026 498
2027 9,386
2028 1,539
2029 and thereafter 6,693
Total long-term debt $ 20,137
A portion of the revolving credit facility in an amount not to exceed $250 million is available for swingline loans,
and a portion in an amount not to exceed $800 million is available for the issuance of letters of credit. During
the year ended December 31, 2023, we issued approximately $218 million of letters of credit under our revolving
credit facility, which reduced our borrowing capacity available thereunder by the same amount. As of December
31, 2023, these issued letters of credit were undrawn.
Lumen Technologies is permitted under the Amended Credit Agreement to request certain incremental
borrowings subject to the satisfaction of various conditions and to certain other limitations. Any incremental
borrowings would be subject to the same terms and conditions under the Amended Credit Agreement.
Qwest Corporation
On October 23, 2020, Qwest Corporation borrowed $215 million under a variable-rate term loan with CoBank
ACB. The outstanding unpaid principal amount of this term loan plus any accrued and unpaid interest is due on
October 23, 2027. Interest is paid at least quarterly based upon either SOFR or the base rate (as defined in the
credit agreement) plus an applicable margin between 1.50% to 2.50% per annum for SOFR loans and 0.50% to
1.50% per annum for base rate loans depending on Qwest Corporation's then current senior unsecured
long-term debt rating.
Senior Notes
Lumen's consolidated indebtedness at December 31, 2023 included (i) senior secured notes issued by Lumen
Technologies, Inc. and Level 3 Financing, Inc. and (ii) senior unsecured notes issued by Lumen Technologies,
Inc., Level 3 Financing, Inc., Qwest Corporation, and Qwest Capital Funding, Inc. All of these notes carry fixed
interest rates and all principal is due on the notes’ respective maturity dates, which rates and maturity dates are
summarized in the table above. The Lumen Technologies, Inc. secured senior notes are guaranteed by the same
domestic subsidiaries that guarantee the Amended Credit Agreement on substantially the same terms and
conditions that govern the guarantees of the Amended Credit Agreement. The Level 3 Financing, Inc. secured
senior notes are secured by a pledge of substantially all of its assets and guaranteed on a secured basis by the
same domestic subsidiaries that guarantee its Term B 2027 Term Loan. The remaining senior notes issued by
Level 3 Financing, Inc. are guaranteed on an unsecured basis by its parent, Level 3 Parent, LLC, and one of its
subsidiaries. The senior notes issued by Qwest Capital Funding, Inc. are guaranteed by its parent, Qwest
Communications International Inc.
B-56
Appendix B
Except for a limited number of senior notes issued by Qwest Corporation, the issuer generally can redeem the
notes, at its option, in whole or in part, (i) pursuant to a fixed schedule of pre-established redemption prices, (ii)
pursuant to a “make whole” redemption price or (iii) under certain other specified limited conditions. Under
certain circumstances in connection with a “change of control” of Lumen Technologies, it will be required to
make an offer to repurchase each series of these senior notes (other than two of its older series of notes) at a
price of 101% of the principal amount redeemed, plus accrued and unpaid interest. Also, under certain
circumstances in connection with a "change of control" of Level 3 Parent, LLC or Level 3 Financing, Inc., Level 3
Financing will be required to make an offer to repurchase each series of its outstanding senior notes at a price of
101% of the principal amount redeemed, plus accrued and unpaid interest.
Aggregate principal
Debt Period of Reduction (amounts in millions)
5.625% Senior Notes, Series X, due 2025 Q1 2023 $ 48
7.200% Senior Notes, Series D, due 2025 Q1 2023 21
5.125% Senior Notes due 2026 Q1 2023 291
6.875% Debentures, Series G, due 2028 Q1 2023 52
5.375% Senior Notes due 2029 Q1 2023 275
4.500% Senior Notes due 2029 Q1 2023 556
7.600% Senior Notes, Series P, due 2039 Q1 2023 161
7.650% Senior Notes, Series U, due 2042 Q1 2023 131
5.625% Senior Notes, Series X, due 2025 Q2 2023 1
4.500% Senior Notes due 2029 Q2 2023 2
7.600% Senior Notes, Series P, due 2039 Q2 2023 3
7.650% Senior Notes, Series U, due 2042 Q2 2023 13
Total $ 1,554
Interest Expense
Interest expense includes interest on total long-term debt. The following table presents the amount of gross
interest expense, net of capitalized interest:
Covenants
B-58
Appendix B
The senior unsecured notes of Lumen Technologies, Inc. were issued under four separate indentures. These
indentures restrict our ability to (i) incur, issue or create liens upon the property of Lumen Technologies, Inc. and
(ii) consolidate with or merge into, or transfer or lease all or substantially all of our assets to any other party.
These indentures do not contain any provisions that restrict the incurrence of additional indebtedness. The
senior secured notes of Lumen Technologies, Inc. were issued under a separate indenture that contains a more
restrictive set of covenants. As indicated above under "Senior Notes", Lumen Technologies, Inc. will be required
to offer to purchase certain of its long-term debt securities issued under its indentures under certain
circumstances in connection with a "change of control" of Lumen Technologies, Inc.
Level 3 Companies
The term loan, senior secured notes and senior unsecured notes of Level 3 Financing, Inc. contain various
representations and extensive affirmative and negative covenants. Such covenants include, among other things
and subject to certain significant exceptions, restrictions on their ability to declare or pay dividends, repay
certain other indebtedness, create liens, incur additional indebtedness, make investments, dispose of assets and
merge or consolidate with any other person. Also, as indicated above under "Senior Notes", Level 3 Financing,
Inc. will be required to offer to repurchase or repay certain of its long-term debt under certain circumstances in
connection with a "change of control" of Level 3 Financing or Level 3 Parent, LLC.
Qwest Companies
Under its term loan, Qwest Corporation must maintain a debt to EBITDA ratio of not more than 2.85 to 1.00, as
determined and calculated in the manner described in the applicable term loan documentation. The term loan
also contains a negative pledge covenant, which generally requires Qwest Corporation to secure equally and
ratably any advances under the term loan if it pledges assets or permits liens on its property for the benefit of
other debtholders.
The senior notes of Qwest Corporation were issued under indentures dated April 15, 1990 and October 15, 1999.
These indentures contain restrictions on the incurrence of liens and the consummation of certain transactions
substantially similar to the above-described covenants in Lumen's indentures (but contain no mandatory
repurchase provisions). The senior notes of Qwest Capital Funding, Inc. were issued under an indenture dated
June 29, 1998 containing terms substantially similar to those set forth in Qwest Corporation's indentures.
Impact of Covenants
The debt covenants applicable to Lumen Technologies, Inc. and its subsidiaries could have a material adverse
impact on their ability to operate or expand their respective businesses, to pursue strategic transactions, or to
otherwise pursue their plans and strategies. The covenants of the Level 3 companies may significantly restrict
the ability of Lumen Technologies, Inc. to receive cash from the Level 3 companies, to distribute cash from the
Level 3 companies to other of Lumen’s affiliated entities, or to enter into other transactions among Lumen’s
wholly-owned entities.
Certain of the debt instruments of Lumen Technologies, Inc. and its subsidiaries contain cross payment default
or cross acceleration provisions. When present, these provisions could have a wider impact on liquidity than
might otherwise arise from a default or acceleration of a single debt instrument.
The ability of Lumen Technologies, Inc. and its subsidiaries to comply with the financial covenants in their
respective debt instruments could be adversely impacted by a wide variety of events, including unforeseen
contingencies, many of which are beyond their control.
Compliance
As of December 31, 2023, Lumen Technologies, Inc. believes it and its subsidiaries were in compliance with the
provisions and financial covenants in their respective material debt agreements in all material respects.
Guarantees
Lumen Technologies does not guarantee the debt of any unaffiliated parties, but, as noted above, as of
December 31, 2023 certain of its largest subsidiaries guaranteed (i) its debt outstanding under its Amended
Secured Credit Facilities, its senior secured notes and its $225 million letter of credit facility and (ii) the
outstanding term loans or senior notes issued by certain other subsidiaries. As further noted above, several of
the subsidiaries guaranteeing these obligations have pledged substantially all of their assets to secure certain of
their respective guarantees.
Subsequent Event
See Note 24—Subsequent Events, for information regarding certain debt restructuring transactions
contemplated under our amended and restated transaction support agreement dated as of January 22, 2024.
As of December 31,
2023 2022(1)
(Dollars in millions)
Trade and purchased receivables $ 1,181 1,319
Earned and unbilled receivables 165 209
Other 39 65
Total accounts receivable 1,385 1,593
Less: allowance for credit losses (67) (85)
Accounts receivable, less allowance $ 1,318 1,508
(1)
Amounts have been adjusted to reflect the immaterial correction of accounts receivable. See Note 1—Background and Summary of
Significant Accounting Policies under the header Correction of Immaterial Errors.
We are exposed to concentrations of credit risk from our customers. We generally do not require collateral to
secure our receivable balances. We have agreements with other communications service providers whereby we
agree to bill and collect on their behalf for services rendered by those providers to our customers within our
local service area. We purchase accounts receivable from other communications service providers primarily on a
recourse basis and include these amounts in our accounts receivable balance. We have not experienced any
significant loss associated with these purchased receivables.
(1)
Fiber, conduit and other outside plant consists of fiber and metallic cable, conduit, poles and other supporting structures.
(2)
Central office and other network electronics consists of circuit and packet switches, routers, transmission electronics and electronics
providing service to customers.
(3)
Support assets consist of buildings, data centers, computers and other administrative and support equipment.
(4)
Construction in progress includes inventory held for construction and property of the aforementioned categories that has not been placed
in service as it is still under construction.
(5)
At December 31, 2022, we had $1.9 billion of certain property, plant and equipment, net related to our EMEA business which was classified as
held for sale at this date and which was sold on November 1, 2023. See Note 2—Divestitures of the Latin American, ILEC and EMEA
Businesses for more information.
We recorded depreciation expense of $1.9 billion, $2.1 billion and $2.7 billion for the years ended
December 31, 2023, 2022 and 2021, respectively.
B-60
Appendix B
(1)
Represents the amounts classified as held for sale related to our EMEA business. See Note 2—Divestitures of the Latin American, ILEC and
EMEA Businesses.
The changes in estimate referred to in the table above were offset against gross property, plant and equipment.
(10) Severance
Periodically, we reduce our workforce and accrue liabilities for the related severance costs. These workforce
reductions result primarily from the progression or completion of our post-acquisition integration plans,
increased competitive pressures, cost reduction initiatives, process improvements through automation and
reduced workloads due to reduced demand for certain services.
During the fourth quarter of 2023 we reduced our global workforce by approximately 4% as part of our ongoing
efforts to reorganize Lumen for growth by right-sizing our operations to improve our profitability. As a result of
this plan, we incurred severance and related costs of approximately $53 million. We do not expect to incur any
material impairment or exit costs related to this plan.
We report severance liabilities within accrued expenses and other liabilities - salaries and benefits in our
consolidated balance sheets and report severance expenses in selling, general and administrative expenses in
our consolidated statements of operations. As described in Note 17—Segment Information, we do not allocate
these severance expenses to our segments.
Changes in our accrued liabilities for severance expenses were as follows:
Severance
(Dollars in millions)
Balance at December 31, 2021 $ 36
Accrued to expense 12
Payments, net (37)
Balance at December 31, 2022 11
Accrued to expense 74
Payments, net (67)
Balance at December 31, 2023 $ 18
Pension Benefits
United States funding laws require a company with a pension shortfall to fund the annual cost of benefits earned
in addition to a seven-year amortization of the shortfall. Our funding policy for our Combined Pension Plan is to
make contributions with the objective of accumulating ample assets to pay all qualified pension benefits when
due under the terms of the plan. The accounting unfunded status of the Combined Pension Plan was
$736 million and $580 million as of December 31, 2023 and 2022, respectively.
We made no voluntary cash contributions to the Combined Pension Plan in 2023 or 2022. As discussed above,
we contributed approximately $319 million of cash to the Lumen Pension Plan trust to fully fund the pension
plan in September 2022 in preparation for the closing of the sale of the ILEC business. We paid $5 million of
benefits directly to participants of our non-qualified pension plans in both 2023 and 2022.
Benefits paid by the Combined Pension Plan are paid through a trust that holds all of the Plan's assets. The
amount of required contributions to the Combined Pension Plan in 2024 and beyond will depend on a variety of
factors, most of which are beyond our control, including earnings on plan investments, prevailing interest rates,
demographic experience, changes in plan benefits and changes in funding laws and regulations. Based on
current laws and circumstances, we do not believe we are required to make any contributions to the Combined
Pension Plan in 2024 and we do not expect to make voluntary contributions to the trust for the Combined
Pension Plan in 2024. We estimate that in 2024 we will pay $4 million of benefits directly to participants of our
non-qualified pension plans.
B-62
Appendix B
We recognize in our consolidated balance sheets the funded status of the legacy Level 3 defined benefit
post-retirement plans. These plans were fully funded as of December 31, 2023 and 2022. Additionally, as
previously mentioned, we sponsor unfunded non-qualified pension plans for certain current and former
highly-compensated employees. The net unfunded status of our non-qualified pension plans was $33 million and
$35 million for the years ended December 31, 2023 and 2022, respectively. Due to the insignificant impact of
these pension plans on our consolidated financial statements, we have predominantly excluded them from the
remaining employee benefit disclosures in this Note, unless otherwise specifically stated.
Post-Retirement Benefits
Our post-retirement benefit plans provide post-retirement benefits to qualified retirees and allow (i) eligible
employees retiring before certain dates to receive benefits at no or reduced cost and (ii) eligible employees
retiring after certain dates to receive benefits on a shared cost basis. The post-retirement benefits not paid by
the trusts are funded by us and we expect to continue funding these post-retirement obligations as benefits are
paid. The accounting unfunded status of our qualified post-retirement benefit plan was $1.9 billion and $2.0
billion as of December 31, 2023 and 2022, respectively.
Assets in the post-retirement trusts were substantially depleted as of December 31, 2016; as of
December 31, 2019 the Company ceased to pay certain post-retirement benefits through the trusts. No
contributions were made to the post-retirement trusts in 2023, nor 2022. Benefits are paid directly by us with
available cash. In 2023, we paid $194 million of post-retirement benefits, net of participant contributions and
direct subsidies. In 2024, we currently expect to pay directly $193 million of post-retirement benefits, net of
participant contributions and direct subsidies.
We expect our expected health care cost trend to range from 5.4% to 7.50% in 2024 and grading to 4.50% by
2031. Our post-retirement benefit cost, for certain eligible legacy Qwest retirees and certain eligible legacy
CenturyLink retirees, is capped at a set dollar amount. Therefore, those health care benefit obligations are not
subject to increasing health care trends after the effective date of the caps.
Prior to the sale of the ILEC business on October 3, 2022, we realized pension costs related to the Lumen
Pension Plan. Net periodic benefit expense (income) for our Combined Pension Plan and the Lumen Pension
Plan (through October 3, 2022, together the "Pension Plans") includes the following components:
Pension Plans
Years Ended December 31,
2023 2022 2021
(Dollars in millions)
Service cost $ 25 44 56
Interest cost 270 194 201
Expected return on plan assets (287) (385) (535)
Settlement charges — — 383
Realized to gain on sale of businesses — 546 —
Special termination benefits charge 2 — 6
Recognition of prior service credit (7) (10) (9)
Recognition of actuarial loss 104 122 184
Net periodic pension expense $ 107 511 286
Net periodic benefit expense for our post-retirement benefit plans includes the following components:
Post-Retirement Plans
Years Ended December 31,
2023 2022 2021
(Dollars in millions)
Service cost $ 5 10 14
Interest cost 103 72 47
Realized to gain on sale of businesses — (32) —
Recognition of prior service cost (8) 8 15
Recognition of actuarial loss (20) (4) 4
Net periodic post-retirement benefit expense $ 80 54 80
Service costs for our Combined Pension Plan and post-retirement benefit plans are included in the cost of
services and products and selling, general and administrative line items on our consolidated statements of
operations and all other costs listed above, except for amounts realized as part of the net gain on sale of
businesses, are included in other (expense) income, net on our consolidated statements of operations for the
years ended December 31, 2023, 2022 and 2021. Additionally, a portion of the service cost is also allocated to
certain assets under construction, which are capitalized and reflected as part of property, plant and equipment
in our consolidated balance sheets. As a result of ongoing efforts to reduce our workforce, we recognized a
one-time charge in 2023 and in 2021 of $2 million and $6 million, respectively, for special termination benefit
enhancements paid to certain eligible employees upon voluntary retirement.
B-64
Appendix B
Our pension plan contains provisions that allow us, from time to time, to offer lump sum payment options to
certain former employees in settlement of their future retirement benefits. We record an accounting settlement
charge, consisting of the recognition of certain deferred costs of the pension plan associated with these lump
sum payments only if, in the aggregate, they exceed or are probable to exceed the sum of the annual service
and interest costs for the plan’s net periodic pension benefit cost, which represents the settlement accounting
threshold. The lump sum pension settlement payments for 2021 exceeded the settlement threshold. In addition,
during the fourth quarter of 2021, we executed an annuity purchase contract with a third party insurer that
triggered additional settlement activity (see discussion above for further information). As a result, we
recognized a non-cash settlement charge of $383 million as of December 31, 2021 to accelerate the recognition
of a portion of the previously unrecognized actuarial losses in the qualified pension plan, which is reflected in
other (expense) income, net in our consolidated statement of operations for the year ended December 31, 2021.
This non-cash charge increased our recorded net loss and increased our recorded accumulated deficit, with an
offset to accumulated other comprehensive loss in shareholders' equity for the year ended December 31, 2021.
The amount of any future non-cash settlement charges will be dependent on several factors, including the total
amount of our future lump sum benefit payments.
Benefit Obligations
The actuarial assumptions used to compute the funded status for the plans are based upon information available
as of December 31, 2023 and 2022 and are as follows:
In 2021, we adopted the revised mortality tables and projection scales released by the Society of Actuaries,
which increased the projected benefit obligation of our benefit plans by $37 million for 2021. The Society of
Actuaries did not release any revised mortality tables or projection scales in 2022 or 2023.
The short-term and long-term interest crediting rates during 2023 for cash balance components of the
Combined Pension Plan were 4.0% and 3.5%, respectively.
The following tables summarize the change in the benefit obligations for the Combined Pension Plan and
post-retirement benefit plans:
Plan Assets
We maintain plan assets for our Combined Pension Plan and certain post-retirement benefit plans. As previously
noted, assets in the post-retirement benefit plan trusts were substantially depleted as of December 31, 2016. The
fair value of post-retirement benefit plan assets was $1 million, $5 million and $5 million at December 31, 2023,
2022 and 2021, respectively. Due to the insignificance of these assets on our consolidated financial statements,
we have predominantly excluded them from the disclosures of plan assets in this Note, unless
otherwise indicated.
The following table summarizes the change in the fair value of plan assets for the Combined Pension Plan:
The expected rate of return on plan assets is the long-term rate of return we expect to earn on the plan's assets,
net of administrative expenses paid from plan assets. It is determined annually based on the strategic asset
allocation and the long-term risk and return forecast for each asset class.
Our investment objective for the Combined Pension Plan assets is to achieve an attractive risk-adjusted return
over time that will provide for the payment of benefits and minimize the risk of large losses. We employ a
liability-aware investment strategy designed to reduce the volatility of pension assets relative to pension
liabilities. This strategy is evaluated frequently and is expected to evolve over time with changes in the funded
status and other factors. Approximately 50% of plan assets is targeted to long-duration investment grade bonds
and interest rate sensitive derivatives and 50% is targeted to diversified equity, fixed income and private market
investments that are expected to outperform the liability with moderate funded status risk. At the beginning of
2024, our expected annual long-term rate of return on pension assets before consideration of administrative
expenses is assumed to be 7.0%. Administrative expenses, including projected PBGC (Pension Benefit Guaranty
Corporation) premiums, reduce the annual long-term expected return, net of administrative expenses, to 6.5%.
Permitted investments: Plan assets are managed consistent with the restrictions set forth by the Employee
Retirement Income Security Act of 1974, as amended.
B-66
Appendix B
Fair Value Measurements: Fair value is defined as the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between independent and knowledgeable parties who are willing and
able to transact for an asset or liability at the measurement date. We use valuation techniques that maximize
the use of observable inputs and minimize the use of unobservable inputs when determining fair value and
then we rank the estimated values based on the reliability of the inputs used following the fair value hierarchy
set forth by the FASB. For additional information on the fair value hierarchy, see Note 14—Fair Value of
Financial Instruments.
At December 31, 2023, we used the following valuation techniques to measure fair value for assets. There were
no changes to these methodologies during 2023:
• Level 1—Assets were valued using the closing price reported in the active market in which the individual
security was traded. U.S. Treasury securities are valued at the bid price reported in an active market in which
the security is traded. Variation margin due from/(to) brokers is valued at the expected next day cash
settlement amount.
• Level 2—Assets were valued using quoted prices in markets that are not active, broker dealer quotations, and
other methods by which all significant inputs were observable at the measurement date. Fixed income
securities primarily utilize observable market information and are based on a spread to U.S. Treasury
securities and consider yields available on comparable securities of issuers with similar credit ratings, the new
issue market for similar securities, secondary trading markets and dealer quotes. Option adjusted spread
models are utilized to evaluate fixed income securities that have early redemption features. Derivative
securities traded over the counter are valued based on gains or losses due to fluctuations in indices, interest
rates, foreign currency exchange rates, security prices or other underlying factors. Repurchase agreements
are valued based on expected settlement per the contract terms.
• Level 3—Assets were valued using unobservable inputs in which little or no market data exists as reported by
the respective institutions at the measurement date. Valuation methods may consider a range of factors,
including estimates based on the assumptions of the investment entity.
The Combined Pension Plan's assets are invested in various asset categories utilizing multiple strategies and
investment managers. Interests in commingled funds are fair valued using a practical expedient to the net asset
value ("NAV") per unit (or its equivalent) of each fund. The NAV reported by the fund manager is based on the
market value of the underlying investments owned by each fund, minus its liabilities, divided by the number of
shares outstanding. Commingled funds can be redeemed at NAV, with a frequency that includes daily, monthly,
quarterly, semi-annually and annually. These commingled funds include redemption notice periods between
same day and 180 days. Investments in private funds, primarily limited partnerships, represent long-term
commitments with a fixed maturity date and are also valued at NAV. The plan has unfunded commitments
related to certain private fund investments, which in aggregate are not material to the plan. Valuation inputs for
these private fund interests are generally based on assumptions and other information not observable in the
market. Underlying investments held in funds are aggregated and are classified based on the fund mandate.
Investments held in separate accounts are individually classified.
The table below presents the fair value of plan assets by category and the input levels used to determine those
fair values at December 31, 2023. It is important to note that the asset allocations do not include market
exposures that are gained with derivatives. Investments include dividend and interest receivables, pending
trades and accrued expenses.
The table below presents the fair value of plan assets by category and the input levels used to determine those
fair values at December 31, 2022. It is important to note that the asset allocations do not include market
exposures that are gained with derivatives. Investments include dividend and interest receivable, pending trades
and accrued expenses.
B-68
Appendix B
The table below presents the fair value of plan assets valued at NAV by category for our Combined Pension Plan
at December 31, 2023 and 2022.
Below is an overview of the asset categories and the underlying strategies used in the preceding tables:
(a)
Investment grade bonds represent investments in U.S. Treasury securities, agencies, corporate bonds, mortgage-backed securities,
asset-backed securities and commercial mortgage-backed securities.
(b)
High yield bonds represent investments in below investment grade fixed income securities.
(c)
Emerging market bonds represent investments issued by governments and other entities located in emerging countries.
(d)
U.S. stocks represent investments in stocks of U.S. based companies.
(e)
Non-U.S. stocks represent investments in companies based in developed countries outside the U.S.
(f)
Emerging market stocks represent investments in stocks of companies located in emerging markets.
(g)
Private equity represents non-public investments in domestic and foreign buy out and venture capital funds. Private equity funds are
primarily structured as limited partnerships and are valued according to the valuation policy of each partnership, subject to prevailing
accounting and other regulatory guidelines.
(h)
Private debt represents non-public investments in distressed or mezzanine debt.
(i)
Market neutral hedge funds hold investments in a diversified mix of instruments that are intended in combination to exhibit low correlations
to market fluctuations. These investments are typically combined with futures to achieve uncorrelated excess returns over various markets.
(j)
Directional hedge funds—This asset category represents investments that may exhibit somewhat higher correlations to market fluctuations
than the market neutral hedge funds.
(k)
Real estate represents investments in a diversified portfolio of real estate properties.
(l)
Multi-asset strategies represent broadly diversified strategies that have the flexibility to tactically adjust exposures to different asset classes
through time.
(m)
Derivatives include exchange traded futures contracts as well as privately negotiated over the counter contracts. The market values
represent gains or losses that occur due to differences between stated contract terms and fluctuations in underlying market instruments.
(n)
Repurchase agreements and other obligations includes contracts where the security owner sells a security with the agreement to buy it
back at a future date and price. Other obligations include obligations to repay cash collateral held by a plan, net liability for investment
purchases pending settlement, and accrued plan expenses.
(o)
Cash equivalents and short-term investments represent investments that are used in conjunction with derivatives positions or are used to
provide liquidity for the payment of benefits or other purposes.
Derivative instruments: Derivative instruments are used to reduce risk as well as provide return. The gross
notional exposure of the derivative instruments directly held by the Combined Pension Plan is shown below.
The notional amount of the derivatives corresponds to market exposure but does not represent an actual
cash investment.
Concentrations of Risk: Investments, in general, are exposed to various risks, such as significant world events,
interest rate, credit, foreign currency and overall market volatility risk. These risks are managed by broadly
diversifying assets across numerous asset classes and strategies with differing expected returns, volatilities and
correlations. Risk is also broadly diversified across numerous market sectors and individual companies. Financial
instruments that potentially subject the plans to concentrations of counterparty risk consist principally of
investment contracts with high quality financial institutions. These investment contracts are typically
collateralized obligations and/or are actively managed, limiting the amount of counterparty exposure to any one
financial institution. Although the investments are well diversified, the value of plan assets could change
materially depending upon the overall market volatility, which could affect the funded status of the plan.
The table below presents a rollforward of the Combined Pension Plan assets valued using Level 3 inputs:
Certain gains and losses are allocated between assets sold during the year and assets still held at year-end
based on transactions and changes in valuations that occurred during the year. These allocations also impact
our calculation of net acquisitions and dispositions.
For the year ended December 31, 2023, the investment program produced actual gains on Combined Pension
Plan assets of $255 million as compared to expected returns of $287 million, for a difference of $32 million. For
the year ended December 31, 2022, the investment program produced actual losses on Combined Pension Plan
assets of $987 million as compared to the expected returns of $329 million, for a difference of $1.3 billion. The
short-term annual returns on plan assets will almost always be different from the expected long-term returns
and the plans could experience net gains or losses, due primarily to the volatility occurring in the financial
markets during any given year.
B-70
Appendix B
Unfunded Status
The following table presents the unfunded status of the Combined Pension Plan and post-retirement
benefit plans:
Post-Retirement
Combined Pension Plan Benefit Plans
Years Ended Years Ended
December 31, December 31,
2023 2022 2023 2022
(Dollars in millions)
Benefit obligation $ (5,212) (5,295) (1,919) (1,995)
Fair value of plan assets 4,476 4,715 1 5
Unfunded status (736) (580) (1,918) (1,990)
Current portion of unfunded status — — (193) (210)
Non-current portion of unfunded status $ (736) (580) (1,725) (1,780)
The current portion of our post-retirement benefit obligations is recorded on our consolidated balance sheets in
accrued expenses and other current liabilities-salaries and benefits.
The following table presents cumulative items not recognized as a component of net periodic benefits expense
as of December 31, 2021, items recognized as a component of net periodic benefits expense in 2022, additional
items deferred during 2022 and cumulative items not recognized as a component of net periodic benefits
expense as of December 31, 2022. The items not recognized as a component of net periodic benefits expense
have been recorded on our consolidated balance sheets in accumulated other comprehensive loss:
401(k) Plans
We sponsor a qualified defined contribution plan covering substantially all of our U.S. employees. Under this
plan, employees may contribute a percentage of their annual compensation up to certain maximums, as defined
by the plan and by the Internal Revenue Service. Currently, we match a percentage of employee contributions in
cash. At December 31, 2023 and 2022, the assets of the plan included approximately 9 million and 10 million
shares of our common stock, all of which were the result of the combination of previous employer match and
participant directed contributions. We recognized expenses related to this plan of $87 million, $91 million and
$96 million for the years ended December 31, 2023, 2022 and 2021, respectively.
B-72
Appendix B
Weighted-
Average
Grant Date
Number of Shares Fair Value
(in thousands)
Non-vested at December 31, 2022 27,279 $ 12.13
Granted 14,787 1.85
Vested (7,170) 10.10
Forfeited (6,844) 13.79
Non-vested at December 31, 2023 28,052 6.82
During 2023, we granted 14.8 million shares of restricted stock and restricted stock unit awards at a
weighted-average price of $1.85. During 2022, we granted 18.8 million shares of restricted stock and restricted
stock unit awards at a weighted-average price of $11.47. During 2021, we granted 13.9 million shares of restricted
stock and restricted stock unit awards at a weighted-average price of $13.95. The total fair value of restricted
stock and restricted stock unit awards that vested during 2023, 2022 and 2021, was $21 million, $98 million and
$139 million, respectively. We do not estimate forfeitures but recognize them as they occur.
(1)
For the years ended December 31, 2023 and December 31, 2022, we excluded from the calculation of diluted loss per share 0.3 million and
3.8 million shares, respectively, potentially issuable under incentive compensation plans or convertible securities, as their effect, if included,
would have been anti-dilutive.
Our calculation of diluted (loss) earnings per common share excludes shares of common stock that are issuable
upon exercise of stock options when the exercise price is greater than the average market price of our common
stock. We also exclude unvested restricted stock awards that are antidilutive as a result of unrecognized
compensation cost. Such shares were 22.5 million, 13.8 million and 3.2 million for 2023, 2022 and
2021, respectively.
B-74
Appendix B
The three input levels in the hierarchy of fair value measurements are defined by the FASB generally as follows:
The following table presents the carrying amounts and estimated fair values of our following financial assets and
liabilities as of December 31, 2023 and 2022:
(1)
For the years ended December 31, 2023 and 2022, we recognized a $22 million and a $109 million of loss on equity securities in other
(expense) income, net in our consolidated statements of operations.
(2)
Nonrecurring fair value is measured as of August 1, 2022.
(1)
For the years ended December 31, 2023 and December 31, 2022, we recognized $75 million and $83 million of loss on investment,
respectively, reflected in other (expense) income, net in our consolidated statement of operations.
Amounts accumulated in accumulated other comprehensive loss related to derivatives were indirectly
recognized in earnings as periodic settlement payments were made throughout the term of the swaps.
The amount of unrealized losses recognized in accumulated other comprehensive loss consists of the following
(in millions):
The amount of realized losses reclassified from accumulated other comprehensive loss to the statement of
operations consists of the following (in millions):
For the year ended December 31, 2022, amounts included in accumulated other comprehensive loss at the
beginning of the period were reclassified into earnings upon the settlement of the cash flow hedging contracts
on March 31, 2022 and June 30, 2022. During the year ended December 31, 2022, $19 million of net losses on the
interest rate swaps have been reflected in our consolidated statements of operations upon settlement of the
agreements in the first half of 2022.
B-76
Appendix B
The following is a reconciliation from the statutory federal income tax rate to our effective income tax rate:
(1)
Includes GILTI (as defined below) incurred as a result of the sale of our Latin American business.
The effective tax rate for the year ended December 31, 2023 includes a $2.2 billion unfavorable impact of a
non-deductible goodwill impairment and a $137 million favorable impact as a result of utilizing available capital
losses generated by the sale of our Latin American business in 2022. The effective tax rate for the year ended
December 31, 2022 includes a $682 million unfavorable impact of non-deductible goodwill impairments and
$128 million unfavorable impact related to incurring tax on Global Intangible Low-Tax Income ("GILTI") as a
result of the sale of our Latin American business.
The tax effects of temporary differences that gave rise to significant portions of the deferred tax assets and
deferred tax liabilities were as follows:
As of December 31,
2023 2022(1)
(Dollars in millions)
Deferred tax assets
Post-retirement and pension benefit costs $ 659 725
Net operating loss carryforwards 794 871
Other employee benefits 23 85
Other 511 519
Gross deferred tax assets 1,987 2,200
Less valuation allowance (399) (550)
Net deferred tax assets 1,588 1,650
Deferred tax liabilities
Property, plant and equipment, primarily due to depreciation differences (3,332) (3,046)
Goodwill and other intangible assets (1,271) (1,634)
Gross deferred tax liabilities (4,603) (4,680)
Net deferred tax liability $(3,015) (3,030)
(1)
Excludes $138 million of deferred tax assets and $38 million of deferred tax liabilities related to the EMEA business sold November 1, 2023,
that were classified as held for sale as of December 31, 2022.
Of the $3.0 billion net deferred tax liability at December 31, 2023 and 2022, respectively, $3.1 billion and
$3.2 billion is reflected as a long-term liability and $112 million and $133 million is reflected as a net
noncurrent deferred tax asset, in other, net on our consolidated balance sheets at December 31, 2023 and
2022, respectively.
Income taxes receivable as of December 31, 2023 was $273 million and income taxes payable as of
December 31, 2022 was $943 million.
At December 31, 2023, we had federal NOLs of approximately $800 million, net of expirations from Section 382
limitations and uncertain tax positions, for U.S. federal income tax purposes. We expect to use substantially all
of these tax attributes to reduce our future federal tax liabilities, although the timing of that use will depend
upon our future earnings and future tax circumstances. Our ability to use these NOLs is subject to annual limits
imposed by Section 382. As a result, we anticipate that our cash income tax liabilities will increase in future
periods. If unused, the NOLs will expire between 2026 and 2029.
At December 31, 2023 we had state net operating loss carryforwards of $13 billion (net of uncertain tax
positions). Our ability to use these NOLs is subject to annual limits imposed by Section 382.
We establish valuation allowances when necessary to reduce the deferred tax assets to amounts we expect to
realize. As of December 31, 2023, we established a valuation allowance of $399 million as it is more likely than
not that this amount of net operating loss will not be utilized prior to expiration. Our valuation allowance at
December 31, 2023 and 2022 is primarily related to NOL carryforwards. This valuation allowance decreased by
$151 million during 2023, primarily due to the impact of utilization of available capital losses.
A reconciliation of the change in our gross unrecognized tax benefits (excluding both interest and any related
federal benefit) from January 1 to December 31 for 2023 and 2022 is as follows:
2023 2022
(Dollars in millions)
Unrecognized tax benefits at beginning of year $ 1,318 1,375
Decrease in tax positions of prior periods netted against deferred tax assets (411) (661)
(Decrease) increase in tax positions taken in the current year (73) 634
Increase (decrease) in tax positions taken in the prior year 752 (3)
Decrease due to payments/settlements (1) —
Decrease from the lapse of statute of limitations (52) —
Decrease related to divestitures of businesses (109) (27)
Unrecognized tax benefits at end of year $1,424 1,318
As of December 31, 2023 the total amount of unrecognized tax benefits that, if recognized, would impact the
effective income tax rate was $280 million. The unrecognized tax benefits also includes tax positions that, if
recognized, would result in adjustments to other tax accounts, primarily deferred taxes, that would not impact
the effective tax rate but could impact cash tax amounts payable to taxing authorities.
Our policy is to reflect interest expense associated with unrecognized tax benefits in income tax expense. We
had accrued interest (presented before related tax benefits) of approximately $100 million and $26 million at
December 31, 2023 and 2022, respectively.
We, or at least one of our subsidiaries, file income tax returns in the U.S. federal jurisdiction and various states
and foreign jurisdictions. With few exceptions, we are no longer subject to U.S. federal, state and local, or
non-U.S. income tax examinations by tax authorities for years before 2004. The Internal Revenue Service and
state and local taxing authorities reserve the right to audit any period where net operating loss carryforwards
are available.
Based on our current assessment of various factors, including (i) the potential outcomes of these ongoing
examinations, (ii) the expiration of statute of limitations for specific jurisdictions, (iii) the negotiated settlement
of certain disputed issues, and (iv) the administrative practices of applicable taxing jurisdictions, it is reasonably
possible that the related unrecognized tax benefits for uncertain tax positions previously taken may decrease by
up to $676 million within the next 12 months. The actual amount of such decrease, if any, will depend on several
future developments and events, many of which are outside our control.
In August 2022, the Inflation Reduction Act was signed into law and which, among other things, implemented a
corporate alternative minimum tax (“CAMT”) on adjusted financial statement income effective for tax periods
occurring after December 31, 2022. The CAMT had no material impact on our financial results as of
December 31, 2023. In addition, the Organization for Economic Co-operation and Development has issued Pillar
Two model rules introducing a new global minimum tax of 15% intended to be effective on January 1, 2024.
While the US has not yet adopted the Pillar Two rules, various other governments around the world are enacting
legislation, some of which are effective for tax periods after December 31, 2023. While the global minimum tax
will increase our administrative and compliance burdens, it is expected to have an immaterial impact to our
financial statements.
B-78
Appendix B
We do not have any single customer that comprises more than 10% of our consolidated total operating revenue.
The assets we hold outside of the U.S. represent less than 10% of our total assets. Revenue from sources outside
of the U.S. comprises less than 10% of our total operating revenue.
B-80
Appendix B
uncertainties and speculative nature of contested proceedings. The establishment of an accrual does not mean
that actual funds have been set aside to satisfy a given contingency. Thus, the resolution of a particular
contingency for the amount accrued could have no effect on our results of operations but nonetheless could
have an adverse effect on our cash flows.
In this Note, when we refer to a class action as "putative" it is because a class has been alleged, but not certified,
in that matter.
Principal Proceedings
The consumer class actions, the securities investor class actions, and the federal derivative actions were
transferred to the U.S. District Court for the District of Minnesota for coordinated and consolidated pretrial
proceedings as In Re: CenturyLink Sales Practices and Securities Litigation. We have settled the consumer and
securities investor class actions and the derivative actions.
We have engaged in discussions regarding related claims with a number of state attorneys general, and have
entered into agreements settling certain of the consumer practices claims asserted by state attorneys general.
While we do not agree with allegations raised in these matters, we have been willing to consider reasonable
settlements where appropriate.
B-82
Appendix B
911 Surcharge
In June 2021, the Company was served with a complaint filed in the Santa Fe County District Court by Phone
Recovery Services, LLC (“PRS”), acting on behalf of the State of New Mexico. The complaint claims Qwest
Corporation and CenturyTel of the Southwest have violated the New Mexico Fraud Against Taxpayers Act since
2004 by failing to bill, collect and remit certain 911 surcharges from customers. Through pre-trial proceedings,
the Court has narrowed the issues to be resolved by jury, ruling that Lumen bears the burden of proving that its
actions were reasonable or known and approved by the State. Qwest is defending the New Mexico claims
vigorously, as it has done successfully with other 911 claims involving PRS in other states.
Right-of-Way
At December 31, 2023, our future rental commitments and Right-of-Way ("ROW") agreements were as follows:
Future Rental
Commitments and ROW
Agreements
(Dollars in millions)
2024 $ 184
2025 64
2026 60
2027 59
2028 51
2029 and thereafter 676
Total future minimum payments $1,094
Purchase Commitments
We have several commitments primarily for marketing activities and support services from a variety of vendors
to be used in the ordinary course of business totaling $1.0 billion at December 31, 2023. Of this amount, we
expect to purchase $403 million in 2024, $378 million in 2025 through 2026, $78 million in 2027 through 2028
and $127 million in 2029 and thereafter. These amounts do not represent our entire anticipated purchases in the
future, but represent only those items for which we were contractually committed as of December 31, 2023.
As of December 31,
2023 2022(1)
(Dollars in millions)
Prepaid expenses $ 395 319
Income tax receivable 273 —
Materials, supplies and inventory 209 236
Contract assets 19 20
Contract acquisition costs 107 123
Contract fulfillment costs 102 100
Other 14 5
Total other current assets $ 1,119 803
(1)
Excludes $59 million of other current assets related to the EMEA business sold on November 1, 2023 that were classified as held for sale as
of December 31, 2022.
Included in accounts payable at December 31, 2023 and 2022 were $274 million and $265 million, respectively,
associated with capital expenditures.
B-84
Appendix B
On August 3, 2021, our Board of Directors authorized a 24-month program to repurchase up to an aggregate of
$1.0 billion of our outstanding common stock. During the year ended December 31, 2021, we repurchased under
this program 80.9 million shares of our outstanding common stock in the open market for an aggregate market
price of $1.0 billion, or an average purchase price of $12.36 per share, thereby fully exhausting the program. All
repurchased common stock has been retired. As a result, common stock and additional paid-in capital were
reduced as of December 31, 2021 by $81 million and $919 million, respectively.
Any repurchases made in 2024 or thereafter will be subject to a non-deductible 1% excise tax on the fair market
value of the stock under the Inflation Reduction Act of 2022.
Foreign
Currency
Post- Translation
Pension Retirement Adjustment
Plans Benefit Plans and Other Total
(Dollars in millions)
Balance at December 31, 2022 $ (985) 308 (422) (1,099)
Other comprehensive loss before reclassifications (110) (11) (1) (122)
Amounts reclassified from accumulated other comprehensive loss 50 (21) 382 411
Net current-period other comprehensive (loss) income (60) (32) 381 289
Balance at December 31, 2023 $ (1,045) 276 (41) (810)
The table below presents further information about our reclassifications out of accumulated other
comprehensive loss by component for the year ended December 31, 2023:
(Decrease)
Increase Affected Line Item in Consolidated
in Net Loss Statement of Operations
Year Ended December 31, 2023 (Dollars in millions)
(1)
Amortization of pension & post-retirement plans
Net actuarial loss $ 82 Other (expense) income, net
Prior service cost (15) Other (expense) income, net
Total before tax 67
Income tax benefit (16) Income tax expense
Net of tax $ 51
Reclassification out
of Accumulated
Other Affected line item in Consolidated
Comprehensive Balance Sheets and Consolidated
Year Ended December 31, 2023 Loss Statement of Operations
Reclassification of realized loss on foreign currency translation
to valuation allowance within assets held for sale(2) $ 389 Assets held for sale
Reclassification of realized loss on foreign currency translation
to loss on sale of business(3) (7) Net loss (gain) on sale of businesses
Subtotal reclassification of realized loss on foreign currency 382
Reclassification of net actuarial loss to valuation allowance
within assets held for sale(2) (24) Assets held for sale
Reclassification of net actuarial gain to loss on sale of
business(3) 2 Net loss (gain) on sale of businesses
Subtotal reclassification of net actuarial loss (22)
Income tax benefit — Income tax expense
Net of tax $ 360
(1)
See Note 11—Employee Benefits for additional information on our net periodic benefit (expense) income related to our pension and post-
retirement plans.
(2)
Recognized in net income through net loss (gain) on sale of business for the year ended December 31, 2022 and included in our valuation
allowance in assets held for sale as of December 31, 2022.
(3)
(Decrease) increase to net loss for the year ended December 31, 2023.
Foreign
Currency
Post- Translation
Pension Retirement Adjustment Interest
Plans Benefit Plans and Other Rate Swap Total
(Dollars in millions)
Balance at December 31, 2021 $ (1,577) (164) (400) (17) (2,158)
Other comprehensive income (loss) before
reclassifications 98 473 (134) — 437
Amounts reclassified from accumulated other
comprehensive loss 494 (1) 112 17 622
Net current-period other comprehensive income (loss) 592 472 (22) 17 1,059
Balance at December 31, 2022 $ (985) 308 (422) — (1,099)
B-86
Appendix B
The table below presents further information about our reclassifications out of accumulated other
comprehensive loss by component for the year ended December 31, 2022:
(1)
See Note 11—Employee Benefits for additional information on our net periodic benefit (expense) income related to our pension and post-
retirement plans.
(23) Dividends
On November 2, 2022, we announced that our Board had terminated our quarterly cash dividend program; as a
result no dividends were declared and paid in 2023.
Our Board of Directors declared the following dividends payable in 2022:
Dividend
Record Date Per Share Total Amount Payment Date
Date Declared (in millions)
August 18, 2022 8/30/2022 $0.25 $253 9/9/2022
May 19, 2022 5/31/2022 0.25 253 6/10/2022
February 24, 2022 3/8/2022 0.25 253 3/18/2022
Tax Refund
During the year ended December 31, 2023 we requested a U.S. Federal income tax refund of approximately
$900 million. We applied approximately $200 million of that refund to pay our 2023 estimated taxes and, in
January 2024, we received a cash refund of approximately $729 million, including interest.
B-88
Appendix C
2024 Equity Incentive Plan
of
Lumen Technologies, Inc.
1. Purpose. The purpose of the 2024 Equity Incentive Plan (the “Plan”) of Lumen Technologies, Inc. (“Lumen”)
is to increase shareholder value and to advance the interests of Lumen and its subsidiaries (collectively, the
“Company”) by furnishing stock-based economic incentives (the “Incentives”) designed to attract, retain,
reward, and motivate the Company’s key employees, officers, directors, consultants, and advisors and to
strengthen the mutuality of interests between such persons and Lumen’s shareholders. Incentives consist of
opportunities to purchase or receive shares of common stock, $1.00 par value per share, of Lumen (the
“Common Stock”) or cash valued in relation to Common Stock, on terms determined under this Plan. As used in
this Plan, the term “subsidiary” means any corporation, limited liability company, or other entity of which Lumen
owns (directly or indirectly) within the meaning of Section 424(f) of the Internal Revenue Code of 1986, as
amended (the “Code”), 50% or more of the total combined voting power of all classes of stock, membership
interests, or other equity interests issued thereby.
2. Administration.
2.1 Composition. This Plan shall generally be administered by the Human Resources and Compensation
Committee of the Board of Directors of Lumen (the “Board”) or by a subcommittee thereof (such administrator,
as used in this Plan, the “Committee”). The Committee shall consist of not fewer than two members of the
Board, each of whom shall qualify as a “non-employee director” under Rule 16b-3 under the Securities Exchange
Act of 1934 (the “1934 Act”) or any successor rule.
2.2 Authority. The Committee shall have plenary authority to award Incentives under this Plan and to
enter into agreements with or provide notices to participants as to the terms of the Incentives (collectively, the
“Incentive Agreements”). The Committee shall have the general authority to interpret this Plan, to establish any
rules or regulations relating to this Plan that it determines to be appropriate, and to make any other
determination that it believes necessary or advisable for the proper administration of this Plan. Committee
decisions regarding matters relating to this Plan shall be final, conclusive, and binding on the Company,
participants, and all other interested persons. The Committee may delegate its authority hereunder to the extent
provided in Section 3.2.
3. Eligible Participants.
3.1 Eligibility. Key employees, officers, and directors of the Company and persons providing services as
consultants or advisors to the Company shall become eligible to receive Incentives under the Plan when
designated by the Committee.
3.2 Delegation of Authority. With respect to participants not subject to Section 16 of the 1934 Act, the
Committee may delegate to Lumen’s chief executive officer and/or one or more of the Company’s executive
officers (collectively, the “Executive Officers”), its authority to designate participants, to determine the size and
type of Incentives to be received by those participants, to determine any performance objectives for these
participants, and to approve or authorize the form of Incentive Agreement governing such Incentives. Following
any grants of Incentives pursuant to such delegated authority, the Executive Officers or any Company officer
designated by the Executive Officers may exercise any powers of the Committee under this Plan to accelerate
vesting or exercise periods, to terminate restricted periods, to waive compliance with specified provisions, or to
otherwise make determinations contemplated hereunder with respect to those participants; provided, however,
that (a) the Executive Officers may only grant options at a per share exercise price equal to or greater than the
Fair Market Value (as defined in Section 12.10) of a share of Common Stock on the later of the date the officer
approves such grant or the date the participant commences employment and (b) the Committee retains sole
authority to make any of the determinations set forth in Section 5.4, 12.10 or Section 11 of this Plan.
4. Types of Incentives. Incentives may be granted under this Plan to eligible participants in the forms of (a)
incentive stock options, (b) non-qualified stock options, (c) stock appreciation rights (“SARs”), (d) restricted
stock, (e) restricted stock units (“RSUs”), and (f) Other Stock-Based Awards (as defined in Section 10).
5. Shares Subject to the Plan.
5.1 Number of Shares. Subject to the provisions of Section 5.2 and adjustment as provided in
Section 5.4, the maximum number of shares of Common Stock that may be delivered to participants and their
permitted transferees under this Plan shall be 43,000,000. Upon approval of this Plan by the Company’s
shareholders, the Company will cease granting Incentives under the Company’s Second Amended and Restated
2018 Equity Incentive Plan (the “Prior Plan”) and any shares of Common Stock remaining available for grant
under the Prior Plan may not be used for Incentives under this Plan.
5.2 Share Counting. Subject to adjustment as provided in Section 5.4:
(a) All of the shares of Common Stock authorized and reserved under the Plan may be issued
upon exercise of stock options intended to qualify as incentive stock options under Section 422 of
the Code.
(b) Any shares of Common Stock subject to an Incentive granted under this Plan that is
subsequently canceled, forfeited, or expires prior to exercise or realization, whether in full or in part,
shall be available again for issuance or delivery under the Plan. Any shares of Common Stock subject to
an Incentive granted under the Prior Plan (including Incentives granted under the Lumen Technologies,
Inc. 2018 Equity Incentive Plan and the first amendment and restatement thereof) that, after the date
this Plan is first approved by shareholders, is cancelled, forfeited, or expires prior to exercise or
realization, whether in full or in part, shall be available for issuance or delivery under this Plan.
Notwithstanding the foregoing, shares subject to an Incentive shall not be available again for issuance or
delivery under this Plan if such shares were (a) tendered in payment of the exercise or base price of a
stock option or stock-settled SAR; (b) covered by, but not issued upon settlement of, stock-settled
SARs; or (c) delivered or withheld by the Company to satisfy any tax withholding obligation related to a
stock option or stock-settled SAR.
(c) If an Incentive, by its terms, may be settled only in cash, then the grant, vesting, payout,
settlement, or forfeiture of such Incentive shall have no impact on the number of shares available for
grant under the Plan.
5.3 Participant Limits. Subject to adjustment as provided in Section 5.4, a limit of $1,000,000 per
calendar year applies to the sum of all cash and Incentives and other compensation granted to a
non-management director of Lumen, although the maximum value of the Incentives that may be granted under
the Plan during any single calendar year may not exceed $500,000 of such annual limit. Incentives shall be
valued at the Fair Market Value on the date of grant for purposes of this Section 5.3.
5.4 Adjustment.
(a) In the event of any recapitalization, reclassification, stock dividend, stock split, combination of
shares or other comparable change in the Common Stock, all limitations on numbers of shares of
Common Stock provided in this Section 5 and the number of shares of Common Stock subject to
outstanding Incentives shall be equitably adjusted in proportion to the change in outstanding shares of
Common Stock. In addition, in the event of any such change in the Common Stock, the Committee shall
make any other adjustment that it determines to be equitable, including adjustments to the exercise
price of any option or the Base Price (defined in Section 7.5) of any SAR and any per share performance
objectives of any Incentive in order to provide participants with the same relative rights before and after
such adjustment.
(b) If the Company merges, consolidates, sells substantially all of its assets, or dissolves, and such
transaction is not a Change of Control as defined in Section 11 (each of the foregoing, a “Fundamental
Change”), then thereafter, upon any exercise or payout of an Incentive granted prior to the
Fundamental Change, the participant shall be entitled to receive (i) in lieu of shares of Common Stock
previously issuable thereunder, the number and class of shares of stock or securities to which the
participant would have been entitled pursuant to the terms of the Fundamental Change if, immediately
prior to such Fundamental Change, the participant had been the holder of record of the number of
shares of Common Stock subject to such Incentive or (ii) in lieu of payments based on the Common
C-2
Appendix C
Stock previously payable thereunder, payments based on any formula that the Committee determines
to be equitable in order to provide participants with substantially equivalent rights before and after the
Fundamental Change. In the event any such Fundamental Change causes a change in the outstanding
Common Stock, the aggregate number of shares available under the Plan may be appropriately adjusted
by the Committee in its sole discretion, whose determination shall be conclusive.
5.5 Type of Common Stock. Common Stock issued under the Plan may be authorized and unissued
shares or issued shares held as treasury shares.
5.6 Minimum Vesting Requirements. Except for any Incentives that are issued in payment of cash
amounts earned under the Company’s short-term incentive program, Incentives under the Plan must be granted
with a minimum vesting period of at least one year without providing for incremental vesting during such
one-year period, except that up to 5% of the shares of Common Stock reserved for issuance under the Plan may
have a vesting period or restricted period, as applicable, of less than one year.
5.7 Dividends and Dividend Equivalent Rights. Incentives granted under this Plan in the form of stock
options and SARs may not be granted with dividend or dividend equivalent rights. Subject to the terms and
conditions of this Plan and the applicable Incentive Agreement, as well as any procedures established by the
Committee, the Committee may determine to pay dividends or dividend equivalents, as applicable, on Incentives
granted under this Plan in the form of restricted stock, RSUs, or Other Stock Based Awards. In the event that the
Committee grants dividend equivalent rights, the Company shall establish an account for the participant and
reflect in that account any securities, cash, or other property comprising any dividend or property distribution
with respect to each share of Common Stock underlying each Incentive. For any Incentives granted under this
Plan with dividend or dividend equivalent rights, such dividends or dividend equivalent rights shall vest and pay
out or be forfeited in tandem with underlying Incentives rather than during the vesting period.
6. Stock Options. A stock option is a right to purchase shares of Common Stock from Lumen. Stock options
granted under the Plan may be incentive stock options (as such term is defined in Section 422 of the Code) or
non-qualified stock options. Any option that is designated as a non-qualified stock option shall not be treated as
an incentive stock option. Each stock option granted by the Committee under this Plan shall be subject to the
following terms and conditions:
6.1 Price. The exercise price per share shall be determined by the Committee, subject to adjustment
under Section 5.4; provided that in no event shall the exercise price be less than the Fair Market Value (as
defined in Section 12.10) of a share of Common Stock as of the date of grant, except in the case of a stock
option granted in assumption of or substitution for an outstanding award of a company acquired by the
Company or with which the Company combines. In the event that an option grant is approved by the
Committee, but is to take effect on a later date, such as when employment or service commences, such later
date shall be the date of grant.
6.2 Number. The number of shares of Common Stock subject to the option shall be determined by the
Committee, subject to Section 5, including, but not limited to, any adjustment as provided in Section 5.4.
6.3 Duration and Time for Exercise. The term of each stock option shall be determined by the
Committee, but shall not exceed a maximum term of ten years. Subject to Section 5.6, each stock option shall
become exercisable at such time or times during its term as determined by the Committee and provided for in
the Incentive Agreement. Notwithstanding the foregoing, the Committee may accelerate the exercisability of
any stock option at any time.
6.4 Manner of Exercise. A stock option may be exercised, in whole or in part, by giving written notice
to the Company, specifying the number of shares of Common Stock to be purchased. The exercise notice shall
be accompanied by the full purchase price for such shares. The option price shall be payable in United States
dollars and may be paid (a) in cash; (b) by check; (c) by delivery to the Company of currently-owned shares of
Common Stock (including through any attestation of ownership that effectively transfers title), which shares
shall be valued for this purpose at the Fair Market Value on the business day immediately preceding the date
such option is exercised; (d) by delivery of irrevocable written instructions to a broker approved by the
Company (with a copy to the Company) to immediately sell a portion of the shares issuable under the option
and to deliver promptly to the Company the amount of sale proceeds (or loan proceeds if the broker lends
funds to the participant for delivery to the Company) to pay the exercise price; (e) if approved by the
Committee, through a net exercise procedure whereby the optionee surrenders the option in exchange for that
number of shares of Common Stock with an aggregate Fair Market Value equal to the difference between the
aggregate exercise price of the options being surrendered and the aggregate Fair Market Value of the shares of
Common Stock subject to the option; (f) in such other manner as may be authorized from time to time by the
Committee; or (g) through any combination of the foregoing methods.
6.5 Limitations on Repricing. Except for adjustments pursuant to Section 5.4 or actions permitted to be
taken by the Committee under Section 11 in the event of a Change of Control, unless approved by the
shareholders of the Company, (a) the exercise price for any outstanding option granted under this Plan may not
be decreased after the date of grant; and (b) an outstanding option that has been granted under this Plan may
not, as of any date that such option has a per share exercise price that is greater than the then-current Fair
Market Value of a share of Common Stock, be surrendered to the Company as consideration for the grant of a
new option or SAR with a lower exercise price, shares of restricted stock, restricted stock units, an Other
Stock-Based Award, a cash payment, or Common Stock.
6.6 Incentive Stock Options. Notwithstanding anything in the Plan to the contrary, the following
additional provisions shall apply to the grant of stock options that are intended to qualify as incentive stock
options (as such term is defined in Section 422 of the Code):
(a) Any incentive stock option agreement authorized under the Plan shall contain such other
provisions as the Committee shall deem advisable, but shall in all events be consistent with and
contain or be deemed to contain all provisions required in order to qualify the options as incentive
stock options.
(b) All incentive stock options must be granted within ten years from the date on which this Plan
is adopted by the Board.
(c) No incentive stock options shall be granted to any non-employee or to any participant who, at
the time such option is granted, would own (within the meaning of Section 422 of the Code) stock
possessing more than 10% of the total combined voting power of all classes of stock of Lumen.
(d) The aggregate Fair Market Value (determined with respect to each incentive stock option as
of the time such incentive stock option is granted) of the Common Stock with respect to which
incentive stock options are exercisable for the first time by a participant during any calendar year
(under the Plan or any other plan of Lumen or any of its subsidiaries) shall not exceed $100,000. To the
extent that such limitation is exceeded, the excess options shall be treated as non-qualified stock
options for federal income tax purposes.
7. Stock Appreciation Rights.
7.1 Grant of Stock Appreciation Rights. A stock appreciation right, or SAR, is a right to receive, without
payment to the Company, a number of shares of Common Stock, cash, or any combination thereof, the number
or amount of which is determined pursuant to the formula set forth in Section 7.5. Each SAR granted by the
Committee under the Plan shall be subject to the terms and conditions of the Plan and the applicable Incentive
Agreement.
7.2 Number. Each SAR granted to any participant shall relate to such number of shares of Common
Stock as shall be determined by the Committee, subject to adjustment as provided in Section 5.4.
7.3 Duration and Time for Exercise. The term of each SAR shall be determined by the Committee, but
shall not exceed a maximum term of ten years. Subject to Section 5.6, each SAR shall become exercisable at
such time or times during its term as shall be determined by the Committee and provided for in the Incentive
Agreement. Notwithstanding the foregoing, the Committee may accelerate the exercisability of any SAR at any
time in its discretion.
7.4 Exercise. A SAR may be exercised, in whole or in part, by giving written notice to the Company,
specifying the number of SARs that the holder wishes to exercise. The date that the Company receives such
written notice shall be referred to herein as the “Exercise Date.” The Company shall, within 30 days of an
Exercise Date, deliver to the exercising holder certificates for the shares of Common Stock to which the holder
is entitled pursuant to Section 7.5 or cash or both, as provided in the Incentive Agreement.
C-4
Appendix C
7.5 Payment.
(a) The number of shares of Common Stock which shall be issuable upon the exercise of a SAR
payable in Common Stock shall be determined by dividing:
(i) the number of shares of Common Stock as to which the SAR is exercised, multiplied by
the amount of the appreciation in each such share (for this purpose, the “appreciation” shall be the
amount by which the Fair Market Value (as defined in Section 12.10) of a share of Common Stock
subject to the SAR on the trading day prior to the Exercise Date exceeds the “Base Price,” which is
an amount, not less than the Fair Market Value of a share of Common Stock on the date of grant,
which shall be determined by the Committee at the time of grant, subject to adjustment under
Section 5.4); by
(ii) the Fair Market Value of a share of Common Stock on the Exercise Date.
(b) No fractional shares of Common Stock shall be issued upon the exercise of a SAR; instead, the
holder of a SAR shall be entitled to purchase the portion necessary to make a whole share at its Fair
Market Value on the Exercise Date.
(c) If so provided in the Incentive Agreement, a SAR may be exercised for cash equal to the Fair
Market Value of the shares of Common Stock that would be issuable under Section 7.5(a), if the exercise
had been for Common Stock.
7.6 Limitations on Repricing. Except for adjustments pursuant to Section 5.4 or actions permitted to be
taken by the Committee under Section 11 in the event of a Change of Control, unless approved by the
shareholders of the Company, (a) the Base Price for any outstanding SAR granted under this Plan may not be
decreased after the date of grant; and (b) an outstanding SAR that has been granted under this Plan may not, as
of any date that such SAR has a Base Price that is greater than the then-current Fair Market Value of a share of
Common Stock, be surrendered to the Company as consideration for the grant of a new option or SAR with a
lower exercise price, shares of restricted stock, restricted stock units, an Other Stock-Based Award, a cash
payment, or Common Stock.
8. Restricted Stock.
8.1 Grant of Restricted Stock. The Committee may award shares of restricted stock to such eligible
participants as determined pursuant to the terms of Section 3. An award of restricted stock shall be subject to
such restrictions on transfer and forfeitability provisions and such other terms and conditions, including the
attainment of specified performance goals, as the Committee may determine, subject to the provisions of
the Plan.
8.2 The Restricted Period. Subject to Section 5.6, at the time an award of restricted stock is made, the
Committee shall establish a period of time during which the transfer of the shares of restricted stock shall be
restricted and after which the shares of restricted stock shall be vested (the “Restricted Period”). Each award of
restricted stock may have a different Restricted Period.
8.3 Escrow. The participant receiving restricted stock shall enter into an Incentive Agreement with the
Company setting forth the conditions of the grant. Any certificates representing shares of restricted stock shall
be registered in the name of the participant and deposited with the Company, together with a stock power
endorsed in blank by the participant. Each such certificate shall bear a legend in substantially the following form:
The transferability of this certificate and the shares of Common Stock represented by it are subject to
the terms and conditions (including conditions of forfeiture) contained in the Lumen Technologies, Inc.
2024 Equity Incentive Plan (the “Plan”), and an agreement entered into between the registered owner
and Lumen Technologies, Inc. (the “Company”) thereunder. Copies of the Plan and the agreement are
on file at the principal office of the Company.
Alternatively, in the discretion of the Company, ownership of the shares of restricted stock and the appropriate
restrictions shall be reflected in the records of the Company’s transfer agent and no physical certificates shall
be issued.
8.4 Forfeiture. In the event of the forfeiture of any shares of restricted stock under the terms provided
in the Incentive Agreement (including any additional shares of restricted stock that may result from the
reinvestment of cash and stock dividends, if so provided in the Incentive Agreement), such forfeited shares shall
be surrendered, any certificates shall be cancelled, and any related accrued but unpaid cash dividends will be
forfeited. The participants shall have the same rights and privileges, and be subject to the same forfeiture
provisions, with respect to any additional shares received pursuant to Section 5.4 due to a recapitalization or
other change in capitalization.
8.5 Expiration of Restricted Period. Upon the expiration or termination of the Restricted Period and the
satisfaction of any other conditions prescribed by the Committee, the restrictions applicable to the restricted
stock shall lapse, and the Company shall cause to be delivered to the participant or the participant’s estate, as
the case may be, the number of shares of restricted stock with respect to which the restrictions have lapsed,
free of all such restrictions and legends, except any that may be imposed by law. The Company, in its discretion,
may elect to deliver such shares through issuance of a stock certificate or by book entry.
8.6 Rights as a Shareholder. Subject to the terms and conditions of the Plan (including, but not limited
to, Section 5.7) and the applicable Incentive Agreement, each participant receiving restricted stock shall have all
the rights of a shareholder with respect to shares of stock during the Restricted Period, including without
limitation, the right to vote any shares of Common Stock.
9. Restricted Stock Units.
9.1 Grant of Restricted Stock Units. A restricted stock unit, or RSU, represents the right to receive from
the Company on the respective scheduled vesting or payment date for such RSU, one share of Common Stock.
An award of RSUs may be subject to the attainment of specified performance goals or targets, forfeitability
provisions and such other terms and conditions as the Committee may determine, subject to the provisions of
the Plan.
9.2 Vesting Period. Subject to Section 5.6, at the time an award of RSUs is made, the Committee shall
establish a period of time during which the restricted stock units shall vest (the “Vesting Period”). Each award of
RSUs may have a different Vesting Period.
9.3 Rights as a Shareholder. Subject to the restrictions imposed under the terms and conditions of this
Plan and subject to any other restrictions that may be imposed in the Incentive Agreement, each participant
receiving restricted stock units shall have no rights as a shareholder with respect to such restricted stock units
until such time as shares of Common Stock are issued to the participant.
10. Other Stock-Based Awards. The Committee may grant to eligible participants “Other Stock-Based Awards,”
which shall consist of awards (other than options, SARs, restricted stock, or RSUs, described in Sections 6
through 9 hereof) paid out in shares of Common Stock or the value of which is based in whole or in part on the
value of shares of Common Stock. Other Stock-Based Awards may be awards of shares of Common Stock,
awards of phantom stock, or may be denominated or payable in, valued in whole or in part by reference to, or
otherwise based on or related to, shares of, or appreciation in the value of, Common Stock (including, without
limitation, securities convertible or exchangeable into or exercisable for shares of Common Stock), as deemed
by the Committee consistent with the purposes of this Plan. Subject to Section 5.6, the Committee shall
determine the terms and conditions of any Other Stock-Based Award (including which rights of a shareholder, if
any, the recipient shall have with respect to Common Stock associated with any such award) and may provide
that such award is payable in whole or in part in cash. An Other Stock-Based Award may be subject to the
attainment of such specified performance goals or targets as the Committee may determine, subject to the
provisions of this Plan.
11. Change of Control.
(a) A Change of Control shall mean:
(i) the acquisition by any person of beneficial ownership of 30% or more of the
outstanding shares of the Common Stock or 30% or more of the combined voting power of
Lumen’s then outstanding securities entitled to vote generally in the election of directors;
provided, however, that for purposes of this subsection (i), the following acquisitions shall not
constitute a Change of Control:
(A) any acquisition (other than a Business Combination (as defined below) which
constitutes a Change of Control under Section 11(a)(iii) hereof) of Common Stock directly
from the Company,
(B) any acquisition of Common Stock by the Company,
C-6
Appendix C
(C) any acquisition of Common Stock by any employee benefit plan (or related trust)
sponsored or maintained by the Company or any corporation controlled by the
Company, or
(D) any acquisition of Common Stock by any corporation pursuant to a Business
Combination that does not constitute a Change of Control under Section 11(a)(iii)
hereof; or
(ii) individuals who, as of May 15, 2024, constituted the Board of Directors of Lumen (the
“Incumbent Board”) cease for any reason to constitute at least a majority of the Board of
Directors; provided, however, that any individual becoming a director subsequent to such date
whose election, or nomination for election by Lumen’s shareholders, was approved by a vote of
at least two-thirds of the directors then comprising the Incumbent Board shall be considered a
member of the Incumbent Board, unless such individual’s initial assumption of office occurs as a
result of an actual or threatened election contest with respect to the election or removal of
directors or other actual or threatened solicitation of proxies or consents by or on behalf of a
person other than the Incumbent Board; or
(iii) consummation of a reorganization, share exchange, merger or consolidation
(including any such transaction involving any direct or indirect subsidiary of Lumen) or sale or
other disposition of all or substantially all of the assets of the Company (a “Business
Combination”); provided, however, that in no such case shall any such transaction constitute a
Change of Control if immediately following such Business Combination:
(A) the individuals and entities who were the beneficial owners of Lumen’s
outstanding Common Stock and Lumen’s voting securities entitled to vote generally in the
election of directors immediately prior to such Business Combination have direct or
indirect beneficial ownership, respectively, of more than 50% of the then outstanding
shares of common stock, and more than 50% of the combined voting power of the then
outstanding voting securities entitled to vote generally in the election of directors of the
surviving or successor corporation, or, if applicable, the ultimate parent company thereof
(the “Post-Transaction Corporation”), and
(B) except to the extent that such ownership existed prior to the Business
Combination, no person (excluding the Post-Transaction Corporation and any employee
benefit plan or related trust of either Lumen, the Post-Transaction Corporation or any
subsidiary of either corporation) beneficially owns, directly or indirectly, 20% or more of
the then outstanding shares of common stock of the corporation resulting from such
Business Combination or 20% or more of the combined voting power of the then
outstanding voting securities of such corporation, and
(C) at least a majority of the members of the board of directors of the Post-
Transaction Corporation were members of the Incumbent Board at the time of the
execution of the initial agreement, or of the action of the Board of Directors, providing for
such Business Combination; or
(iv) approval by the shareholders of Lumen of a complete liquidation or dissolution
of Lumen.
For purposes of this Section 11, the term “person” shall mean a natural person or entity, and shall also mean the
group or syndicate created when two or more persons act as a syndicate or other group (including a
partnership or limited partnership) for the purpose of acquiring, holding, or disposing of a security, except that
“person” shall not include an underwriter temporarily holding a security pursuant to an offering of the security.
(b) Except with respect to Incentives granted to non-management directors, no Incentive
Agreement shall provide for (1) the acceleration of the vesting of time-based Incentives upon the
occurrence of a Change of Control without a contemporaneous or subsequent actual or constructive
involuntary termination of the participant’s employment or service relationship or (2) the payout of any
performance-based Incentives upon a Change of Control in an amount exceeds the greater of (i) the
payout of a pro-rata portion of such Incentive, based on the portion of the performance period that has
elapsed and assuming target performance and (ii) payout of such Incentive based on actual
performance. Notwithstanding the foregoing, no later than 30 days after a Change of Control of the
type described in subsections (a)(i) or (a)(ii) of this Section 11 and no later than 30 days after the
approval by the Board of a Change of Control of the type described in subsections (a)(iii) or (a)(iv) of
this Section 11, the Committee, acting in its sole discretion without the consent or approval of any
participant (and notwithstanding any removal or attempted removal of some or all of the members
thereof as directors or Committee members), may act to effect one or more of the alternatives listed
below, which may vary among individual participants and which may vary among Incentives held by any
individual participant; provided, however, that no such action may be taken if it would result in the
imposition of a penalty on the participant under Section 409A of the Code as a result thereof:
(i) require that all outstanding options, SARs or Other Stock-Based Awards be exercised
on or before a specified date (before or after such Change of Control) fixed by the Committee,
after which specified date all unexercised options, SARs and Other Stock-Based Awards and all
rights of participants thereunder would terminate,
(ii) make such equitable adjustments to Incentives then outstanding as the Committee
deems appropriate to reflect such Change of Control and provide participants with substantially
equivalent rights before and after such Change of Control (provided, however, that the
Committee may determine in its sole discretion that no adjustment is necessary),
(iii) provide for mandatory conversion or exchange of some or all of the outstanding
options, SARs, restricted stock units or Other Stock-Based Awards held by some or all
participants as of a date, before or after such Change of Control, specified by the Committee,
in which event such Incentives would be deemed automatically cancelled and the Company
would pay, or cause to be paid, to each such participant an amount of cash per share equal to
the excess, if any, of the Change of Control Value of the shares subject to such option, SAR,
restricted stock unit or Other Stock-Based Award, as defined and calculated below, over the
per share exercise price or Base Price of such Incentive or, in lieu of such cash payment,
the issuance of Common Stock or securities of an acquiring entity having a Fair Market Value
equal to such excess, or
(iv) provide that thereafter, upon any exercise or payment of an Incentive that entitles
the holder to receive Common Stock, the holder shall be entitled to purchase or receive under
such Incentive, in lieu of the number of shares of Common Stock then covered by such
Incentive, the number and class of shares of stock or other securities or property (including
cash) to which the holder would have been entitled pursuant to the terms of the agreement
providing for the reorganization, share exchange, merger, consolidation or asset sale, if,
immediately prior to such Change of Control, the holder had been the record owner of the
number of shares of Common Stock then covered by such Incentive.
(c) For the purposes of conversions or exchanges under paragraph (iii) of Section 11(c),
the “Change of Control Value” shall equal the amount determined by whichever of the following items
is applicable:
(i) the per share price to be paid to holders of Common Stock in any such merger,
consolidation or other reorganization,
(ii) the price per share offered to holders of Common Stock in any tender offer or
exchange offer whereby a Change of Control takes place, or
(iii) in all other events, the fair market value of a share of Common Stock, as determined
by the Committee as of the time determined by the Committee to be immediately prior to the
effective time of the conversion or exchange.
(d) In the event that the consideration offered to shareholders of Lumen in any transaction
described in this Section 11 consists of anything other than cash, the Committee shall determine the fair
cash equivalent of the portion of the consideration offered that is other than cash.
12. General.
12.1 Duration. No Incentives may be granted under the Plan after May 15, 2034; provided, however,
that subject to Section 12.8, the Plan shall remain in effect after such date with respect to Incentives granted
prior to that date, until all such Incentives have either been satisfied by the issuance of shares of Common Stock
or otherwise been terminated under the terms of the Plan and all restrictions imposed on shares of Common
Stock in connection with their issuance under the Plan have lapsed.
C-8
Appendix C
12.2 Transferability.
(a) No Incentives granted hereunder may be transferred, pledged, assigned, or otherwise
encumbered by a participant except:
(i) by will;
(ii) by the laws of descent and distribution;
(iii) if permitted by the Committee and so provided in the Incentive Agreement or an
amendment thereto, pursuant to a domestic relations order, as defined in the Code; or
(iv) as to options only, if permitted by the Committee and so provided in the Incentive
Agreement or an amendment thereto, (i) to Immediate Family Members (as defined in
Section 12.2(b)); (ii) to a partnership in which the participant and/or Immediate Family Members,
or entities in which the participant and/or Immediate Family Members are the sole owners,
members, or beneficiaries, as appropriate, are the sole partners; (iii) to a limited liability
company in which the participant and/or Immediate Family Members, or entities in which the
participant and/or Immediate Family Members are the sole owners, members, or beneficiaries,
as appropriate, are the sole members; or (iv) to a trust for the sole benefit of the participant
and/or Immediate Family Members.
(b) “Immediate Family Members” shall be defined as the spouse and natural or adopted
children or grandchildren of the participant and their spouses. To the extent that an incentive stock
option is permitted to be transferred during the lifetime of the participant, it shall be treated thereafter
as a nonqualified stock option. Any attempted assignment, transfer, pledge, hypothecation, or other
disposition of Incentives, or levy of attachment or similar process upon Incentives not specifically
permitted herein, shall be null and void and without effect.
12.3 Effect of Termination of Employment or Death. In the event that a participant ceases to be an
employee of the Company or to provide services to the Company for any reason, including death, disability,
early retirement or normal retirement, any Incentives may be exercised, shall vest or shall expire at such times as
may be determined by the Committee or as provided in the Incentive Agreement.
12.4 Additional Conditions. Anything in this Plan to the contrary notwithstanding: (a) the Company
may, if it shall determine it necessary or desirable for any reason, at the time of award of any Incentive or the
issuance of any shares of Common Stock pursuant to any Incentive, require the recipient of the Incentive, as a
condition to the receipt thereof or to the receipt of shares of Common Stock issued pursuant thereto, to deliver
to the Company a written representation of present intention to acquire the Incentive or the shares of Common
Stock issued pursuant thereto for his own account for investment and not for distribution; and (b) if at any time
the Company further determines, in its sole discretion, that the listing, registration or qualification (or any
updating of any such document) of any Incentive or the shares of Common Stock issuable pursuant thereto is
necessary on any securities exchange or under any federal or state securities or blue sky law, or that the consent
or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection
with the award of any Incentive, the issuance of shares of Common Stock pursuant thereto, or the removal of
any restrictions imposed on such shares, such Incentive shall not be awarded or such shares of Common Stock
shall not be issued or such restrictions shall not be removed, as the case may be, in whole or in part, unless such
listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions
not acceptable to the Company.
12.5 Withholding.
(a) The Company shall have the right to withhold from any payments made or stock issued
under the Plan or to collect as a condition of payment, issuance or vesting, any taxes required by law to
be withheld (up to the maximum permissible withholding rate). At any time that a participant is required
to pay to the Company an amount required to be withheld under applicable income tax laws in
connection with an Incentive (each such date, a “Tax Date”), the participant may, subject to Section
12.5(b) below, satisfy this obligation in whole or in part by electing (the “Election”) to deliver currently
owned shares of Common Stock or to have the Company withhold shares of Common Stock, in each
case having a value equal to the maximum statutory amount required to be withheld under federal,
state and local law. The value of the shares to be delivered or withheld shall be based on the Fair Market
Value of the Common Stock on the Tax Date.
(b) Each Election must be made prior to the Tax Date. For participants who are not subject to
Section 16 of the 1934 Act, the Committee may disapprove of any Election, may suspend or terminate
the right to make Elections, or may provide with respect to any Incentive that the right to make
Elections shall not apply to such Incentive. If a participant makes an election under Section 83(b) of the
Code with respect to shares of restricted stock, an Election to have shares withheld to satisfy
withholding taxes is not permitted to be made.
12.6 No Continued Employment. No participant under the Plan shall have any right, solely based on his
or her participation in the Plan, to continue to serve as an employee, officer, director, consultant, or advisor of
the Company for any period of time or to any right to continue his or her present or any other rate
of compensation.
12.7 Deferral Permitted. Payment of an Incentive may be deferred at the option of the participant if
permitted in the Incentive Agreement. Any deferral arrangements shall comply with Section 409A of the Code.
12.8 Amendments to or Termination of the Plan. The Board may amend or discontinue this Plan at any
time; provided, however, that no such amendment may:
(a) amend Section 6.5 or Section 7.6 to permit repricing of options or SARs without the
approval of shareholders;
(b) materially impair, without the consent of the recipient, an Incentive previously granted,
except that the Company retains all of its rights under Section 11; or
(c) materially revise the Plan without the approval of the shareholders. A material revision of
the Plan includes (i) except for adjustments permitted herein, a material increase to the maximum
number of shares of Common Stock that may be issued through the Plan, (ii) a material increase to the
benefits accruing to participants under the Plan, (iii) a material expansion of the classes of persons
eligible to participate in the Plan, (iv) an expansion of the types of awards available for grant under the
Plan, (v) a material extension of the term of the Plan and (vi) a material change that reduces the price at
which shares of Common Stock may be offered through the Plan.
12.9 Repurchase. Upon approval of the Committee, the Company may repurchase all or a portion of a
previously granted Incentive from a participant by mutual agreement by payment to the participant of cash or
Common Stock or a combination thereof with a value equal to the value of the Incentive determined in good
faith by the Committee; provided, however, that in no event will this section be construed to grant the
Committee the power to take any action in violation of Section 6.5, 7.6, or 12.13.
12.10 Definition of Fair Market Value. Whenever “Fair Market Value” of Common Stock shall be
determined for purposes of this Plan, except as provided below in connection with a cashless exercise through a
broker, it shall be determined as follows: (a) if the Common Stock is listed on an established stock exchange or
any automated quotation system that provides sale quotations, the closing sale price for a share of the Common
Stock on such exchange or quotation system on the date as of which fair market value is to be determined, (b) if
the Common Stock is not listed on any exchange or quotation system, but bid and asked prices are quoted and
published, the mean between the quoted bid and asked prices on the date as of which fair market value is to be
determined, and if bid and asked prices are not available on such day, on the next preceding day on which such
prices were available; and (c) if the Common Stock is not regularly quoted, the fair market value of a share of
Common Stock on the date as of which fair market value is to be determined, as established by the Committee
in good faith. In the context of a cashless exercise through a broker, the “Fair Market Value” shall be the price at
which the Common Stock subject to the stock option is actually sold in the market to pay the option exercise
price. Notwithstanding the foregoing, if so determined by the Committee, “Fair Market Value” may be
determined as an average selling price during a period specified by the Committee that is within 30 days before
or 30 days after the date of grant, provided that the commitment to grant the stock right based on such
valuation method must be irrevocable before the beginning of the specified period, and such valuation method
must be used consistently for grants of stock rights under the same and substantially similar programs during
any particular calendar year.
12.11 Liability.
(a) Neither Lumen, its affiliates or any of their respective directors or officers shall be liable to
any participant relating to the participant’s failure to (i) realize any anticipated benefit under an
Incentive due to the failure to satisfy any applicable conditions to vesting, payment or settlement, or
C-10
Appendix C
(ii) realize any anticipated tax benefit or consequence due to changes in applicable law, the particular
circumstances of the participant, or any other reason.
(b) No member of the Committee (or officer of the Company exercising delegated authority
of the Committee under Section 3 thereof) will be liable for any action or determination made in good
faith with respect to this Plan or any Incentive.
12.12 Interpretation.
(a) Unless the context otherwise requires, (i) all references to Sections are to Sections of this
Plan, (ii) the term “including” means including without limitation, (iii) all references to any particular
Incentive Agreement shall be deemed to include any amendments thereto or restatements thereof,
and (iv) all references to any particular statute shall be deemed to include any amendment, restatement
or re-enactment thereof or any statute or regulation substituted therefore.
(b) The titles and subtitles used in this Plan or any Incentive Agreement are used for
convenience only and are not to be considered in construing or interpreting this Plan or the
Incentive Agreement.
(c) All pronouns contained in this Plan or any Incentive Agreement, and any variations thereof,
shall be deemed to refer to the masculine, feminine or neutral, singular or plural, as the identities of the
parties may require.
(d) Whenever any provision of this Plan authorizes the Committee to take action or make
determinations with respect to outstanding Incentives that have been granted or awarded by the chief
executive officer of Lumen under Section 3.2 hereof, each such reference to “Committee” shall be
deemed to include a reference to any officer of the Company that has delegated administrative
authority under Section 3.2 of this Plan (subject to the limitations of such section).
12.13 Compliance with Section 409A. It is the intent of the Company that this Plan comply with the
requirements of Section 409A of the Code with respect to any Incentives that constitute non-qualified deferred
compensation under Section 409A, and the Company intends to operate the Plan in compliance with
Section 409A and the Department of Treasury’s guidance or regulations promulgated thereunder. If the
Committee grants any Incentives or takes any other action that would, either immediately or upon vesting or
payment of the Incentive, inadvertently result in the imposition of a penalty on a participant under Section 409A
of the Code, then the Company, in its discretion, may, to the maximum extent permitted by law, unilaterally
rescind ab initio, sever, amend or otherwise modify the grant or action (or any provision of the Incentive) in such
manner necessary for the penalty to be inapplicable or reduced.
12.14 Data Privacy. As a condition of receipt of any Incentive, each participant explicitly and
unambiguously consents to the collection, use, and transfer, in electronic or other form, of personal data as
described in this Section by and among, as applicable, the Company and its affiliates for the exclusive purpose
of implementing, administering, and managing the Plan and Incentives and such participant’s participation in the
Plan. In furtherance of such implementation, administration, and management, the Company and its affiliates
may hold certain personal information about a participant, including, but not limited to, the participant’s name,
home address, telephone number, date of birth, social security or insurance number or other identification
number, salary, nationality, job title(s), information regarding any securities of the Company or any of its
affiliates, and details of all Incentives (the “Data”). In addition to transferring the Data amongst themselves as
necessary for the purpose of implementation, administration, and management of the Plan and Incentives and
the participant’s participation in the Plan, the Company and its affiliates may each transfer the Data to any third
parties assisting the Company in the implementation, administration, and management of the Plan and
Incentives and such participant’s participation in the Plan. Recipients of the Data may be located in the
participant’s country or elsewhere, and the participant’s country and any given recipient’s country may have
different data privacy laws and protections. By accepting an Incentive, each participant authorizes such
recipients to receive, possess, use, retain, and transfer the Data, in electronic or other form, for the purposes of
assisting the Company in the implementation, administration, and management of the Plan and Incentives and
such participant’s participation in the Plan, including any requisite transfer of such Data as may be required to a
broker or other third party with whom the Company or the participant may elect to deposit any shares of
Common Stock. The Data related to a participant will be held only as long as is necessary to implement,
administer, and manage the Plan and Incentives and the participant’s participation in the Plan. A participant
may, at any time, view the Data held by the Company with respect to such Participant, request additional
information about the storage and processing of the Data with respect to such participant, recommend any
necessary corrections to the Data with respect to the participant, or refuse or withdraw the consents herein in
writing, in any case without cost, by contacting his or her local human resources representative. However, if a
participant refuses or withdraws the consents described herein, the Company may cancel the participant’s
eligibility to participate in the Plan, and in the Committee’s discretion, the participant may forfeit any
outstanding Incentive. For more information on the consequences of refusal to consent or withdrawal of
consent, participants may contact their local human resources representative.
12.15 Participants Outside of the United States. The Committee may modify the terms of any Incentive
under the Plan made to or held by a participant who is then a resident, or is primarily employed or providing
services, outside of the United States in any manner deemed by the Committee to be necessary or appropriate
in order that such Incentive shall conform to laws, regulations, and customs of the country in which the
Participant is then a resident or primarily employed or providing services, or so that the value and other benefits
of the Incentive to such participant, as affected by non-United States tax laws and other restrictions applicable
as a result of the participant’s residence, employment, or providing services abroad, shall be comparable to the
value of such Incentive to a Participant who is a resident, or is primarily employed or providing services, in the
United States. An Incentive may be modified under this Section 12.15 in a manner that is inconsistent with the
express terms of the Plan, so long as such modifications will not contravene any applicable law or regulation or
result in actual liability under Section 16(b) of the 1934 Act for the participant whose Incentive is modified.
Additionally, the Committee may adopt such procedures and sub-plans as are necessary or appropriate to
permit participation in the Plan by Eligible Persons who are non-United States nationals or are primarily
employed or providing services outside the United States.
12.16 Clawback. Incentives granted to a participant (including any proceeds, gains or other economic
benefit the participant actually or constructively receives upon receipt or exercise of any Incentive or the receipt
or resale of any shares of Common Stock underlying the Incentive) will be subject to any Company clawback
policy applicable to the participant, including its Policy for the Recovery of Erroneously Awarded Compensation
adopted in accordance with Section 303A.14 of the Listed Company Manual of the New York Stock Exchange
and Section 10D and Rule 10D-1 of the 1934 Act, as it may be amended from time to time.
C-12
Appendix D
(amended and restated on November 15, 2023 and effective as of December 1, 2023)
TABLE OF CONTENTS
Page
Section 1. Definitions D-3
Section 2. Appointment of Rights Agent D-6
Section 3. Issue of Right Certificates D-6
Section 4. Form of Right Certificates D-8
Section 5. Countersignature and Registration D-8
Section 6. Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated,
Destroyed, Lost or Stolen Right Certificates D-8
Section 7. Exercise of Rights; Purchase Price; Expiration Date of Rights D-9
Section 8. Cancellation and Destruction of Right Certificates D-10
Section 9. Availability of Preferred Shares D-10
Section 10. Preferred Shares Record Date D-11
Section 11. Adjustment of Purchase Price, Number of Shares or Number of Rights D-11
Section 12. Certificate of Adjusted Purchase Price or Number of Shares D-15
Section 13. [Reserved] D-15
Section 14. Fractional Rights and Fractional Shares D-15
Section 15. Rights of Action D-16
Section 16. Agreement of Right Holders D-16
Section 17. Right Certificate Holder Not Deemed a Shareholder D-17
Section 18. Concerning the Rights Agent D-17
Section 19. Merger or Consolidation or Change of Name of Rights Agent D-18
Section 20. Duties of Rights Agent D-19
Section 21. Change of Rights Agent D-21
Section 22. Issuance of New Right Certificates D-22
Section 23. Redemption D-22
Section 24. Exchange D-22
Section 25. Notice of Certain Events D-23
Section 26. Notices D-24
Section 27. Supplements and Amendments D-24
Section 28. Successors D-24
Section 29. Benefits of this Agreement D-24
Section 30. Severability D-25
Section 31. Governing Law D-25
Section 32. Counterparts D-25
Section 33. Descriptive Headings; Interpretation D-25
Section 34. Determinations and Actions by the Board D-25
Section 35. Process to Seek Exemption D-25
Section 36. Tax Compliance and Withholding D-26
Section 37. Force Majeure D-26
Section 38. [Reserved] D-26
Exhibit A — [Reserved]* XX
Exhibit B — Form of Right Certificate* XX
Exhibit C — Summary of Rights to Purchase Preferred Shares* XX
* The exhibits to the Restated Plan have been intentionally omitted from this Appendix D, but are available in the Company’s other filings with
the SEC.
D-2
Appendix D
This Second Amended and Restated Section 382 Rights Agreement (this “Agreement”), by and between
Lumen Technologies, Inc., a Louisiana corporation (the “Company”), and Computershare Trust Company, N.A.,
as rights agent (the “Rights Agent”), is entered into on November 15, 2023, effective as of December 1, 2023.
RECITALS
WHEREAS, the Company and the Rights Agent entered into that certain Section 382 Rights Agreement,
dated as of February 13, 2019, which was amended and restated by that certain Amended and Restated
Section 382 Rights Agreement, dated as of May 9, 2019, and further amended by that certain First Amendment
to Amended and Restated Rights Agreement, effective as of December 1, 2020 (collectively referred to as the
“Original Agreement”).
WHEREAS, the Company has generated net operating loss carryovers and tax credit carryovers for
United States federal income tax purposes (“NOLs”), which are expected to provide valuable tax benefits to the
Company. The ability to use the NOLs may be impaired or destroyed by an “ownership change” within the
meaning of Section 382 (as such term is hereinafter defined). The Company desires to avoid such an “ownership
change” and thereby preserve the ability to use the NOLs without limitation.
WHEREAS, in connection with the adoption of the Original Agreement, the Board of Directors of the
Company (the “Board”) authorized and declared a dividend of one preferred share purchase right (a “Right”) for
each Common Share (as hereinafter defined) of the Company outstanding on February 25, 2019 (the “Record
Date”), each Right representing the right to purchase one ten-thousandth of a Preferred Share (as hereinafter
defined), upon the terms and subject to the conditions herein set forth, and authorized and directed the
issuance of one Right with respect to each Common Share that become outstanding between the Record Date
and the earliest of the Distribution Date, the Redemption Date, the Early Expiration Date and the Final Expiration
Date (as such terms are hereinafter defined);
WHEREAS, Section 27 of the Original Agreement provides that prior to the Distribution Date, the
Company may supplement or amend any provision of the Original Agreement without the approval of any
holders of Rights;
WHEREAS, the Board deems it advisable and in the best interests of the Company and its shareholders
to amend the terms of the Original Agreement as set forth herein; and
WHEREAS, on November 15, 2023, the Board authorized and approved this Agreement.
Accordingly, in consideration of the premises and the mutual agreements herein set forth, the parties
hereby agree to amend, restate and supersede the Original Agreement in its entirety as follows:
Section 1. Definitions. For purposes of this Agreement, the following terms have the
meanings indicated:
(a) “5 Percent Shareholder” shall mean a “5% shareholder” of the Company within the meaning of
Section 382(k)(7) of the Internal Revenue Code of 1986, as amended.
(b) “Acquiring Person” shall mean any Person (other than any Exempt Person) who or which, together
with all Affiliates and Associates of such Person, shall be the Beneficial Owner of 4.9% or more of the Common
Shares of the Company then outstanding, but shall not include the Company, any Subsidiary of the Company,
any employee benefit plan of the Company or any Subsidiary of the Company, or any entity holding Common
Shares for or pursuant to the terms of any such plan; provided, however, that (i) any Person who or which would
otherwise be an Acquiring Person as of February 13, 2019 by virtue of being a 5 Percent Shareholder will not be
deemed to be an Acquiring Person for any purpose of this Agreement prior to or after February 13, 2019 unless
and until such time as (A) such Person or any Affiliate or Associate of such Person thereafter becomes,
individually or in the aggregate, by reason of a transaction or transactions after February 13, 2019 the Beneficial
Owner of additional Common Shares representing one-half of one percent (0.5%) or more of the Common
Shares outstanding at the time of such acquisition, other than (1) pursuant to any agreement or
regular-way purchase order for Common Shares that is in effect on or prior to February 13, 2019 and
consummated in accordance with its terms after February 13, 2019, or (2) as a result of a stock dividend, rights
dividend, subdivision of the Common Shares (such as a forward stock split) or similar transaction effected by
the Company in which all holders of Common Shares are treated equally, or (B) any other Person who is the
Beneficial Owner of Common Shares becomes an Affiliate or Associate of such Person after February 13, 2019;
provided, further, that the foregoing exclusion in this clause (i) shall cease to apply with respect to any Person
at such time as such Person, together with all Affiliates and Associates of such Person, Beneficially Owns less
than 4.9% of the then-outstanding Common Shares; (ii) a Person will not be deemed to have become an
Acquiring Person solely as a result of a reduction in the number of Common Shares outstanding unless and until
such time as (A) such Person or any Affiliate or Associate of such Person thereafter becomes the Beneficial
Owner of any additional Common Shares, other than as a result of a stock dividend, subdivision, consolidation or
combination of the Common Shares (by reclassification or otherwise) or similar transaction effected by the
Company in which all holders of Common Shares are treated equally, or (B) any other Person who is the
Beneficial Owner of Common Shares becomes an Affiliate or Associate of such Person after February 13, 2019;
and (iii) a Person will not be deemed to have become an Acquiring Person solely as a result of an Exempted
Transaction, provided, however, that the foregoing exclusion in this clause (iii) shall cease to apply with respect
to any Person at such time as such Person (or any Affiliates or Associates of such Person) acquires any
additional Common Shares.
In addition, notwithstanding the foregoing, and notwithstanding anything to the contrary provided in
this Agreement, a Person shall not be an “Acquiring Person” if the Board determines at any time prior to the
Distribution Date that a Person who would otherwise be an “Acquiring Person,” has become such inadvertently
or without intending to become an “Acquiring Person,” and such Person divests as promptly as practicable (or
within such period of time as the Board determines is reasonable) a sufficient number of Common Shares so
that such Person would no longer be an “Acquiring Person,” as defined pursuant to the foregoing.
(c) “Affiliate” shall have the meaning ascribed to such term in Rule 12b-2 of the General Rules and
Regulations under the Exchange Act, as in effect on December 1, 2023 and, to the extent not included within the
foregoing, will also include, with respect to any Person, any other Person (other than an Exempt Person) whose
Common Shares would be deemed constructively owned by such first Person pursuant to the provisions of
Section 382; provided, however, that a Person will not be deemed to be the Affiliate or Associate of another
Person solely because either or both Persons are or were directors or officers of the Company.
(d) “Associate” shall have the meaning ascribed to such term in Rule 12b-2 of the General Rules and
Regulations under the Exchange Act as in effect on December 1, 2023.
(e) A Person shall be deemed the “Beneficial Owner” of and shall be deemed to “beneficially own”
any securities:
which such Person or any of such Person’s Affiliates or Associates beneficially owns, directly
or indirectly;
which such Person or any of such Person’s Affiliates or Associates has the right to acquire
(whether such right is exercisable immediately or only after the passage of time) pursuant to any
agreement, arrangement or understanding (other than customary agreements with and between
underwriters and selling group members with respect to a bona fide public offering of securities), or
upon the exercise of conversion rights, exchange rights, rights (other than these Rights), warrants or
options, or otherwise; provided, however, that a Person shall not be deemed the Beneficial Owner of,
or to beneficially own, securities tendered pursuant to a tender or exchange offer made by or on behalf
of such Person or any of such Person’s Affiliates or Associates until such tendered securities are
accepted for purchase or exchange; or
which such Person or any of such Person’s Affiliates or Associates has the right to vote pursuant to
any agreement, arrangement or understanding; provided, however, that a Person shall not be deemed
the Beneficial Owner of, or to beneficially own, any securities if the agreement, arrangement or
understanding to vote such securities (1) arises solely from a revocable proxy or consent given to such
Person in response to a public proxy or consent solicitation made pursuant to, and in accordance with,
the applicable rules and regulations promulgated under the Exchange Act and (2) is not also then
reportable on Schedule 13D under the Exchange Act (or any comparable or successor report); or
D-4
Appendix D
which are beneficially owned, directly or indirectly, by any other Person with which such Person or
any of such Person’s Affiliates or Associates has any agreement, arrangement or understanding (other
than customary agreements with and between underwriters and selling group members with respect to
a bona fide public offering of securities) for the purpose of acquiring, holding, voting (except to the
extent contemplated by the proviso to Section 1(e)(iii) hereof) or disposing of any securities of the
Company; or
which such Person would be deemed to own (whether constructively, indirectly or otherwise) or
which otherwise would be aggregated with shares owned by such Person pursuant to Section 382.
Notwithstanding anything in this definition of Beneficial Ownership to the contrary, the phrase “then
outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, shall
mean the number of such securities then issued and outstanding together with the number of such securities
not then actually issued and outstanding which such Person would be deemed to beneficially own hereunder.
(f) “Business Day” shall mean any day other than a Saturday, a Sunday, or a day on which banking
institutions in New York are authorized or obligated by law or executive order to close.
(g) “Close of Business” on any given date shall mean 5:00 P.M., New York time, on such date;
provided, however, that, if such date is not a Business Day, it shall mean 5:00 P.M., New York time, on the next
succeeding Business Day.
(h) “Common Shares” when used with reference to the Company shall mean the shares of common
stock of the Company, which currently have a par value of $1.00 per share, but also shall mean such shares if
such par value is hereafter reduced or eliminated in accordance with applicable law. “Common Shares” when
used with reference to any Person other than the Company shall mean the capital stock (or equity interest) with
the greatest voting power of such other Person or, if such other Person is a Subsidiary of another Person, the
Person or Persons which ultimately control such first-mentioned Person.
(i) “Common Share Equivalents” shall have the meaning set forth in Section 11(a)(iii) hereof.
(j) [Reserved]
(k) “Distribution Date” shall have the meaning set forth in Section 3(a) hereof.
(l) “Early Expiration Date” shall have the meaning set forth in Section 7(a) hereof.
(m) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.
(n) “Exchange Ratio” shall have the meaning set forth in Section 24(a) hereof.
(o) “Exempt Person” shall mean any Person whose Beneficial Ownership (together with all Affiliates
and Associates of such Person) of 4.9% or more of the then-outstanding Common Shares (1) will not jeopardize
or endanger the availability to the Company of any income tax benefit or (2) is otherwise in the best interests of
the Company, in each case as determined by the Board in its sole discretion prior to the Distribution Date;
provided, however, that such a Person will cease to be an Exempt Person if the Board makes a contrary
determination with respect to the effect of such Person’s Beneficial Ownership (together with all Affiliates and
Associates of such Person) in its sole discretion prior to the Distribution Date regardless of the reason therefor.
(p) “Exempted Transaction” means any transaction that the Board, in its sole discretion, has declared
exempt pursuant to Section 35, which determination shall be irrevocable with respect to such transaction.
(q) “Final Expiration Date” shall have the meaning set forth in Section 7(a) hereof.
(r) [Reserved]
(s) [Reserved]
(t) “NOLs” shall have the meaning set forth in the second recital hereof.
(u) “NYSE” shall mean the New York Stock Exchange.
(v) “Person” shall mean any individual, firm, corporation, partnership, limited liability company, limited
liability partnership, trust or other entity, or a group of Persons making a “coordinated acquisition” of shares or
otherwise treated as an entity within the meaning of Section 1.382-3(a)(1) of the Treasury Regulations, and any
successor (by merger or otherwise) of such individual or entity, but shall not include a Public Group (as such
term is defined in Section 1.382-2T(f)(13) of the Treasury Regulations).
(w) “Preferred Shares” shall mean shares of Series CC Junior Participating Preferred Shares, par value
$25.00 per share, of the Company.
(x) “Purchase Price” shall have the meaning set forth in Section 4 hereof.
(y) “Record Date” shall have the meaning set forth in the third recital hereof.
(z) “Redemption Date” shall have the meaning set forth in Section 7(a) hereof.
(aa) “Redemption Price” shall have the meaning set forth in Section 23(a) hereof.
(bb) “Right” shall have the meaning set forth in the third recital hereof.
(cc) “Right Certificate” shall have the meaning set forth in Section 3(a) hereof.
(dd) “Section 382” shall mean Section 382 of the Internal Revenue Code of 1986, as amended, and any
successor provision or replacement provision.
(ee) [Reserved]
(ff) [Reserved]
(gg) “Shares Acquisition Date” shall mean the date of the first public announcement by the Company
that an Acquiring Person has become such, which announcement shall follow a determination by the Board to
such effect, which is made and reflected in a Board resolution prior to the earliest of the Redemption Date, the
Early Expiration Date and the Final Expiration Date.
(hh) [Reserved]
(ii) “Shareholder Approval” shall mean the approval of this Second Amended and Restated Rights
Agreement, effective as of December 1, 2023, between the Company and the Rights Agent, by the affirmative
vote of a majority of the votes cast at the meeting of shareholders of the Company duly held in accordance with
the Company’s articles of incorporation (as amended) and applicable law.
(jj) [Reserved]
(kk) [Reserved]
(ll) “Subsidiary” of any Person shall mean any corporation or other entity of which a majority of the
voting power of the voting equity securities or equity interest is owned, directly or indirectly, by such Person.
(mm) “Summary of Rights” shall have the meaning set forth in Section 3(b) hereof.
(nn) [Reserved]
(oo) “Trading Day” shall have the meaning set forth in Section 11(d)(i) hereof.
(pp) “Treasury Regulations” shall mean final, temporary and proposed income tax regulations
promulgated under the Internal Revenue Code of 1986, as amended, including any amendments thereto.
Section 2. Appointment of Rights Agent. The Company hereby appoints the Rights Agent to act as
rights agent for the Company in accordance with the express terms and conditions hereof (and no implied terms
or conditions), and the Rights Agent hereby accepts such appointment. The Company may from time to time
appoint such co-Rights Agents as it may deem necessary or desirable; provided that the Company shall notify
the Rights Agent in writing ten (10) Business Days prior to such appointment. In the event the Company
appoints one or more co-Rights Agents, the respective duties of the Rights Agent and any co-Rights Agents
under the provisions of this Agreement shall be as the Company reasonably determines; provided that such
duties are consistent with the terms and conditions of this Agreement and that contemporaneously with such
appointment the Company shall notify, in writing, the Rights Agent and any co-Rights Agents of such duties.
The Rights Agent shall have no duty to supervise, and shall in no event be liable for, the acts or omissions of any
such co-Rights Agents.
Section 3. Issue of Right Certificates.
(a) Until the tenth Business Day after the Shares Acquisition Date (including any such Shares
Acquisition Date which is after February 13, 2019 and prior to the issuance of the Rights) (or such later day,
if any, as the Board determines in its sole discretion to be no longer than a fifteen (15) Business Day extension)
(as may be extended, the “Distribution Date”), (i) the Rights will be evidenced (subject to the provisions of
D-6
Appendix D
Section 3(b) and 3(c) hereof) by the certificates for Common Shares of the Company or book entry Common
Shares of the Company registered in the names of the holders thereof (which certificates or book entry shares
shall also be deemed to be Right Certificates) and not by separate Right Certificates, and (ii) the Rights will be
transferable only in connection with the transfer of Common Shares of the Company. As soon as practicable
after the Distribution Date, the Company will prepare and execute, the Rights Agent will countersign, and the
Company will send or cause to be sent (and the Rights Agent will, if requested to do so by the Company and
provided with all necessary information and documentation, in form and substance reasonably satisfactory to
the Rights Agent, send) to each record holder of Common Shares of the Company as of the Close of Business
on the Distribution Date (other than any Acquiring Person or any Associate or Affiliate of any Acquiring Person),
at the address of such holder shown on the records of the Company or transfer agent or registrar for Common
Shares, a Right Certificate, in substantially the form of Exhibit B hereto (a “Right Certificate”), evidencing one
Right for each Common Share so held (other than with respect to Rights that have become void pursuant to
Section 11(a)(ii) hereof or that have been exchanged pursuant to Section 24 hereof). As of the Distribution Date,
the Rights will be evidenced solely by such Right Certificates, and the Rights Certificates and the Rights shall be
transferable separately from the transfer of Common Shares. The Company shall promptly notify the Rights
Agent in writing upon the occurrence of the Distribution Date and, if such notification is given orally, the
Company shall confirm the same in writing on or prior to the Business Day next following. Until such written
notice is received by the Rights Agent, the Rights Agent may presume conclusively for all purposes that the
Distribution Date has not occurred.
(b) After the Record Date, the Company will send (directly or, at the expense of the Company,
through the Rights Agent or its transfer agent if the Rights Agent or transfer agent is directed by the Company
and provided with all necessary information and documents) a copy of a Summary of Rights to Purchase
Preferred Shares, in substantially the form of Exhibit C hereto (the “Summary of Rights”), to each record holder
of Common Shares as of the Close of Business on the Record Date (other than any Acquiring Person or any
Associate or Affiliate of any Acquiring Person), at the address of such holder shown on the records of the
Company or transfer agent or registrar for Common Shares.
(c) Certificates for Common Shares (or confirmation or account statements sent to holders of
Common Shares in book-entry form) which become outstanding (including, without limitation, reacquired
Common Shares referred to in this paragraph (c)) after the Record Date but prior to the earliest of the
Distribution Date, the Redemption Date, the Early Expiration Date or the Final Expiration Date shall bear the
following legend:
This certificate also evidences and entitles the holder hereof to certain rights as set forth in
the Second Amended and Restated Section 382 Rights Agreement between Lumen
Technologies, Inc. (the “Company”) and Computershare Trust Company, N.A., or any
successor rights agent, effective as of December 1, 2023, as it may be amended from time
to time (the “Agreement”), the terms of which are hereby incorporated herein by reference
and a copy of which is on file at the principal executive offices of the Company. Under
certain circumstances, as set forth in the Agreement, such Rights (as defined in the
Agreement) will be evidenced by separate certificates and will no longer be evidenced by
this certificate. The Company will mail to the holder of this certificate a copy of the
Agreement without charge after receipt of a written request therefor. As set forth in the
Agreement, Rights beneficially owned by any Person (as defined in the Agreement) who
becomes an Acquiring Person (as defined in the Agreement) become null and void and are
no longer transferable.
With respect to such certificates bearing the foregoing legend, until the earliest of the Distribution Date, the
Redemption Date, the Early Expiration Date or the Final Expiration Date, the Rights associated with the
Common Shares of the Company represented by such certificates shall be evidenced by such certificates alone,
and the surrender for transfer of any such certificate shall also constitute the transfer of the Rights associated
with the Common Shares of the Company represented thereby.
With respect to Common Shares in book-entry form for which there has been sent a confirmation or
account statement containing the foregoing legend in substantially similar form, until the earliest of the
Distribution Date, the Redemption Date, the Early Expiration Date or the Final Expiration Date, the Rights
associated with the Common Shares shall be evidenced by such Common Shares alone and registered holders
of Common Shares shall also be the registered holders of the associated Rights, and the transfer of any such
Common Shares shall also constitute the transfer of the Rights associated with such Common Shares.
In the event that the Company purchases or acquires any Common Shares of the Company after the
Record Date but prior to the Distribution Date, any Rights associated with such Common Shares of the
Company shall be deemed cancelled and retired so that the Company shall not be entitled to exercise any
Rights associated with the Common Shares of the Company which are no longer outstanding.
Notwithstanding this paragraph (c), the omission of the legend or the failure to send, deliver or provide
the registered owner of Common Shares a copy of the Summary of Rights shall not affect the enforceability of
any part of this Agreement or the rights of any holder of the Rights.
Section 4. Form of Right Certificates. The Right Certificates (and the forms of election to purchase
Preferred Shares and of assignment to be printed on the reverse thereof) shall be substantially the same as
Exhibit B hereto if the Company elects to issue physical certificates, and may have such changes or marks of
identification or designation and such legends, summaries or endorsements printed thereon as the Company
may deem appropriate (but which do not affect the rights, duties, liabilities, protections or responsibilities of the
Rights Agent hereunder) and as are not inconsistent with the provisions of this Agreement, or as may be
required to comply with any applicable law or with any applicable rule or regulation made pursuant thereto or
with any applicable rule or regulation of any stock exchange or the Financial Industry Regulatory Authority, or
to conform to usage. Subject to the provisions of Section 22 hereof, the Right Certificates shall entitle the
holders thereof to purchase such number of one ten-thousandths of a Preferred Share as shall be set forth
therein at the price per one ten-thousandth of a Preferred Share set forth therein (the “Purchase Price”), but the
number of such one ten-thousandths of a Preferred Share and the Purchase Price shall be subject to adjustment
as provided herein. Notwithstanding anything contrary provided herein, the Company may elect to maintain the
Rights in book-entry form rather than issuing Rights Certificates.
Section 5. Countersignature and Registration. The Right Certificates shall be executed on behalf of
the Company by its Chief Executive Officer, Chief Financial Officer, President, General Counsel, Corporate
Secretary, any of its Executive or Senior Vice Presidents or its Treasurer, either manually or by electronic
signature (e.g., PDF). The Right Certificates shall be countersigned manually or by facsimile or by other
electronic means (e.g., PDF) by an authorized signatory of the Rights Agent and shall not be valid for any
purpose unless countersigned. In case any officer of the Company who shall have signed any of the Right
Certificates shall cease to be such officer of the Company before countersignature by the Rights Agent and
issuance and delivery by the Company, such Right Certificates, nevertheless, may be countersigned by the
Rights Agent and issued and delivered by the Company with the same force and effect as though the individual
who signed such Right Certificates had not ceased to be such officer of the Company; and any Right Certificate
may be signed on behalf of the Company by any individual who, at the actual date of the execution of such
Right Certificate, shall be a proper officer of the Company to sign such Right Certificate, although at the date of
the execution of this Agreement any such individual was not such an officer.
Following the Distribution Date, upon receipt by the Rights Agent of notice to that effect and all other
relevant information and documents referred to in Section 3(a), the Rights Agent will keep or cause to be kept,
at its office(s) designated for such purpose, books for registration and transfer of the Right Certificates issued
hereunder. Such books shall show the names and addresses of the respective holders of the Right Certificates,
the number of Rights evidenced on its face by each of the Right Certificates and the date of each of the
Right Certificates.
Section 6. Transfer, Split Up, Combination and Exchange of Right Certificates; Mutilated, Destroyed,
Lost or Stolen Right Certificates. Subject to the provisions of Section 14 hereof, at any time after the Close of
Business on the Distribution Date, and at or prior to the Close of Business on the earliest of the Redemption
Date, the Early Expiration Date or the Final Expiration Date, any Right Certificate or Right Certificates (other
than Right Certificates representing Rights that have become void pursuant to Section 11(a)(ii) hereof, that have
been redeemed pursuant to Section 23, or that have been exchanged pursuant to Section 24 hereof) may be
transferred, split up, combined or exchanged for another Right Certificate or Right Certificates entitling the
registered holder to purchase a like number of one ten-thousandths of a Preferred Share as the Right Certificate
or Right Certificates surrendered then entitled such holder to purchase. Any registered holder desiring to
transfer, split up, combine or exchange any Right Certificate or Right Certificates shall make such request in
writing delivered to the Rights Agent, and shall surrender, together with any required form of assignment duly
executed and properly completed, the Right Certificate or Right Certificates to be transferred, split up,
combined or exchanged at the office(s) of the Rights Agent designated for such purpose, along with a signature
guarantee from an eligible guarantor institution participating in a signature guarantee program approved by the
Securities Transfer Association (a “Signature Guarantee”), and such other and further documentation as the
D-8
Appendix D
Company or the Rights Agent may reasonably request. The Rights Certificates are transferable only on the
books and records of the Rights Agent. Neither the Rights Agent nor the Company shall be obligated to take
any action whatsoever with respect to the transfer, split up, combination or exchange of any such surrendered
Right Certificate until the registered holder has properly completed and duly executed the certificate set forth in
the form of assignment on the reverse side of such Rights Certificate accompanied by a Signature Guarantee
and such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) of the Rights
represented by such Rights Certificate as the Company or the Rights Agent may reasonably request. Thereupon
the Rights Agent shall countersign and deliver to the Person entitled thereto a Right Certificate or Right
Certificates, as the case may be, as so requested. The Company or the Rights Agent may require payment by
the holder of the Rights of a sum sufficient to cover any tax or governmental charge that may be imposed in
connection with any transfer, split up, combination or exchange of Right Certificates. If and to the extent the
Company does require payment of any such taxes or governmental charges, the Company shall give the Rights
Agent prompt written notice thereof and the Rights Agent shall not deliver any Rights Certificate unless and
until it is satisfied that all such payments have been made, and the Rights Agent shall forward any such sum
collected by it to the Company or to such Persons as the Company specifies by written notice. The Rights Agent
shall have no duty or obligation to take any action under any Section of this Agreement which requires the
payment of applicable taxes and/or governmental charges unless and until it is satisfied that all such taxes
and/or governmental charges have been paid.
Upon receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the
loss, theft, destruction or mutilation of a Right Certificate, and, in case of loss, theft or destruction, of indemnity
or security reasonably satisfactory to them, along with such other and further documentation as the Company
or the Rights Agent may reasonably request and, at the Company’s request, reimbursement to the Company
and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to the Rights Agent and
cancellation of the Right Certificate if mutilated, the Company will execute and deliver a new Right Certificate of
like tenor to the Rights Agent for countersignature and delivery to the registered holder in lieu of the Right
Certificate so lost, stolen, destroyed or mutilated.
Notwithstanding any other provision hereof, the Company and the Rights Agent may (i) agree to
provide for uncertificated Rights in addition to or in lieu of Rights evidenced by Right Certificates, in which case
all terms and conditions set forth herein governing Rights Certificates shall be deemed to be modified as
necessary or appropriate to reflect uncertificated or book-entry ownership of Rights, and (ii) amend this
Agreement, to the extent they deem it necessary or appropriate, to give effect to the foregoing.
Section 7. Exercise of Rights; Purchase Price; Expiration Date of Rights.
(a) The registered holder of any Right Certificate may exercise the Rights evidenced thereby (except
as otherwise provided herein), in whole or in part, at any time after the Distribution Date, upon surrender of the
Right Certificate, with the form of election to purchase and the certificate on the reverse side thereof properly
completed and duly executed (with such signature duly guaranteed, if required), to the Rights Agent at the
office or offices of the Rights Agent designated for such purpose, accompanied by a Signature Guarantee and
such other documentation as the Rights Agent may reasonably request, together with payment of the Purchase
Price for each one ten-thousandth of a Preferred Share as to which the Rights are exercised, at or prior to the
earliest of (i) December 1, 2026 (the “Final Expiration Date”), (ii) the time at which the Rights are redeemed as
provided in Section 23 hereof (the “Redemption Date”), (iii) the time at which such Rights are exchanged as
provided in Section 24 hereof, (iv) the time at which the Board determines that the NOLs are utilized in all
material respects or that an ownership change under Section 382 would not adversely impact in any material
respect the time period in which the Company could use the NOLs, or materially impair the amount of the NOLs
that could be used by the Company in any particular time period, for applicable tax purposes,
(v) December 1, 2024 if Shareholder Approval has not been obtained prior to such date, or (vi) a determination
by the Board, prior to the Distribution Date, that this Agreement and the Rights are no longer in the best
interests of the Company and its shareholders (the earliest of the dates set forth in clauses (iv), (v) and (vi),
the “Early Expiration Date”).
(b) The Purchase Price for each one ten-thousandth of a Preferred Share purchasable pursuant to the
exercise of a Right shall be $9.00, and shall be subject to adjustment from time to time as provided in Section 11
hereof, and shall be payable in lawful money of the United States of America in accordance with paragraph
(c) below.
(c) Upon receipt of a Right Certificate representing exercisable Rights, with the form of election to
purchase properly completed and duly executed, accompanied by payment of the Purchase Price for the shares
to be purchased and an amount equal to any applicable transfer tax required to be paid by the holder of such
Right Certificate in accordance with Section 9 hereof in cash or by certified check, cashier’s check or money
order payable to the order of the Rights Agent, the Rights Agent shall thereupon promptly (i) (A) requisition
from any transfer agent of the Preferred Shares certificates for the number of Preferred Shares to be purchased
and the Company hereby irrevocably authorizes any such transfer agent to comply with all such requests, or
(B) requisition from the depositary agent depositary receipts representing such number of one ten-thousandths
of a Preferred Share as are to be purchased (in which case certificates for the Preferred Shares represented by
such receipts shall be deposited by the transfer agent of the Preferred Shares with such depositary agent) and
the Company shall direct such depositary agent to comply with such request; (ii) when necessary to comply
with this Agreement, requisition from the Company the amount of cash to be paid in lieu of issuance of
fractional shares in accordance with Section 14 hereof; (iii) promptly after receipt of such certificates or
depositary receipts, cause the same to be delivered to or upon the order of the registered holder of such Right
Certificate, registered in such name or names as may be designated by such holder; and (iv) when necessary to
comply with this Agreement, after receipt, promptly deliver such cash to or upon the order of the registered
holder of such Right Certificate.
(d) In case the registered holder of any Right Certificate shall properly exercise less than all the Rights
evidenced thereby, a new Right Certificate evidencing Rights equivalent to the Rights remaining unexercised
shall be issued by the Rights Agent to registered holder of such Right Certificate or to such holder’s duly
authorized assigns, subject to the provisions of Section 14 hereof.
(e) Notwithstanding anything in this Agreement or any Right Certificate to the contrary, neither the
Rights Agent nor the Company shall be obligated to take any action with respect to a registered holder upon
the occurrence of any purported transfer or exercise as set forth in this Section 7 by such registered holder
unless such registered holder has (i) properly completed and duly executed the certificate following the form of
election to purchase set forth on the reverse side of the Right Certificate surrendered for such exercise, and (ii)
provided such additional evidence of the identity of the Beneficial Owner (or former Beneficial Owner) of the
Rights represented by such Rights Certificate as the Company or the Rights Agent reasonably requests.
(f) Except for those provisions herein that expressly survive the termination of this Agreement, this
Agreement shall terminate upon the earlier of the Redemption Date, Early Expiration Date or Final Expiration
Date and such time as all outstanding Rights have been exercised, redeemed or exchanged hereunder.
Section 8. Cancellation and Destruction of Right Certificates. All Right Certificates surrendered for the
purpose of exercise, transfer, split up, combination or exchange shall, if surrendered to the Company or to any
of its agents, be delivered to the Rights Agent for cancellation or in cancelled form, or, if surrendered to the
Rights Agent, shall be cancelled by it, and no Right Certificates shall be issued in lieu thereof except as expressly
permitted by any of the provisions of this Agreement. The Company shall deliver to the Rights Agent for
cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Right Certificate
purchased or acquired by the Company otherwise than upon the exercise thereof. Subject to applicable law and
regulation, the Rights Agent shall maintain in a retrievable database electronic records of all cancelled or
destroyed Rights Certificates which have been canceled or destroyed by the Rights Agent. At the expense of
the Company, the Rights Agent shall deliver all cancelled Rights Certificates to the Company, or shall, at the
written request of the Company, destroy or cause to be destroyed such cancelled Rights Certificates, and in
such case shall deliver a certificate of destruction thereof, executed by the Rights Agent, to the Company.
Section 9. Availability of Preferred Shares. The Company covenants and agrees that it will cause to
be reserved and kept available out of its authorized and unissued Preferred Shares or any Preferred Shares held
in its treasury the number of Preferred Shares that will be sufficient to permit the exercise in full of all
outstanding Rights in accordance with Section 7 hereof. The Company covenants and agrees that it will take all
such action as may be necessary to ensure that all Preferred Shares delivered upon exercise of Rights shall,
at the time of delivery of the certificates for such Preferred Shares (subject to payment of the Purchase Price),
be duly and validly authorized and issued and fully paid and nonassessable shares.
D-10
Appendix D
The Company further covenants and agrees that it will pay when due and payable any and all federal
and state transfer taxes and charges which may be payable in respect of the issuance or delivery of the Right
Certificates or of any Preferred Shares upon the exercise of Rights. The Company shall not, however, be
required to pay any transfer tax which may be payable in respect of any transfer or delivery of Right Certificates
to a Person other than, or the issuance or delivery of certificates or depositary receipts for the Preferred Shares
in a name other than that of, the registered holder of the Right Certificate evidencing Rights surrendered for
exercise or to issue or to deliver any certificates or depositary receipts for Preferred Shares upon the exercise of
any Rights until any such tax shall have been paid (any such tax being payable by the holder of such Right
Certificate at the time of surrender) or until it has been established to the Company’s reasonable satisfaction
that no such tax is due.
Section 10. Preferred Shares Record Date. Each Person in whose name any certificate for Preferred
Shares is issued upon the exercise of Rights shall for all purposes be deemed to have become the holder of
record of the Preferred Shares represented thereby on, and such certificate shall be dated, the date upon which
the Right Certificate evidencing such Rights was duly surrendered and payment of the Purchase Price (and any
applicable transfer taxes) was made; provided, however, that, if the date of such surrender and payment is a
date upon which the Preferred Shares transfer books of the Company are closed, such Person shall be deemed
to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding
Business Day on which the Preferred Shares transfer books of the Company are open. Prior to the exercise of
the Rights evidenced thereby, the holder of a Right Certificate shall not be entitled to any rights of a holder of
Preferred Shares for which the Rights shall be exercisable, including, without limitation, the right to vote, to
receive dividends or other distributions or to exercise any preemptive rights, and shall not be entitled to receive
any notice of any proceedings of the Company, except as provided herein.
Section 11. Adjustment of Purchase Price, Number of Shares or Number of Rights. The Purchase Price,
the number of Preferred Shares covered by each Right and the number of Rights outstanding are subject to
adjustment from time to time as provided in this Section 11.
(a) (i) In the event the Company shall at any time after February 13, 2019 (A) declare a dividend on
the Preferred Shares payable in Preferred Shares, (B) subdivide the outstanding Preferred Shares, (C)
combine or consolidate the outstanding Preferred Shares into a smaller number of Preferred Shares or
(D) issue any shares of its capital stock in a reclassification of the Preferred Shares (including any such
reclassification in connection with a consolidation or merger in which the Company is the continuing or
surviving corporation), except as otherwise provided in this Section 11(a), the Purchase Price in effect at
the time of the record date for such dividend or of the effective date of such subdivision, combination,
consolidation or reclassification, and the number and kind of shares of capital stock issuable on such
date, shall be proportionately adjusted so that the holder of any Right exercised after such time shall be
entitled to receive the aggregate number and kind of shares of capital stock which, if such Right had
been exercised immediately prior to such date and at a time when the Preferred Shares transfer books
of the Company were open, such holder would have owned upon such exercise and been entitled to
receive by virtue of such dividend, subdivision, combination, consolidation or reclassification; provided,
however, that in no event shall the consideration to be paid upon the exercise of one Right be less than
the aggregate par value of the shares of capital stock of the Company issuable upon exercise of
one Right.
(ii) Subject to Section 24 hereof, in the event any Person becomes an Acquiring Person after
February 13, 2019 (including becoming such prior to the Record Date), each holder of a Right (other
than an Acquiring Person or an Affiliate or Associate of an Acquiring Person) shall thereafter have a
right to receive, upon exercise thereof at a price equal to the then current Purchase Price multiplied by
the number of one ten-thousandths of a Preferred Share for which a Right is then exercisable,
in accordance with the terms of this Agreement and in lieu of Preferred Shares, such number of
Common Shares of the Company as shall equal the result obtained by (A) multiplying the then current
Purchase Price by the number of one ten-thousandths of a Preferred Share for which a Right is then
exercisable and dividing that product by (B) 50% of the then current per share market price of the
Common Shares of the Company (determined pursuant to Section 11(d) hereof) on the date of the
occurrence of such event. In the event that any Person shall become an Acquiring Person and the Rights
shall then be outstanding, the Company shall not take any action which would eliminate or diminish the
benefits intended to be afforded by the Rights, other than those expressly permitted hereunder.
From and after the occurrence of such event, any Rights that are or were acquired or beneficially
owned by any Acquiring Person (or any Associate or Affiliate of such Acquiring Person) shall be void,
and any holder of such Rights shall thereafter have no right to exercise such Rights under any provision
of this Agreement. No Right Certificate shall be issued pursuant to Section 3 hereof that represents
Rights beneficially owned by an Acquiring Person whose Rights would be void pursuant to the
preceding sentence or any Associate or Affiliate thereof; no Right Certificate shall be issued at any time
upon the transfer of any Rights to an Acquiring Person whose Rights would be void pursuant to the
preceding sentence or any Associate or Affiliate thereof or to any nominee of such Acquiring Person,
Associate or Affiliate; and any Right Certificate delivered to the Rights Agent for transfer to an
Acquiring Person whose Rights would be void pursuant to the preceding sentence shall be cancelled.
(iii) In the event that there shall not be sufficient Common Shares issued but not outstanding or
authorized but unissued to permit the exercise in full of the Rights in accordance with subparagraph
(ii) above, the Company shall take all such action as may be necessary to authorize additional Common
Shares for issuance upon exercise of the Rights. In the event the Company shall, after good faith effort,
be unable to take all such action as may be necessary to authorize such additional Common Shares, the
Company shall, to the extent permitted by applicable law and any agreements or instruments then in
effect to which the Company is a party, make adequate provision to substitute, for each Common Share
that would otherwise be issuable upon exercise of a Right, upon exercise of a Right and payment of the
applicable Purchase Price, (1) cash; (2) Preferred Shares or fractions of Preferred Shares or other equity
securities of the Company (including, without limitation, shares, or units of shares, of Preferred Shares
which the Board has determined to have the same value as the Common Shares) (such shares of equity
securities being herein called “Common Share Equivalents”); (3) debt securities of the Company;
(4) other assets; or (5) any combination of the foregoing, in each case having an aggregate value,
as determined by the Board based upon the advice of a financial advisor selected by the Board, equal to
the current per share market price of the Common Shares as of the Shares Acquisition Date.
(b) In case the Company shall fix a record date for the issuance of rights, options or warrants to all
holders of Preferred Shares entitling them (for a period expiring within forty-five (45) days after such record
date) to subscribe for or purchase Preferred Shares (or shares having the same rights, privileges and
preferences as the Preferred Shares (“Equivalent Preferred Shares”)) or securities convertible into Preferred
Shares or Equivalent Preferred Shares at a price per Preferred Share or Equivalent Preferred Share (or having a
conversion price per share, if a security convertible into Preferred Shares or Equivalent Preferred Shares) less
than the then current per share market price of the Preferred Shares (as defined in Section 11(d)) on such record
date, the Purchase Price to be in effect after such record date shall be determined by multiplying the Purchase
Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the number
of Preferred Shares outstanding on such record date plus the number of Preferred Shares which the aggregate
offering price of the total number of Preferred Shares and/or Equivalent Preferred Shares so to be offered
(and/or the aggregate initial conversion price of the convertible securities so to be offered) would purchase at
such current market price and the denominator of which shall be the number of Preferred Shares outstanding on
such record date plus the number of additional Preferred Shares and/or Equivalent Preferred Shares to be
offered for subscription or purchase (or into which the convertible securities so to be offered are initially
convertible); provided, however, that in no event shall the consideration to be paid upon the exercise of one
Right be less than the aggregate par value of the shares of capital stock of the Company issuable upon exercise
of one Right. In case such subscription price may be paid in a consideration part or all of which shall be in a form
other than cash, the value of such consideration shall be as determined in good faith by the Board, whose
determination shall be described in a statement filed with the Rights Agent and shall be binding and conclusive
for all purposes on the Rights Agent and holders of the Rights. Preferred Shares owned by or held for the
account of the Company shall not be deemed outstanding for the purpose of any such computation. Such
adjustment shall be made successively whenever such a record date is fixed; and, in the event that such rights,
options or warrants are not so issued, the Purchase Price shall be adjusted to be the Purchase Price which would
then be in effect if such record date had not been fixed.
D-12
Appendix D
(c) In case the Company shall fix a record date for the making of a distribution to all holders of the
Preferred Shares (including any such distribution made in connection with a consolidation or merger in which
the Company is the continuing or surviving corporation) of evidences of indebtedness or assets (other than a
regular quarterly cash dividend or a dividend payable in Preferred Shares) or subscription rights or warrants
(excluding those referred to in Section 11(b) hereof), the Purchase Price to be in effect after such record date
shall be determined by multiplying the Purchase Price in effect immediately prior to such record date by a
fraction, the numerator of which shall be the then-current per share market price of the Preferred Shares on
such record date, less the fair market value (as determined in good faith by the Board, whose determination
shall be described in a statement filed with the Rights Agent and shall be binding on the Rights Agent and
holders of the Rights) of the portion of the assets or evidences of indebtedness so to be distributed or of such
subscription rights or warrants applicable to one Preferred Share and the denominator of which shall be such
then-current per share market price of the Preferred Shares on such record date; provided, however, that in no
event shall the consideration to be paid upon the exercise of one Right be less than the aggregate par value of
the shares of capital stock of the Company to be issued upon exercise of one Right. Such adjustments shall be
made successively whenever such a record date is fixed; and, in the event that such distribution is not so made,
the Purchase Price shall again be adjusted to be the Purchase Price which would then be in effect if such record
date had not been fixed.
(d) (i) For the purpose of any computation hereunder, the “current per share market price” of any
security (a “Security” for the purpose of this Section 11(d)(i)) on any date shall be deemed to be the average of
the daily closing prices per share of such Security for the thirty (30) consecutive Trading Days immediately prior
to such date; provided, however, that, in the event that the current per share market price of the Security is
determined during a period following the announcement by the issuer of such Security of (A) a dividend or
distribution on such Security payable in shares of such Security or Securities convertible into such shares,
or (B) any subdivision, combination, consolidation or reclassification of such Security and prior to the expiration
of thirty (30) Trading Days after the ex-dividend date for such dividend or distribution, or the record date for
such subdivision, combination, consolidation or reclassification, then, and in each such case, the current per
share market price shall be appropriately adjusted to reflect the current market price per share equivalent of
such Security. The closing price for each day shall be the last sale price, regular way, reported at or prior to 4:00
P.M. Eastern time or, in case no such sale takes place on such day, the average of the bid and asked prices,
regular way, reported as of 4:00 P.M. Eastern time, in either case, as reported on the NYSE or NASDAQ or, if the
Security is not listed or admitted to trading on any national securities exchange, the last quoted price reported
at or prior to 4:00 P.M. Eastern time or, if not so quoted, the average of the high bid and low asked prices in the
over-the-counter market, as reported as of 4:00 P.M. Eastern time by the OTC Bulletin Board or such other
system then in use, or, if on any such date the Security is not quoted by any such organization, the average of
the closing bid and asked prices as furnished by a professional market maker making a market in the Security
selected by the Board. If on any such date no such market maker is making a market in the Security, the fair
value of the Security on such date as determined in good faith by the Board shall be used.
The term “Trading Day” shall mean a day on which the principal national securities exchange on
which the Security is listed or admitted to trading is open for the transaction of business, or, if the
Security is not listed or admitted to trading on any national securities exchange, a Business Day.
(ii) For the purpose of any computation hereunder, the “current per share market price” of the
Preferred Shares shall be determined in accordance with the method set forth in Section 11(d)(i).
However, if the Preferred Shares are not publicly traded, the “current per share market price” of each
one ten-thousandth of a Preferred Share shall be conclusively deemed to be the current per share
market price of a Common Share as determined pursuant to Section 11(d)(i) hereof (appropriately
adjusted to reflect any stock dividend, subdivision, combination or consolidation of the Common Shares
(by reclassification or otherwise), or similar transaction occurring after the date hereof). If neither the
Common Shares nor the Preferred Shares are publicly held or so listed or traded, “current per share
market price” shall mean the fair value per share as determined in good faith by the Board,
whose determination shall be described in a statement filed with the Rights Agent.
(e) No adjustment in the Purchase Price shall be required unless such adjustment would require an
increase or decrease of at least 1% in the Purchase Price; provided, however, that any adjustments which by
reason of this Section 11(e) are not required to be made shall be carried forward and taken into account in any
subsequent adjustment. All calculations under this Section 11 shall be made to the nearest cent or to the nearest
one one-millionth of a Preferred Share or one ten-thousandth of any other share or security as the case may be.
Notwithstanding the first sentence of this Section 11(e), any adjustment required by this Section 11 shall be made
no later than the earlier of (i) three (3) years from the date of the transaction which requires such adjustment or
(ii) the date of the expiration of the right to exercise any Rights.
(f) If, as a result of an adjustment made pursuant to Section 11(a) hereof, the holder of any Right
thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than
Preferred Shares, thereafter the number of such other shares so receivable upon exercise of any Right shall be
subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the
provisions with respect to the Preferred Shares contained in Section 11(a) through (c) hereof, inclusive, and the
provisions of Sections 7, 9 and 10 hereof with respect to the Preferred Shares shall apply on like terms to any
such other shares.
(g) All Rights originally issued by the Company subsequent to any adjustment made to the Purchase
Price hereunder shall evidence the right to purchase, at the adjusted Purchase Price, the number of one
ten-thousandths of a Preferred Share purchasable from time to time hereunder upon exercise of the Rights,
all subject to further adjustment as provided herein.
(h) Unless the Company shall have exercised its election as provided in Section 11(i) hereof, upon each
adjustment of the Purchase Price as a result of the calculations made in Sections 11(b) and (c) hereof, each Right
outstanding immediately prior to the making of such adjustment shall thereafter evidence the right to purchase,
at the adjusted Purchase Price, that number of one ten-thousandths of a Preferred Share (calculated to the
nearest one one-millionth of a Preferred Share) obtained by (A) multiplying (x) the number of one
ten-thousandths of a Preferred Share covered by a Right immediately prior to this adjustment by (y) the
Purchase Price in effect immediately prior to such adjustment of the Purchase Price and (B) dividing the product
so obtained by the Purchase Price in effect immediately after such adjustment of the Purchase Price.
(i) The Company may elect, on or after the date of any adjustment of the Purchase Price, to adjust the
number of Rights in substitution for any adjustment in the number of one ten-thousandths of a Preferred Share
purchasable upon the exercise of a Right. Each of the Rights outstanding after such adjustment of the number
of Rights shall be exercisable for the number of one ten-thousandths of a Preferred Share for which a Right was
exercisable immediately prior to such adjustment. Each Right held of record prior to such adjustment of the
number of Rights shall become that number of Rights (calculated to the nearest one ten-thousandth) obtained
by dividing the Purchase Price in effect immediately prior to adjustment of the Purchase Price by the Purchase
Price in effect immediately after adjustment of the Purchase Price. The Company shall make a public
announcement (with simultaneous written notice to the Rights Agent) of its election to adjust the number of
Rights, indicating the record date for the adjustment, and, if known at the time, the amount of the adjustment to
be made. This record date may be the date on which the Purchase Price is adjusted or any day thereafter, but, if
the Right Certificates have been issued, shall be at least ten (10) days later than the date of the public
announcement. If Right Certificates have been issued, upon each adjustment of the number of Rights pursuant
to this Section 11(i), the Company shall, as promptly as practicable, cause to be distributed to holders of record
of Right Certificates on such record date Right Certificates evidencing, subject to Section 14 hereof,
the additional Rights to which such holders shall be entitled as a result of such adjustment, or, at the option of
the Company, shall cause to be distributed to such holders of record in substitution and replacement for the
Right Certificates held by such holders prior to the date of adjustment, and upon surrender thereof, if required
by the Company, new Right Certificates evidencing all the Rights to which such holders shall be entitled after
such adjustment. Right Certificates so to be distributed shall be issued, executed and countersigned in the
manner provided for herein, and shall be registered in the names of the holders of record of Right Certificates
on the record date specified in the public announcement.
(j) Irrespective of any adjustment or change in the Purchase Price or in the number of one
ten-thousandths of a Preferred Share issuable upon the exercise of the Rights, the Right Certificates theretofore
and thereafter issued may continue to express the Purchase Price and the number of one ten-thousandths of a
Preferred Share which were expressed in the initial Right Certificates issued hereunder.
D-14
Appendix D
(k) Before taking any action that would cause an adjustment reducing the Purchase Price below one
ten-thousandth of the then par value, if any, of the Preferred Shares issuable upon exercise of the Rights,
the Company shall take any corporate action which may, in the opinion of its counsel, be necessary in order that
the Company may validly and legally issue fully paid and nonassessable Preferred Shares at such adjusted
Purchase Price.
(l) In any case in which this Section 11 shall require that an adjustment in the Purchase Price be made
effective as of a record date for a specified event, the Company may elect to defer (with prompt written notice
thereof to the Rights Agent; and until such written notice is received by the Rights Agent, the Rights Agent may
presume conclusively that no such election has occurred) until the occurrence of such event issuing to the
holder of any Right exercised after such record date of the Preferred Shares and other capital stock or securities
of the Company, if any, issuable upon such exercise over and above the Preferred Shares and other capital stock
or securities of the Company, if any, issuable upon such exercise on the basis of the Purchase Price in effect
prior to such adjustment; provided, however, that the Company shall deliver to such holder a due bill or other
appropriate instrument evidencing such holder’s right to receive such additional shares upon the occurrence of
the event requiring such adjustment.
(m) Anything in this Section 11 to the contrary notwithstanding, the Company shall be entitled to make
such reductions in the Purchase Price, in addition to those adjustments expressly required by this Section 11,
as and to the extent that it, in its sole discretion, shall determine to be advisable in order that any consolidation
or subdivision of the Preferred Shares, issuance wholly for cash of any Preferred Shares at less than the current
market price, issuance wholly for cash of Preferred Shares or securities which by their terms are convertible into
or exchangeable for Preferred Shares, dividends on Preferred Shares payable in Preferred Shares or issuance of
rights, options or warrants referred to in Section 11(b) hereof, hereafter made by the Company to holders of the
Preferred Shares shall not be taxable to such shareholders.
(n) In the event that, at any time after February 13, 2019 and prior to the Distribution Date, the
Company shall (i) declare or pay any dividend on the Common Shares payable in Common Shares, or (ii) effect
a subdivision, combination or consolidation of the Common Shares (by reclassification or otherwise) into a
greater or lesser number of Common Shares, then, in any such case, (A) the number of one ten-thousandths of a
Preferred Share purchasable after such event upon proper exercise of each Right shall be determined by
multiplying the number of one ten-thousandths of a Preferred Share so purchasable immediately prior to such
event by a fraction, the numerator of which is the number of Common Shares outstanding immediately before
such event and the denominator of which is the number of Common Shares outstanding immediately after such
event, and (B) each Common Share outstanding immediately after such event shall have issued with respect to
it that number of Rights which each Common Share outstanding immediately prior to such event had issued
with respect to it. The adjustments provided for in this Section 11(n) shall be made successively whenever such a
dividend is declared or paid or such a subdivision, combination or consolidation is effected.
Section 12. Certificate of Adjusted Purchase Price or Number of Shares. Whenever an adjustment is
made as provided in Section 11 hereof, the Company shall promptly (a) prepare a certificate setting forth such
adjustment and a brief, reasonably detailed statement of the facts and computations accounting for such
adjustment, (b) promptly file with the Rights Agent and with each transfer agent for the Common Shares or the
Preferred Shares and the Securities and Exchange Commission a copy of such certificate and (c) if such
adjustment occurs at any time after the Distribution Date, mail a brief summary thereof to each holder of a Right
Certificate in accordance with Section 25 hereof. The Rights Agent shall be fully protected in relying on any such
certificate and on any adjustments or statements therein contained and shall have no duty or liability with
respect to, and shall not be deemed to have knowledge of, any such adjustment or event unless and until it shall
have received such certificate.
Section 13. [Reserved].
Section 14. Fractional Rights and Fractional Shares.
(a) The Company shall not be required to issue fractions of Rights or to distribute Right Certificates
which evidence fractional Rights. In lieu of such fractional Rights, there shall be paid to the registered holders of
the Right Certificates with regard to which such fractional Rights would otherwise be issuable, an amount in
cash equal to the same fraction of the current market value of a whole Right. For the purposes of this Section
14(a), the current market value of a whole Right shall be the closing price of the Rights (as determined pursuant
to the second sentence of Section 11(d)(i) hereof) for the Trading Day immediately prior to the date on which
such fractional Rights would have been otherwise issuable.
(b) The Company shall not be required to issue fractions of Preferred Shares (other than fractions
which are integral multiples of one ten-thousandth of a Preferred Share) upon exercise of the Rights or to
distribute certificates which evidence fractional Preferred Shares (other than fractions which are integral
multiples of one ten-thousandth of a Preferred Share). Fractions of Preferred Shares in integral multiples of one
ten-thousandth of a Preferred Share may, at the election of the Company, be evidenced by depositary receipts,
pursuant to an appropriate agreement between the Company and a depositary selected by it; provided that
such agreement shall provide that the holders of such depositary receipts shall have all the rights, privileges and
preferences to which they are entitled as beneficial owners of the Preferred Shares represented by such
depositary receipts. In lieu of fractional Preferred Shares that are not integral multiples of one ten-thousandth of
a Preferred Share, the Company shall pay to the registered holders of Right Certificates at the time such Rights
are exercised as herein provided an amount in cash equal to the same fraction of the current market value of
one Preferred Share. For the purposes of this Section 14(b), the current market value of a Preferred Share shall
be the closing price of a Preferred Share (as determined pursuant to the second sentence of Section 11(d)(i)
hereof) for the Trading Day immediately prior to the date of such exercise.
(c) Following the occurrence of one of the events specified in Section 11 hereof giving rise to the right
to receive Common Shares or other securities upon the exercise of a Right, the Company will not be required to
issue fractions of Common Shares or other securities upon exercise of the Rights or to distribute certificates
which evidence fractional Common Shares or other securities. In lieu of fractional Common Shares or other
securities, the Company may pay to the registered holders of Rights Certificates at the time such Rights are
exercised as herein provided an amount in cash equal to the same fraction of the current market value of one
share of Common Shares or other securities. For purposes of this Section 14(c), the current market value of one
share of Common Shares is the closing price of one share of a Common Share for the Trading Day immediately
prior to the date of such exercise.
(d) The holder of a Right, by the acceptance of the Right, expressly waives such holder’s right to
receive any fractional Rights or any fractional shares upon exercise of a Right (except as provided above).
(e) Whenever a payment for fractional Rights or fractional shares is to be made by the Rights Agent
under this Agreement, the Company shall (i) promptly prepare and deliver to the Rights Agent a certificate
setting forth in reasonable detail the facts related to such payments and the prices and formulas utilized in
calculating such payments; and (ii) provide sufficient monies to the Rights Agent in the form of fully collected
funds to make such payments. The Rights Agent shall be fully protected in relying upon such a certificate and
has no duty with respect to, and will not be deemed to have knowledge of, any payment for fractional Rights or
fractional shares under any Section of this Agreement relating to the payment of fractional Rights or fractional
shares unless and until the Rights Agent has received such a certificate and sufficient monies.
Section 15. Rights of Action. All rights of action in respect of this Agreement, excepting the rights of
action given to the Rights Agent hereunder, are vested in the respective registered holders of the Right
Certificates (and, prior to the Distribution Date, the registered holders of the Common Shares); and any
registered holder of any Right Certificate (or, prior to the Distribution Date, of the Common Shares), without the
consent of the Rights Agent or of the holder of any other Right Certificate (or, prior to the Distribution Date, of
the Common Shares), may, on such holder’s own behalf and for such holder’s own benefit, enforce, and may
institute and maintain any suit, action or proceeding against the Company to enforce, or otherwise act in
respect of, such holder’s right to exercise the Rights evidenced by such Right Certificate in the manner provided
in such Right Certificate and in this Agreement. Without limiting the foregoing or any remedies available to the
holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy
at law for any breach of this Agreement by the Company, and will be entitled to specific performance of the
obligations hereunder, and injunctive relief against actual or threatened violations by the Company of its
obligations hereunder.
Section 16. Agreement of Right Holders. Every holder of a Right, by accepting the same, consents and
agrees with the Company and the Rights Agent and with every other holder of a Right that:
(a) prior to the Distribution Date, the Rights shall be evidenced by the balances indicated in the
book-entry account system of the transfer agent for the Common Shares registered in the names of the holders
of Common Shares (which Common Shares shall also be deemed to represent certificates for Rights) or, in the
case of certificated shares, the certificates for the Common Shares registered in the names of the holders of the
Common Shares (which certificates for Common Shares also constitute certificates for Rights) and each Right is
transferable only in connection with the transfer of the Common Shares;
D-16
Appendix D
(b) after the Distribution Date, the Right Certificates are transferable only on the registry books of the
Rights Agent if surrendered at the office(s) of the Rights Agent designated for such purpose, duly endorsed or
accompanied by a proper instrument of transfer and with the appropriate forms and certificates properly
completed and duly executed, accompanied by a Signature Guarantee and such other documentation as the
Rights Agent may reasonably request;
(c) the Company and the Rights Agent may deem and treat the person in whose name the Right
Certificate (or, prior to the Distribution Date, the associated balance indicated in the book-entry account system
of the transfer agent for the Common Shares, or in the case of certificated shares, by the associated Common
Shares certificate) is registered as the absolute owner thereof and of the Rights evidenced thereby
(notwithstanding any notations of ownership or writing on the Right Certificate or the associated balance
indicated in the book-entry account system of the transfer agent for the Common Shares. or in the case of
certificated shares, by the associated Common Shares certificate made by anyone other than the Company or
the Rights Agent) for all purposes whatsoever, and neither the Company nor the Rights Agent shall be affected
by any notice to the contrary; and
(d) notwithstanding anything in this Agreement to the contrary, neither the Company nor the Rights
Agent has any liability to any holder of a Right or any other Person (without limiting any of the rights of the
Rights Agent under Section 18) as a result of the inability of the Company or the Rights Agent to perform any of
its or their obligations under this Agreement by reason of any preliminary or permanent injunction or other
order, decree, judgment or ruling (whether interlocutory or final) issued by a court of competent jurisdiction or
by a governmental, regulatory, self-regulatory or administrative agency or commission, or any statute, rule,
regulation or executive order promulgated or enacted by any governmental authority, prohibiting or otherwise
restraining performance of such obligation; provided, however, the Company shall use its commercially
reasonable efforts to have any such injunction, order, decree, judgment or ruling lifted or otherwise overturned
as promptly as practicable.
Section 17. Right Certificate Holder Not Deemed a Shareholder. No holder, as such, of any Right
Certificate shall be entitled to vote, receive dividends or be deemed for any purpose the holder of the Preferred
Shares or any other securities of the Company which may at any time be issuable on the exercise of the Rights
represented thereby, nor shall anything contained herein or in any Right Certificate be construed to confer upon
the holder of any Right Certificate, as such, any of the rights of a shareholder of the Company or any right to
vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to
give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting
shareholders (except as provided in Section 25 hereof), or to receive dividends or subscription rights,
or otherwise, until the Right or Rights evidenced by such Right Certificate shall have been exercised in
accordance with the provisions hereof.
Section 18. Concerning the Rights Agent.
(a) The Company agrees to pay to the Rights Agent reasonable compensation for all services
rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon and from time to time,
on demand of the Rights Agent, to reimburse the Rights Agent for all of its reasonable and documented
expenses and counsel fees and other disbursements incurred in the preparation, negotiation, delivery,
amendment, administration and execution of this Agreement and the exercise and performance of its duties
hereunder. The Company also agrees to indemnify the Rights Agent and its Affiliates, employees, officers,
directors, representatives and advisors for, and to hold it harmless against, any loss, liability, damage, demand,
judgment, fine, penalty, claim, settlement, cost or expense (including the reasonable and documented fees and
expenses of legal counsel) for any action taken, suffered or omitted to be taken by the Rights Agent pursuant to
or arising from this Agreement or in connection with the execution, acceptance, administration, exercise and
performance of its duties under this Agreement, including the reasonable and documented costs and expenses
of defending against any claim of liability arising therefrom, directly or indirectly. The reasonable costs and
expenses incurred in enforcing this right of indemnification shall also be paid by the Company.
(b) The Rights Agent shall be authorized and protected and shall incur no liability for or in respect of
any action taken, suffered or omitted to be taken by it in connection with its acceptance and administration of
this Agreement and the exercise and performance of its duties hereunder in reliance upon any Rights Certificate
or book-entry for Common Shares or other securities of the Company, instrument of assignment or transfer,
power of attorney, endorsement, affidavit, letter, notice, instruction, direction, consent, certificate, statements or
other paper or document believed by it to be genuine and to be executed and shall not be obligated to verify
the accuracy or completeness of such instrument, power of attorney, endorsement, affidavit, letter, notice,
direction, consent, certificate, statements or other paper or document and, where necessary, guaranteed,
verified or acknowledged, by the proper Person or Persons, or upon any written instructions or statements from
the Company with respect to any matter relating to its acting as Rights Agent hereunder without further inquiry
or examination on its part, or otherwise upon the advice or opinion of counsel as set forth in Section 20(a)
hereof. The Rights Agent shall not be deemed to have knowledge of any event of which it was supposed to
receive notice thereof hereunder, and the Rights Agent shall be fully protected and shall incur no liability for
failing to take action in connection therewith unless and until it has received such notice in writing.
(c) Notwithstanding anything in this Agreement to the contrary, in no case shall the Company be liable
with respect to any action, proceeding, suit or claim against the Rights Agent unless the Rights Agent shall have
notified the Company hereof of the assertion of such action, proceeding, suit or claim against the Rights Agent,
promptly after the Rights Agent shall have notice of such assertion of an action, proceeding, suit or claim or
have been served with the summons or other first legal process giving information as to the nature and basis of
the action, proceeding, suit or claim; provided that the failure to provide such notice promptly shall not affect
the rights of the Rights Agent hereunder and shall not relieve the Company of any liability to the Rights Agent,
except to the extent that such failure actually prejudices the Company. The Company shall be entitled to
participate at its own expense in the defense of any such action, proceeding, suit or claim. The Rights Agent
agrees not to settle any litigation in connection with any action, proceeding, suit or claim with respect to which
it may seek indemnification from the Company without the prior written consent of the Company, which shall
not be unreasonably withheld, conditioned or delayed.
(d) The provisions of this Section 18 and Section 20 hereof shall survive the termination or expiration
of this Agreement, the resignation, replacement or removal of the Rights Agent and the exercise, termination or
expiration of the Rights. Notwithstanding anything in this Agreement to the contrary, in no event shall the
Rights Agent be liable for special, punitive, incidental, indirect or consequential loss or damage of any kind
whatsoever (including but not limited to lost profits), even if the Rights Agent has been advised of the likelihood
of such loss or damage and regardless of the form of the action; and the Company agrees to indemnify the
Rights Agent and its affiliates, directors, employees, representatives and advisors and hold them harmless to the
fullest extent permitted by law against any loss, liability or expense incurred as a result of claims for special,
punitive, incidental, indirect or consequential loss or damages of any kind whatsoever. Any liability of the Rights
Agent under this Agreement shall be limited to the amount of annual fees (but not including any reimbursed
costs) paid by the Company to the Rights Agent during the twelve (12) months immediately preceding the
event for which recovery from the Rights Agent is being sought.
Section 19. Merger or Consolidation or Change of Name of Rights Agent.
(a) Any Person into which the Rights Agent or any successor Rights Agent is merged or with which
the Rights Agent or any successor Rights Agent is consolidated, or any Person resulting from any merger or
consolidation to which the Rights Agent or any successor Rights Agent is a party, or any Person succeeding to
the corporate trust, stock transfer or other shareholder services business of the Rights Agent or any successor
Rights Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of
any paper or any further act on the part of any of the parties hereto; but only if such Person would be eligible
for appointment as a successor Rights Agent under the provisions of Section 21 hereof. The purchase of all or
substantially all of the Rights Agent’s assets employed in the performance of transfer agent activities shall be
deemed a merger or consolidation for purposes of this Section 19. In case at the time such successor Rights
Agent shall succeed to the agency created by this Agreement, any of the Rights Certificates have been
countersigned but not delivered, any such successor Rights Agent may adopt the countersignature of a
predecessor Rights Agent and deliver such Rights Certificates so countersigned; and in case at that time any of
the Rights Certificates have not been countersigned, any successor Rights Agent may countersign such Rights
Certificates either in the name of the predecessor or in the name of the successor Rights Agent; and in all such
cases such Rights Certificates shall have the full force provided in the Rights Certificates and in this Agreement.
(b) In case at any time the name of the Rights Agent shall be changed and at such time any of the
Rights Certificates shall have been countersigned but not delivered, the Rights Agent may adopt the
countersignature under its prior name and deliver Rights Certificates so countersigned; and in case at that time
any of the Rights Certificates shall not have been countersigned, the Rights Agent may countersign such Rights
Certificates either in its prior name or in its changed name; and in all such cases such Rights Certificates shall
have the full force provided in the Rights Certificates and in this Agreement.
D-18
Appendix D
Section 20. Duties of Rights Agent. The Rights Agent undertakes the duties and obligations expressly
imposed by this Agreement (and no implied duties or obligations) upon the following terms and conditions,
by all of which the Company and the holders of Right Certificates, by their acceptance thereof, shall be bound:
(a) The Rights Agent may consult with legal counsel (who may be legal counsel for the Company or an
employee of the Rights Agent), and the advice or opinion of such counsel shall be full and complete
authorization and protection to the Rights Agent, and the Rights Agent will have no liability for or in respect of,
any action taken or omitted by it in the absence of bad faith and in accordance with such advice or opinion.
(b) Whenever in the performance of its duties under this Agreement the Rights Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking or
suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein
specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by
any one of the Chief Executive Officer, Chief Financial Officer, the President, General Counsel, any Senior Vice
President, the Treasurer or the Secretary of the Company and delivered to the Rights Agent; and such certificate
shall be full and complete authorization and protection to the Rights Agent for any action taken or suffered or
omitted to be taken by it in the absence of bad faith under the provisions of this Agreement in reliance upon
such certificate. The Rights Agent shall have no duty to act without such a certificate from an officer of the
Company as set forth in the preceding sentence.
(c) The Rights Agent shall be liable hereunder to the Company and any other Person only for its own
gross negligence, bad faith, or willful misconduct (which gross negligence, bad faith or willful misconduct must
be determined by a court of competent jurisdiction in a final non-appealable order, judgment, decree or ruling).
Anything to the contrary notwithstanding, in no event shall the Rights Agent be liable for special, punitive,
indirect, consequential or incidental loss or damage of any kind whatsoever (including but not limited to lost
profits), even if the Rights Agent has been advised of the likelihood of such loss or damage and regardless of
the form of the action; and the Company agrees to indemnify the Rights Agent and its Affiliates, directors,
employees, representatives and advisors and to hold them harmless to the fullest extent permitted by law
against any loss, liability or expense incurred as a result of claims for special, punitive, incidental, indirect or
consequential loss or damage of any kind whatsoever.
(d) The Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals
contained in this Agreement or in the Right Certificates (except its countersignature thereof) or be required to
verify the same, but all such statements and recitals are and shall be deemed to have been made by the
Company only.
(e) The Rights Agent shall not have any liability nor be under any responsibility in respect of the
legality or validity of this Agreement or the execution and delivery hereof (except the due execution hereof by
the Rights Agent) or in respect of the validity or execution of any Right Certificate (except its countersignature
thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in
this Agreement or in any Right Certificate; nor shall it be responsible for any change in the exercisability of the
Rights (including the Rights becoming void pursuant to Section 11(a)(ii) hereof) or any adjustment in the terms
of the Rights (including the manner, method or amount thereof) provided for in Section 3, 11, 23 or 24 hereof,
or the ascertaining of the existence of facts that would require any such change or adjustment (except with
respect to the exercise of Rights evidenced by Right Certificates subject to the terms and conditions hereof
after actual notice that such change or adjustment is required); nor shall it by any act hereunder be deemed to
make any representation or warranty as to the authorization or reservation of any Preferred Shares to be issued
pursuant to this Agreement or any Right Certificate or as to whether any Preferred Shares will, when issued,
be validly authorized and issued, fully paid and nonassessable.
(f) The Rights Agent shall not be liable or responsible for any failure of the Company to comply with
any of its obligations relating to any registration statement filed with the Securities and Exchange Commission
or this Agreement, including obligations under application regulation or law.
(g) The Rights Agent shall not have any duty or responsibility in the case of the receipt of any written
demand from any holder of Rights with respect to any action or default by the Company, including, without
limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any
proceedings at law or otherwise or to make any demand upon the Company.
(h) The Company agrees that it will perform, execute, acknowledge and deliver or cause to be
performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances
as may reasonably be required by the Rights Agent for the carrying out or performing by the Rights Agent of
the provisions of this Agreement.
(i) The Rights Agent is hereby authorized and directed to accept verbal or written instructions with
respect to the performance of its duties hereunder from any person reasonably believed by the Rights Agent to
be one of the Chief Executive Officer, Chief Financial Officer, the President, General Counsel, any Senior Vice
President, the Secretary or the Treasurer of the Company, and to apply to such officers for advice or instructions
in connection with its duties under this Agreement, and such advice or instruction shall be full authorization and
protection to the Rights Agent and the Rights Agent shall have no duty to independently verify the accuracy or
completeness of such advice or such instructions and it shall not be liable for any action taken or suffered by it
in the absence of bad faith in accordance with instructions of any such officer or for any delay in acting while
waiting for those instructions. The Rights Agent will not be held to have notice of any change of authority of any
person until its receipt of written notice thereof from the Company in accordance with this Agreement. Any
application by the Rights Agent for written instructions from the Company may, at the option of the Rights
Agent, set forth in writing any action proposed to be taken, suffered or omitted to be taken by the Rights Agent
under this Agreement and the date on and/or after which such action shall be taken or such omission shall be
effective. The Rights Agent shall be fully authorized and protected in relying upon the most recent verbal or
written instructions received from any such officer, and shall not be liable for any action taken, suffered or
omitted to be taken by the Rights Agent in accordance with a proposal included in any such application on or
after the date specified in such application (which date shall not be less than five (5) Business Days after the
date any officer of the Company actually receives such application unless any such officer shall have consented
in writing to an earlier date) unless, prior to taking any such action (or the effective date in the case of an
omission), the Rights Agent shall have received written instructions in response to such application specifying
the action to be taken, suffered or omitted to be taken.
(j) The Rights Agent and any shareholder, director, officer or employee of the Rights Agent may buy,
sell or deal in any of the Rights or other securities of the Company or become pecuniarily interested in any
transaction in which the Company may be interested, or contract with or lend money to the Company or
otherwise act as fully and freely as though it were not Rights Agent under this Agreement. Nothing herein shall
preclude the Rights Agent from acting in any other capacity for the Company or for any other legal entity.
(k) The Rights Agent may execute and exercise any of the rights or powers hereby vested in it or
perform any duty hereunder either itself (through its directors, officers and/or employees) or by or through its
attorneys or agents, and the Rights Agent shall not be answerable or accountable for any act, omission, default,
neglect or misconduct of any such attorneys or agents or for any loss to the Company, any holder of Rights or
any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence,
bad faith or willful misconduct (which gross negligence, bad faith or willful misconduct must be determined by a
final, non-appealable order, judgment, decree or ruling of a court of competent jurisdiction) in the selection and
continued employment thereof.
(l) No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or
otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any
of its rights or powers if the Rights Agent has reasonable grounds for believing that repayment of such funds or
adequate indemnification against such risk or liability is not reasonably assured to it.
(m) If, with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer,
either (i) the certificate attached to the form of assignment or form of election to purchase, as the case may be,
has either not been properly completed or indicates an affirmative response to clause 1 and/or 2 thereof, or (ii)
any other actual or suspected irregularity exists, the Rights Agent shall not take any further action with respect
to such requested exercise or transfer without first consulting with the Company, and the Rights Agent shall not
be liable for any delays arising from the duties under this Section 20(m).
(n) In the event that the Rights Agent reasonably believes any ambiguity or uncertainty exists
hereunder or in any notice, instruction, direction, request or other communication, paper or document received
by the Rights Agent hereunder, the Rights Agent may (upon notice to the Company of such ambiguity or
uncertainty), in its sole discretion, refrain from taking any action, and will be fully protected and will not be liable
or responsible in any way to the Company or other Person or entity for refraining from taking such action, unless
the Rights Agent receives written instructions signed by the Company which eliminates such ambiguity or
uncertainty to the reasonable satisfaction of the Rights Agent.
D-20
Appendix D
(o) The Rights Agent shall have no responsibility to the Company, any holders of Rights or any holders
of Common Shares for interest or earnings on any moneys held by the Rights Agent pursuant to this Agreement.
(p) The Rights Agent shall not be required to take notice or be deemed to have notice of any event or
condition hereunder, including any event or condition that may require action by the Rights Agent, unless the
Rights Agent shall be specifically notified in writing of such event or condition by the Company, and all notices
or other instruments required by this Agreement to be delivered to the Rights Agent must, in order to be
effective, be received by the Rights Agent, and in the absence of such notice so delivered, the Rights Agent may
conclusively assume no such event or condition exists.
(q) The Rights Agent may rely on and be fully authorized and protected in acting or failing to act upon
(a) any guaranty of signature by an “eligible guarantor institution” that is a member or participant in the
Securities Transfer Agents Medallion Program or other comparable “signature guarantee program” or insurance
program in addition to, or in substitution for, the foregoing; or (b) any law, act or regulation of the same.
Section 21. Change of Rights Agent. The Rights Agent or any successor Rights Agent may resign and
be discharged from its duties under this Agreement upon at least thirty (30) days’ notice in writing to the
Company in accordance with Section 26 hereof, and in the event that the Rights Agent or one of its Affiliates is
not also the transfer agent for the Company, to each transfer agent of the Common Shares or Preferred Shares
in which case the Company will give or cause to be given written notice to the holders of the Right Certificates
by first-class mail. In the event the transfer agency relationship in effect between the Company and the Rights
Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its
duties under this Agreement as of the effective date of such termination, and the Company shall be responsible
for sending any required notice. The Company may remove the Rights Agent or any successor Rights Agent
upon at least thirty (30) days’ notice in writing, mailed to the Rights Agent or successor Rights Agent, as the
case may be, and to each transfer agent of the Common Shares or Preferred Shares by registered or certified
mail, and, if such removal occurs after the Distribution Date, to the holders of the Right Certificates by first-class
mail. If the Rights Agent resigns or is removed or otherwise becomes incapable of acting, the Company shall
appoint a successor to the Rights Agent. If the Company fails to make such appointment within a period of
thirty (30) days after giving notice of such removal or after it has been notified in writing of such resignation or
incapacity by the resigning or incapacitated Rights Agent or by the holder of a Right Certificate (which holder
shall, with such notice, submit such holder’s Right Certificate for inspection by the Company), then the
registered holder of any Right Certificate may apply to any court of competent jurisdiction for the appointment
of a new Rights Agent. Any successor Rights Agent, whether appointed by the Company or by such a court,
shall be (a) a Person organized and doing business under the laws of the United States or of any State, in good
standing, which is authorized under such laws to exercise corporate trust, stock transfer, or shareholder services
powers and is subject to supervision or examination by federal or state authority and which at the time of its
appointment as Rights Agent has, along with its Affiliates, a combined capital and surplus of at least $50 million,
or (b) an Affiliate of a Person described in clause (a) of this sentence. After appointment, the successor Rights
Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named
as Rights Agent under this Agreement without further act or deed; but the predecessor Rights Agent shall
deliver and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute
and deliver any conveyance, act or deed necessary for the purpose (but such predecessor Rights Agent shall
not be required to make any additional expenditure or assume any additional liability in connection with the
foregoing), in each case at the sole expense of the Company. Not later than the effective date of any such
appointment, the Company shall file notice thereof in writing with the predecessor Rights Agent and each
transfer agent of the Common Shares or Preferred Shares, and mail a notice thereof in writing to the registered
holders of the Right Certificates. Failure to give any notice provided for in this Section 21, however, or any
defect therein, shall not affect the legality or validity of the resignation or removal of the Rights Agent or the
appointment of the successor Rights Agent, as the case may be.
Section 22 Issuance of New Right Certificates. Notwithstanding any of the provisions of this
Agreement or of the Rights to the contrary, the Company may, at its option, issue new Right Certificates
evidencing Rights in such form as may be approved by the Board to reflect any adjustment or change made in
accordance with the provisions of this Agreement in the Purchase Price and the number or kind or class of
shares or other securities or property purchasable under the Right Certificates made in accordance with the
provisions of this Agreement. In addition, in connection with the issuance or sale of Common Shares following
the Distribution Date (other than upon exercise of a Right) and prior to the earlier of the Redemption Date, Early
Expiration Date or Final Expiration Date, the Company (a) shall, with respect to Common Shares so issued or
sold pursuant to the exercise of stock options or under any employee plan or arrangement, or upon the exercise,
conversion or exchange of securities hereinafter issued by the Company, and (b) may, in any other case, if
deemed necessary or appropriate by the Board, issue Rights Certificates representing the appropriate number
of Rights in connection with such issuance or sale; provided, however, that (i) no such Rights Certificate may be
issued if, and to the extent that, the Company, in its sole discretion, determines that such issuance would
jeopardize or endanger the value or availability to the Company of the NOLs or otherwise create a significant
risk of material adverse tax consequences to the Company or the Person to whom such Rights Certificate would
be issued, and (ii) no such Rights Certificate may be issued if, and to the extent that, appropriate adjustment
shall otherwise have been made in lieu of the issuance thereof.
Section 23 Redemption.
(a) The Board may, at its option, at any time prior to the Distribution Date, redeem all but not less than
all of the then outstanding Rights at a redemption price of $0.0001 per Right, appropriately adjusted to reflect
any stock dividend, subdivision, combination or consolidation of the Common Shares (by reclassification or
otherwise) or similar transaction occurring after the date hereof (such redemption price being hereinafter
referred to as the “Redemption Price”). The redemption of the Rights by the Board may be made effective at
such time, on such basis and with such conditions as the Board, in its sole discretion, may establish.
(b) Immediately upon the action of the Board ordering the redemption of the Rights pursuant to
paragraph (a) of this Section 23, and without any further action and without any notice, the right to exercise the
Rights will terminate and the only right thereafter of the holders of Rights shall be to receive the Redemption
Price. The Company shall promptly give (i) written notice to the Rights Agent of any such redemption (and until
such written notice is received by the Rights Agent, the Rights Agent may presume conclusively that no such
redemptions have occurred); and (ii) public notice of any such redemption; provided, however, that the failure
to give, or any defect in, any such notice shall not affect the validity of such redemption. Within ten (10) days
after such action of the Board ordering the redemption of the Rights, the Company shall mail a notice of
redemption to all the holders of the then outstanding Rights at their last addresses as they appear upon the
registry books of the Rights Agent or, prior to the Distribution Date, on the registry books of the transfer agent
for the Common Shares. Any notice which is mailed in the manner herein provided shall be deemed given,
whether or not the holder receives the notice. Each such notice of redemption will state the method by which
the payment of the Redemption Price will be made. Neither the Company nor any of its Affiliates or Associates
may redeem, acquire or purchase for value any Rights at any time in any manner other than that specifically set
forth in this Section 23 or in Section 24 hereof, and other than in connection with the purchase of Common
Shares prior to the Distribution Date.
Section 24. Exchange.
(a) The Board may, at its option, at any time after any Person becomes an Acquiring Person, exchange
all or part of the then outstanding and exercisable Rights (which shall not include Rights that have become void
pursuant to the provisions of Section 11(a)(ii) hereof) for Common Shares at an exchange ratio of one Common
Share per Right, appropriately adjusted to reflect any adjustment in the number of Rights pursuant to Section
11(a)(i) (such exchange ratio being hereinafter referred to as the “Exchange Ratio”).
(b) Immediately upon the action of the Board ordering the exchange of any Rights pursuant to
paragraph (a) of this Section 24 and without any further action and without any notice, the right to exercise
such Rights shall terminate and the only right thereafter of a holder of such Rights shall be to receive that
number of Common Shares equal to the number of such Rights held by such holder multiplied by the Exchange
Ratio. The Company shall promptly give (i) written notice to the Rights Agent of any such exchange, and
(ii) public notice of any such exchange; provided, however, that the failure to give, or any defect in, such notice
shall not affect the validity of such exchange (and until such written notice is received by the Rights Agent, the
Rights Agent may presume conclusively that no such exchange has occurred). The Company shall promptly mail
a notice of any such exchange to all of the holders of such Rights at their last addresses as they appear upon the
D-22
Appendix D
registry books of the Rights Agent. Any notice which is mailed in the manner herein provided shall be deemed
given, whether or not the holder receives the notice. Each such notice of exchange will state the method by
which the exchange of the Common Shares for Rights will be effected, and, in the event of any partial exchange,
the number of Rights which will be exchanged. Any partial exchange shall be effected pro rata based on the
number of Rights (other than Rights which have become void pursuant to the provisions of Section 11(a)(ii)
hereof) held by each holder of Rights.
(c) In the event that there shall not be sufficient Common Shares issued but not outstanding or
authorized but unissued to permit any exchange of Rights as contemplated in accordance with this Section 24,
the Company shall take all such action as may be necessary to authorize additional Common Shares for issuance
upon exchange of the Rights. In the event the Company shall, after good faith effort, be unable to take all such
action as may be necessary to authorize such additional Common Shares, the Company shall substitute, for each
Common Share that would otherwise be issuable upon exchange of a Right, a number of one ten-thousandths of
a Preferred Share that would have been purchasable assuming exercise of a Right immediately before the
Shares Acquisition Date.
(d) The Company shall not be required to issue fractions of Common Shares or to distribute
certificates which evidence fractional Common Shares. In lieu of such fractional Common Shares, the Company
shall pay to the registered holders of the Right Certificates with regard to which such fractional Common Shares
would otherwise be issuable an amount in cash equal to the same fraction of the current market value of a
whole Common Share. For the purposes of this paragraph (d), the current market value of a whole Common
Share shall be the closing price of a Common Share (as determined pursuant to the second sentence of Section
11(d)(i) hereof) for the Trading Day immediately prior to the date of exchange pursuant to this Section 24.
Section 25. Notice of Certain Events.
(a) In case the Company shall, at any time after the Distribution Date, propose (i) to pay any dividend
payable in stock of any class to the holders of the Preferred Shares or to make any other distribution to the
holders of the Preferred Shares (other than a regular quarterly cash dividend), (ii) to offer to the holders of the
Preferred Shares rights or warrants to subscribe for or to purchase any additional Preferred Shares or shares of
stock of any class or any other securities, rights or options, (iii) to effect any reclassification of the Preferred
Shares (other than a reclassification involving only the subdivision of outstanding Preferred Shares), (iv) to
effect any consolidation or merger into or with, or to effect any sale or other transfer (or to permit one or more
of its Subsidiaries to effect any sale or other transfer), in one or more transactions, of 50% or more of the assets
or earning power of the Company and its Subsidiaries (taken as a whole) to, any other Person, (v) to effect the
liquidation, dissolution or winding up of the Company, or (vi) to declare or pay any dividend on the Common
Shares payable in Common Shares or to effect a subdivision, combination or consolidation of the Common
Shares (by reclassification or otherwise), then, in each such case, the Company shall give to each holder of a
Right Certificate, in accordance with Section 26 hereof, a notice of such proposed action, which shall specify the
record date for the purposes of such stock dividend, or distribution of rights or warrants, or the date on which
such subdivision, combination or consolidation (by way of reclassification or otherwise), merger, sale, transfer,
liquidation, dissolution, or winding up is to take place and the date of participation therein by the holders of the
Common Shares and/or Preferred Shares, if any such date is to be fixed, and such notice shall be so given in the
case of any action covered by clause (i) or (ii) above at least ten (10) days prior to the record date for
determining holders of the Preferred Shares for purposes of such action, and, in the case of any such other
action, at least ten (10) days prior to the date of the taking of such proposed action or the date of participation
therein by the holders of the Common Shares and/or Preferred Shares, whichever shall be the earlier.
(b) In case the event set forth in Section 11(a)(ii) hereof shall occur, then the Company shall, as soon as
practicable thereafter, give to each holder of a Right Certificate, in accordance with Section 26 hereof, a notice
of the occurrence of such event, which notice shall describe such event and the consequences of such event to
holders of Rights under Section 11(a)(ii) hereof.
Section 26. Notices. Notices or demands authorized by this Agreement to be given or made by the
Rights Agent or by the holder of any Right Certificate to or on the Company shall be sufficiently given or made
if by electronic transmission or sent by first-class or express United States mail, or recognized overnight
delivery, postage prepaid, addressed (until another address is filed in writing with the Rights Agent) as follows:
Lumen Technologies, Inc.
100 CenturyLink Drive
Monroe, LA 71203
Attention: Company Secretary
Email: stacey.goff@lumen.com
Subject to the provisions of Section 21 hereof, any notice or demand authorized by this Agreement to be given
or made by the Company or by the holder of any Right Certificate to or on the Rights Agent shall be sufficiently
given or made if in writing by or sent by first-class mail or express United States mail, or recognized overnight
delivery, postage prepaid, addressed (until another address is filed in writing with the Company) or by facsimile
transmission (with receipt confirmation) as follows:
Computershare Trust Company, N.A.
150 Royall Street
Canton, MA 02021
Attention: Client Services
Facsimile: (781) 575-4210
Notices or demands authorized by this Agreement to be given or made by the Company or the Rights Agent to
the holder of any Right Certificate shall be sufficiently given or made if sent by first-class mail, postage prepaid,
addressed to such holder at the address of such holder as shown on the registry books of the Rights Agent (or
the Company’s transfer agent prior to the Distribution Date); provided that prior to the Distribution Date a filing
by the Company with the Securities and Exchange Commission shall constitute sufficient notice to the holders
of securities of the Company, including the Rights, for purposes of this Agreement and no other notice need
be given.
Section 27. Supplements and Amendments. The Company may from time to time supplement or
amend this Agreement without the approval of any holders of Right Certificates in order to cure any ambiguity,
to correct or supplement any provision contained herein which may be defective or inconsistent with any other
provisions herein, to shorten or lengthen any time period hereunder, or to amend or make any other provisions
with respect to the Rights which the Company may deem necessary or desirable, any such supplement or
amendment to be evidenced by a writing signed by the Company and the Rights Agent; provided, however,
that, from and after the Distribution Date, this Agreement shall not be amended in any manner which would
adversely affect the interests of the holders of Rights (other than an Acquiring Person or an Affiliate or
Associate of an Acquiring Person). Upon the delivery of a certificate from any appropriate officer of the
Company authorized to executed Right Certificates (or specified in Section 5 hereof) that states that the
proposed supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent shall
execute such supplement or amendment; provided, however, that the Rights Agent may, but shall not be
obligated to, enter into any supplement or amendment that affects the Rights Agent’s own rights, duties,
obligations or immunities under this Agreement. No supplement or amendment to this Agreement shall be
effective unless duly executed by the Rights Agent and the Company.
Section 28. Successors. All the covenants and provisions of this Agreement by or for the benefit of
the Company or the Rights Agent shall bind and inure to the benefit of their respective successors and
assigns hereunder.
Section 29. Benefits of this Agreement. Nothing in this Agreement shall be construed to give to any
Person other than the Company, the Rights Agent and the registered holders of the Right Certificates (and,
prior to the Distribution Date, the Common Shares) any legal or equitable right, remedy or claim under
this Agreement.
D-24
Appendix D
Section 30. Severability. If any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction or other authority to be invalid, null and void or unenforceable, the remainder of
the terms, provisions, covenants and restrictions of this Agreement will remain in full force and effect and will in
no way be affected, impaired or invalidated; provided, however, that notwithstanding anything in this
Agreement to the contrary, if any such term, provision, covenant or restriction is held by such court or authority
to be invalid, null and void or unenforceable and the Board determines in good faith judgment that severing the
invalid language from this Agreement would adversely affect the purpose or effect of this Agreement, the right
of redemption set forth in Section 23 hereof shall be reinstated and will not expire until the Close of Business on
the tenth (10th) Business Day following the date of such determination by the Board; provided, further, that if
any such severed term, provision, covenant or restriction shall adversely affect the rights, immunities, duties or
obligations of the Rights Agent, then the Rights Agent shall be entitled to resign immediately.
Section 31. Governing Law. This Agreement, each Right, and each Right Certificate issued hereunder
shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be
governed by and construed in accordance with the laws of such state applicable to contracts to be made and
performed entirely within such state, except that the rights, duties and obligations of the Rights Agent shall be
governed by and construed in accordance with the laws of the State of New York applicable to contracts to be
made and performed entirely within such state.
Section 32. Counterparts. This Agreement may be executed in one or more counterparts and each of
such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together
constitute but one and the same instrument. Delivery of an executed signature page of this Agreement by
facsimile or any other customary means of electronic transmission (e.g., PDF) shall be effective as delivery of a
manually executed counterpart hereof.
Section 33. Descriptive Headings; Interpretation. Descriptive headings of the several Sections of this
Agreement are inserted for convenience only and shall not control or affect in any way the meaning or
construction of any of the provisions hereof. The words “include,” “includes” and “including” shall be deemed to
be followed by the phrase “without limitation.” Each reference in this Agreement to a period of time following or
after a specified date or event shall be calculated without including such specified date or the day on which
such specified event occurs.
Section 34. Determinations and Actions by the Board. For all purposes of this Agreement, any
calculation of the number of Common Shares outstanding at any particular time, including for purposes of
determining the particular percentage of such outstanding Common Shares of which any Person is the
Beneficial Owner, will be made in accordance with, as the Board deems to be applicable, the last sentence of
Rule 13d-3(d)(1)(i) of the General Rules and Regulations under the Exchange Act or the provisions of
Section 382. The Board will have the exclusive power and authority to administer this Agreement and to
exercise all rights and powers specifically granted to the Board or to the Company, or as may be necessary or
advisable in the administration of this Agreement, including without limitation the right and power to (i)
interpret the provisions of this Agreement (including without limitation Section 23, Section 24, Section 27, this
Section 34, Section 35 and other provisions hereof relating to its powers or authority hereunder) and (ii) make
all determinations deemed necessary or advisable for the administration of this Agreement (including without
limitation any determination contemplated by Section 1(b) and 1(o) or any determination as to whether
particular Rights shall have become void). All such actions, calculations, interpretations and determinations
(including, for purposes of clause (y) below, any omission with respect to any of the foregoing) which are done
or made by the Board in good faith will (x) be final, conclusive and binding on the Company, the Rights Agent,
the holders of the Rights and all other parties and (y) not subject any member of the Board to any liability to
any Person, including without limitation the Rights Agent and the holders of the Rights.
Section 35. Process to Seek Exemption. Any Person who desires to effect any acquisition of Common
Shares that would, if consummated, result in such Person (together with its Affiliates and Associates)
beneficially own 4.9% or more of the then outstanding Common Shares (or, in the case of a Person excluded
from the definition of “Acquiring Person” in clause (i) of such definition, such applicable percentage) (a
“Requesting Person”) may, prior to the Shares Acquisition Date, and in accordance with this Section 35,
request that the Board grants an exemption with respect to such acquisition under this Agreement (an
“Exemption Request”). An Exemption Request shall be in proper form and shall be delivered by registered mail,
return receipt requested, to the Secretary of the Company at the principal executive office of the Company. To
be in proper form, an Exemption Request shall set forth (a) the name and address of the Requesting Person,
(b) the number and percentage of Common Shares then Beneficially Owned by the Requesting Person, together
with all Affiliates and Associates of the Requesting Person, (c) a reasonably detailed description of the
transaction or transactions by which the Requesting Person would propose to acquire Beneficial Ownership of
Common Shares aggregating 4.9% or more of the then outstanding Common Shares (or, in the case of a person
excluded from the definition of “Acquiring Person” in clause (i) of such definition, such applicable percentage)
and the maximum number and percentage of Common Shares that the Requesting Person proposes to acquire
and (d) a reasonably detailed statement of the benefits such Requesting Person expects to be received by the
Company and the other shareholders of the Company were the exemption to be granted. The Board shall make
a determination whether to grant an exemption in response to an Exemption Request as promptly as
practicable (and, in any event, within ten (10) Business Days) after receipt thereof; provided, that the failure of
the Board to make a determination within such period shall be deemed to constitute the denial by the Board of
the Exemption Request. The Board may deny an Exemption Request if the Board determines, in its sole
discretion, that the acquisition of Beneficial Ownership of Common Shares by the Requesting Person could
jeopardize or endanger the availability to the Company of the NOLs or for whatever other reason the Board
deems reasonable, desirable or appropriate. Any exemption granted hereunder may be granted in whole or in
part, and may be subject to limitations or conditions (including a requirement that the Requesting Person agree
that it will not acquire Beneficial Ownership of Common Shares in excess of the maximum number and
percentage of shares approved by the Board or that it will not make another Exemption Request), in each case
as and to the extent the Board shall determine necessary, desirable or appropriate.
Section 36. Tax Compliance and Withholding. The Company hereby authorizes the Rights Agent to
deduct from all payments disbursed by the Rights Agent to the holders of the Rights, if applicable, the tax
required to be withheld pursuant to Sections 1441, 1442, 1445, 1471 through 1474, and 3406 of the Internal
Revenue Code of 1986, as amended, or by any federal or state statutes subsequently enacted, and to make the
necessary returns and payments of such tax to the relevant taxing authority. The Company will provide
withholding and reporting instructions to the Rights Agent from time to time as relevant, and upon request of
the Rights Agent. The Rights Agent shall have no duties with respect to tax withholding, reporting, or payment
except as specifically instructed by the Company to be performed in accordance with applicable law.
Section 37. Force Majeure. Notwithstanding anything to the contrary contained herein, the Rights
Agent will not have any liability for not performing, or a delay in the performance of, any act, duty, obligation or
responsibility by reason of any occurrence beyond the reasonable control of the Rights Agent (including,
without limitation, any act or provision of any present or future law or regulation or governmental authority,
any act of God, epidemics, pandemics, war, civil or military disobedience or disorder, riot, rebellion, terrorism,
insurrection, fire, earthquake, storm, flood, strike, work stoppage, interruptions or malfunctions of computer
facilities, loss of data due to power failures or mechanical difficulties with information, labor dispute, accident
or failure or malfunction of any utilities, communication or computer (software or hardware) services or
similar occurrence).
Section 38. [Reserved].
[Remainder of this page intentionally left blank.]
D-26
Appendix D
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
attested, all as of the day and year first above written.
[Signature Page to Second Amended and Restated Section 382 Rights Agreement]
E-1
Corporate Headquarters
100 CenturyLink Drive
Monroe, Louisiana 71203
General Information: 318-388-9000
Transfer Agent
For address changes, stock transfers, name changes, registration changes, lost stock certificates and stock
holdings, please contact:
Computershare Investor Services L.L.C.
Post Office Box 505000
Louisville, Kentucky 40233
1-800-969-6718
www.computershare.com/lumen
Auditors
KPMG LLP
1225 17th Street, Suite 800
Denver, Colorado 80202
Investor Relations
Inquiries by securities analysts, investment professionals and shareholders about Lumen Technologies, Inc.
common stock, including requests for any SEC or other shareholder reports should be directed to:
investor.relations@lumen.com
ir.lumen.com
Annual Report
After the close of each fiscal year, Lumen Technologies, Inc. submits an Annual Report on Form 10-K to the SEC
containing certain additional information about its business. A copy of the 10-K report may be obtained without
charge by addressing your request to Stacey W. Goff, Secretary, Lumen Technologies, Inc., 100 CenturyLink
Drive, Monroe, Louisiana 71203, or by visiting our website at www.lumen.com.
Common Stock
Lumen common stock is traded on the New York Stock Exchange under the symbol LUMN.
As of the Record Date, we had 1,016,005,958 shares of common stock and 7,018 shares of Series L preferred
stock issued and outstanding. There were 77,671 shareholders of record.
Lumen, Lumen Technologies, Inc. and the Lumen logos are either registered service marks or service marks of
Lumen Technologies, Inc. and/or one of its affiliates in the United States and/or other countries. Any other
service names, product names, company names or logos included herein are the trademarks or service marks of
their respective owners.
Communications to the Board
Communication with shareholders and other interested parties is an important part of the governance process.
Any shareholder or other stakeholder who wishes to contact the Board, Chairman or any Director can send
correspondence to:
Write: P.O. Box 5061; Monroe, Louisiana 71211
Email: boardinquiries@lumen.com